
<html lang="en"     class="pb-page"  data-request-id="cb65c6bf-da2d-4fcf-acea-613052a38ca1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c01727;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-1;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Antitubercular 2-Pyrazolylpyrimidinones: Structure–Activity Relationship and Mode-of-Action Studies" /></meta><meta name="dc.Creator" content="Candice  Soares de Melo" /></meta><meta name="dc.Creator" content="Vinayak  Singh" /></meta><meta name="dc.Creator" content="Alissa  Myrick" /></meta><meta name="dc.Creator" content="Sandile B.  Simelane" /></meta><meta name="dc.Creator" content="Dale  Taylor" /></meta><meta name="dc.Creator" content="Christel  Brunschwig" /></meta><meta name="dc.Creator" content="Nina  Lawrence" /></meta><meta name="dc.Creator" content="Dirk  Schnappinger" /></meta><meta name="dc.Creator" content="Curtis A.  Engelhart" /></meta><meta name="dc.Creator" content="Anuradha  Kumar" /></meta><meta name="dc.Creator" content="Tanya  Parish" /></meta><meta name="dc.Creator" content="Qin  Su" /></meta><meta name="dc.Creator" content="Timothy G.  Myers" /></meta><meta name="dc.Creator" content="Helena I. M.  Boshoff" /></meta><meta name="dc.Creator" content="Clifton E.  Barry, III" /></meta><meta name="dc.Creator" content="Frederick A.  Sirgel" /></meta><meta name="dc.Creator" content="Paul D.  van Helden" /></meta><meta name="dc.Creator" content="Kirsteen I.  Buchanan" /></meta><meta name="dc.Creator" content="Tracy  Bayliss" /></meta><meta name="dc.Creator" content="Simon R.  Green" /></meta><meta name="dc.Creator" content="Peter C.  Ray" /></meta><meta name="dc.Creator" content="Paul G.  Wyatt" /></meta><meta name="dc.Creator" content="Gregory S.  Basarab" /></meta><meta name="dc.Creator" content="Charles J.  Eyermann" /></meta><meta name="dc.Creator" content="Kelly  Chibale" /></meta><meta name="dc.Creator" content="Sandeep R.  Ghorpade" /></meta><meta name="dc.Description" content="Phenotypic screening of a Medicines for Malaria Venture compound library against Mycobacterium tuberculosis (Mtb) identified a cluster of pan-active 2-pyrazolylpyrimidinones. The biology triage of ..." /></meta><meta name="Description" content="Phenotypic screening of a Medicines for Malaria Venture compound library against Mycobacterium tuberculosis (Mtb) identified a cluster of pan-active 2-pyrazolylpyrimidinones. The biology triage of ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 4, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01727" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 The Authors. Published by American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01727" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01727" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01727" /></link>
        
    
    

<title>Antitubercular 2-Pyrazolylpyrimidinones: Structure–Activity Relationship and Mode-of-Action Studies | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01727" /></meta><meta property="og:title" content="Antitubercular 2-Pyrazolylpyrimidinones: Structure–Activity Relationship and Mode-of-Action Studies" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0022.jpeg" /></meta><meta property="og:description" content="Phenotypic screening of a Medicines for Malaria Venture compound library against Mycobacterium tuberculosis (Mtb) identified a cluster of pan-active 2-pyrazolylpyrimidinones. The biology triage of these actives using various tool strains of Mtb suggested a novel mechanism of action. The compounds were bactericidal against replicating Mtb and retained potency against clinical isolates of Mtb. Although selected MmpL3 mutant strains of Mtb showed resistance to these compounds, there was no shift in the minimum inhibitory concentration (MIC) against a mmpL3 hypomorph, suggesting mutations in MmpL3 as a possible resistance mechanism for the compounds but not necessarily as the target. RNA transcriptional profiling and the checkerboard board 2D-MIC assay in the presence of varying concentrations of ferrous salt indicated perturbation of the Fe-homeostasis by the compounds. Structure–activity relationship studies identified potent compounds with good physicochemical properties and in vitro microsomal metabolic stability with moderate selectivity over cytotoxicity against mammalian cell lines." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01727"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01727">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01727&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01727&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01727&amp;href=/doi/10.1021/acs.jmedchem.0c01727" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 719-740</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01711" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01735" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Antitubercular 2-Pyrazolylpyrimidinones: Structure–Activity Relationship and Mode-of-Action Studies</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Candice Soares de Melo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Candice Soares de Melo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Candice++Soares+de+Melo">Candice Soares de Melo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vinayak Singh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vinayak Singh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa</div><div class="loa-info-affiliations-info">South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch 7701, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vinayak++Singh">Vinayak Singh</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9002-2489" title="Orcid link">http://orcid.org/0000-0001-9002-2489</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alissa Myrick</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alissa Myrick</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alissa++Myrick">Alissa Myrick</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sandile B. Simelane</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sandile B. Simelane</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sandile+B.++Simelane">Sandile B. Simelane</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dale Taylor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dale Taylor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Centre (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory 7925, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dale++Taylor">Dale Taylor</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christel Brunschwig</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christel Brunschwig</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Centre (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory 7925, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christel++Brunschwig">Christel Brunschwig</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nina Lawrence</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nina Lawrence</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Centre (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory 7925, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nina++Lawrence">Nina Lawrence</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dirk Schnappinger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dirk Schnappinger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York 10065, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dirk++Schnappinger">Dirk Schnappinger</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Curtis A. Engelhart</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Curtis A. Engelhart</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York 10065, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Curtis+A.++Engelhart">Curtis A. Engelhart</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anuradha Kumar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anuradha Kumar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Infectious Disease Research Institute, 1616 Eastlake Ave E, Suite 400, Seattle, Washington 98102, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anuradha++Kumar">Anuradha Kumar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tanya Parish</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tanya Parish</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Infectious Disease Research Institute, 1616 Eastlake Ave E, Suite 400, Seattle, Washington 98102, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tanya++Parish">Tanya Parish</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7507-0423" title="Orcid link">http://orcid.org/0000-0001-7507-0423</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qin Su</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qin Su</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genomic Technologies Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qin++Su">Qin Su</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Timothy G. Myers</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Timothy G. Myers</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genomic Technologies Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+G.++Myers">Timothy G. Myers</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Helena I. M. Boshoff</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Helena I. M. Boshoff</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Helena+I.+M.++Boshoff">Helena I. M. Boshoff</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4333-206X" title="Orcid link">http://orcid.org/0000-0002-4333-206X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Clifton E. Barry III</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Clifton E. Barry, III</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Clifton+E.++Barry%2C++III">Clifton E. Barry, III</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Frederick A. Sirgel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frederick A. Sirgel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">South African Medical Research Council Centre for Tuberculosis Research/DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Science, Stellenbosch University, Tygerberg 7505, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Frederick+A.++Sirgel">Frederick A. Sirgel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paul D. van Helden</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul D. van Helden</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">South African Medical Research Council Centre for Tuberculosis Research/DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Science, Stellenbosch University, Tygerberg 7505, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul+D.++van+Helden">Paul D. van Helden</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kirsteen I. Buchanan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kirsteen I. Buchanan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kirsteen+I.++Buchanan">Kirsteen I. Buchanan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tracy Bayliss</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tracy Bayliss</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tracy++Bayliss">Tracy Bayliss</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Simon R. Green</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Simon R. Green</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Simon+R.++Green">Simon R. Green</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5054-4792" title="Orcid link">http://orcid.org/0000-0001-5054-4792</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter C. Ray</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter C. Ray</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter+C.++Ray">Peter C. Ray</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paul G. Wyatt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul G. Wyatt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul+G.++Wyatt">Paul G. Wyatt</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0397-245X" title="Orcid link">http://orcid.org/0000-0002-0397-245X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gregory S. Basarab</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gregory S. Basarab</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa</div><div class="loa-info-affiliations-info">Drug Discovery and Development Centre (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory 7925, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+S.++Basarab">Gregory S. Basarab</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5684-6046" title="Orcid link">http://orcid.org/0000-0001-5684-6046</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Charles J. Eyermann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Charles J. Eyermann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Charles+J.++Eyermann">Charles J. Eyermann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kelly Chibale</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kelly Chibale</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa</div><div class="loa-info-affiliations-info">South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch 7701, South Africa</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#78131d141401561b10111a19141d380d1b0c56191b560219"><span class="__cf_email__" data-cfemail="b0dbd5dcdcc99ed3d8d9d2d1dcd5f0c5d3c49ed1d39ecad1">[email protected]</span></a>. Phone: +27 21 650 2553.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kelly++Chibale">Kelly Chibale</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1327-4727" title="Orcid link">http://orcid.org/0000-0002-1327-4727</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Sandeep R. Ghorpade</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sandeep R. Ghorpade</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#dc8fbdb2b8b9b9acf2bbb4b3aeacbdb8b99ca9bfa8f2bdbff2a6bd"><span class="__cf_email__" data-cfemail="92c1f3fcf6f7f7e2bcf5fafde0e2f3f6f7d2e7f1e6bcf3f1bce8f3">[email protected]</span></a>. Phone: +27 21 650 1250.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sandeep+R.++Ghorpade">Sandeep R. Ghorpade</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9311-1572" title="Orcid link">http://orcid.org/0000-0002-9311-1572</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01727&amp;href=/doi/10.1021%2Facs.jmedchem.0c01727" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 719–740</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 4, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 October 2020</li><li><span class="item_label"><b>Published</b> online</span>4 January 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01727" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01727</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 The Authors. Published by American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01727"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2030</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01727" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Antitubercular 2-Pyrazolylpyrimidinones: Structure–Activity Relationship and Mode-of-Action Studies&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Candice&quot;,&quot;last_name&quot;:&quot;Soares de Melo&quot;},{&quot;first_name&quot;:&quot;Vinayak&quot;,&quot;last_name&quot;:&quot;Singh&quot;},{&quot;first_name&quot;:&quot;Alissa&quot;,&quot;last_name&quot;:&quot;Myrick&quot;},{&quot;first_name&quot;:&quot;Sandile&quot;,&quot;last_name&quot;:&quot;B. Simelane&quot;},{&quot;first_name&quot;:&quot;Dale&quot;,&quot;last_name&quot;:&quot;Taylor&quot;},{&quot;first_name&quot;:&quot;Christel&quot;,&quot;last_name&quot;:&quot;Brunschwig&quot;},{&quot;first_name&quot;:&quot;Nina&quot;,&quot;last_name&quot;:&quot;Lawrence&quot;},{&quot;first_name&quot;:&quot;Dirk&quot;,&quot;last_name&quot;:&quot;Schnappinger&quot;},{&quot;first_name&quot;:&quot;Curtis&quot;,&quot;last_name&quot;:&quot;A. Engelhart&quot;},{&quot;first_name&quot;:&quot;Anuradha&quot;,&quot;last_name&quot;:&quot;Kumar&quot;},{&quot;first_name&quot;:&quot;Tanya&quot;,&quot;last_name&quot;:&quot;Parish&quot;},{&quot;first_name&quot;:&quot;Qin&quot;,&quot;last_name&quot;:&quot;Su&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;G. Myers&quot;},{&quot;first_name&quot;:&quot;Helena&quot;,&quot;last_name&quot;:&quot;I. M. Boshoff&quot;},{&quot;first_name&quot;:&quot;Clifton&quot;,&quot;last_name&quot;:&quot;E. Barry&quot;},{&quot;first_name&quot;:&quot;Frederick&quot;,&quot;last_name&quot;:&quot;A. Sirgel&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;D. van Helden&quot;},{&quot;first_name&quot;:&quot;Kirsteen&quot;,&quot;last_name&quot;:&quot;I. Buchanan&quot;},{&quot;first_name&quot;:&quot;Tracy&quot;,&quot;last_name&quot;:&quot;Bayliss&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;R. Green&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;C. Ray&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;G. Wyatt&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;S. Basarab&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;J. Eyermann&quot;},{&quot;first_name&quot;:&quot;Kelly&quot;,&quot;last_name&quot;:&quot;Chibale&quot;},{&quot;first_name&quot;:&quot;Sandeep&quot;,&quot;last_name&quot;:&quot;R. Ghorpade&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;719-740&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01727&quot;},&quot;abstract&quot;:&quot;Phenotypic screening of a Medicines for Malaria Venture compound library against Mycobacterium tuberculosis (Mtb) identified a cluster of pan-active 2-pyrazolylpyrimidinones. The biology triage of these actives using various tool strains of Mtb suggested a novel mechanism of action. The compounds were bactericidal against replicating Mtb and retained potency against clinical isolates of Mtb. Although selected MmpL3 mutant strains of Mtb showed resistance to these compounds, there was no shift in the minimum inhibitory concentration (MIC) against a mmpL3 hypomorph, suggesting mutations in MmpL3 as a possible resistance mechanism for the compounds but not necessarily as the target. RNA transcriptional profiling and the checkerboard board 2D-MIC assay in the presence of varying concentrations of ferrous salt indicated perturbation of the Fe-homeostasis by the compounds. Structure–activity relationship studies identified potent compounds with good physicochemical properties and in vitro microsomal metabolic stabi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01727&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01727" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01727&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01727" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01727&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01727" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01727&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01727&amp;href=/doi/10.1021/acs.jmedchem.0c01727" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01727" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01727" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01727%26sid%3Dliteratum%253Aachs%26pmid%3D33395287%26genre%3Darticle%26aulast%3DSoares%2Bde%2BMelo%26date%3D2021%26atitle%3DAntitubercular%2B2-Pyrazolylpyrimidinones%253A%2BStructure%25E2%2580%2593Activity%2BRelationship%2Band%2BMode-of-Action%2BStudies%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D1%26spage%3D719%26epage%3D740%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292365" title="Electromagnetic radiation">Electromagnetic radiation</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=292553" title="Ethanol">Ethanol</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/jmcmar.2021.64.issue-1/20210114/jmcmar.2021.64.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Phenotypic screening of a Medicines for Malaria Venture compound library against <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>) identified a cluster of pan-active 2-pyrazolylpyrimidinones. The biology triage of these actives using various tool strains of <i>Mtb</i> suggested a novel mechanism of action. The compounds were bactericidal against replicating <i>Mtb</i> and retained potency against clinical isolates of <i>Mtb</i>. Although selected MmpL3 mutant strains of <i>Mtb</i> showed resistance to these compounds, there was no shift in the minimum inhibitory concentration (MIC) against a mmpL3 hypomorph, suggesting mutations in MmpL3 as a possible resistance mechanism for the compounds but not necessarily as the target. RNA transcriptional profiling and the checkerboard board 2D-MIC assay in the presence of varying concentrations of ferrous salt indicated perturbation of the Fe-homeostasis by the compounds. Structure–activity relationship studies identified potent compounds with good physicochemical properties and <i>in vitro</i> microsomal metabolic stability with moderate selectivity over cytotoxicity against mammalian cell lines.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08308" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08308" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tuberculosis (TB) caused by <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>) continues to be one of the leading causes of death and morbidity globally, claiming 1.2 million lives in 2018.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The emergence and spread of multi drug-resistant (MDR) and extensively drug-resistant (XDR) strains of <i>Mtb</i> that are resistant to the first- and second-line drugs have further exacerbated the situation.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The rise in anti-microbial resistance warrants the search for new drugs with unique modes of action that can bypass existing modes of resistance or can be used as adjunctive therapy to compensate for those that are vulnerable to promoting resistance. While considerable progress has been made toward establishing a TB drug pipeline, the high attrition rate in clinical development reinforces the need to continually replenish the pipeline with high-quality leads that act through the inhibition of novel targets.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">In light of the above, we have been engaged in early TB drug discovery to identify and progress new chemical series with potentially novel modes of action lacking cross-resistance with existing drugs.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> One approach to identify compounds with a novel mode of action is to phenotypically screen compound libraries against <i>Mtb</i> growing under different media conditions with different carbon sources followed by a biology triage process to weed out actives hitting frequently encountered targets such as the respiratory system (e.g., QcrB) and cell–wall synthesis (e.g., MmpL3 and DprE1), as well as DNA damaging agents. Herein, we describe structure–activity relationship (SAR) and target identification studies of one novel chemical series, 2-pyrazolylpyrimidinones—represented in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. This series was identified through high-throughput screening of a Medicines for Malaria Venture (MMV) compound library.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Generic structure of pyrazolylpyrimidones.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78801" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78801" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Phenotypic Hits with a Novel Mode of Action</h3><div class="NLM_p">A high-throughput screen of a ∼530,000 diverse set of compounds from MMV compound library against <i>Mtb</i> was conducted at the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID/NIH, U.S.). Reconfirmed hits were followed up for determination of minimum inhibitory concentration (MIC) on multiple media that identified a cluster of pan-active pyrazolylpyrimidinones represented by compounds <b>1</b> and <b>2</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The biology triage of these actives (described in the target identification section), suggestive of a unique mechanism of action (MoA), generated further interest in the exploration of these hits. We recognized that pyrazolylpyrimidinones potentially possess iron-chelating properties by virtue of their two sp2 heteroatoms in a 1,4-relationship on adjacent rings, which might play a crucial role in the SAR and mode of action.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> During these studies, we came across the related pyrazolopyrimidinone (PZP, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a) compound reported as an intracellular iron chelator in <i>Mtb</i>.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> PZP is reported to chelate iron through the pyrimidinone carbonyl and 2-position pyrazole nitrogen. Similarly, bidentate iron chelation by the pyrazolylpyrimidinones from the pyrimidinone nitrogen and pyrazole nitrogen as depicted in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b may be hypothesized. A single-crystal X-ray structure of the pyrazolylpyridines–Fe complex is reported in the literature which supports this hypothesis.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> This aspect of metal chelation by the compounds was considered while planning further SAR exploration and target identification studies with the series.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Structure of PZP; and (b) depiction of metal chelation by pyrazolylpyrimidinone <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Properties of the Hits from the MMV Library Screen<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0017.gif" alt="" id="gr16" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Properties</th><th class="colsep0 rowsep0" align="center">1</th><th class="colsep0 rowsep0" align="center"><b>2</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MIC 7H9/ADC/Tw (μM)</td><td class="colsep0 rowsep0" align="center">0.6</td><td class="colsep0 rowsep0" align="center">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MIC GAST-Fe (μM)</td><td class="colsep0 rowsep0" align="center">0.02</td><td class="colsep0 rowsep0" align="center">0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MIC 7H9/Glu/BSA/Tx (μM)</td><td class="colsep0 rowsep0" align="center">1.5</td><td class="colsep0 rowsep0" align="center">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MIC 7H9/Glu/Cas/Tx (μM)</td><td class="colsep0 rowsep0" align="center">0.3</td><td class="colsep0 rowsep0" align="center">0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MIC 7H9/DPCC/Cas/Tx (μM)</td><td class="colsep0 rowsep0" align="center">0.4</td><td class="colsep0 rowsep0" align="center">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MIC 7H9/DPCC/Chol/BSA/Tx (μM)</td><td class="colsep0 rowsep0" align="center">1.5</td><td class="colsep0 rowsep0" align="center">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Vero IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="center">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HepG2 IC<sub>50</sub> (Glu/Gal μM)</td><td class="colsep0 rowsep0" align="center">4/4</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Solubility<sub>pH7.4</sub> (μM)</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center"><5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LogD<sub>pH7.4</sub></td><td class="colsep0 rowsep0" align="center">2.5</td><td class="colsep0 rowsep0" align="center">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Molecular Weight</td><td class="colsep0 rowsep0" align="center">266.304</td><td class="colsep0 rowsep0" align="center">295.346</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Microsomal stability H/R/Mo %remaining</td><td class="colsep0 rowsep0" align="center">98/69/22</td><td class="colsep0 rowsep0" align="center">73/76/78</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">MIC—minimum inhibitory concentration against <i>Mtb</i> H37Rv; 7H9—Middlebrook 7H9; ADC—albumin–dextrose–catalase supplement; Tw—Tween 80; GAST-Fe—glycerol-alanine-salts with Tween and iron salts; Glu—glucose; BSA—bovine serum albumin; Tx—Tyloxapol; Cas—Casitone; DPCC—dipalmitoylphosphatidylcholine and cholesterol; Chol—cholesterol; H/R/Mo—human/rat/mouse; IC<sub>50</sub>—50% inhibitory concentrations; solubility<sub>pH7.4</sub>—aqueous solubility at pH 7.4.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Synthesis</h3><div class="NLM_p">In order to explore the SAR profiles of the series, various routes were explored toward the synthesis of diverse range of analogues as represented by compounds <b>3–54</b> in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>–<named-content content-type="anchor" rid="tbl3" type="simple"></named-content><named-content content-type="anchor" rid="tbl4" type="simple"></named-content><a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. To facilitate exploration of a broad array of substituents off the pyrazole ring and pyrimidinone core, a concise and scalable synthesis leading to an advanced intermediate was desired. As summarized in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, this was achieved by the ring formation reaction of 6-substituted-2-thiomethyl-pyrimidin-4-one <b>55</b> via condensation of the appropriate β-keto-ester and thiourea, and subsequent methylation of the thiol.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Intermediates <b>55a–g</b> were reacted with hydrazine hydrate in refluxing ethanol to give the versatile 2-hydrazinylpyrimidin-4(1<i>H</i>)-ones <b>56a–g</b>, which gave access to analogues for SAR exploration on the pyrazole ring and the R1 substituent on the pyrimidinone core. Similarly, substitution of a phenyl group at the R2 position was achieved through bromination at C5 of 6-methyl-2-thiomethyl-pyrimidin-4-one (<b>55</b>, R1 = CH<sub>3</sub>) followed by a Suzuki cross-coupling reaction with phenyl boronic acid to provide <b>55h</b>, which was then treated with hydrazine to form <b>56h</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to Explore R1 and R2 on the Pyrimidinone and Polar Modifications at R5 on the Pyrazole<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (a) thiourea, KOH, EtOH, reflux (b) iodomethane, NaOH, H<sub>2</sub>O/EtOH; (ii) NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O, EtOH, reflux; (iii) Br<sub>2</sub>, AcOH, 60 °C; (iv) phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, 1,4-dioxane, K<sub>2</sub>CO<sub>3</sub>; (v) acetylacetone, EtOH, AcOH, reflux; (vi) 3-aminocrotonitrile, EtOH, reflux; (vii) acetyl chloride, pyridine, CH<sub>2</sub>Cl<sub>2</sub>; and (viii) ethyl acetoacetate, EtOH, AcOH, reflux.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacophore Evaluation of Pyrazolylpyrimidinones<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0018.gif" alt="" id="gr17" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">MIC were measured in Middlebrook 7H9/Glu/BSA/Tyloxapol media at day 7; IC<sub>50</sub>—50% inhibitory concentrations; solubility—aqueous solubility measured at pH 7.4; CHO—an epithelial cell-line derived from the ovary of the Chinese hamster; and V—Vero cell-line; SI—selectivity index between CHO IC<sub>50</sub> and <i>Mtb</i> MIC.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Polar Substitutions on Pyrimidinone<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0019.gif" alt="" id="gr18" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">MIC—were measured in Middlebrook 7H9/Glu/BSA/Tyloxapol media at day 7; IC<sub>50</sub>—50% inhibitory concentrations; solubility—aqueous solubility measured at pH 7.4; CHO—an epithelial cell-line derived from the ovary of the Chinese hamster; and SI—selectivity index between CHO IC<sub>50</sub> and <i>Mtb</i> MIC.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR at the Pyrazole R5 Position<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0020.gif" alt="" id="gr19" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">MIC—were measured in Middlebrook 7H9/Glu/BSA/Tyloxapol media at day 7; IC<sub>50</sub>—50% inhibitory concentrations; solubility—aqueous solubility measured at pH 7.4; CHO—an epithelial cell-line derived from the ovary of the Chinese hamster; and SI—selectivity index between CHO IC<sub>50</sub> and <i>Mtb</i> MIC.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR at the Pyrazole R3 Position<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0021.gif" alt="" id="gr20" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">MIC—were measured in Middlebrook 7H9/Glu/BSA/Tyloxapol media at day 7; IC<sub>50</sub>—50% inhibitory concentrations; solubility—aqueous solubility at pH 7.4; CHO—an epithelial cell-line derived from the ovary of the Chinese hamster; and SI—selectivity index between CHO IC<sub>50</sub> and <i>Mtb</i> MIC.</p></div></div><div></div></div><div class="NLM_p">The Knorr reaction was used to incorporate the 3,5-dimethylpyrazole via an acid-catalyzed condensation of hydrazine precursors <b>56a–h</b> and acetylacetone. This led to hit compound <b>1</b> and related analogues exploring the R1 (<b>11</b>, <b>12</b>, <b>19</b>, <b>20</b>, and <b>21</b>) and R2 (<b>8–9</b>) positions of the pyrimidinone core as well as quinazolin-4(3<i>H</i>)-one analogue (<b>10</b>). In addition, 2-hydrazinylpyrimidin-4(1<i>H</i>)-one <b>56a</b> and <b>56d</b> were reacted with (<i>Z</i>)-3-aminocrotonitrile to afford 5-aminopyrazolylpyrimidinone analogues <b>14</b> and <b>33</b>,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> which allowed for several transformations to be carried out to expand SAR exploration on the pyrazole ring later described in <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>. To explore polar modifications off the pyrazole ring, a mixture of 2-(5-amino-3-methyl-1<i>H</i>-pyrazol-1-yl)-6-phenylpyrimidin-4(3<i>H</i>)-one <b>14</b> and pyridine in dichloromethane was treated with acetyl chloride to provide <i>N</i>-acetyl amide <b>15</b>.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In addition, hydrazine <b>56a</b> was heated with ethyl acetoacetate in acidic ethanol to yield pyrazolone <b>13</b>.</div><div class="NLM_p">Syntheses of compounds <b>3–7</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) with changes in the central core ring are summarized in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Compounds masking the pyrimidinone amide were synthesized from compound <b>1</b> via a Mitsunobu reaction to form methyl ether <b>3</b> and N-methylation of <b>1</b> with iodomethane using potassium carbonate in <i>N</i>,<i>N</i>-dimethylformamide (DMF) to afford <i>N</i>-methyl pyrimidinone <b>4</b>. The nucleophilic aromatic substitution reaction of 2,6-dichloro-4-iodopyridine with sodium methoxide gave intermediates <b>57</b> and <b>58</b> in a 2:1 ratio, which upon separation allowed for the synthesis of compounds <b>5</b> and <b>6</b>, respectively. Briefly, the three-step synthesis from <b>57</b> and <b>58</b> involved a Suzuki cross-coupling reaction with phenylboronic acid to afford intermediates <b>59</b> and <b>60</b>, respectively, followed by a Buchwald Hartwig amination to introduce the pyrazole (intermediates <b>61</b> and <b>62</b>, respectively), and finally O-demethylation with boron tribromide to afford compounds <b>5</b> and <b>6</b>, respectively.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes to Access Core Modifications<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) MeOH, PPh<sub>3</sub>, DIAD, THF, 25 °C; (ii) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C; (iii) NaOCH<sub>3</sub>, MeOH, 80 °C; (iv) phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, reflux; (v) 3,5-dimethylpyrazole, xanphos, Pd(OAc)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 130 °C; (vi) BBr<sub>3</sub>, MeOH; (vii) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (viii) urea, 1,4-dioxane, 140 °C, microwave; (ix) POCl<sub>3,</sub> DMF; (x) 3,5-dimethylpyrazole, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 80 °C, microwave; and (xi) 20% aq NaOH, 80 °C.</p></p></figure><div class="NLM_p">Pyrimidin-2(1<i>H</i>)-one <b>7</b> was synthesized by the cyclization of ethyl benzoylacetate with urea to provide uracil <b>63</b>, which was then reacted with phosphorus oxychloride in the presence of a catalytic amount of DMF to give 2,4-dichloropyrimidine <b>64</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The activated 2,4-dichloropyrimidine readily undergoes nucleophilic substitution with the pyrazole at the 4-chloro position by heating in the microwave at 80 °C (intermediate <b>65</b>) and subsequent hydrolysis of 2-Cl afforded compound <b>7</b>, with the carbonyl functionality between the ring nitrogens.</div><div class="NLM_p">Compounds <b>16</b> and <b>17</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), in which the pyrazole ring was replaced with other 5-membered heterocycles, were synthesized in a similar manner from 2,4-dichloro-6-phenylpyrimidine <b>64</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The alkaline hydrolysis of intermediate <b>64</b> with 20% aqueous sodium hydroxide occurred primarily at the 4-Cl position to provide advanced intermediate <b>66</b> (isomer ratio 70:30),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> which was reacted with the corresponding 5-membered heterocycle to displace 2-Cl using cesium carbonate under microwave heating at 80 °C (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Compound <b>18</b> with an <i>N</i>-methylimidazole was synthesized by condensing 1-methyl-1<i>H</i>-imidazole-2-carboximidamide with ethyl benzoylacetate in low yields.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route for Pyrazole Replacements<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) urea, 1,4-dioxane, 140 °C, microwave; (ii) POCl<sub>3</sub>, DMF; (iii) 20% aq NaOH, 80 °C (iv) 5-membered heterocycle, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 80 °C, microwave; and (v) EtOH, reflux, 1 h.</p></p></figure><div class="NLM_p">In order to introduce groups with polar functionalities at the R1 and R2 positions on the pyrimidinone core, 2,4,6-trichloropyrimidine was a useful and accessible starting material when the appropriate β-keto-ester was not readily available to pursue synthetic routes, as shown in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Treatment of 2,4,6-trichloropyrimidine in aqueous 1,4-dioxane, brought to the alkaline reaction with NaOH, led to hydrolysis at room temperature with the formation of 4,6-dichloro-2-hydroxypyrimidine <b>67</b> and 2,6-dichloropyrimidin-4(3<i>H</i>)-one <b>68</b>, with the former precipitating out as the sodium salt (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The filtrate was concentrated to approximately half the volume and cooled to afford a precipitate which was filtered off and acidified to pH 2 using 5 N HCl to give the required regioisomer <b>68</b>, in approximately 40% yield. The reactivity of each position of the pyrimidine halides follows the general order C6(4) > C2 ≫ C5.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> A strong preference for the C6 position has been observed in Suzuki cross-coupling reactions.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20">(16−20)</a> Coupled with the use of a lower temperature for the Suzuki coupling, this allowed for the sequential introduction of different substituents.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route to Polar Substitutions on R1 of the Pyrimidinone<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) aqueous NaOH, dioxane; (ii) boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(OAc)<sub>2</sub>, dppf, 1,4-dioxane, 70 °C or K<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub>(dppf)<sub>2</sub>, 1,4-dioxane, 70 °C; and (iii) 3,5-dimethylpyrazole, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 130 °C, microwave.</p></p></figure><div class="NLM_p">Thus, 2,6-dichloropyrimidin-4(3<i>H</i>)-one <b>68</b> underwent a Suzuki cross-coupling with the appropriate boronic acid, using Pd(OAc)<sub>2</sub>/dppf or PdCl<sub>2</sub>(dppf)<sub>2</sub> as the catalyst to afford compounds <b>69a–d</b>. Coupling of intermediates <b>69a–d</b> with 3,5-dimethylpyrazole was achieved by heating to 130 °C under microwave irradiation using 15 mol % Pd<sub>2</sub>(dba)<sub>3</sub>, xanphos, and Cs<sub>2</sub>CO<sub>3</sub> in 1,4-dioxane to afford the desired compounds <b>22–25</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). A slightly modified procedure, as shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>, was used to prepare amide <b>26</b>. Methyl 2,6-dichloropyrimidine-4-carboxylate was treated with sodium methoxide at 0 °C to obtain intermediate <b>70</b>. Intermediate <b>70</b> was then reacted with 3,5-dimethylpyrazole under microwave heating using Cs<sub>2</sub>CO<sub>3</sub> as a base to give acid <b>71</b>, which was followed by subsequent in situ hydrolysis of the methyl ester. Acid <b>71</b> was coupled with 4-fluoroaniline using 1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxid hexafluorophosphate (HATU) to give amide intermediate <b>72</b>, which was demethylated using boron tribromide in dichloromethane to give compound <b>26</b>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route to Amide <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) CH<sub>3</sub>ONa, THF, 0 °C; (ii) 3,5-dimethylpyrazole, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C, microwave; (iii) 4-fluoroaniline, HATU, Et<sub>3</sub>N, DMF; and (iv) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div class="NLM_p">To determine if polarity at the R2 position on the pyrimidinone core was tolerated, compounds <b>27–29</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) were synthesized using the route, as shown in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. 4-Fluorobenzaldehyde was condensed with thiourea and ethyl cyanoacetate using potassium hydroxide in refluxing ethanol to give 2-mecapto-5-cyanopyrimidinone intermediate <b>73</b>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The thiol of intermediate <b>73</b> was methylated using methyl iodide in the presence of sodium hydroxide followed by displacement with hydrazine in refluxing ethanol to give 2-hydrazinyl-5-cyanopyrimidinone intermediate <b>74</b>. This intermediate was then condensed with acetylacetone by heating in acetic acid-ethanol at 85 °C to obtain compound <b>27</b>, which was hydrolyzed to amide <b>28</b> by heating in concentrated sulfuric acid at 85 °C.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The conversion of amide <b>28</b> to acid <b>29</b> was achieved via nitrosation by heating with <i>tert</i>-butyl nitrite in acetic acid at 85 °C followed by hydrolysis.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Route to Polar Substitutions on R2 of the Pyrimidinone<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) ethyl 2-cyanoacetate, KOH, ethanol, reflux; (ii) (a) MeI, NaOH, H<sub>2</sub>O (b) NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O, EtOH, reflux; (iii) acetylacetone, AcOH, EtOH, 85 °C; (iv) H<sub>2</sub>SO<sub>4</sub>, 80 °C; and (v) <i>tert</i>-butyl nitrite, AcOH, 75 °C.</p></p></figure><div class="NLM_p">Compounds <b>30–47</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) were synthesized to explore the SAR around the R5 position of the pyrazole ring, keeping the C6-position on the pyrimidinone core fixed as trifluoromethyl. Using the same methodology, as shown <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, the condensation of <b>56d</b> with the corresponding 1,3-dicarbonyl compound afforded compounds <b>30–32</b> exclusively as one regioisomer as confirmed by NOESY NMR (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). In addition, <b>56d</b> provided access to compound <b>33</b>, which served as a versatile intermediate and allowed for several transformations to form N-substituted pyrazole derivatives. The reductive amination of acetaldehyde with <b>33</b> in the presence of sodium cyanoborohydride in methanol gave ethylaminopyrazole <b>34</b>. Attempts to synthesize the <i>N</i>,<i>N</i>-dialkyl derivative from compound <b>34</b> failed as the corresponding derivatives decomposed on standing. Compound <b>47</b> was synthesized in the same manner by reductive amination of acetaldehyde with 2-hydrazineyl-6-(3-pyridinyl)pyrimidinone <b>56g</b>. The synthesis of 5-(aryl-amino)pyrazoles <b>40–46</b> was achieved via a Buchwald Hartwig amination of <b>33</b> and the corresponding aryl halide.</div><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthetic Routes Used to Explore the Pyrazole R5 Position<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) diketone, EtOH, AcOH, reflux; (ii) 3-aminocrotonitrile, EtOH, reflux; (iii) acetaldehyde, DMF, AcOH, NaCNBH<sub>4</sub>, MeOH, 25 °C; (iv) <i>N</i>-(2-methoxyethyl)-3-oxobutanamide, Lawesson’s reagent, THF, 25 °C; and (v) Cs<sub>2</sub>CO<sub>3</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, XantPhos, 1,4-dioxane, aryl halide, 120 °C</p></p></figure><div class="NLM_p">Compound <b>38</b> was synthesized from hydrazine <b>56d</b> and <i>N</i>-(2-methoxyethyl)-3-oxobutanamide with Lawesson’s reagent, which allows for the efficient installation of substituted-5-amino groups on the pyrazole core in a single step.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> However, this methodology failed in the case of the synthesis of compounds <b>36</b>, <b>37</b>, and <b>39</b>, with 2-(5-hydroxy-3-methyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one being obtained as the major product. An alternate highly regioselective route to 5-(substituted-amino)pyrazoles <b>36</b>, <b>37</b>, and <b>39</b> was achieved following a modified literature procedure.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">As shown in <a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>, the displacement of one methylthio group of the α-oxoketene dithioacetal <b>75</b><a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> by the appropriate amine in the presence of acetic acid in ethanol afforded the <i>N</i>,<i>S</i>-acetals <b>76a</b>-<b>c</b>, which were useful three-carbon 1,3-electrophiles.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Cyclocondensation with hydrazine <b>56d</b> in refluxing ethanol, gave access to 5-(substituted-amino)pyrazoles <b>36</b>, <b>37</b>, and <b>39</b>. The regioisomeric products with 3-(substituted-amino)pyrazoles could be isolated in minor quantities and showed much less potent activity against <i>Mtb</i> (data not shown).</div><figure id="sch8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthetic Route to Compounds <b>36–39</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) NH<sub>2</sub>-R, EtOH, reflux; (ii) <b>33</b>, AcOH, EtOH, 100 °C.</p></p></figure><div class="NLM_p">Compound <b>35</b>, with an <i>O</i>-ethyl group at R5, was synthesized, as shown in <a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>. The condensation of ethyl acetoacetate and hydrazine delivered pyrazolone <b>77</b>, which on subsequent <i>O</i>-ethylation with ethyl iodide gave <b>78</b>. Intermediate <b>78</b> was coupled with <b>79</b>, synthesized by the oxidation of thiomethyl-pyrimidin-4-one <b>55d</b> with <i>m</i>CPBA to yield <b>35</b>.</div><figure id="sch9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Compound <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (a) thiourea, KOH, EtOH and (b) MeI, NaOH, H<sub>2</sub>O; (ii) <i>m</i>CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C; (iii) N<sub>2</sub>H<sub>2</sub>. H<sub>2</sub>O, EtOH; (iv) EtI, K<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C; and (v) Cs<sub>2</sub>CO<sub>3</sub>, 1,4-Dioxane, 130 °C.</p></p></figure><div class="NLM_p">Compounds <b>48–50</b> with substitutions on the pyrazole C4 position were synthesized, as shown in <a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a>. The bromination of compound <b>12</b> gave compound <b>48</b>, which on Suzuki cross-coupling with pyridine-3-boronic acid gave compound <b>49</b>. Attempts to displace C4-Br of <b>48</b> with morpholine to synthesize compound <b>50</b> were unsuccessful. In an alternative route, the morpholine ring was preinstalled on acetylacetone via bromination with <i>N</i>-bromosuccinimide (intermediate <b>80</b>) followed by the reaction with morpholine in the presence of triethylamine to give intermediate <b>81</b>. This intermediate was then condensed with hydrazine <b>56d</b> by refluxing in ethanol-acetic acid to give compound <b>50</b>.</div><figure id="sch10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Compounds with Pyrazole C4 Substitutions<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Br<sub>2</sub>, AcOH, 100 °C, 2h; (ii) pyridine-3-boronic acid, K<sub>2</sub>CO<sub>3</sub>, Pd(dppf)Cl<sub>2</sub>, THF/water (10:1), 70 °C, 16h; (iii) <i>N</i>-bromosuccinamide, <i>p</i>-toluene sulphonic acid, CH<sub>2</sub>Cl<sub>2</sub>; 0 °C; (iv) morpholine, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; and (v) EtOH/AcOH reflux, 16 h.</p></p></figure><div class="NLM_p">Compound <b>51</b> was synthesized in a similar fashion to compound <b>33</b>, by condensing hydrazine <b>56d</b> with 3-cyclopropyl-3-oxopropanenitrile (<b>82</b>) (<a class="ref internalNav" href="#sch11" aria-label="Scheme 11">Scheme 11</a>). The synthesis of compounds <b>52–54</b> was accomplished from <b>83</b>, as shown in <a class="ref internalNav" href="#sch11" aria-label="Scheme 11">Scheme 11</a>. The reaction of <b>83</b> with <b>85</b> under microwave heating gave acid <b>53</b>. This compound was then coupled with dimethylamine using HATU to give compound <b>54</b>. Pyrazole ester <b>83</b> was converted to the corresponding dimethylaminomethyl derivative <b>84</b> via a standard two-step protocol involving the reduction of the ester to the aldehyde followed by reductive amination with dimethylamine. Intermediate <b>84</b> was reacted with 2-methylsulphonylpyrimidinone <b>79</b> under microwave heating to obtain compound <b>52</b>.</div><figure id="sch11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Synthesis of Compounds with Pyrazole C3 Modifications<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions. (i) DMF, 130 °C, 2 h; (ii) Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 130 °C, microwave; (iii) <i>N</i>,<i>N</i>-dimethylamine, HATU, Et<sub>3</sub>N, DMF; (iv) (a) DIBALH, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C; (b) <i>N</i>,<i>N</i>-dimethylamine, NaCNBH<sub>3</sub>, THF, RT, 24 h; and (v) Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 130 °C, microwave.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Formal Hit Assessment to Determine the Pharmacophore Critical for Antitubercular Activity</h3><div class="NLM_p">Although the initial hits, <b>1</b> and <b>2</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), showed reasonably potent antitubercular activity (MIC < 2 μM), they suffered from unfavorable physicochemical properties including low solubility, low to moderate microsomal metabolic stability (MS), and a low selectivity index (SI) between <i>Mtb</i> MIC and mammalian cell toxicity as determined by measuring 50% inhibitory concentrations (IC<sub>50</sub>) determined against a CHO cell-line (an epithelial cell-line derived from the Chinese-hamster ovary). A formal hit assessment study was undertaken to determine the minimum pharmacophoric features critical for antitubercular potency and to understand the SAR features needed to improve the SI. Initially, compounds with single point modifications on the pyrimidinone and pyrazole portions of the molecule were synthesized and profiled in a first wave of assays comprising <i>Mtb</i> MIC, CHO IC<sub>50</sub>, and aqueous solubility. The substituents on the pyrimidinone and pyrazole rings were labeled R1-R5, as shown <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> (see <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Masking of the pyrimidinone amide as −OCH<sub>3</sub> (<b>3</b>) or <i>N</i>-CH<sub>3</sub> (<b>4</b>) abolished the <i>Mtb</i> activity, indicating the essentiality of the NH, which might be involved in the critical hydrogen bond (HB) donor–acceptor interactions with the target. Each of the nitrogens of the pyrimidinone ring were found to be essential for maintaining <i>Mtb</i> activity (<b>5</b> and <b>6</b>). Interestingly, compound <b>7</b> with the carbonyl functionality between the ring nitrogens pyrimidin-2(1<i>H</i>)-one vs pyrimidin-4(3<i>H</i>)-one as in <b>1</b> maintained similar <i>Mtb</i> activity. The additional SAR explorations in this work were limited to the pyrimidin-4(3<i>H</i>)-one core as in compound <b>1</b>, considering the ease of synthesis.</div><div class="NLM_p">Compound <b>8</b> with a methyl group added at the pyrimidinone C5 (R2) position, while keeping a phenyl substituent at C6 (R1), retained a good MIC value (2 μM) while improving aqueous solubility (120 μM) and the SI (12.5) for cytotoxicity. However, isomeric compound <b>9</b> with C5-phenyl (R2) and C6-methyl (R1) showed a poor MIC value (9 μM) with a lower SI of 1, whereas the fusion of the phenyl ring with the pyrimidinone ring to form the corresponding quinazolinone (compound <b>10</b>) retained potency but with a low SI of only 2. A phenyl substituent at the R1 (pyrimidinone C6) position was necessary to maintain <i>Mtb</i> activity. Compounds <b>11</b> and <b>12</b> with CH<sub>3</sub> and CF<sub>3</sub> groups, respectively, at R1 instead of the phenyl substituent showed a 10–15-fold loss in activity. As compound <b>12</b> with the CF<sub>3</sub> group at R1 showed higher solubility and SI relative to <b>1</b>, this modification was included in further explorations for potency and selectivity. Overall, these SAR observations suggested the requirement for hydrophobic substitutions on the pyrimidinone ring for the retention of potent <i>in vitro</i> activity against <i>Mtb</i>.</div><div class="NLM_p">A few polar modifications on the pyrazole ring were attempted in order to evaluate the scope of reducing lipophilicity and improving drug-like properties. Changing the C5′-methyl (R5) on the pyrazole to oxygen abolished the activity as observed for compound <b>13</b>, whereas an amino group at the C5′-position as in compound <b>14</b> resulted in the retention of activity comparable to compound <b>1</b> (3 μM) and significantly improved solubility (180 μM). Unfortunately, this polar modification did not improve the SI. <i>N</i>-acetyl amide derivative <b>15</b> retained the activity and SI profile similar to parent amine <b>14</b>. Compound <b>16</b>, with an unsubstituted pyrazole, lost potency considerably (MIC 50 μM). A similar loss in potency was observed when the pyrazole ring was replaced with other 5-membered rings like triazole or imidazole, as in compounds <b>17</b> and <b>18</b>, respectively. This suggests the critical nature of an appropriately substituted pyrazole moiety for maintaining antitubercular activity.</div><div class="NLM_p">The SAR observations regarding the critical pharmacophoric features required for maintaining and/or improving antitubercular activity along with the scope for further SAR studies are summarized in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. In summary, the pyrimidin-4(3<i>H</i>)-one ring was retained for further SAR studies considering the critical nature of the cyclic amide as well as the ring nitrogens for maintaining the antitubercular activity. The SAR observations suggest the important role of hydrophobic substituents at the R1 and R2 positions for potency. We explored the scope of polar interactions further away from the main scaffold by extending polar groups from the aryl ring at the R1 position. In addition, we also explored a few polar groups at the R2 position instead of a methyl group, which could influence HB-donor acceptor interactions of the pyrimidinone ring amide. The 3,5-disubstituted pyrazole ring was critical for maintaining activity, but there was a clear scope to extend substituents from the R5 position to improve potency and physicochemical properties. The scope of substitution at the R4-postion remained to be explored.</div><figure id="fig3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Essential pharmacophoric features and scope for further SAR studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> SAR of Polar Groups at R1 and R2 Positions of the Pyrimidinone Core</h3><div class="NLM_p">Several polar R1 and R2 substituents on the pyrimidinone ring were incorporated in order to expand the scope relative to activity (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) and increase solubility and SI. Compound <b>19</b> with a 4-fluorophenyl group at the R1 position retained activity and cytotoxicity similar to compound <b>1</b>. The replacement of the phenyl ring with pyridine rings considerably improved solubility, as observed for compounds <b>20</b> and <b>21</b>, although with some loss in <i>Mtb</i> activity. Compound <b>20</b>, with a 4-pyridyl ring, was more potent (MIC 9 μM) than compound <b>21</b> with a 3-pyridyl ring (MIC 50 μM) leading to the speculation of the role of HB-interactions through the 4-pyridine nitrogen. Hence, compounds <b>22</b> to <b>25</b> with various polar substitutions at the para-position of the phenyl ring at the R1 position were prepared. Unfortunately, all these compounds lost activity. Next, we considered the option of inserting a polar linker between the pyrimidinone and phenyl rings. Among the various groups attempted, only compound <b>26</b> with a 4-flurophenyl group extended by a carboxamide linker at the R1 position, retained weak activity (25 μM).</div><div class="NLM_p last">Based on the encouraging data for compound <b>8</b> with a C5-methyl group on the pyrimidinone, we explored adding a few polar groups such as CN, CONH<sub>2</sub>, and CO<sub>2</sub>H at this position, but unfortunately this led to the loss of activity (compounds <b>27</b>, <b>28</b>, and <b>29</b>). Overall, these observations indicated very limited scope for adding polar substitutions on the pyrimidinone ring. Hence, we turned our attention to exploring possible interactions from the pyrazole ring.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> SAR of the Pyrazole Ring</h3><div class="NLM_p">Further exploration on the pyrazole ring was planned, maintaining the CF<sub>3</sub> as the R1 substituent on the pyrimidinone, as it increased the solubility and SI exemplified for compound <b>12</b>. In addition, the smaller CF<sub>3</sub> group kept the molecular weight and lipophilicity on the low side compared to the phenyl. The addition of bulkier alkyls like ethyl and cyclopropyl (compounds <b>30</b> and <b>31</b>) at the R5 position on the pyrazole were tolerated for <i>Mtb</i> activity relative to <b>12</b> but with a deterioration of the SI, whereas a slight loss in activity was observed for compound <b>32</b> with the phenyl group at the R5 position. Isomers of these compounds with bulkier groups at the R3 position could not be synthesized because of the selectivity observed in the condensation reaction of hydrazine with requisite diketones favoring the placement of bulkier groups at the R5 position. Compound <b>33</b> with a NH<sub>2</sub> at the R5 position maintained a profile similar to compound <b>12</b>, whereas compound <b>34</b> with an aminoethyl at the R5 position showed increased toxicity against CHO cell lines without a significant improvement in activity. Compound <b>35</b> with an <i>O</i>-ethyl group at the R5 position had a potency and selectivity profile similar to compound <b>12</b>. The extension of polar groups like −NH<sub>2</sub> or −OH via a short ethylamino linker from the R5 position as in compounds <b>36</b> and <b>37</b>, respectively, was detrimental to activity against <i>Mtb</i>. Compounds <b>38</b> and <b>39</b>, with the neutral ether substituents like methoxyethylamino and pyranamino, respectively, at the R5 position, showed more potent activity (MIC 1.5–2 μM) as compared to <b>12</b> while the SI was about the same. Based on these observations, it is speculated that the R5 position lies in a more hydrophobic region of the compound binding site within the target in <i>Mtb</i>. Hence, we decided to examine aryl groups, some with polarity, at R5 toward maintaining activity while improving solubility with polar substituents placed distant from the main scaffold.</div><div class="NLM_p">Compound <b>40</b> with a 4-F-aniline at the R5 position showed <i>Mtb</i> potency and a SI profile similar to <b>39</b>, with an aminopyran at position R5, but had lower aqueous solubility (15 μM) as expected because of the overall increase in lipophilicity with an additional aryl ring. Compound <b>41</b> with a 2,4-difluoroanilino group at the R5 position was the most potent compound (MIC 0.2 μM) obtained so far in these studies but was poorly soluble (<5 μM) in aqueous media. The addition of polar groups like CN and dimethylcarboxamide (<b>42</b> and <b>43</b>) at the para-position of the R5-anilino groups decreased activity (MIC 9 and >50 μM, respectively). Similarly, compound <b>44</b> with a 4-pyridylamino at the R5 position was inactive against <i>Mtb</i> up to the highest concentration tested (MIC > 50 μM). Interestingly, compound <b>45</b> with a 2-pyridylamino group at the same R5 position was quite potent with a MIC of ≤1 μM. The compound had moderate aqueous solubility (25 μM) with a modest SI of 25 for CHO cell-line toxicity, thus making it a valuable compound for MoA studies (see below). A few compounds with polar substituents para to the amino group on the 2-pyridyl ring were synthesized and screened with a view to improving physicochemical properties. For example, compound <b>46</b> with a 4-morpholino-2-pyridylamino group at the R5 position retained good activity (MIC = 2 μM) with improved solubility (180 μM) but was significantly more cytotoxic (SI 0.6).</div><div class="NLM_p">Compound <b>47</b>, with a 3-pyridyl at the R1 position and an ethylamino group at the R5 position, showed modest activity with an MIC of 6.25 μM and CHO IC<sub>50</sub> of >50 μM.</div><div class="NLM_p">A limited SAR exploration at the R4 position on the pyrazole was conducted to evaluate the scope for further improvement in potency and selectivity. Compound <b>48</b> with 4-bromopyrazole showed only moderate activity (MIC 25 μM, CHO IC<sub>50</sub> > 50 μM) and was used as an intermediate for further synthesis. Replacing the bromine with a 3-pyridyl ring (<b>49</b>) abolished <i>Mtb</i> activity (MIC >50 μM), whereas the morpholine ring at this position (<b>50</b>) was well tolerated with an MIC = 6.25 μM and a cleaner cytotoxicity profile (CHO IC<sub>50</sub> > 50 μM). In comparison, the R3 position on the pyrazole showed a very limited scope for further modifications. In general, a cyclopropyl group as in compound <b>51</b> was well tolerated for <i>Mtb</i> potency but larger groups in general gave weakly active compounds. Polar groups like dimethylaminomethyl, carboxylic acid, and amide as in compounds <b>52</b>, <b>53</b>, and <b>54</b>, respectively, led to considerable loss of activity against <i>Mtb</i> (MICs > 50 μM).</div><div class="NLM_p">In summary, various modification on the pyrimidinone and pyrazole portions of the scaffold showed potential for improvement in potency against <i>Mtb in vitro</i> and MICs as low as 200 nM could be achieved. However, in general there was a narrow scope to improve the SI against mammalian cell-line toxicity. The potential impact of both these activities <i>in vivo</i> remains to be determined.</div><div id="sec2_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Physicochemical, DMPK, and Safety Profiles</h4><div class="NLM_p">Presented in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> are physicochemical and <i>in vitro</i> DMPK properties of representative compounds, including solubility, microsomal MS, and human plasma protein binding (PPB). Compounds showed moderate to high aqueous solubility with excellent <i>in vitro</i> microsomal stability, with the exception of compound <b>8</b> that was only moderately stable in microsomes. A small number of compounds that were tested for the inhibition of liver cytochrome P450 enzymes did not show significant inhibition up to 20 μM (data not shown), indicating minimal possibility of metabolism-based drug–drug interactions of these compounds, which is a desirable attribute of a TB drug.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> The compounds tested in the series were highly bound to the human plasma most likely due to the albumin binding of acidic pyrimidinone.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The safety profiles of compounds <b>1</b> and <b>12</b> were evaluated across a panel of 21 liability targets (39 functional assays), which included cell-based GPCRs and ion channels in both agonist and antagonist readout, and biochemical functional assays for nuclear hormone receptors and phosphodiesterases.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Both compounds showed no significant inhibition or activation of the enzyme/receptors at 10 μM test concentration. Both compounds showed hERG IC<sub>50</sub> > 30 μM. In summary, the <i>in vitro</i> safety profile of the compounds indicated no obvious safety liability even though the reason for mammalian cytotoxicity observed was not clear.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. <i>In Vitro</i> ADME Properties of Selected Compounds<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center"><b>8</b></th><th class="colsep0 rowsep0" align="center"><b>12</b></th><th class="colsep0 rowsep0" align="center"><b>39</b></th><th class="colsep0 rowsep0" align="center"><b>40</b></th><th class="colsep0 rowsep0" align="center"><b>45</b></th><th class="colsep0 rowsep0" align="center"><b>47</b></th><th class="colsep0 rowsep0" align="center" char="."><b>50</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">clog <i>P</i><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">1.82</td><td class="colsep0 rowsep0" align="left">1.36</td><td class="colsep0 rowsep0" align="left">1.30</td><td class="colsep0 rowsep0" align="left">2.52</td><td class="colsep0 rowsep0" align="left">1.46</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="char" char=".">1.54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">clog <i>D</i><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">1.82</td><td class="colsep0 rowsep0" align="left">1.36</td><td class="colsep0 rowsep0" align="left">1.09</td><td class="colsep0 rowsep0" align="left">2.52</td><td class="colsep0 rowsep0" align="left">1.46</td><td class="colsep0 rowsep0" align="left">1.09</td><td class="colsep0 rowsep0" align="char" char=".">1.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility (μM)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">90</td><td class="colsep0 rowsep0" align="char" char=".">160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MS<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> H/R/Mo % remaining after 30 min</td><td class="colsep0 rowsep0" align="left">65/54/45</td><td class="colsep0 rowsep0" align="left">>99/92/>99</td><td class="colsep0 rowsep0" align="left">>99/>99/93</td><td class="colsep0 rowsep0" align="left">98/98/96</td><td class="colsep0 rowsep0" align="left">>99/96/>99</td><td class="colsep0 rowsep0" align="left">80/95/94</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PPB<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a> human <i>fu</i></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.006</td><td class="colsep0 rowsep0" align="left">0.014</td><td class="colsep0 rowsep0" align="left">0.013</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.009</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Calculated log <i>P</i>/log <i>D</i> (StarDrop).</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Kinetic solubility measured at pH 7.4.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">Microsomal stability H: human, R: rat Mo: mouse.</p></div><div class="footnote" id="t6fn4"><sup><sup>d</sup></sup><p class="last">PPB; <i>fu</i>—fraction unbound.</p></div></div></div><div class="NLM_p">The pharmacokinetic parameters of representative compounds, <b>12</b>, <b>47</b>, and <b>40</b> were measured from mouse blood at intravenous doses of 2 mg/kg and oral doses of 20 mg/kg in the mouse (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). The compounds were well tolerated following either route of administration, with no obvious effects noted in the animals over the course of the exposure. Compounds <b>12</b> and <b>40</b> showed a low volume of distribution and low rate of clearance with moderate oral bioavailability of approximately 40%. Compound <b>47</b> showed rapid blood clearance and high volume of distribution with an oral bioavailability of 33%. Further analysis of mouse blood samples from the PK studies of <b>47</b> showed the glucuronide as the major metabolite. However, further optimization of physicochemical properties to improve pharmacokinetic properties, along with improved SI, is warranted in order to identify a compound suitable for <i>in vivo</i> efficacy studies in TB animal models.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Pharmacokinetic Parameters in Male C57/BL6 Mouse Blood<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">route of administration</th><th class="colsep0 rowsep0" align="center">i.v.</th><th class="colsep0 rowsep0" align="center">oral</th><th class="colsep0 rowsep0" align="center">i.v.</th><th class="colsep0 rowsep0" align="center">oral</th><th class="colsep0 rowsep0" align="center">i.v.</th><th class="colsep0 rowsep0" align="center">oral</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" colspan="2" align="center"><b>12</b></td><td class="colsep0 rowsep0" colspan="2" align="center"><b>47</b></td><td class="colsep0 rowsep0" colspan="2" align="center"><b>40</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dose (mg/kg)</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">apparent t<sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>total</sub> (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">80.9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>int</sub> (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">476</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>4000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>d</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">37.4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μM)</td><td class="colsep0 rowsep0" align="left">29.1</td><td class="colsep0 rowsep0" align="left">65.6</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">33.1</td><td class="colsep0 rowsep0" align="left">104.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–∞</sub> (min·μM)</td><td class="colsep0 rowsep0" align="left">2928</td><td class="colsep0 rowsep0" align="left">12004</td><td class="colsep0 rowsep0" align="left">91</td><td class="colsep0 rowsep0" align="left">313</td><td class="colsep0 rowsep0" align="left">15373</td><td class="colsep0 rowsep0" align="left">65417</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">oral bioavailability F (%)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">44</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">i.v.: intravenous; <i>t</i><sub>1/2</sub>: elimination half-life; CL<sub>total</sub>: total blood clearance; CL<sub>int</sub>: intrinsic clearance; <i>V</i><sub>d</sub>: volume of distribution during elimination phase; <i>C</i><sub>max</sub>, maximum (peak) plasma concentration following oral administration; and AUC: area under the curve.</p></div></div></div></div><div id="sec2_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Bactericidality and Activity against Clinical Isolates</h4><div class="NLM_p last">The compounds were found to be bactericidal against replicating <i>Mtb</i> showing 2 log CFU reduction at 1–2× MIC over the time period of 7 days (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_001.pdf" class="ext-link">Fig. S1</a>). Importantly, we also evaluated the activity of <b>1</b>, <b>12</b>, <b>15</b>, and <b>20</b> against a panel of clinical isolates (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_001.pdf" class="ext-link">Table S1</a>). All the tested compounds retained MICs against clinical isolates within the 4-fold range of MICs against the drug-sensitive <i>Mtb</i> H37Rv strain.</div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Target Deconvolution Studies</h3><div id="sec2_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Biology Triaging</h4><div class="NLM_p">In order to explore the MoA, potent compounds were initially screened against various tool strains to rule out the involvement of known mechanisms and/or targets. The tested compounds retained activity against a QcrB mutant (A396T) and did not show hypersensitivity against a cytochrome-bd oxidase knockout mutant strain (<i>cyd</i>KO),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> thereby eliminating them as potential targets. The compounds did not show a positive signal in two standard bioluminescence reporter assays: PiniB-LUX<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a>—detects modulation in the <i>iniB</i> expression, if a compound targets <i>Mtb</i> cell–wall biosynthesis, and PrecA-LUX<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a>—detects modulation in the <i>recA</i> expression, an indicator of genotoxic compounds. A strain carrying a mutation in DprE1 (C387S), which confers resistance to other DprE1 inhibitors, was not resistant, suggesting DprE1 is not the target. However, strains carrying mutations in MmpL3 were cross-resistant to compounds (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The compounds showed an increase of 8–100-fold in MIC values against the strains with either MmpL3<sub>F255L</sub> or MmpL3<sub>V681I</sub> or MmpL3<sub>G596R</sub>, whereas, there was no change in activity against the MmpL3<sub>F644L</sub> mutant. Most of these mutations lie within the region required for proton translocation.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Variability in the MICs against these mutant strains is suggestive of the fact that the compounds may bind differently to the protein depending on the mutation. To investigate whether or not compounds <b>1</b>, <b>2</b>, <b>12</b>, <b>15</b>, <b>47</b>, <b>40</b>, and <b>38</b> retain target selectivity for MmpL3 in <i>Mtb</i> cells, we asked whether or not conditional depletion of MmpL3 in a <i>mmpL3</i> hypomorph (Grover et al., manuscript under review) would sensitize <i>Mtb</i> to the growth inhibitory effects of the compounds. However, transcriptional silencing of <i>mmpL3</i> resulted in no significant change in the MICs of the compounds, confirming that MmpL3 is not the direct target of this series (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_001.pdf" class="ext-link">Table S2</a>). We hypothesize that MmpL3 acts as a transporter of these compounds across the cell membrane as the compounds can form heme-like iron-complexes, and MmpL3 is known to act as a heme transporter.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> Hence, MmpL3 is likely to be responsible for building resistance toward compounds through the impairment of transport of compounds across the cell membrane rather than being a direct target. It is to be noted that the compounds were PiniB-LUX negative—indicating a non-cell wall MoA.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Cross-Screening against mmpL3 Mutants<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">strain</th><th class="colsep0 rowsep0" align="center" char="."><b>1</b></th><th class="colsep0 rowsep0" align="center" char="."><b>2</b></th><th class="colsep0 rowsep0" align="center" char="."><b>12</b></th><th class="colsep0 rowsep0" align="center"><b>15</b></th><th class="colsep0 rowsep0" align="center" char="."><b>47</b></th><th class="colsep0 rowsep0" align="center"><b>40</b></th><th class="colsep0 rowsep0" align="center" char="."><b>38</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H37Rv WT MIC (μM)</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MmpL3 F255L MIC (μM)</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char=".">170</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="char" char=".">39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MmpL3 F644L MIC (μM)</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MmpL3 V681 MIC (μM)</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MmpL3 G596R MIC (μM)</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">110</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">WT: wild-type.</p></div></div></div><div class="NLM_p last">Based on the structural similarity of the compounds with the published thymidylate kinase inhibitors,<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> we asked whether this compound series can inhibit <i>Mtb</i> thymidylate kinase, which is an essential target encoded by Rv3247c. To investigate this, we tested the activity of the compounds <b>1</b>, <b>2</b>, and <b>12</b> against the Rv3247c hypomorph. However, we did not observe any MIC modulation of the compounds upon silencing of Rv3247c, suggesting that the tested compounds are not the thymidylate kinase inhibitors.</div></div><div id="sec2_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Treatment with <b>45</b> and <b>12</b> Affects Genes Involved in Fe Homeostasis</h4><div class="NLM_p">In continuation of our efforts to explore MoA, the effects of <b>45</b> (at 1 μM and 10 μM) and <b>12</b> (at 20 μM) treatment on the gene expression of <i>Mtb</i> was investigated. <i>Mtb</i> cultures were treated with the compound for 6 h, harvested, and the RNA extracted for transcriptional profiling by microarray analysis. The data obtained from the transcriptional profiling of <i>Mtb</i> exposed to <b>45</b> and <b>12</b> were similar (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_001.pdf" class="ext-link">Table S3</a>). We performed in-depth analysis of the data obtained from samples treated with <b>45</b>, which was tested at two concentrations. The 50 most upregulated (>4-fold) genes were selected in order to understand their potential contribution in the cellular response based on the MoA of <b>45</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_001.pdf" class="ext-link">Table S4</a>). This indicated a transcriptional signature related to iron-sequestration. The upregulated genes included <i>rv2377c-78c-79c-80c-81c-82c-83c-84-85-2386c</i> (<i>mbtA-H</i>)—all of which are associated with mycobactin biosynthesis or regulation,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> which are known to be upregulated in response to iron deprivation.</div><div class="NLM_p">Another upregulated gene-set <i>rv1342-43-44-45-46-47-48-49</i> is also associated with the mycobactin biosynthesis or regulation or with iron transport where <i>rv1348</i> and <i>rv1349</i> were annotated as iron-regulated transporters, both being essential for growth <i>in vitro</i>.<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42−44)</a> The <i>esx-3</i> gene cluster is composed of 11 genes stretching from <i>rv0282</i> to <i>rv0292.</i> All of these were upregulated 2–5-fold in response to the stress caused by the compound. <i>rv0287</i> and <i>rv0288</i> are predicted to be essential for growth <i>in vitro</i>. Interestingly, ESX-3 is known to be required for the mycobactin-mediated siderophore iron uptake pathway,<a onclick="showRef(event, 'ref45 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47 ref48">(45−48)</a> and it is essential in <i>Mtb</i> but not in <i>Mycobacterium smegmatis</i>, a species which, in addition to mycobactins, produces exochelin that functions independently of ESX-3. However, ESX-3 is still required for mycobactin-mediated iron uptake in the latter species.<a onclick="showRef(event, 'ref45 ref46 ref48'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref48">(45,46,48)</a> The nonessential nature of ESX-3 in <i>M. smegmatis</i> has previously proven to be of a great advantage when resolving mechanisms related to ESX-3 and mycobactin iron metabolism.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Some of the top upregulated genes are involved in lipid metabolism, for example, <i>rv3249-51-52</i> potentially a transcriptional response to correct damage to fatty acids. Fe has been reported to affect lipid metabolism, specifically because of Fe-catalyzed lipid oxidation. In line with this, we observed that genes, including <i>rv3741-42</i>, (oxidoreductase) were upregulated. The observed upregulation of the <i>rv3269-70</i> operon encoding a stress response protein and a metal cation transporter, respectively, further supports the notion that the cellular response to <b>45</b> is one of the disruption of iron homeostasis. R<i>v0285</i>—PE5 which was upregulated in our study, is downregulated in the presence of iron.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Importantly, most of the upregulated genes of our data set were found to be downregulated when <i>Mtb</i> was exposed to an excess of iron.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Our data set also complements the recently published work by Kurthkoti et al.,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> where authors performed transcriptomics in iron-starved cultures and identified similar upregulated clusters of genes. This strongly suggests that the disruption of Fe homeostasis is an important component of the MoA of <b>45</b>.</div><div class="NLM_p last">In summary, our data suggest that upon exposure to 2-pyrazolylpyrimidinones, <i>Mtb</i> goes into an iron-starvation state. As expected, it upregulates genes involved in the mycobactin (siderophore) synthesis pathway and its regulation. Siderophores are small, high-affinity iron-chelating compounds secreted by microorganisms such as bacteria and fungi. In the process of cellular uptake, the Fe<sup>3+</sup>-siderophore complex is subsequently reduced to Fe<sup>2+</sup> to release the iron.</div></div><div id="sec2_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Iron Plays a Significant Role in the MoA</h4><div class="NLM_p">To confirm the role of iron in the MoA of this series, an Fe rescue experiment was performed by supplementing standard Middlebrook 7H9/Glu/CAS/Tx media with 200 μM ferric ammonium citrate. The supplementation of Fe<sup>3+</sup> resulted in a 4-fold increase in the MIC (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_001.pdf" class="ext-link">Table S5</a>). Under physiological conditions, iron can exist in either the reduced ferrous (Fe<sup>2+</sup>) form or the oxidized ferric (Fe<sup>3+</sup>) form. The redox potential of Fe<sup>2+</sup>/Fe<sup>3+</sup> makes iron extremely versatile when it is incorporated into proteins as a catalytic center or as an electron carrier. Thus, iron is important for numerous biological processes, which include the tricarboxylic acid cycle, gene regulation, DNA biosynthesis, and so forth. Although iron is abundant in nature, it does not normally occur in its biologically relevant but aerobically unstable ferrous form. To evaluate this, we supplemented the <i>Mtb</i> culture with 200 μM ferrous sulfate, resulting in an 8-fold increase in the MIC for <b>45</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_001.pdf" class="ext-link">Table S5</a>). Next, we confirmed the ability of Fe<sup>2+</sup> to rescue the <i>Mtb</i> from <b>45</b> toxicity in a checkerboard (2D) assay using GAST (glycerol-alanine-salts-Tween 80) media which is devoid of Fe unlike Middlebrook 7H9/Glu/CAS/Tx (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). The inhibition of <i>Mtb</i> growth by <b>45</b> in GAST medium supplemented with 12.5 μM Fe<sup>+2</sup> (MIC 0.12 μM) decreased in a dose-dependent manner with increasing concentration of Fe<sup>2+</sup> and resulted in a ≥32-fold increase in MIC at 100/200 μM Fe<sup>2+</sup>. To determine that <b>45</b> forms a complex with Fe<sup>2+</sup>, we performed UV–vis scanning of <b>45</b> with increasing amounts of Fe<sup>2+</sup> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). The band intensity at 270, which was observed for <b>45</b> alone, decreased after the addition of Fe<sup>2+</sup>, whereas the absorbance around 285 is shifted to 300 with the increase in intensity, indicating the formation of the <b>45</b>-Fe<sup>2+</sup> complex.</div><figure id="fig4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Fe<sup>2+</sup> plays a critical role in the MoA of <b>45</b>. (A) Fe<sup>2+</sup> rescue of <i>Mtb</i> from growth inhibition mediated by <b>45</b>. (B) Spectroscopic titration of <b>45</b> with Fe<sup>2+</sup>. The data are representative of two biological replicates performed in duplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In line with the observation of better rescue with ferrous than ferric iron and a preference of heme for the former, there is a strong possibility that the compound binds iron to form a heme-like complex that enters <i>Mtb</i> via MmpL3. This also supports the reason for resistance with some of the MmpL3 mutants as described previously—heme prefers ferrous over ferric. Involvement of a heme-like structure could also explain the associated cytotoxicity of the series, as described earlier. This is because of the toxic nature of heme to eukaryotic cells, which require specific heme-binding proteins to maintain a nontoxic homeostasis.</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57418" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57418" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Whole-cell phenotypic screening of MMV compound library led to the identification of 2-pyrazolylpyrimidinones with potent antitubercular activity and a novel mode of action. Detailed SAR studies identified several compounds with potent activity against <i>Mtb</i> with moderate to high aqueous solubility and excellent <i>in vitro</i> microsomal stability. The compounds were bactericidal against replicating <i>Mtb</i> and retained potency against clinical isolates. Transcriptional profiling suggested that upon exposure to 2-pyrazolylpyrimidinones, <i>Mtb</i> goes into an iron-starvation state that may account for lethality. Iron supplementation using a high concentration of ferrous salts showed shifts in MICs of the compounds, further confirming that 2-pyrazolylpyrimidinones perturbs the Fe-homeostasis in <i>Mtb</i>. Further optimization of pharmacokinetic properties, along with improved SI between MIC and mammalian cytotoxicity, is needed to identify a compound suitable for <i>in vivo</i> efficacy studies in mouse TB models and eventual development as a viable drug useful for the treatment of TB in humans.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08542" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08542" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> MIC Testing and Triage Assays</h3><div class="NLM_p last">Unless otherwise indicated, an Alamar Blue fluorescence-based broth microdilution assay was used to assess MIC of compounds against <i>Mtb</i> strains, as described previously.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> Rifampicin was included as a control. Biology triage assays were carried out as described by Naran et al.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> MICs against Mutant Strains</h3><div class="NLM_p last">MICs were determined after 5 days of growth in Middlebrook 7H9 medium plus OADC supplement and 0.05% w/v Tween 80 as described previously.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Growth was monitored by OD. Data were fit using the Levenberg–Marquardt least-squares plot. MIC was defined as the concentration required to inhibit growth by 90%.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> RNA Extraction and Transcriptional Profiling</h3><div class="NLM_p">Total RNA was extracted from <i>Mtb</i> H37Rv that had been treated for 6 h with 1× and 10× MIC of the compound or vehicle control as previously described.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> RNA quality was confirmed by UV spectral analysis and Agilent 2100 Bioanalyzer returning a RNA integrity number of 8 or higher. Fluorescent-tagged cDNA was prepared via a direct random-primed labeling method as follows. To 4.0 μg of RNA, 4.5 μg of a random hexamer (Invitrogen# 48190-011) was added, a final volume of 14.5 μL, heat denatured at 70 °C for 5 min then immediately cooled to 0 °C on ice. cDNA synthesis and fluorophore (Cy3 or Cy5) incorporation were carried out using the following reverse transcription reaction components 5 μL of 5× First-Strand buffer, 1.25 μL of 0.1 M DTT, 2.5 μL of dNTP mix (made by 5 mM each of dATP, dGTP), dTTP, 0.5 mM dCTP, plus 1 μL of 200 U/μL SuperScriptIII (Invitrogen# 18080-044), 1 μL of 40 U/μL RNAseOut, and 1 μL of Cy3 or Cy5-dCTP (GE# PA55321) were added for incubation at 25 °C for 5 min and at 48 °C for 90 min. Template RNA was chemically hydrolyzed by 5 μL of 1 M NaOH and heated at 70 °C for 15 min. The hydrolysis reaction was neutralized with 5 μL of 1 M HCl. The labeled cDNA was purified on an Amicon Ultra-0.5 column (Millipor# C82301) following the manufacturer’s recommendations for PCR purification. cDNA yields and dye incorporation were measured with a Nanodrop ND-1000. A mixture of equal amounts (0.7 μg) of Cy3- and Cy5-labeled cDNA was loaded into hybridization chambers for incubation with an Agilent SurePrint G3 4x44K custom oligonuclotide microarray (design number 021966, 021362).</div><div class="NLM_p last">Microarrays were hybridized robotically using a TECAN HS Pro 4800 hybridization station, Agilent 2× gene expression hybridization HI-RPM buffer, and 10× blocking reagent at 65 °C for 17 h and washed with Agilent Gene Expression Wash Buffer 1 at room temperature and Gene Expression Wash Buffer 2 at 37 °C. Then, slides were dried under a nitrogen gas for 3 min at 30 °C. The slides were imaged using an Agilent high-resolution DNA microarray scanner (model G2505C) at 5 μm resolution and 100/10% PMT dual scanning for XDR extended dynamic range. Agilent Feature Extraction software was used for image analysis.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> DMPK</h3><div class="NLM_p last">All protocols for <i>in vitro</i> DMPK studies and mouse PK studies are available in the supplementary document. Animal studies were conducted following guidelines and policies as stipulated in the UCT Research Ethics Code for Use of Animals in Research and Teaching, after review and approval of the experimental protocol by the UCT Senate Animal Ethics Committee (protocol FHS-AEC 013/032).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Chemistry</h3><div class="NLM_p">All commercial reagents were purchased from Sigma-Aldrich, Combi-Blocks, Enamine, or Fluorochem and were used without further purification. Solvents were used as received unless otherwise stated. Analytical thin-layer chromatography was performed on SiO2 plates on aluminum backing. Visualization was accomplished by UV irradiation at 254 and 220 nm. Flash column chromatography was performed using a Teledyne ISCO flash purification system with SiO<sub>2</sub> 60 (particle size 0.040–0.055 mm, 230–400 mesh). Purity of all final derivatives for biological testing was confirmed to be >95% as determined using an Agilent 1260 Infinity binary pump, Agilent 1260 Infinity diode array detector (DAD), Agilent 1290 Infinity column compartment, Agilent 1260 Infinity standard autosampler, and Agilent 6120 quadrupole (single) mass spectrometer, equipped with APCI and ESI multimode ionization sources. Using a Kinetex Core C18 2.6 μm column (50 mm × 3 mm); mobile phase B of 0.4% acetic acid, 10 mM ammonium acetate in a 9:1 ratio of HPLC grade methanol and type 1 water, mobile phase A of 0.4% acetic acid in 10 mM ammonium acetate in HPLC grade (type 1) water, with a flow rate of 0.9 mL/min, DAD; or an Agilent UPLC–MS was used: Agilent Technologies 6150 quadrupole, ES ionization, coupled with an Agilent Technologies 1290 Infinity II series UPLC system Agilent 1290 series HPLC at two wavelengths 254 and 290 nm using the following conditions: Kinetex 1.7 μm Evo C18 100A, LC column 50 mm × 2.1 mm, solvent A of 0.1% (formic acid) water, and solvent B of 0.1% (formic acid) acetonitrile. The structures of the intermediates and end products were confirmed by <sup>1</sup>H NMR and mass spectrometry. Proton magnetic resonance spectra were determined in an appropriate deuterated solvent on a Varian Mercury spectrometer at 300 MHz or a Varian Unity spectrometer at 400 MHz.</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-6-phenylpyrimidin-4(3<i>H</i>)-one (<b>1</b>)</h4><div class="NLM_p last">A mixture of 2-hydrazinyl-6-phenylpyrimidin-4(3<i>H</i>)-one (<b>56a</b> 0.2 g, 0.989 mmol) and pentane-2,4-dione (0.121 mL, 1.187 mmol) was heated in a mixture of ethanol (0.5 mL) and acetic acid (1.5 ml) at 100 °C for 16 h. After cooling to room temperature, the reaction mixture was poured into ice cooled water and stirred for 30 min. Solids formed were filtered, washed with water, and dried to yield <b>1</b> as a white solid (200 mg, 0.744 mmol, 75% yield). HPLC purity: >99%. LC–MS APCI: calcd for C<sub>15</sub>H<sub>14</sub>N<sub>4</sub>O, 266.304; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 267.1. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.01–7.97 (m, 2H), 7.53–7.50 (m, 3H), 6.73 (s, 1H), 6.12 (s, 1H), 2.55 (s, 3H), 2.32 (s, 3H).</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 6-Methyl-2-(3-methyl-5-(<i>p</i>-tolylamino)-1<i>H</i>-pyrazol-1-yl)pyrimidin-4(3<i>H</i>)-one (<b>2</b>)</h4><div class="NLM_p last">Compound was received from the MMV screening library. For synthesis and analytical data, please refer WO2012154880.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-4-methoxy-6-phenylpyrimidine (<b>3</b>)</h4><div class="NLM_p last">DIAD (0.110 mL, 0.563 mmol) was added dropwise to a solution of 2-(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)-6-phenylpyrimidin-4(3<i>H</i>)-one (<b>1</b>) (100 mg, 0.376 mmol), triphenylphosphine (148 mg, 0.563 mmol) in methanol (12.03 mg, 0.376 mmol), and tetrahydrofuran (100 mL), and the reaction mixture was stirred at room temperature for 4 h. The mixture was concentrated under reduced pressure, the residue partitioned between dichloromethane and water, and the layers separated. The aqueous phase was extracted with dichloromethane, the combined organic solutions washed consecutively with water, 2 N aqueous sodium hydroxide, water, and finally brine. The solution was then dried over sodium sulfate and evaporated under reduced pressure. The crude product was purified on an ISCO system using a 4 g silicycle column and eluting with a gradient 0 to 70% ethyl acetate in hexane over 20 min to yield <b>3</b> as a white solid (27 mg, 0.09 mmol, 24% yield). HPLC purity: 95%. LC–MS APCI: calcd for C<sub>16</sub>H<sub>16</sub>N<sub>4</sub>O, 280.33; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 281.1. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.99–7.96 (m, 2H), 7.49–7.47 (m, 3H), 6.92 (s, 1H), 6.31 (br s, 1H), 6.08 (s, 1H), 3.56 (s, 3H), 2.50 (s, 3H), 2.33 (s, 3H).</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-3-methyl-6-phenylpyrimidin-4(3<i>H</i>)-one (<b>4</b>)</h4><div class="NLM_p last">To a stirred solution of 2-(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)-6-phenylpyrimidin-4(3<i>H</i>)-one (<b>1</b>) (50 mg, 0.188 mmol) in DMF (2 mL) was added potassium carbonate (52 mg, 0.563 mmol). The reaction mixture was stirred for 5 min and iodomethane (35 μL, 0.563 mmol) was added. The reaction mixture was stirred at 100 °C overnight. The reaction mixture was extracted with ethyl acetate (3 × 10 mL). The combined organic layer was washed with LiCl solution (1 × 10 mL) and dried over sodium sulfate, and the solvent was evaporated. The obtained residue was purified by flash chromatography by using 15% ethyl acetate in hexane obtained <b>4</b> as a white solid (39 mg, 0.141 mmol, 75% yield). HPLC Purity: 96%. LC–MS APCI: calcd for C1<sub>6</sub>H<sub>16</sub>N<sub>4</sub>O, 280.33; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 281.1. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.01–7.97 (m, 2H), 7.53–7.50 (m, 3H), 6.73 (s, 1H), 6.18 (s, 1H), 3.52 (s, 3H), 2.55 (s, 3H), 2.32 (s, 3H).</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 6-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-4-phenylpyridin-2(1<i>H</i>)-one (<b>5</b>)</h4><div class="NLM_p last">To a cooled solution of crude <b>61</b> (0.40 g, 1.43 mmol) in methanol (7 mL) was added boron tribromide (1 M solution in dichloromethane) (4.2 mL, 4.29 mmol) and stirred for 16 h at room temperature. Water was added to the reaction mixture and extracted with dichloromethane. The combined organic phase was dried over sodium sulfate, concentrated under vacuum, and purified by preparative HPLC to give <b>5</b> as a white solid (0.08 g, 21%). HPLC purity: 98.6%. LC–MS APCI: calcd for C<sub>16</sub>H<sub>15</sub>N<sub>3</sub>O, 265.122; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 266.2. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.38 (br s, 1H), 7.64–7.62 (m, 2H), 7.51–7.47 (m, 3H), 6.76 (s, 1H), 6.70 (s, 1H), 6.07 (s, 1H), 2.58 (s, 3H), 2.3 (s, 3H).</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-6-phenylpyridin-4(1<i>H</i>)-one (<b>6</b>)</h4><div class="NLM_p last">Synthesized from intermediate <b>62</b> with a protocol similar to the one described for compound <b>5</b>. Yield 25% (white solid); HPLC purity: 98.9%. LC–MS APCI: calcd for C<sub>16</sub>H<sub>15</sub>N<sub>3</sub>O, 265.122; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 266.2. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.49 (br s, 1H), 7.96 (d, <i>J</i> = 6.4 Hz, 2H), 7.46–7.40 (m, 4H), 7.11 (s, 1H), 6.07 (s, 1H), 2.70 (s, 3H), 2.35 (s, 3H).</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 6-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-4-phenylpyrimidin-2(1<i>H</i>)-one (<b>7</b>)</h4><div class="NLM_p last">To the solution of 2-chloro-4-(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)-6-phenylpyrimidine (intermediate <b>65</b>, 0.16 g, 0.56 mmol) in THF (2 mL) was added 2 M aqueous NaOH solution (2 mL) at room temperature, and the mixture was heated at 80 °C for 4 h. The reaction mixture was then cooled in ice-bath and acidified with glacial acetic acid. The precipitated solid was filtered under vacuum, washed with chilled water, and dried to get 6-(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)-4-phenylpyrimidin-2(1<i>H</i>)-one (<b>7</b>, 0.12 g, 80% yield) as a white crystalline powder. HPLC purity: 99.2%. LC–MS APCI: calcd for C<sub>15</sub>H<sub>14</sub>N<sub>4</sub>O, 266.117; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 267.2. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.11 (m, 2H), 7.53 (m, 3H), 6.92 (s, 1H), 6.26 (s, 1H), 2.71 (s, 3H), 2.23 (s, 3H).</div></div><div id="sec4_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-5-methyl-6-phenylpyrimidin-4(3<i>H</i>)-one (<b>8</b>)</h4><div class="NLM_p last">Synthesized from intermediate <b>56b</b> following a protocol similar to compound <b>1</b>. Yield 10% (white solid). HPLC purity: 97%. LC–MS APCI: calcd for C<sub>16</sub>H<sub>16</sub>N<sub>4</sub>O, 280.331; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 281.1. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.68–7.58 (m, 2H), 7.55–7.39 (m, 3H), 6.05 (s, 1H), 2.69 (s, 3H), 2.30 (s, 3H), 2.19 (s, 3H).</div></div><div id="sec4_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-6-methyl-5-phenylpyrimidin-4(3<i>H</i>)-one (<b>9</b>)</h4><div class="NLM_p last">Synthesized from intermediate <b>56h</b> following a protocol similar to compound <b>1</b>. Yield 10% (white solid). HPLC purity: 98.9%. LC–MS APCI: calcd for C<sub>16</sub>H<sub>16</sub>N<sub>4</sub>O, 280.132; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 281.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.59 (s, 1H), 7.27–7.44 (m, 5H), 6.05 (s, 1H), 2.71 (s, 3H), 2.26 (s, 3H), 2.22 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): 13.63, 15.08, 22.99, 111.38, 122.18, 127.70, 128.36, 130.17, 133.72, 143.40, 145.66, 151.82, 161.01, 161.19.</div></div><div id="sec4_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)quinazolin-4(3<i>H</i>)-one (<b>10</b>)</h4><div class="NLM_p last">Synthesized from 2-hydrazineylquinazolin-4(3<i>H</i>)-one following a protocol similar to compound <b>1</b>. Yield 47% (white solid). HPLC purity: 96.3%. LC–MS APCI: calcd for C<sub>13</sub>H<sub>12</sub>N<sub>4</sub>O, 240.10; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 241.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.92 (s, 1H), 8.11 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 7.81 (ddd, <i>J</i> = 8.5, 7.2, 1.6 Hz, 1H), 7.65 (d, <i>J</i> = 8.1 Hz, 1H), 7.53–7.43 (m, 1H), 6.27 (s, 1H), 2.69 (s, 3H), 2.26 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.68, 151.04, 147.19, 143.23, 139.59, 135.19, 126.65, 126.46, 118.79, 115.59, 111.34, 14.74, 13.85.</div></div><div id="sec4_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-6-methylpyrimidin-4(3<i>H</i>)-one (<b>11</b>)</h4><div class="NLM_p last">Synthesized from intermediate <b>56c</b> following a protocol similar to compound <b>1</b>. Yield 78% (white solid). HPLC purity: 96%. LC–MS APCI: calcd for C<sub>10</sub>H<sub>12</sub>N<sub>4</sub>O, 204.23; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 205.1 <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 6.73 (s, 1H), 6.12 (d, 1H), 2.55 (s, 3H), 2.32 (s, 3H), 2.23 (d, 1H).</div></div><div id="sec4_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>12</b>)</h4><div class="NLM_p last">Synthesized from intermediate <b>56d</b> following a protocol similar to compound <b>1</b>. Yield 70% (white solid). HPLC purity: 98.9%. LC–MS APCI: calcd for C<sub>10</sub>H<sub>9</sub>F<sub>3</sub>N<sub>4</sub>O, 258.07; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 259.0. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 6.79 (s, 1H), 6.27 (s, 1H), 2.56 (s, 3H), 2.23 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.83, 14.77, 111.89, 119.62, 122.34, 143.71, 152.04.</div></div><div id="sec4_5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-(3-Methyl-5-oxo-2,5-dihydro-1<i>H</i>-pyrazol-1-yl)-6-phenylpyrimidin-4(1<i>H</i>)-one (<b>13</b>)</h4><div class="NLM_p last">A mixture of 2-hydrazineyl-6-phenylpyrimidin-4(1<i>H</i>)-one (<b>56a</b>, 150 mg, 0.742 mmol) and ethyl acetoacetate (0.114 mL, 0.890 mmol) was heated in a mixture of ethanol: acetic acid, 1:3, under reflux for 5 h. The solid product obtained after cooling and pouring onto ice-cold water was filtered off, washed with water, and crystallized from ethanol to give <b>13</b> as a white solid (39 mg, 0.148 mmol, 20% yield). HPLC purity 93%. LC–MS APCI: calcd for C<sub>14</sub>H<sub>12</sub>N<sub>4</sub>O<sub>2</sub>, 268.27; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 269.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.22–8.20 (m, 2H), 7.54–7.51 (m, 2H), 6.74 (s, 1H), 5.31 (s, 1H), 2.29 (s, 3H).</div></div><div id="sec4_5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-(5-Amino-3-methyl-1<i>H</i>-pyrazol-1-yl)-6-phenylpyrimidin-4(1<i>H</i>)-one (<b>14</b>)</h4><div class="NLM_p last">2-Hydrazineyl-6-phenylpyrimidin-4(1<i>H</i>)-one <b>56a</b> (0.1 g, 0.495 mmol) and 3-aminocrotonitrile (0.042 g, 0.519 mmol) were stirred in ethanol (5 mL) and refluxed for 5 h. The solvent was removed, and the crude product was recrystallized from methanol to afford <b>14</b> as a white solid (55 mg, 0.742 mmol, 42% yield). HPLC purity: 97%. LC–MS APCI: calcd for C<sub>14</sub>H<sub>13</sub>N<sub>5</sub>O, 267.29; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 268.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.04–7.92 (m, 2H), 7.60–7.49 (m, 3H), 6.91 (s, 2H), 6.73 (s, 1H), 5.35 (s, 1H), 2.13 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 192.03, 152.67, 151.14, 136.44, 131.20, 129.40, 127.22, 89.28, 14.37.</div></div><div id="sec4_5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-(3-Methyl-1-(4-oxo-6-phenyl-1,4-dihydropyrimidin-2-yl)-1<i>H</i>-pyrazol-5-yl)acetamide (<b>15</b>)</h4><div class="NLM_p last">A mixture of 2-(5-amino-3-methyl-1<i>H</i>-pyrazol-1-yl)-6-phenylpyrimidin-4(1<i>H</i>)-one (<b>14</b>, 100 mg, 0.374 mmol) and pyridine (0.04 mL, 0.442 mmol) in dichloromethane (2 mL) was treated with a solution of acetyl chloride (0.04 mL, 0.0448 mmol) in dichloromethane (1 mL). The reaction mixture was stirred at room temperature for 24 h before it was diluted with dichloromethane (5 mL). The mixture was washed with 2 N HCl (10 mL), 5% aqueous solution of NaHCO<sub>3</sub>, and brine. The organic phase was dried over sodium sulfate, filtered, and concentrated <i>in vacuo</i> to give <b>15</b> as a white solid (45 mg, 0.145 mmol, 39% yield). HPLC purity: 98%. LC–MS APCI: calcd for C<sub>16</sub>H<sub>15</sub>N<sub>5</sub>O<sub>2</sub>, 309.33; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 310.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.55 (s, 1H), 8.13–8.03 (m, 2H), 7.63–7.52 (m, 3H), 6.95 (s, 1H), 6.64 (s, 1H), 2.22 (d, <i>J</i> = 15.1 Hz, 6H).</div></div><div id="sec4_5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 6-Phenyl-2-(1<i>H</i>-pyrazol-1-yl)pyrimidin-4(3<i>H</i>)-one (<b>16</b>)</h4><div class="NLM_p last">In a 10 mL microwave vial, 2-chloro-6-phenylpyrimidin-4(3<i>H</i>)-one (<b>66</b>, 0.1 g, 0.484 mmol), 1<i>H</i>-pyrazole (0.066 g, 0.968 mmol), and cesium carbonate (0.473 g, 1.452 mmol) were mixed in 1,4-dioxane (1 mL). The vial was capped and microwaved at 100 °C for 1 h. LCMS indicated two products of the same mass (isomers from 70:30 ratio of the starting material). The reaction mixture was concentrated and purified by preparative HPLC to afford <b>16</b> as a white solid (29 mg, 0.121 mmol, 25% yield). HPLC purity: 96%. LC–MS APCI: calcd for C<sub>13</sub>H<sub>10</sub>N<sub>4</sub>O, 238.25; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 239.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.78 (d, 1H, <i>J</i> = 3 Hz), 8.24–8.20 (m, 2H), 7.89 (d, 1H, <i>J</i> = 1.2 Hz), 7.56–7.53 (m, 3H), 7.07 (s, 1H), 6.65 (dd, 1H, <i>J</i> = 3 and 1.8 Hz).</div></div><div id="sec4_5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2-(3,5-Dimethyl-1<i>H</i>-1,2,4-triazol-1-yl)-6-phenylpyrimidin-4(3<i>H</i>)-one (<b>17</b>)</h4><div class="NLM_p last">Synthesized from intermediate <b>66</b> and 3,5-dimethyl-1<i>H</i>-1,2,4-triazole following a protocol similar to compound <b>16</b>. Yield 28% (white solid). HPLC purity: 99%. LC–MS APCI: calcd for C<sub>14</sub>H<sub>13</sub>N<sub>5</sub>O, 267.29; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 268.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.95–7.93 (m, 2H), 7.63–7.57 (m, 3H), 7.22 (s, 1H), 2.80 (s, 3H), 2.32 (s, 3H).</div></div><div id="sec4_5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-(1-Methyl-1<i>H</i>-imidazole-2-yl)-6-phenylpyrimidin-4(1<i>H</i>)-one (<b>18</b>)</h4><div class="NLM_p last">1-methyl-1<i>H</i>-imidazole-2-carboximidamide (0.075 g, 0.61 mmol) and ethyl benzoylacetate (0.12 g, 0.61 mmol) were refluxed in EtOH for 2 h. The reaction was cooled, solvent was evaporated under vacuo, and the residue was purified on preparative HPLC to give 2-(1-methyl-1<i>H</i>-imidazol-2-yl)-6-phenylpyrimidin-4(1<i>H</i>)-one (<b>18</b>, 15 mg, Yield 10%) as a brown solid. HPLC purity: 94.2%. LC–MS APCI: calcd for C<sub>14</sub>H<sub>12</sub>N<sub>4</sub>O, 252.101; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 253.4, <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.99 (t, <i>J</i> = 3.6 Hz, 2H), 7.52–7.49 (m, 3H), 7.21 (s, 1H), 7.14 (s, 1H), 6.83 (s, 1H), 4.29 (s, 3H).</div></div><div id="sec4_5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-6-(4-fluorophenyl)pyrimidin-4(3<i>H</i>)-one (<b>19</b>)</h4><div class="NLM_p last">Synthesized from intermediate <b>56e</b> following a protocol similar to compound <b>1</b>. Yield 33% (white solid). HPLC purity: 93%. LC–MS APCI: calcd for C<sub>15</sub>H<sub>13</sub>FN<sub>4</sub>O, 284.29; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 285.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.18–8.14 (m, 2H), 7.58–7.32 (m, 2H), 6.89 (s, 1H), 6.26 (s, 1H), 2.71 (s, 3H), 2.24 (s, 3H), 2.09 (br s, 1H).</div></div><div id="sec4_5_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-6-(pyridin-4-yl)pyrimidin-4(3<i>H</i>)-one (<b>20</b>)</h4><div class="NLM_p last">Synthesized from intermediate <b>56f</b> following a protocol similar to compound <b>1</b>. Yield 45% (white solid). HPLC purity: 96%. LC–MS APCI: calcd for C<sub>14</sub>H<sub>13</sub>N<sub>5</sub>O, 267.29; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 268.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.76 (d, 1H, <i>J</i> = 1.5 Hz), 8.74 (d, 1H, <i>J</i> = 1.5 Hz), 8.04 (d, 1H, <i>J</i> = 1.8 Hz), 8.02 (d, 1H, <i>J</i> = 1.8 Hz), 7.07 (s, 1H), 6.28 (s, 1H), 2.72 (s, 3H), 2.25 (s, 3H).</div></div><div id="sec4_5_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-6-(pyridin-3-yl)pyrimidin-4(3<i>H</i>)-one (<b>21</b>)</h4><div class="NLM_p last">Synthesized from intermediate <b>56g</b> following a protocol similar to compound <b>1</b>. Yield 56% (white solid). HPLC purity: 99%. LC–MS APCI: calcd for C<sub>14</sub>H<sub>13</sub>N<sub>5</sub>O, 267.29; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 268.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.27 (dd, 1H, <i>J</i> = 3 and 1.5 Hz), 8.72 (dd, 1H, <i>J</i> = 6 and 3 Hz), 8.45 (dt, 1H, <i>J</i> = 9 and 3 Hz), 7.56 (ddd, 1H, <i>J</i> = 9, 6 and 1.5 Hz), 7.02 (s, 1H), 6.27 (s, 1H), 2.71 (s, 3H), 2.24 (s, 3H).</div></div><div id="sec4_5_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>-(4-(2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-6-oxo-1,6-dihydropyrimidin-4-yl)phenyl) Methanesulfonamide (<b>22</b>)</h4><div class="NLM_p last">In 1,4-dioxane (2 mL) solution of <i>N</i>-(4-(2-chloro-6-oxo-1,6-dihydropyrimidin-4-yl)phenyl)methanesulfonamide (<b>69a</b> 0.09 g, 0.300 mmol), under a nitrogen atmosphere, cesium carbonate (0.147 g, 0.450 mmol), 3,5-Dimethylpyrazole (0.035 g, 0.360 mmol), XantPhos (0.052 g, 0.090 mmol), and Tris(dibenzylideneacetone)dipalladium(0) (0.041 g, 0.045 mmol) were added, and the mixture was heated at 130 °C for 18 h in a sealed tube. The reaction mixture was cooled to room temperature, concentrated in vacuo, filtered, and washed with DCM/MeOH, (80:20) and the filtrate concentrated to yield the crude product. The crude product was dissolved in 1 mL of water and acidified with 1 M HCl, then concentrated and purified by preparative HPLC to afford <b>22</b> as an off-white solid (3 mg, 8.01 μmol, 3% yield). HPLC purity: 96%. LC–MS APCI: calcd for C<sub>16</sub>H<sub>17</sub>N<sub>5</sub>O<sub>3</sub>S, 359.40; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 360.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.00 (d, <i>J</i> = 8.4 Hz, 2H), 7.27 (d, <i>J</i> = 8.3 Hz, 2H), 6.57 (s, 1H), 6.14 (s, 1H), 3.03 (s, 3H), 2.65 (s, 3H), 2.21 (s, 3H).</div></div><div id="sec4_5_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 4-(2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-6-oxo-3,6-dihydropyrimidin-4-yl)-<i>N</i>-methylbenzamide (<b>23</b>)</h4><div class="NLM_p last">Synthesis protocol was the same as for compound <b>22</b>, starting from intermediate 4-(2-chloro-6-oxo-1,6-dihydropyrimidin-4-yl)-<i>N</i>-methylbenzamide (<b>69b</b>). Yield: 38% (white solid). HPLC purity: 97%; LC–MS APCI: calcd for C<sub>17</sub>H<sub>17</sub>N<sub>5</sub>O<sub>2</sub>, 323.128; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 324.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.27 (d, <i>J</i> = 8.5 Hz, 2H), 7.96 (d, <i>J</i> = 8.5 Hz, 2H), 6.67 (s, 1H), 6.18 (s, 1H), 2.80 (s, 3H), 2.73 (s, 3H), 2.20 (s, 3H).</div></div><div id="sec4_5_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-6-(4-(methylsulfonyl)phenyl)pyrimidin-4(1<i>H</i>)-one (<b>24</b>)</h4><div class="NLM_p last">Synthesis protocol was the same as for compound <b>22</b>, starting from intermediate 2-chloro-6-(4-(methylsulfonyl)phenyl)pyrimidin-4(3H)-one (<b>69c</b>). Yield: 32% (white solid). HPLC purity: 98%; LC–MS APCI: calcd for C<sub>16</sub>H<sub>16</sub>N<sub>4</sub>O<sub>3</sub>S, 344.39; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 345.1. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.52–8.42 (m, 2H), 8.09 (d, <i>J</i> = 8.3 Hz, 2H), 6.77 (s, 1H), 6.20 (s, 1H), 3.29 (s, 3H), 2.75 (s, 3H), 2.22 (s, 3H).</div></div><div id="sec4_5_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-6-(4-morpholinophenyl)pyrimidin-4(1<i>H</i>)-one (<b>25</b>)</h4><div class="NLM_p last">Synthesis protocol was the same as for compound <b>22</b>, starting from intermediate 2-chloro-6-(4-morpholinophenyl)pyrimidin-4(3<i>H</i>)-one (<b>69d</b>). Yield: 3% (white solid). HPLC purity: 95%; LC–MS APCI: calcd for C<sub>19</sub>H<sub>21</sub>N<sub>5</sub>O<sub>2</sub>, 351.41; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 352.1.<sup>1</sup>H NMR (300 MHz, Methanol-<i>d</i><sub>4</sub>): δ 8.07 (d, <i>J</i> = 8.8 Hz, 2H), 7.09 (d, <i>J</i> = 8.8 Hz, 2H), 6.63 (s, 1H), 6.14 (s, 1H), 3.86 (s, 6H), 2.76 (s, 3H), 2.27 (s, 3H), 1.91 (s, 2H).</div></div><div id="sec4_5_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-<i>N</i>-(4-fluorophenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide (<b>26</b>)</h4><div class="NLM_p last">2-(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)-<i>N</i>-(4-fluorophenyl)-6-methoxypyrimidine-4-carboxamide <b>72</b> (40 mg, 0.117 mmol) was dissolved in dichloromethane (2 mL) under N<sub>2</sub> and BBr<sub>3</sub>, 1 M in dichloromethane (0.352 mL, 0.352 mmol) was added and stirred under N<sub>2</sub> at room temperature for 48 h. The reaction was quenched with dilute HCl and diluted with dichloromethane. The dichloromethane layer was separated, and the aqueous layer was again extracted with dichloromethane. Organic layers were combined, washed with brine, and concentrated under vacuum. The residue was purified by column chromatography using 0–20% methanol in dichloromethane to give <b>26</b> as an off-white solid (12 mg, 0.035 mmol, 30% yield). HPLC purity: 96.5% LC–MS ESI: calcd for C<sub>16</sub>H<sub>14</sub>FN<sub>5</sub>O<sub>2</sub>, 327.113; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 328.10. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.80 (br s, 1H), 10.15 (br s, 1H), 7.81–7.86 (m, 2H), 7.24 (t, <i>J</i> = 9 Hz, 2H), 6.94 (s, 1H), 6.28 (s, 1H), 2.72 (s, 3H), (s, 3H).</div></div><div id="sec4_5_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-4-(4-fluorophenyl)-6-oxo-1,6-dihydropyrimidine-5-carbonitrile (<b>27</b>)</h4><div class="NLM_p last">A mixture of 4-(4-fluorophenyl)-2-hydrazinyl-6-oxo-1,6-dihydropyrimidine-5-carbonitrile <b>74</b> (50 mg, 0.204 mmol) and pentane-2,4-dione (0.025 mL, 0.245 mmol) was heated in a mixture of ethanol (0.5 mL) and acetic acid (1.5 mL) at 85 °C for 3 h. The reaction was cooled, and a yellow crystalline precipitate formed was filtered under vacuum, triturated with a small amount of ethanol, and dried to afford <b>27</b> as a light-yellow solid (37 mg, 0.120 mmol, 59% yield). HPLC purity: 95.8%. LC–MS ESI: calcd for C<sub>16</sub>H<sub>12</sub>FN<sub>5</sub>O, 309.103; observed <i>m</i>/<i>z</i> [M – H]<sup>+</sup>, 308.10. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.05–8.10 (m, 2H), 7.46 (t, <i>J</i> = 9 Hz, 2H), 6.35 (s, 1H), 2.65 (s, 3H), 2.27 (s, 3H).</div></div><div id="sec4_5_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-4-(4-fluorophenyl)-6-oxo-1,6-dihydropyrimidine-5-carboxamide (<b>28</b>)</h4><div class="NLM_p last">2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-4-(4-fluorophenyl)-6-oxo-1,6-dihydropyrimidine-5-carbonitrile <b>27</b> (50 mg, 0.162 mmol) was heated with H<sub>2</sub>SO<sub>4</sub> (0.5 mL, 9.38 mmol) for 2 h at 80 °C. The reaction mixture was then poured slowly on ice with vigorous stirring. A white precipitate was formed which was filtered, washed with cold water and cold ethanol, and dried to give <b>28</b> as a light-yellow solid (32 mg, 0.098 mmol, 60% yield). HPLC purity: >98% LC–MS ESI: calcd for C<sub>16</sub>H<sub>14</sub>FN<sub>5</sub>O<sub>2</sub>, 327.113; observed <i>m</i>/<i>z</i> [M – H]<sup>+</sup>, 326.10. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.87–7.92 (m, 2H), 7.83 (br s, 1H), 7.50 (br s, 1H), 7.32 (t, <i>J</i> = 9 Hz, 2H), 6.25 (s, 1H), 2.62 (s, 3H), 2.24 (s, 3H).</div></div><div id="sec4_5_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 2-(3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)-4-(4-fluorophenyl)-6-oxo-1,6-dihydropyrimidine-5-carboxylic Acid (<b>29</b>)</h4><div class="NLM_p last">In a 7 mL reaction vial, 2-(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)-4-(4-fluorophenyl)-6-oxo-1,6-dihydropyrimidine-5-carboxamide <b>28</b> (20 mg, 0.061 mmol) and <i>tert</i>-butyl nitrite (0.022 mL, 0.183 mmol) were stirred in acetic acid (0.5 mL) a 75 °C for 3 h. A white precipitate was formed. It was centrifuged out, washed with cold ethanol, and dried in an oven to give <b>29</b> as a white solid (12 mg, 0.037 mmol, 60% yield). HPLC purity: >99% LC–MS ESI: calcd for C<sub>16</sub>H<sub>13</sub>FN<sub>4</sub>O<sub>3</sub>, 328.097; observed <i>m</i>/<i>z</i> [M – H]<sup>+</sup>, 327.10. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.77–7.81 (m, 2H), 7.35 (t, <i>J</i> = 9 Hz, 2H), 6.27 (s, 1H), 2.62 (s, 3H), 2.24 (s, 3H).</div></div><div id="sec4_5_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 2-(5-Ethyl-3-methyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>30</b>)</h4><div class="NLM_p last">Synthesized from <b>56d</b> and hexane-2,4-dione following a protocol similar to compound <b>1</b>. Yield: 35% (white solid). HPLC purity: 99%. LC–MS APCI: calcd for C<sub>11</sub>H<sub>11</sub>F<sub>3</sub>N<sub>4</sub>O, 272.088; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 272.8. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 6.71 (s, 1H), 6.27 (s, 1H), 3.04 (q, <i>J</i> = 1.60 Hz, 2H), 2.58 (s, 1H), 2.24 (s, 2H), 1.22 (t, <i>J</i> = 7.20 Hz, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.22, 13.38, 13.89, 21.53, 108.02, 110.15, 110.32, 149.74, 151.87.</div></div><div id="sec4_5_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 2-(5-Cyclopropyl-3-methyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>31</b>)</h4><div class="NLM_p last">Synthesized from <b>56d</b> and 1-cyclopropylbutane-1,3-dione following a protocol similar to compound <b>1</b>. Yield: 30% (white solid). HPLC purity: 98.4%. LC–MS APCI: calcd for C<sub>12</sub>H<sub>11</sub>F<sub>3</sub>N<sub>4</sub>O, 284.088; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 285.4. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 6.75 (s, 1H), 6.09 (s, 1H), 2.20 (s, 3H), 0.94–0.99 (m, 2H), 0.70–0.72 (m, 2H).</div></div><div id="sec4_5_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-(3-Methyl-5-phenyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>32</b>)</h4><div class="NLM_p last">Synthesized from <b>56d</b> and 1-phenylbutane-1,3-dione following a protocol similar to compound <b>1</b>. Yield: 39% (white solid). HPLC purity: 98.5%. LC–MS APCI: calcd for C<sub>15</sub>H<sub>11</sub>F<sub>3</sub>N<sub>4</sub>O, 320.088; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 320.8. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 13.59 (s, 1H), 7.34–7.42 (m, 5H), 6.84 (s, 1H), 6.59 (s, 1H), 2.51 (s, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.82, 108.53, 111.52, 119.39, 121.94, 128.40, 128.81, 129.18, 130.59, 130.59, 146.20, 151.83, 153.0.</div></div><div id="sec4_5_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 2-(5-Amino-3-methyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>33</b>)</h4><div class="NLM_p last">To a solution of <b>56d</b> (0.70 g, 1.28 mmol) in DMF was added 3-aminocrotonitrile (0.70 g, 8.43 mmol) and heated to 100 °C for 16 h. Water was added, extracted with ethyl acetate, and the combined organic layer was washed with saturated sodium bicarbonate solution, water, and brine solution, dried over sodium sulfate, and concentrated under vacuum. The crude product was purified by preparative HPLC to yield <b>33</b> as a white solid (0.076 g, 23%). HPLC purity: 95.5%. LC–MS APCI: calcd for C<sub>9</sub>H<sub>8</sub>F<sub>3</sub>N<sub>5</sub>O, 259.068; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 259.8. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.15 (s, 2H), 6.30 (s, 1H), 5.23 (s, 1H), 2.08 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 14.34, 88.68, 105.72, 120.24, 122.97, 151.14, 151.32, 151.55, 151.88, 156.03, 168.05.</div></div><div id="sec4_5_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 2-(5-(Ethylamino)-3-methyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>34</b>)</h4><div class="NLM_p last">To a solution of <b>33</b> (0.20 g, 0.77 mmol), acetic acid (0.14 g, 2.30 mmol) in DMF (5 mL) and acetaldehyde (0.10 g, 2.31 mmol) were added and the reaction was allowed to stir at room temperature for 16 h. Sodium cyanoborohydride (0.24 g, 3.86 mmol) in methanol (2 mL) was added and stirred at room temperature overnight. The reaction mixture was concentrated, water was added, and extracted with ethyl acetate. The organic layer was concentrated and purified by preparative HPLC to give <b>34</b> as a white solid (0.07 g, 32%). HPLC purity: 95.2%; LC–MS APCI: calcd for C<sub>11</sub>H<sub>12</sub>F<sub>3</sub>N<sub>5</sub>O, 287.099; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 288.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.14 (s, 1H), 6.48 (s, 1H), 5.19 (s, 1H), 3.23 (q, <i>J</i> = 6.40 Hz, 2H), 2.19 (s, 3H), 1.32 (t, <i>J</i> = 7.20 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): δ 12.56, 13.40, 39.09, 104.82, 119.62, 122.34, 152.30, 152.51, 152.85, 153.14, 155.01.</div></div><div id="sec4_5_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 2-(5-Ethoxy-3-methyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>35</b>)</h4><div class="NLM_p last">To solution of sulphonyl intermediate <b>79</b> (0.50 g, 2.06 mmol) and cesium carbonate (1.6 g, 5.16 mmol) in 1,4-dioxane was added <b>78</b> (0.52 g, 4.12 mmol) in sealed tube and heated to 100 °C for 16 h. Solids were filtered through Celite and the filtrate concentrated under vacuum. The crude product was purified by preparative HPLC to afford <b>35</b> as a white solid (0.07 g, 12%). HPLC purity: 95%; LC–MS APCI: calcd for C<sub>11</sub>H<sub>11</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub>, 288.083; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 288.8. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.43 (s, 1H), 6.53 (s, 1H), 5.80 (s, 1H), 4.28 (q, <i>J</i> = 7.20 Hz, 2H), 2.67 (s, 3H), 1.43 (t, <i>J</i> = 7.20 Hz, 3H).</div></div><div id="sec4_5_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 2-(5-((2-(Dimethylamino)ethyl)amino)-3-methyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>36</b>)</h4><div class="NLM_p last">To a solution of <b>76a</b> (0.10 g, 0.49 mmol) in ethanol (2.5 mL) and acetic acid (7.5 mL) was added 2-hydrazinyl-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>56d</b>, 0.09 g, 0.49 mmol) and heated to reflux for 5 h. The solvent was evaporated under vacuum. The crude product was purified with preparative HPLC to yield <b>36</b> as a white solid (0.06 g, 0.181 mmol, 37% yield). HPLC purity: 99.2%. LC–MS APCI: calcd for C<sub>13</sub>H<sub>17</sub>F<sub>3</sub>N<sub>6</sub>O, 330.142; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 331.0. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.65 (s, 1H), 6.48 (s, 1H), 5.17 (s, 1H), 3.21 (q, <i>J</i> = 6.00 Hz, 2H), 2.60 (t, <i>J</i> = 6.00 Hz, 2H), 2.31 (s, 6H), 2.19 (s, 3H).</div></div><div id="sec4_5_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 2-(5-((2-Hydroxyethyl)amino)-3-methyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>37</b>)</h4><div class="NLM_p last">A protocol similar to compound <b>36</b>. Yield: 16% (white solid). HPLC purity: 97.28%; LC–MS APCI: calcd for C<sub>11</sub>H<sub>12</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub>, 303,094; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 304.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.45 (s, 1H), 6.68 (s, 1H), 5.44 (s, 1H), 3.58 (t, <i>J</i> = 5.20 Hz, 2H), 3.21 (t, <i>J</i> = 5.20 Hz, 2H), 2.16 (s, 3H).</div></div><div id="sec4_5_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 2-(5-((2-Methoxyethyl)amino)-3-methyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>38</b>)</h4><div class="NLM_p last"><i>Step 1:</i> To a −5 °C cooled solution of 4-methyleneoxetan-2-one (1.0 g, 11.90 mmol) in tetrahydrofuran (10 mL) was added 2-methoxyethylamine (0.90 g, 11.30 mmol) and stirred for 30 min. The solvent was evaporated under vacuum. The crude product was purified by column chromatography using 3–5% methanol in dichloromethane to afford <i>N</i>-(2-methoxyethyl)-3-oxobutanamide (1.2 g, 7.50 mmol, 63%). LC–MS APCI: calcd for C<sub>7</sub>H<sub>13</sub>NO<sub>3</sub>, 159.19; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 160.2. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.13 (s, 1H), 3.29–3.36 (m, 4H), 3.20–3.27 (m, 5H), 2.13 (s, 3H). <i>Step 2:</i> To a solution of <i>N</i>-(2-methoxyethyl)-3-oxobutanamide (0.50 g, 3.14 mmol) in tetrahydrofuran (10 mL) was added Lawesson’s reagent (1.40 g, 3.45 mmol) and stirred for 30 min at room temperature under a nitrogen atmosphere. Hydrazine <b>33</b> (0.61 g, 3.45 mmol) was added to the reaction mixture and stirred at room temperature for 24 h. The reaction was quenched with saturated sodium bicarbonate solution and extracted with ethyl acetate. The combined organic phase was washed with water and brine, dried over sodium sulfate, and concentrated under vacuum. The crude product was purified by preparative HPLC to yield <b>38</b> as a white solid (0.065 g, 0.22 mmol. 7% yield). HPLC purity: 98.9%. LC–MS APCI: calcd for C<sub>12</sub>H<sub>14</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub>, 317.110; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 318.0. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.71 (s, 1H), 6.45 (s, 1H), 5.37 (s, 1H), 3.52 (t, <i>J</i> = 5.20 Hz, 2H), 3.27–3.33 (m, 5H), 2.13 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 14.44, 44.66, 58.52, 70.51, 87.07, 106.26, 120.03, 122.75, 151.28, 152.24, 154.78, 166.47.</div></div><div id="sec4_5_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 2-(3-Methyl-5-((tetrahydro-2<i>H</i>-pyran-4-yl)amino)-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>39</b>)</h4><div class="NLM_p last">A protocol similar to compound <b>36</b>. Yield: 20% (white solid). HPLC purity: 97%. LC–MS APCI: calcd for C<sub>14</sub>H<sub>16</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub>, 343.126; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 344.1. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.35 (s, 1H), 7.54 (s, 1H), 6.53 (s, 1H), 5.23 (s, 1H), 3.95–4.00 (m, 2H), 3.55–3.61 (m, 2H), 0.42–3.44 (m, 1H), 2.22 (s, 3H), 2.06–2.09 (m, 2H), 1.60–1.68 (m, 2H).</div></div><div id="sec4_5_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 2-(5-((4-Fluorophenyl)amino)-3-methyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>40</b>)</h4><div class="NLM_p last">In a sealed tube <b>33</b> (0.25 g, 0.96 mmol), 1-bromo-4-fluoro benzene (0.33 g, 1.92 mmol) and cesium carbonate (0.93 g, 2.88 mmol) were taken in dioxane (10 mL). The mixture was purged with nitrogen gas for 20 min. To this tris(dibenzylideneacetone)dipalladium(0) (0.079 g, 0.08 mmol) and XantPhos (0.07 g, 0.13 mmol) was added and sealed. The reaction mixture was stirred at 120 °C for 4 h. The reaction mixture filtered through Celite and filtrate was concentrated under vacuum. The crude product was purified by preparative HPLC to obtain <b>40</b> as a white solid (0.09 g, 0.51 mmol, 26% yield). HPLC purity: 95.4%; LC–MS APCI: calcd for C<sub>15</sub>H<sub>11</sub>F<sub>4</sub>N<sub>5</sub>O, 353.090; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 354.0. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.22–7.34 (m, 2H), 6.97–7.09 (m, 2H), 6.40 (s, 1H), 5.87 (s, 1H), 2.24 (s, 3H). <sup>13</sup>C NMR (400 MHz, CD<sub>3</sub>OD): δ 14.00, 90.34, 105.40, 118.74, 121.42, 122.71, 124.14, 130.36, 138.72, 148.73, 152.72, 158.26, 160.06, 160.64, 176.68.</div></div><div id="sec4_5_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 2-(5-((2,4-Difluorophenyl)amino)-3-methyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>41</b>)</h4><div class="NLM_p last">A protocol similar to compound <b>36</b>. Yield: 8% (white solid). HPLC purity: 97.5%; LC–MS APCI: calcd for C<sub>15</sub>H<sub>10</sub>F<sub>5</sub>N<sub>5</sub>O, 371.081; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 372.4. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.46 (s, 1H), 9.81 (s, 1H), 7.31–7.34 (m, 1H), 6.92–6.99 (m, 2H), 6.58 (s, 1H), 5.81 (s, 1H), 2.27 (s, 3H).</div></div><div id="sec4_5_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 4-((3-Methyl-1-(6-oxo-4-(trifluoromethyl)-1,6-dihydropyrimidin-2-yl)-1<i>H</i>-pyrazol-5-yl)amino)benzonitrile (<b>42</b>)</h4><div class="NLM_p last">Protocol similar to compound <b>36</b>. Yield 29% (white solid). HPLC purity: 99.9%; LC–MS APCI: calcd for C<sub>16</sub>H<sub>11</sub>F<sub>3</sub>N<sub>6</sub>O, 360.30; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 361.0. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.43 (s, 1H), 7.73 (d, <i>J</i> = 8.80 Hz, 2H), 7.17 (d, <i>J</i> = 8.80 Hz, 2H), 6.17 (s, 1H), 6.06 (s, 1H), 2.21 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 14.46, 92.36, 101.50, 105.83, 116.12, 120.01, 123.59, 134.42, 143.47, 145.22, 149.10, 159.53, 171.58.</div></div><div id="sec4_5_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> <i>N</i>,<i>N</i>-Dimethyl-4-((3-Methyl-1-(6-oxo-4-(trifluoromethyl)-1,6-dihydropyrimidin-2-yl)-1<i>H</i>-pyrazol-5-yl)amino)benzamide (<b>43</b>)</h4><div class="NLM_p last">Protocol similar to compound <b>36</b>. Yield 30% (white solid). HPLC purity: 97.9%. LC–MS APCI: calcd for C<sub>18</sub>H<sub>17</sub>F<sub>3</sub>N<sub>6</sub>O<sub>2</sub>, 406.137; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 407.0. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.89 (s, 1H), 7.40 (d, <i>J</i> = 8.00 Hz, 2H), 7.09 (d, <i>J</i> = 8.00 Hz, 2H), 6.07 (s, 1H), 6.06 (s, 1H), 2.97 (s, 6H), 2.19 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 14.47, 91.18, 115.60, 128.27, 129.59, 142.49, 144.92, 149.29, 170.44, 171.90.</div></div><div id="sec4_5_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 2-(3-Methyl-5-(pyridin-4-ylamino)-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>44</b>)</h4><div class="NLM_p last">Protocol similar to compound <b>36</b>. Yield 12% (white solid). HPLC purity 99.8%; LC–MS APCI: calcd for C<sub>14</sub>H<sub>11</sub>F<sub>3</sub>N<sub>6</sub>O, 336.28; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 337.0. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.29 (s, 1H), 8.33 (d, <i>J</i> = 6.40 Hz, 2H), 6.98 (d, <i>J</i> = 6.40 Hz, 2H), 6.18 (s, 1H), 6.05 (s, 1H), 5.32 (s, 1H), 2.21 (s, 3H).</div></div><div id="sec4_5_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 2-(3-Methyl-5-(pyridin-2-ylamino)-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>45</b>)</h4><div class="NLM_p last">Protocol similar to compound <b>36</b>. Yield 38% (white solid). HPLC purity: 98.2%. LC–MS APCI: calcd for C<sub>14</sub>H<sub>11</sub>F<sub>3</sub>N<sub>6</sub>O, 336.095; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 336.8. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.55 (s, 1H), 8.36 (d, <i>J</i> = 3.20 Hz, 1H), 7.64 (t, <i>J</i> = 7.20 Hz, 1H), 6.91–6.94 (m, 2H), 6.75 (d, <i>J</i> = 7.48 Hz, 1H), 6.59 (s, 1H), 2.32 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 14.3, 96.13, 108.63, 111.78, 116.90, 137.89, 148.0, 151.95.</div></div><div id="sec4_5_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 2-(3-Methyl-5-((5-morpholinopyridin-2-yl)amino)-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>46</b>)</h4><div class="NLM_p last">A protocol similar to compound <b>36</b>. Yield 15% (white solid). HPLC purity: 99.6%. LC–MS APCI: calcd for C<sub>18</sub>H<sub>18</sub>F<sub>3</sub>N<sub>7</sub>O<sub>2</sub>, 421.147; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 422.4. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.37 (s, 1H), 8.03 (s, 1H), 7.32 (s, 1H), 6.79 (s, 1H), 6.73 (d, <i>J</i> = 8.00 Hz, 1H), 6.57 (s, 1H), 3.91 (t, <i>J</i> = 4.80 Hz, 4H), 3.13 (t, <i>J</i> = 4.40 Hz, 4H), 2.30 (s, 3H).</div></div><div id="sec4_5_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 2-(5-(Ethylamino)-3-methyl-1<i>H</i>-pyrazol-1-yl)-6-(pyridin-3-yl)pyrimidin-4(3<i>H</i>)-one (<b>47</b>)</h4><div class="NLM_p last">To a solution of 2-(5-amino-3-methyl-1<i>H</i>-pyrazol-1-yl)-6-(pyridin-3-yl)pyrimidin-4(3<i>H</i>)-one (0.10 g, 0.37 mmol), acetic acid (0.07 g, 1.11 mmol) in DMF (5 mL) and acetaldehyde (0.05 g, 1.11 mmol) were added, and reaction mixture stirred at room temperature for 16 h. Sodium cyanoborohydride (0.11 g, 1.86 mmol) in methanol (2 mL) was added, and the reaction mixture stirred at room temperature overnight. The reaction mixture was concentrated, water was added, and extracted with ethyl acetate. The organic layer was concentrated and purified by preparative HPLC to give <b>47</b> as a white solid (0.03 g, 0.299 mmol, 27%). HPLC purity 97.53%; LC–MS APCI: calcd for C<sub>15</sub>H<sub>16</sub>N<sub>6</sub>O, 296.139; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 297.2. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 9.42 (s, 1H), 8.77–8.82 (m, 2H), 7.82 (q, <i>J</i> = 5.20 Hz, 1H), 7.15 (s, 1H), 3.42 (q, <i>J</i> = 7.20 Hz, 2H), 2.40 (s, 3H), 1.39 (t, <i>J</i> = 7.20 Hz, 3H).</div></div><div id="sec4_5_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 2-(4-Bromo-3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>48</b>)</h4><div class="NLM_p last">To a solution of <b>12</b> (1.0 g, 3.87 mmol) in acetic acid (20 mL) was added bromine (0.24 mL, 4.65 mmol) at 20 °C and stirred at room temperature for 3 days. Water was added to the reaction mixture. Solids formed were filtered, washed with water, and dried. The crude product was purified by preparative HPLC to yield <b>48</b> as a white solid (0.3 g, 1.07 mmol, 23.0%). HPLC purity: 99.3%; LC–MS APCI: calcd for C<sub>10</sub>H<sub>8</sub>BrF<sub>3</sub>N<sub>4</sub>O, 335.983; observed <i>m</i>/<i>z</i> [M – H]<sup>+</sup>, 337.0; 1H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.58 (s, 1H), 6.93 (s, 1H), 2.58 (s, 3H), 2.24 (s, 3H).</div></div><div id="sec4_5_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 2-(3,5-Dimethyl-4-(pyridin-3-yl)-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>49</b>)</h4><div class="NLM_p last">A solution of <b>48</b> (0.50 g, 1.48 mmol), pyridine-3-boronic acid (0.22 g, 1.78 mmol) and potassium carbonate (0.41 g, 2.96 mmol) in tetrahydrofuran/water (20/2 mL) was repeatedly purged with nitrogen. Pd(dppf)Cl<sub>2</sub> (0.18 g, 0.22 mmol) was added and heated at 70 °C for 16 h. The reaction mixture was cooled, water was added, and extracted with ethyl acetate. Combined organic layers were washed with water and brine solution, dried over sodium sulfate, and concentrated under vacuum. The crude product was purified by preparative HPLC to yield <b>49</b> as a white solid (0.10 g, 0.36 mmol, 20% yield). HPLC purity: 99.8%; LC–MS APCI: calcd for C<sub>15</sub>H<sub>12</sub>F<sub>3</sub>N<sub>5</sub>O, 335.099; observed <i>m</i>/<i>z</i> [M – H]<sup>+</sup>, 336.1. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 400 MHz, CDCl<sub>3</sub>: δ 8.68 (d, <i>J</i> = 4.88 Hz, 1H), 8.58 (s, 1H), 7.66 (d, <i>J</i> = 7.60 Hz, 1H), 7.48 (t, <i>J</i> = 7.28 Hz, 1H), 6.64 (s, 1H), 2.68 (s, 3H), 2.29 (s, 3H).</div></div><div id="sec4_5_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 2-(3,5-Dimethyl-4-morpholino-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>50</b>)</h4><div class="NLM_p last"><i>Step 1: 3-Bromopentane-2,4-dione (</i><b><i>80</i></b><i>)</i>—To a solution of acetylacetone (1.0 g, 10.0 mmol) in acetic acid (15 mL) was added bromine (1.9 g, 12.0 mmol) at 0 °C. The reaction was heated at 60 °C for 3 h. Saturated sodium bicarbonate solution was added, and the layer was separated. The combined organic layer was washed with water, dried over sodium sulfate, and concentrated under vacuum to yield <b>80</b> as a light-yellow solid (1.2 g, 67.0%). This was taken as such to the next step without further analysis. <i>Step 2: 3-Morpholinopentane-2,4-dione (</i><b><i>81</i></b><i>)</i>—To a solution of morpholine (0.58 g, 6.70 mmol) and triethylamine (1.1 g, 11.17 mmol) in dichloromethane (10 mL) was added <b>80</b> (1.0 g, 5.58 mmol) dissolved in dichloromethane (10 mL) at 0 °C. The reaction was stirred at room temperature for 2 h. Water was added, and the layers separated. The combined organic layers were washed with water, dried over sodium sulfate, and concentrated under vacuum to yield <b>81</b> (0.80 g, 78%) as viscous brown oil. LC–MS APCI: calcd for C<sub>9</sub>H<sub>15</sub>NO<sub>3</sub>, 185.22; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 186.2. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 4.31 (s, 1H), 3.57–3.62 (m, 4H), 2.84 (d, <i>J</i> = 4.40 Hz, 2H), 2.60 (d, <i>J</i> = 4.80 Hz, 2H), 2.18 (s, 6H). <i>Step 3: 2-(3,5-Dimethyl-4-morpholino-1H-pyrazol-1-yl)-6-trifluoromethylpyrimidin-4(3H)-one (</i><b><i>50</i></b><i>)</i>—A solution of <b>81</b> (0.30 g, 1.62 mmol) and <b>56d</b> (0.31 g, 1.62 mmol) in ethanol/acetic acid mixture (15/5 mL) was refluxed for 16 h. The solvent was evaporated under vacuum. Crude product was purified by preparative HPLC to yield <b>50</b> (0.07 g, 13%). HPLC purity: 99.9%; LC–MS APCI: calcd for C<sub>14</sub>H<sub>16</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub>, 343.126; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 344.1.<sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.10 (s, 1H), 6.79 (s, 1H), 3.69 (d, <i>J</i> = 2.80 Hz, 4H), 2.96 (d, <i>J</i> = 3.60 Hz, 4H), 2.51 (s, 3H), 2.30 (s, 3H).</div></div><div id="sec4_5_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 2-(5-Amino-3-cyclopropyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>51</b>)</h4><div class="NLM_p last">To a solution of 2-hydrazinyl-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>56d</b>, 0.25, 1.28 mmol) in DMF (5 mL) was added 3-cyclopropyl-3-oxopropanenitrile (0.15 g, 1.41 mmol) and heated at 130 °C in a microwave for 1 h. The reaction mixture was poured into water and extracted with ethyl acetate. The organic layer washed with plenty of water and brine solution, dried over sodium sulfate, and concentrated in vacuo. The crude mass was purified by prep HPLC to give 2-(5-amino-3-cyclopropyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one <b>51</b> as a white solid (51 mg, 0.179 mmol, 14% yield). HPLC purity: 96%; LC–MS APCI: calcd for C<sub>11</sub>H<sub>10</sub>F<sub>3</sub>N<sub>5</sub>O, 285.084; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 286.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.54 (s, 1H), 5.79 (br s, 2H), 5.25 (s, 1H), 1.82 (t, <i>J</i> = 4.40 Hz, 1H), 1.00 (d, <i>J</i> = 8.00 Hz, 2H), 0.82 (d, <i>J</i> = 2.00 Hz, 2H).</div></div><div id="sec4_5_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 2-(3-((Dimethylamino)methyl)-5-methyl-1<i>H</i>-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4(3<i>H</i>)-one (<b>52</b>)</h4><div class="NLM_p last"><i>Step 1: ethyl 2,4-dioxopentanoate</i>—To a solution of sodium metal (0.86 g, 37.67 mmol) dissolved in ethanol (15 mL) was added a mixture of diethyl oxalate (5.0 g, 34.24 mmol) and acetone (2.0 g, 34.24 mmol) and heated at 60 °C for 16 h. The reaction mass was concentrated under vacuum, diluted with water, and the product was extracted with ethyl acetate. The organic phase was washed with water and brine, dried over sodium sulfate, and concentrated. The crude product was then purified by column chromatography using silica gel (230–400 mesh) with 10–20% ethyl acetate in petroleum ether as an eluent to yield ethyl 2,4-dioxopentanoate as yellow oil (2.1 g, 13.93 mmol, 37%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 14.40 (s, 1H), 6.39 (s, 1H), 4.37 (q, <i>J</i> = 7.20 Hz, 2H), 2.28 (s, 3H), 1.40 (t, <i>J</i> = 7.20 Hz, 3H). <i>Step 2: Ethyl 5-methyl-1H-pyrazole-3-carboxylate (</i><b><i>83</i></b><i>)</i>—To a solution of ethyl 2,4-dioxopentanoate (2.0 g, 12.65 mmol) in ethanol (10 mL) and acetic acid (20 mL) was added hydrazine hydrate (0.75 g, 15.18 mmol). The reaction mixture was heated at the reflux for 16 h. Solvents were evaporated under vacuum. Water was added, and the product was extracted with ethyl acetate. The organic layer washed with saturated sodium bicarbonate solution, water, and brine, dried over sodium sulfate, and concentrated under vacuum to afford <b>83</b> an off-white solid (1.3 g, 8.6 mmol, 68%). LC–MS APCI: calcd for C<sub>7</sub>H<sub>10</sub>N<sub>2</sub>O<sub>2</sub>, 154.17; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 154.8. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.15 (s, 1H), 6.46 (s, 1H), 4.25 (q, <i>J</i> = 7.20 Hz, 2H), 2.26 (s, 3H), 1.27 (t, <i>J</i> = 6.80 Hz, 3H). <i>Step 3: 5-methyl-1H-pyrazole-3-carbaldehyde</i>—To a solution of <b>83</b> (4.0 g, 25.97 mmol) in dichloromethane (50 mL) at −78 °C was added di-isobutylaluminiumhydride (1 M in dichloromethane, 52.0 mL, 51.94 mmol) dropwise under a nitrogen atmosphere. The reaction mixture was stirred at −78 °C for 2 h. It was then quenched with methanol at −78 °C, warmed to room temperature, and washed with water. The organic phase was dried over sodium sulfate and concentrated under vacuum to yield 5-methyl-1<i>H</i>-pyrazole-3-carbaldehyde. This material was taken as such for the next step without purification. <i>Step 4: N,N-Dimethyl-1-(5-methyl-1H-pyrazol-3-yl)methanamine (</i><b><i>84</i></b><i>)</i>—To a solution of 5-methyl-1<i>H</i>-pyrazole-3-carbaldehyde (1.0 g, 9.09 mmol) in methanol was added <i>N</i>,<i>N</i>-dimethyl amine (2a M in tetrahydrofuran, 23 mL, 45.45 mmol) and stirred for 24 h at room temperature. Sodium cyanoborohydride (1.7 g, 27.27 mmol) was added to the reaction and stirred at room temperature for another 4 h. The reaction mixture was concentrated, the crude material diluted with water, and the product was extracted with ethyl acetate. The organic layer washed with water and brine solution, dried over sodium sulfate, and concentrated under vacuum to afford <b>84</b> as a white solid (0.60 g, 4.31 mmol, 48%). LC–MS APCI: calcd for C<sub>7</sub>H<sub>13</sub>N<sub>3</sub>, 139.20; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 139.8. <i>Step 5: 2-(3-((Dimethylamino)methyl)-5-methyl-1H-pyrazol-1-yl)-6-(trifluoromethyl) pyrimidin-4(3H)-one (</i><b><i>52</i></b><i>)</i>—A solution of <b>84</b> (0.60 g, 4.31 mmol), sulfonyl intermediate <b>79</b> (0.48 g, 2.15 mmol) and cesium carbonate (2.0 g, 6.37 mmol) in 1,4-dioxane was heated in sealed tube at 130 °C for 16 h. The reaction mixture was filtered through Celite and the filtrate was concentrated under vacuum. The crude product was then purified by preparative HPLC to yield the free base as a gum. It was dissolved in dichloromethane and stirred with hydrogen chloride in 1,4-dioxane (in excess) for 2 h. Solvents were evaporated under vacuum, formed solids were washed with diethyl ether, and dried under vacuum to afford <b>52</b> (0.06 g, 9.38%) as a white hydrochloride salt. HPLC purity: 99.8%. LC–MS APCI: calcd for C<sub>12</sub>H<sub>14</sub>F<sub>3</sub>N<sub>5</sub>O, 301.115; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 302.2. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 6.83 (s, 1H), 6.59 (s, 1H), 4.43 (s, 2H), 2.98 (s, 6H), 2.75 (s, 3H).</div></div><div id="sec4_5_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 1-(4-(4-Fluorophenyl)-6-oxo-1,6-dihydropyrimidin-2-yl)-5-methyl-1<i>H</i>-pyrazole-3-carboxylic Acid (<b>53</b>)</h4><div class="NLM_p last">To solution of 6-(4-fluorophenyl)-2-(methylsulfonyl)pyrimidin-4(3<i>H</i>)-one (0.3 g, 1.118 mmol) <b>85</b> (Synthesized according to protocol for compound <b>79</b>) and cesium carbonate (0.911 g, 2.80 mmol) in DMF was added <b>83</b> (0.172 g, 1.118 mmol) in a sealed tube and heated to 130 °C in a microwave for 2 h. The reaction mixture was concentrated under vacuum and then was purified by preparative HPLC to yield <b>53</b> as an off-white solid (60 mg, 0.179 mmol, 16% yield). HPLC purity: 94%. LC–MS APCI: calcd for C<sub>15</sub>H<sub>11</sub>FN<sub>5</sub>O<sub>3</sub>, 314.27; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 315.1. <sup>1</sup>H NMR (300 MHz, Methanol-<i>d</i><sub>4</sub>): δ 8.19–8.08 (m, 2H), 7.26 (t, <i>J</i> = 8.8 Hz, 2H), 6.77 (s, 1H), 6.66 (d, <i>J</i> = 1.1 Hz, 1H), 2.93–2.82 (m, 3H).</div></div><div id="sec4_5_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 1-(4-(4-Fluorophenyl)-6-oxo-1,6-dihydropyrimidin-2-yl)-<i>N</i>,<i>N</i>,5-trimethyl-1<i>H</i>-pyrazole-3-carboxamide (<b>54</b>)</h4><div class="NLM_p last">To a solution of HATU (0.036 g, 0.095 mmol), <b>53</b> (0.02 g, 0.064 mmol) and dimethylamine (0.017 mL, 0.191 mmol) in DMF was added triethylamine (0.018 mL, 0.127 mmol) and reaction mixture was stirred at 35 °C overnight. Upon completion, the reaction mixture was concentrated <i>in vacuo</i>, washed with 10% LiCl, and the resulting precipitate was filtered to yield <b>54</b> as a white solid (5 mg, 0.014 mmol, 22% yield). HPLC purity: 96%. LC–MS APCI: calcd for C<sub>17</sub>H<sub>16</sub>FN<sub>5</sub>O<sub>2</sub>, 341.34; observed <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 342.1.<sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.21 (dd, <i>J</i> = 8.9, 5.6 Hz, 2H), 7.37 (t, <i>J</i> = 8.9 Hz, 2H), 7.08 (s, 1H), 6.64 (d, <i>J</i> = 1.0 Hz, 1H), 3.27 (s, 3H), 3.01 (s, 3H), 2.74 (d, <i>J</i> = 0.9 Hz, 3H).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01727" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01727?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01727</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthesis and analytical data of intermediates, microbiology assays, MIC data against clinical isolates, screening data against MmpL3 under-expressing strain of <i>Mtb</i>, <i>in vitro</i> DMPK assays, and mouse pharmacokinetic studies (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">LCMS HPLC and NMRs of lead compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Data from RNA microarray experiment (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_003.xlsx" class="ext-link">XLSX</a>)</p></li><li><p class="inline">Data from RNA microarray experiment (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_004.xlsx" class="ext-link">XLSX</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_005.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_001.pdf">jm0c01727_si_001.pdf (440.97 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_002.pdf">jm0c01727_si_002.pdf (1.22 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_003.xlsx">jm0c01727_si_003.xlsx (385.88 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_004.xlsx">jm0c01727_si_004.xlsx (12.7 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_005.csv">jm0c01727_si_005.csv (3.58 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01727" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83030" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83030" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kelly Chibale</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa</span>; 
    <span class="hlFld-Affiliation affiliation">South
African Medical Research Council Drug Discovery and Development Research
Unit, Department of Chemistry and Institute of Infectious Disease
and Molecular Medicine, University of Cape
Town, Rondebosch 7701, South Africa</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1327-4727" title="Orcid link">http://orcid.org/0000-0002-1327-4727</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f8939d949481d69b90919a99949db88d9b8cd6999bd68299"><span class="__cf_email__" data-cfemail="2d4648414154034e45444f4c41486d584e59034c4e03574c">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandeep R. Ghorpade</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9311-1572" title="Orcid link">http://orcid.org/0000-0002-9311-1572</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6c3f0d020809091c420b04031e1c0d08092c190f18420d0f42160d"><span class="__cf_email__" data-cfemail="3a695b545e5f5f4a145d5255484a5b5e5f7a4f594e145b5914405b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Candice Soares de Melo</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vinayak Singh</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa</span>; 
    <span class="hlFld-Affiliation affiliation">South
African Medical Research Council Drug Discovery and Development Research
Unit, Department of Chemistry and Institute of Infectious Disease
and Molecular Medicine, University of Cape
Town, Rondebosch 7701, South Africa</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9002-2489" title="Orcid link">http://orcid.org/0000-0001-9002-2489</a></span></div></li><li><div class="authorItemInformation"><sup>††</sup><span class="hlFld-ContribAuthor strong">Alissa Myrick</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandile B. Simelane</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dale Taylor</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Centre (H3D), Division of Clinical Pharmacology,
Department of Medicine, University of Cape
Town, Observatory 7925, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christel Brunschwig</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Centre (H3D), Division of Clinical Pharmacology,
Department of Medicine, University of Cape
Town, Observatory 7925, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nina Lawrence</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Centre (H3D), Division of Clinical Pharmacology,
Department of Medicine, University of Cape
Town, Observatory 7925, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dirk Schnappinger</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, Weill Cornell
Medical College, New York, New York 10065, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Curtis A. Engelhart</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, Weill Cornell
Medical College, New York, New York 10065, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anuradha Kumar</span> - <span class="hlFld-Affiliation affiliation">Infectious
Disease Research Institute, 1616 Eastlake Ave E, Suite 400, Seattle, Washington 98102, United States</span>; 
    <span>Present Address:
                        Center for Global Infectious Disease Research, Seattle Children’s Research Institute, Seattle, WA 98101, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tanya Parish</span> - <span class="hlFld-Affiliation affiliation">Infectious
Disease Research Institute, 1616 Eastlake Ave E, Suite 400, Seattle, Washington 98102, United States</span>; 
    <span>Present Address:
                        Center for Global Infectious Disease Research, Seattle Children’s Research Institute, Seattle, WA 98101, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7507-0423" title="Orcid link">http://orcid.org/0000-0001-7507-0423</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qin Su</span> - <span class="hlFld-Affiliation affiliation">Genomic
Technologies Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes
of Health, Bethesda, Maryland 20892, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy G. Myers</span> - <span class="hlFld-Affiliation affiliation">Genomic
Technologies Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes
of Health, Bethesda, Maryland 20892, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Helena I. M. Boshoff</span> - <span class="hlFld-Affiliation affiliation">Tuberculosis
Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Bethesda, Maryland 20892, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4333-206X" title="Orcid link">http://orcid.org/0000-0002-4333-206X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clifton E. Barry</span> - <span class="hlFld-Affiliation affiliation">Tuberculosis
Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederick A. Sirgel</span> - <span class="hlFld-Affiliation affiliation">South
African Medical Research Council Centre for Tuberculosis Research/DST/NRF
Centre of Excellence for Biomedical Tuberculosis Research, Division
of Molecular Biology and Human Genetics, Faculty of Medicine and Health
Science, Stellenbosch University, Tygerberg 7505, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul D. van Helden</span> - <span class="hlFld-Affiliation affiliation">South
African Medical Research Council Centre for Tuberculosis Research/DST/NRF
Centre of Excellence for Biomedical Tuberculosis Research, Division
of Molecular Biology and Human Genetics, Faculty of Medicine and Health
Science, Stellenbosch University, Tygerberg 7505, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kirsteen I. Buchanan</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tracy Bayliss</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon R. Green</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5054-4792" title="Orcid link">http://orcid.org/0000-0001-5054-4792</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter C. Ray</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul G. Wyatt</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0397-245X" title="Orcid link">http://orcid.org/0000-0002-0397-245X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory S. Basarab</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Centre (H3D), Division of Clinical Pharmacology,
Department of Medicine, University of Cape
Town, Observatory 7925, South Africa</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5684-6046" title="Orcid link">http://orcid.org/0000-0001-5684-6046</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles J. Eyermann</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>C.S.d.M. and V.S. contributed equally to the work. Chemical synthesis, compound design, and SAR expansion were performed by C.S.d.M., S.B.S., and S.R.G. Computational and compound design support was provided by C.J.E. Iron complementation experiment and the analysis was performed by V.S. Analysis and interpretation of the biology data from target deconvolution studies was performed by V.S. and A.M. In vivo PK experiments including MetID studies were performed by D.T. and C.B. In vitro DMPK data were analyzed by N.L. The cytochrome P450 inhibition experiment was performed by N.L. Screening against MmpL3 conditional knockdown mutant was conducted by C.E. and the data were analyzed by C.E. and D.S. Screening against MmpL3 mutant strains was carried out by A.K. with data analysis by A.K. and T.P. The screening of MMV compound library and RNA microarray experiment were performed by H.I.M.B. Screening conceptualization and funding support by C.E.B. Agilent microarray protocols were developed by Q.S. and T.G.M. The synthesis of initial hits was performed by K.I.B. Data analysis and compound acquisition performed by T.B. Compound design and data analysis performed by P.C.R. data analysis and manuscript review by S.R.G.. Scientific concept and funding acquisition by P.G.W. G.S.B. provided scientific and strategic guidance for the work and edited the manuscript. Introduction and target deconvolution sections of the manuscript were written by V.S. SAR, DMPK and part of synthesis and experimental sections were written by S.R.G. Synthesis and chemistry experimental sections were written by C.S.d.M, and K.C. provided inputs on compound design, SAR analysis, and edited the manuscript. All the authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>The project was funded through Global Health Grants (numbers OPP1066878 and OPP1024038) received from the Bill and Melinda Gates Foundation, the Division of Intramural Research of the NIAID/NIH and the Strategic Health Innovation Partnerships (SHIP) unit of the South African Medical Research Council (SAMRC). The University of Cape Town, SAMRC, and South African Research Chairs Initiative of the Department of Science and Technology, administered through the South African National Research Foundation are gratefully acknowledged for support (K.C.).</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><sup>††</sup>AM deceased in November 2019.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i99">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14801" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14801" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">MMV, Meyrin, Switzerland for donating the compound library. Dr. Sridevi Bashayam, Dr. Jayan Joseph, Dr. Jayanth Thiruvellore, and Rajkumar Dhinakaran, Syngene, India for profound chemistry support. Ronnett Seldon from TB biology, H3D for performing MIC and biology triage assays. Dr. Nicole Cardoso from TB biology, H3D for helping in Fe-chelation experiment. Prof. Digby Warner, University of Cape Town for useful discussions on biology triage assays, Technical staff at <i>in vitro</i> DMPK and parasitology divisions of H3D for excellent technical assistance in generating all <i>in vitro</i> DMPK and cytotoxicity data, Marianna de Kock and Claudia Spies, SAMRC and Stellenbosch University, South Africa for excellent technical assistance in generating MICs against clinical TB isolates. AbbVie Incorporation, North Chicago, IL, USA for <i>in vitro</i> safety screening. Lina Castro, Shilah Bonnett and Megha Gupta from Infectious Disease Research Institute for technical assistance and support.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BuOH</td><td class="NLM_def"><p class="first last">butanol</p></td></tr><tr><td class="NLM_term">CS<sub>2</sub></td><td class="NLM_def"><p class="first last">carbon disulfide</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">fu</td><td class="NLM_def"><p class="first last">fraction unbound</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxid hexafluorophosphate</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimum inhibitory concentration</p></td></tr><tr><td class="NLM_term">mCPBA</td><td class="NLM_def"><p class="first last"><i>meta</i>-chloroperbenzoic acid</p></td></tr><tr><td class="NLM_term">NaBH<sub>4</sub></td><td class="NLM_def"><p class="first last">NaCNBH<sub>3</sub>, sodium cyanoborohydride</p></td></tr><tr><td class="NLM_term">POCl<sub>3</sub></td><td class="NLM_def"><p class="first last">phosphorus(V) oxychloride</p></td></tr><tr><td class="NLM_term">RT</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SOCl<sub>2</sub></td><td class="NLM_def"><p class="first last">thionyl chloride</p></td></tr><tr><td class="NLM_term">TB</td><td class="NLM_def"><p class="first last">tuberculosis</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i101">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37254" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37254" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 54 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">World Health Organization</span>.  <i>Global Tuberculosis Report</i>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=World+Health+Organization&title=Global+Tuberculosis+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DGlobal%2520Tuberculosis%2520Report%26pub%3DWorld%2520Health%2520Organization%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mabhula, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span> <span> </span><span class="NLM_article-title">Drug-resistance in Mycobacterium tuberculosis: where we stand</span>. <i>Medchemcomm</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1342</span>– <span class="NLM_lpage">1360</span>, <span class="refDoi"> DOI: 10.1039/c9md00057g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1039%2FC9MD00057G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=31534654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFeqsbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1342-1360&author=A.+Mabhulaauthor=V.+Singh&title=Drug-resistance+in+Mycobacterium+tuberculosis%3A+where+we+stand&doi=10.1039%2Fc9md00057g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-resistance in Mycobacterium tuberculosis: where we stand</span></div><div class="casAuthors">Mabhula, Amanda; Singh, Vinayak</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1342-1360</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Tuberculosis (TB), an infectious disease caused by the bacterium Mycobacterium tuberculosis (Mtb), has burdened vulnerable populations in modern day societies for decades.  Recently, this global health threat has been heightened by the emergence and propagation of multi drug-resistant (MDR) and extensively drug-resistant (XDR) strains of Mtb that are resistant to current treatment regimens.  The End-TB strategy, launched by the World Health Organization (WHO), aims to reduce TB-related deaths by 90%.  This program encourages universal access to drug susceptibility testing, which is not widely available owing to the lack of lab. capacity or resources in certain under-resourced areas.  Clin. assays are further complicated by the slow growth of Mtb, resulting in the long turn-around time of tests which severely limits their application in guiding a patient's treatment regimen.  This review provides a comprehensive overview of current TB treatments, mechanisms of resistance to anti-tubercular drugs and their diagnosis and the current pipeline of drugs targeting drug-resistant TB (DR-TB) with particular attention paid to ways in which drug-resistance is combated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTopGTHhPSh7Vg90H21EOLACvtfcHk0liRanOcdQzFYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFeqsbzN&md5=0894281ecd5a9d9353f97a8ea79c3d33</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1039%2FC9MD00057G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9MD00057G%26sid%3Dliteratum%253Aachs%26aulast%3DMabhula%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DV.%26atitle%3DDrug-resistance%2520in%2520Mycobacterium%2520tuberculosis%253A%2520where%2520we%2520stand%26jtitle%3DMedchemcomm%26date%3D2019%26volume%3D10%26spage%3D1342%26epage%3D1360%26doi%3D10.1039%2Fc9md00057g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><a href="https://www.newtbdrugs.org/pipeline" class="extLink">https://www.newtbdrugs.org/pipeline</a> (accessed March 18, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.newtbdrugs.org%2Fpipeline+%28accessed+March+18%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soares
de Melo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, T.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Westhuyzen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessner, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgans, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moosa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span> <span> </span><span class="NLM_article-title">Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: structure activity relationships and ADME characterization</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">7240</span>– <span class="NLM_lpage">7250</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2Fj.bmc.2015.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=26522089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslent7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=7240-7250&author=C.+Soares%0Ade+Meloauthor=T.-S.+Fengauthor=R.+van+der+Westhuyzenauthor=R.+K.+Gessnerauthor=L.+J.+Streetauthor=G.+L.+Morgansauthor=D.+F.+Warnerauthor=A.+Moosaauthor=K.+Naranauthor=N.+Lawrenceauthor=H.+I.+M.+Boshoffauthor=C.+E.+Barryauthor=C.+J.+Harrisauthor=R.+Gordonauthor=K.+Chibale&title=Aminopyrazolo%5B1%2C5-a%5Dpyrimidines+as+potential+inhibitors+of+Mycobacterium+tuberculosis%3A+structure+activity+relationships+and+ADME+characterization&doi=10.1016%2Fj.bmc.2015.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization</span></div><div class="casAuthors">Soares de Melo, Candice; Feng, Tzu-Shean; van der Westhuyzen, Renier; Gessner, Richard K.; Street, Leslie J.; Morgans, Garreth L.; Warner, Digby F.; Moosa, Atica; Naran, Krupa; Lawrence, Nina; Boshoff, Helena I. M.; Barry, Clifton E., III; Harris, C. John; Gordon, Richard; Chibale, Kelly</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7240-7250</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Whole-cell high-throughput screening of a diverse SoftFocus library against Mycobacterium tuberculosis (Mtb) generated a novel aminopyrazolo[1,5-a]pyrimidine hit series.  The synthesis and structure activity relationship studies identified compds. with potent antimycobacterial activity.  The SAR of over 140 compds. shows that the 2-pyridylmethylamine moiety at the C-7 position of the pyrazolopyrimidine scaffold was important for Mtb activity, whereas the C-3 position offered a higher degree of flexibility.  The series was also profiled for in vitro cytotoxicity and microsomal metabolic stability as well as physicochem. properties.  Consequently liabilities to be addressed in a future lead optimization campaign have been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTbOBTZI7RdrVg90H21EOLACvtfcHk0liRanOcdQzFYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslent7zL&md5=29c1f665f7c8e2039e9ae1c9d9aa2d1e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DSoares%2Bde%2BMelo%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DT.-S.%26aulast%3Dvan%2Bder%2BWesthuyzen%26aufirst%3DR.%26aulast%3DGessner%26aufirst%3DR.%2BK.%26aulast%3DStreet%26aufirst%3DL.%2BJ.%26aulast%3DMorgans%26aufirst%3DG.%2BL.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26aulast%3DMoosa%26aufirst%3DA.%26aulast%3DNaran%26aufirst%3DK.%26aulast%3DLawrence%26aufirst%3DN.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DAminopyrazolo%255B1%252C5-a%255Dpyrimidines%2520as%2520potential%2520inhibitors%2520of%2520Mycobacterium%2520tuberculosis%253A%2520structure%2520activity%2520relationships%2520and%2520ADME%2520characterization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D7240%26epage%3D7250%26doi%3D10.1016%2Fj.bmc.2015.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessner, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moosa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seldon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizrahi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares de
Melo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simelane, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nchinda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abay, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunschwig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirgel, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Helden, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli-Disse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pflaumer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boesche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebollo-Lopez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urones, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selenski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafuente-Monasterio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axtman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelièvre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghorpade, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span> <span> </span><span class="NLM_article-title">Novel antitubercular 6-dialkylaminopyrimidine carboxamides from phenotypic whole-cell high throughput screening of a softfocus library: structure-activity relationship and target identification studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">10118</span>– <span class="NLM_lpage">10134</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01347</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01347" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVWqtbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=10118-10134&author=C.+R.+Wilsonauthor=R.+K.+Gessnerauthor=A.+Moosaauthor=R.+Seldonauthor=D.+F.+Warnerauthor=V.+Mizrahiauthor=C.+Soares+de%0AMeloauthor=S.+B.+Simelaneauthor=A.+Nchindaauthor=E.+Abayauthor=D.+Taylorauthor=M.+Njorogeauthor=C.+Brunschwigauthor=N.+Lawrenceauthor=H.+I.+M.+Boshoffauthor=C.+E.+Barryauthor=F.+A.+Sirgelauthor=P.+van+Heldenauthor=C.+J.+Harrisauthor=R.+Gordonauthor=S.+Ghidelli-Disseauthor=H.+Pflaumerauthor=M.+Boescheauthor=G.+Drewesauthor=O.+Sanzauthor=G.+Santosauthor=M.+J.+Rebollo-Lopezauthor=B.+Uronesauthor=C.+Selenskiauthor=M.+J.+Lafuente-Monasterioauthor=M.+Axtmanauthor=J.+Leli%C3%A8vreauthor=L.+Ballellauthor=R.+Muellerauthor=L.+J.+Streetauthor=S.+R.+Ghorpadeauthor=K.+Chibale&title=Novel+antitubercular+6-dialkylaminopyrimidine+carboxamides+from+phenotypic+whole-cell+high+throughput+screening+of+a+softfocus+library%3A+structure-activity+relationship+and+target+identification+studies&doi=10.1021%2Facs.jmedchem.7b01347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification Studies</span></div><div class="casAuthors">Wilson, Colin R.; Gessner, Richard K.; Moosa, Atica; Seldon, Ronnett; Warner, Digby F.; Mizrahi, Valerie; Soares de Melo, Candice; Simelane, Sandile B.; Nchinda, Aloysius; Abay, Efrem; Taylor, Dale; Njoroge, Mathew; Brunschwig, Christel; Lawrence, Nina; Boshoff, Helena I. M.; Barry, Clifton E.; Sirgel, Frederick A.; van Helden, Paul; Harris, C. John; Gordon, Richard; Ghidelli-Disse, Sonja; Pflaumer, Hannah; Boesche, Markus; Drewes, Gerard; Sanz, Olalla; Santos, Gracia; Rebollo-Lopez, Maria Jose; Urones, Beatriz; Selenski, Carolyn; Lafuente-Monasterio, Maria Jose; Axtman, Matthew; Lelievre, Joel; Ballell, Lluis; Mueller, Rudolf; Street, Leslie J.; Ghorpade, Sandeep R.; Chibale, Kelly</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10118-10134</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A BioFocus DPI SoftFocus library of ∼35,000 compds. was screened against Mycobacterium tuberculosis (Mtb) to identify novel hits with antitubercular activity.  The hits were evaluated in biol. triage assays to exclude compds. suggested to function via frequently encountered promiscuous mechanisms of action including inhibition of the QcrB subunit of the cytochrome bc1 complex, disruption of cell-wall homeostasis, and DNA damage.  Among the hits that passed this screening cascade, a 6-dialkylaminopyrimidine carboxamide series was prioritized for hit to lead optimization.  Compds. from this series were active against clin. Mtb strains, while no cross-resistance to conventional antituberculosis drugs was obsd.  This suggested a novel mechanism of action, which was confirmed by chemoproteomic anal. leading to the identification of BCG_3193 and BCG_3827 as putative targets of the series with unknown function.  Initial structure-activity relationship studies have resulted in compds. with moderate to potent antitubercular activity and improved physicochem. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdBt_xcb2SIbVg90H21EOLACvtfcHk0liwUMKdthI1xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWqtbjL&md5=364c9cd37481ad64be7ea86ea0c042e3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01347%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DC.%2BR.%26aulast%3DGessner%26aufirst%3DR.%2BK.%26aulast%3DMoosa%26aufirst%3DA.%26aulast%3DSeldon%26aufirst%3DR.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DSoares%2Bde%2BMelo%26aufirst%3DC.%26aulast%3DSimelane%26aufirst%3DS.%2BB.%26aulast%3DNchinda%26aufirst%3DA.%26aulast%3DAbay%26aufirst%3DE.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DNjoroge%26aufirst%3DM.%26aulast%3DBrunschwig%26aufirst%3DC.%26aulast%3DLawrence%26aufirst%3DN.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DSirgel%26aufirst%3DF.%2BA.%26aulast%3Dvan%2BHelden%26aufirst%3DP.%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DGhidelli-Disse%26aufirst%3DS.%26aulast%3DPflaumer%26aufirst%3DH.%26aulast%3DBoesche%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DSanz%26aufirst%3DO.%26aulast%3DSantos%26aufirst%3DG.%26aulast%3DRebollo-Lopez%26aufirst%3DM.%2BJ.%26aulast%3DUrones%26aufirst%3DB.%26aulast%3DSelenski%26aufirst%3DC.%26aulast%3DLafuente-Monasterio%26aufirst%3DM.%2BJ.%26aulast%3DAxtman%26aufirst%3DM.%26aulast%3DLeli%25C3%25A8vre%26aufirst%3DJ.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DMueller%26aufirst%3DR.%26aulast%3DStreet%26aufirst%3DL.%2BJ.%26aulast%3DGhorpade%26aufirst%3DS.%2BR.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DNovel%2520antitubercular%25206-dialkylaminopyrimidine%2520carboxamides%2520from%2520phenotypic%2520whole-cell%2520high%2520throughput%2520screening%2520of%2520a%2520softfocus%2520library%253A%2520structure-activity%2520relationship%2520and%2520target%2520identification%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D10118%26epage%3D10134%26doi%3D10.1021%2Facs.jmedchem.7b01347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labadie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinogradova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehling, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmange, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Porten, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liederer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Classon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragovich, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L.</span></span> <span> </span><span class="NLM_article-title">From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2974</span>– <span class="NLM_lpage">2981</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2Fj.bmcl.2017.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=28512031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvFCqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2974-2981&author=J.+Liangauthor=S.+Labadieauthor=B.+Zhangauthor=D.+F.+Ortwineauthor=S.+Patelauthor=M.+Vinogradovaauthor=J.+R.+Kieferauthor=T.+Mauerauthor=V.+S.+Gehlingauthor=J.-C.+Harmangeauthor=R.+Cummingsauthor=T.+Laiauthor=J.+Liaoauthor=X.+Zhengauthor=Y.+Liuauthor=A.+Gustafsonauthor=E.+Van+der+Portenauthor=W.+Maoauthor=B.+M.+Liedererauthor=G.+Deshmukhauthor=L.+Anauthor=Y.+Ranauthor=M.+Classonauthor=P.+Trojerauthor=P.+S.+Dragovichauthor=L.+Murray&title=From+a+novel+HTS+hit+to+potent%2C+selective%2C+and+orally+bioavailable+KDM5+inhibitors&doi=10.1016%2Fj.bmcl.2017.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors</span></div><div class="casAuthors">Liang, Jun; Labadie, Sharada; Zhang, Birong; Ortwine, Daniel F.; Patel, Snahel; Vinogradova, Maia; Kiefer, James R.; Mauer, Till; Gehling, Victor S.; Harmange, Jean-Christophe; Cummings, Richard; Lai, Tommy; Liao, Jiangpeng; Zheng, Xiaoping; Liu, Yichin; Gustafson, Amy; Van der Porten, Erica; Mao, Weifeng; Liederer, Bianca M.; Deshmukh, Gauri; An, Le; Ran, Yingqing; Classon, Marie; Trojer, Patrick; Dragovich, Peter S.; Murray, Lesley</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2974-2981</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A high-throughput screening (HTS) of the Genentech/Roche library identified a novel, uncharged scaffold as a KDM5A inhibitor.  Lacking insight into the binding mode, initial attempts to improve inhibitor potency failed to improve potency, and synthesis of analogs was further hampered by the presence of a C-C bond between the pyrrolidine and pyridine.  Replacing this with a C-N bond significantly simplified synthesis, yielding pyrazole analog, [3-(4-bromo-1H-pyrazol-1-yl)-1-pyrrolidinyl][5-(1-methylethyl)-1H-pyrazol-3-yl]methanone (35), of which the authors obtained a co-crystal structure with KDM5A.  Using structure-based design approach, the authors identified, N-[(3R)-1-[[5-(1-methylethyl)-1H-pyrazol-3-yl]carbonyl]-3-pyrrolidinyl]cyclopropanecarboxamide (50), with improved biochem., cell potency and reduced MW and lower lipophilicity (Log D) compared with the original hit.  Furthermore, 50 showed lower clearance than [5-(1-methylethyl)-1H-pyrazol-3-yl][(3S)-3-[6-methyl-4-(1-methyl-1H-pyrazol-4-yl)-2-pyridinyl]-1-pyrrolidinyl]methanone (9) in mice.  In combination with its remarkably low plasma protein binding (PPB) in mice (40%), oral dosing of 50 at 5 mg/kg resulted in unbound Cmax ∼2-fold of its cell potency (PC9 H3K4Me3 0.96 μM), meeting the authors' criteria for an in vivo tool compd. from a new scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpksjXQBrVYsrVg90H21EOLACvtfcHk0liwUMKdthI1xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvFCqtr4%253D&md5=04bee4e29775202fb1882adeccb8e722</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DLabadie%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DVinogradova%26aufirst%3DM.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DMauer%26aufirst%3DT.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DLai%26aufirst%3DT.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DVan%2Bder%2BPorten%26aufirst%3DE.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DAn%26aufirst%3DL.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DClasson%26aufirst%3DM.%26aulast%3DTrojer%26aufirst%3DP.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DMurray%26aufirst%3DL.%26atitle%3DFrom%2520a%2520novel%2520HTS%2520hit%2520to%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520KDM5%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2974%26epage%3D2981%26doi%3D10.1016%2Fj.bmcl.2017.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dragset, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poce, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfonso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padilla-Benavides, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biava, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argüello, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steigedal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E. J.</span></span> <span> </span><span class="NLM_article-title">A novel antimycobacterial compound acts as an intracellular iron chelator</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2256</span>– <span class="NLM_lpage">2264</span>, <span class="refDoi"> DOI: 10.1128/aac.05114-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1128%2FAAC.05114-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=25645825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvFSgt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=2256-2264&author=M.+S.+Dragsetauthor=G.+Poceauthor=S.+Alfonsoauthor=T.+Padilla-Benavidesauthor=T.+R.+Ioergerauthor=T.+Kanekoauthor=J.+C.+Sacchettiniauthor=M.+Biavaauthor=T.+Parishauthor=J.+M.+Arg%C3%BCelloauthor=M.+Steigedalauthor=E.+J.+Rubin&title=A+novel+antimycobacterial+compound+acts+as+an+intracellular+iron+chelator&doi=10.1128%2Faac.05114-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A novel antimycobacterial compound acts as an intracellular iron chelator</span></div><div class="casAuthors">Dragset, Marte S.; Poce, Giovanna; Alfonso, Salvatore; Padilla-Benavides, Teresita; Ioerger, Thomas R.; Kaneko, Takushi; Sacchettini, James C.; Biava, Mariangela; Parish, Tanya; Arguello, Jose M.; Steigedal, Magnus; Rubin, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2256-2264</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Efficient iron acquisition is crucial for the pathogenesis of Mycobacterium tuberculosis.  Mycobacterial iron uptake and metab. are therefore attractive targets for antitubercular drug development.  Resistance mutations against a novel pyrazolopyrimidinone compd. (PZP) that is active against M. tuberculosis have been identified within the gene cluster encoding the ESX-3 type VII secretion system.  ESX-3 is required for mycobacterial iron acquisition through the mycobactin siderophore pathway, which could indicate that PZP restricts mycobacterial growth by targeting ESX-3 and thus iron uptake.  Surprisingly, we show that ESX-3 is not the cellular target of the compd.  We demonstrate that PZP indeed targets iron metab.; however, we found that instead of inhibiting uptake of iron, PZP acts as an iron chelator, and we present evidence that the compd. restricts mycobacterial growth by chelating intrabacterial iron.  Thus, we have unraveled the unexpected mechanism of a novel antimycobacterial compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUHSJO1B-DKrVg90H21EOLACvtfcHk0lgdO38yk6claA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvFSgt7c%253D&md5=e4e9b83c344f8f2be78ee613c7f26ae0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FAAC.05114-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.05114-14%26sid%3Dliteratum%253Aachs%26aulast%3DDragset%26aufirst%3DM.%2BS.%26aulast%3DPoce%26aufirst%3DG.%26aulast%3DAlfonso%26aufirst%3DS.%26aulast%3DPadilla-Benavides%26aufirst%3DT.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DBiava%26aufirst%3DM.%26aulast%3DParish%26aufirst%3DT.%26aulast%3DArg%25C3%25BCello%26aufirst%3DJ.%2BM.%26aulast%3DSteigedal%26aufirst%3DM.%26aulast%3DRubin%26aufirst%3DE.%2BJ.%26atitle%3DA%2520novel%2520antimycobacterial%2520compound%2520acts%2520as%2520an%2520intracellular%2520iron%2520chelator%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D2256%26epage%3D2264%26doi%3D10.1128%2Faac.05114-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Bis{tris-[3-(2-pyrid-yl)-1H-pyrazole]nickel(II)} dodeca-molybdo(V,VI)phosphate hexa-hydrate</span>. <i>Acta Crystallogr., Sect. E: Struct. Rep. Online</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">m319</span>– <span class="NLM_lpage">m320</span>, <span class="refDoi"> DOI: 10.1107/s1600536810005945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1107%2FS1600536810005945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=21580258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3cXislWrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=m319-m320&author=L.+Haoauthor=T.+Liuauthor=J.+Chenauthor=X.+Zhang&title=Bis%7Btris-%5B3-%282-pyrid-yl%29-1H-pyrazole%5Dnickel%28II%29%7D+dodeca-molybdo%28V%2CVI%29phosphate+hexa-hydrate&doi=10.1107%2Fs1600536810005945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Bis{tris[3-(2-pyridyl)-1H-pyrazole]nickel(II)} dodecamolybdo(V,VI)phosphate hexahydrate</span></div><div class="casAuthors">Hao, Lujiang; Liu, Tongjun; Chen, Jiangkui; Zhang, Xiaofei</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section E: Structure Reports Online</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">m319-m320</span>CODEN:
                <span class="NLM_cas:coden">ACSEBH</span>;
        ISSN:<span class="NLM_cas:issn">1600-5368</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The hydrothermally prepd. title compd., [Ni(C8H7N3)3]2[PMo12O40]·6H2O, is a member of the isotypic series [M(C8H7N3)3]2[PMo12O40]·6H2O where M is Mn, Cd, and Fe.  Crystallog. data and at. coordinates are given.  The Ni2+ cation is in a distorted octahedral environment, coordinated by six N atoms from three chelating 3-(2-pyridyl)-1H-pyrazole ligands.  In the 1-electron reduced heteropolyanion, two O atoms of the central PO4 group (‾1 symmetry) are equally disordered about an inversion center.  N-H...O and O-H...O H bonds contribute to the crystal packing.  Compared with the isotypic structures, the main difference is related with the M-N bond lengths, whereas all other bond lengths, angles and the H-bonding motifs are very similar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoQvxRrfRPvbVg90H21EOLACvtfcHk0lgdO38yk6claA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXislWrsL8%253D&md5=53d4087fd37992c1c546e96614d894aa</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1107%2FS1600536810005945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1600536810005945%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DBis%257Btris-%255B3-%25282-pyrid-yl%2529-1H-pyrazole%255Dnickel%2528II%2529%257D%2520dodeca-molybdo%2528V%252CVI%2529phosphate%2520hexa-hydrate%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520E%253A%2520Struct.%2520Rep.%2520Online%26date%3D2010%26volume%3D66%26spage%3Dm319%26epage%3Dm320%26doi%3D10.1107%2Fs1600536810005945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rajnák, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šalitroš, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuhr, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruben, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boča, R.</span></span> <span> </span><span class="NLM_article-title">Influence of the charge of the complex unit on the SCO properties in pyrazolyl-pyridinyl-benzimidazole based Fe(II) complexes</span>. <i>Polyhedron</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.1016/j.poly.2017.06.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2Fj.poly.2017.06.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFChtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2017&pages=189-194&author=C.+Rajn%C3%A1kauthor=B.+Sch%C3%A4ferauthor=I.+%C5%A0alitro%C5%A1author=O.+Fuhrauthor=M.+Rubenauthor=R.+Bo%C4%8Da&title=Influence+of+the+charge+of+the+complex+unit+on+the+SCO+properties+in+pyrazolyl-pyridinyl-benzimidazole+based+Fe%28II%29+complexes&doi=10.1016%2Fj.poly.2017.06.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of the charge of the complex unit on the SCO properties in pyrazolyl-pyridinyl-benzimidazole based Fe(II) complexes</span></div><div class="casAuthors">Rajnak, C.; Schafer, B.; Salitros, I.; Fuhr, O.; Ruben, M.; Boca, R.</div><div class="citationInfo"><span class="NLM_cas:title">Polyhedron</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">189-194</span>CODEN:
                <span class="NLM_cas:coden">PLYHDE</span>;
        ISSN:<span class="NLM_cas:issn">0277-5387</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A tridentate ligand 2-(6-pyrazol-1-yl-pyridin-2-yl)-1H-benzimidazole (L1H) was synthesized and characterized by NMR, UV-visible, IR and MS spectroscopy.  Starting from L1H, two complexes were prepd., one contg. a complex dication counterbalanced by anions, [Fe(L1H)2](BF4)2 (1), and the other one is a charge neutral complex [Fe(L1)2] (2).  The distorted octahedral coordination of 1 was confirmed by x-ray diffraction anal.  Both complexes show a thermally induced spin crossover with the crit. temp. lying above room temp.  The photomagnetic study confirmed the LIESST effect for both compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpImxAQDM0xJrVg90H21EOLACvtfcHk0lgdO38yk6claA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFChtL7M&md5=2a3ffa08fa121aabfacc9613fced44a0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.poly.2017.06.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.poly.2017.06.035%26sid%3Dliteratum%253Aachs%26aulast%3DRajn%25C3%25A1k%26aufirst%3DC.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DB.%26aulast%3D%25C5%25A0alitro%25C5%25A1%26aufirst%3DI.%26aulast%3DFuhr%26aufirst%3DO.%26aulast%3DRuben%26aufirst%3DM.%26aulast%3DBo%25C4%258Da%26aufirst%3DR.%26atitle%3DInfluence%2520of%2520the%2520charge%2520of%2520the%2520complex%2520unit%2520on%2520the%2520SCO%2520properties%2520in%2520pyrazolyl-pyridinyl-benzimidazole%2520based%2520Fe%2528II%2529%2520complexes%26jtitle%3DPolyhedron%26date%3D2017%26volume%3D135%26spage%3D189%26epage%3D194%26doi%3D10.1016%2Fj.poly.2017.06.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Attaby, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldin, S. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of pyrimidine, thiazolopyrimidine, pyrimidotriazine and triazolopyrimidine derivatives and their biological evaluation</span>. <i>Z. Naturforsch., B: J. Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">788</span>– <span class="NLM_lpage">798</span>, <span class="refDoi"> DOI: 10.1515/znb-1999-0614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1515%2Fznb-1999-0614" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1999&pages=788-798&author=F.+A.+Attabyauthor=S.+M.+Eldin&title=Synthesis+of+pyrimidine%2C+thiazolopyrimidine%2C+pyrimidotriazine+and+triazolopyrimidine+derivatives+and+their+biological+evaluation&doi=10.1515%2Fznb-1999-0614"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1515%2Fznb-1999-0614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fznb-1999-0614%26sid%3Dliteratum%253Aachs%26aulast%3DAttaby%26aufirst%3DF.%2BA.%26aulast%3DEldin%26aufirst%3DS.%2BM.%26atitle%3DSynthesis%2520of%2520pyrimidine%252C%2520thiazolopyrimidine%252C%2520pyrimidotriazine%2520and%2520triazolopyrimidine%2520derivatives%2520and%2520their%2520biological%2520evaluation%26jtitle%3DZ.%2520Naturforsch.%252C%2520B%253A%2520J.%2520Chem.%2520Sci.%26date%3D1999%26volume%3D54%26spage%3D788%26epage%3D798%26doi%3D10.1515%2Fznb-1999-0614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tait, B. P.</span>; <span class="NLM_string-name">Noel, A.</span>; <span class="NLM_string-name">Cullen, M.</span></span> <span> </span><span class="NLM_article-title">Proteostasis Regulators for Treating Cystic Fibrosis and other Protein Misfolding Diseases</span>. <span class="NLM_patent">WO2012154880 A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=B.+P.+Tait&author=A.+Noel&author=M.+Cullen&title=Proteostasis+Regulators+for+Treating+Cystic+Fibrosis+and+other+Protein+Misfolding+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTait%26aufirst%3DB.%2BP.%26atitle%3DProteostasis%2520Regulators%2520for%2520Treating%2520Cystic%2520Fibrosis%2520and%2520other%2520Protein%2520Misfolding%2520Diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burgula, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radhakrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, L. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of modified uracil and cytosine nucleobases using a microwave-assisted method</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2639</span>– <span class="NLM_lpage">2642</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2012.03.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2Fj.tetlet.2012.03.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFWhtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=2639-2642&author=L.+N.+Burgulaauthor=K.+Radhakrishnanauthor=L.+M.+Kundu&title=Synthesis+of+modified+uracil+and+cytosine+nucleobases+using+a+microwave-assisted+method&doi=10.1016%2Fj.tetlet.2012.03.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of modified uracil and cytosine nucleobases using a microwave-assisted method</span></div><div class="casAuthors">Burgula, Laxmi Narayana; Radhakrishnan, K.; Kundu, Lal Mohan</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2639-2642</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Here we report a microwave-directed synthesis of a variety of modified uracil and cytosine nucleobases with high yields under solvent-free conditions.  The reaction yields were further improved by addn. of Lewis acid.  The crystal structures of 5-isopropyl-6-methyluracil and 6-phenyluracil were also detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYrvNqHPAexrVg90H21EOLACvtfcHk0ljEgqfpZHMCSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFWhtbs%253D&md5=c6f5fa2f912c067c66db1c980f0ffb98</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2012.03.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2012.03.056%26sid%3Dliteratum%253Aachs%26aulast%3DBurgula%26aufirst%3DL.%2BN.%26aulast%3DRadhakrishnan%26aufirst%3DK.%26aulast%3DKundu%26aufirst%3DL.%2BM.%26atitle%3DSynthesis%2520of%2520modified%2520uracil%2520and%2520cytosine%2520nucleobases%2520using%2520a%2520microwave-assisted%2520method%26jtitle%3DTetrahedron%2520Lett.%26date%3D2012%26volume%3D53%26spage%3D2639%26epage%3D2642%26doi%3D10.1016%2Fj.tetlet.2012.03.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aertgeerts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassel, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaldor, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwaltney, S. L.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1021/jm101016w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101016w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1WgtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=510-524&author=Z.+Zhangauthor=M.+B.+Wallaceauthor=J.+Fengauthor=J.+A.+Staffordauthor=R.+J.+Skeneauthor=L.+Shiauthor=B.+Leeauthor=K.+Aertgeertsauthor=A.+Jenningsauthor=R.+Xuauthor=D.+B.+Kasselauthor=S.+W.+Kaldorauthor=M.+Navreauthor=D.+R.+Webbauthor=S.+L.+Gwaltney&title=Design+and+synthesis+of+pyrimidinone+and+pyrimidinedione+inhibitors+of+dipeptidyl+peptidase+IV&doi=10.1021%2Fjm101016w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV</span></div><div class="casAuthors">Zhang, Zhi-Yuan; Wallace, Michael B.; Feng, Jun; Stafford, Jeffrey A.; Skene, Robert J.; Shi, Li-Hong; Lee, Bum-Sup; Aertgeerts, Kathleen; Jennings, Andy; Xu, Rong-Da; Kassel, Daniel B.; Kaldor, Stephen W.; Navre, Marc; Webb, David R.; Gwaltney, Stephen L., II</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">510-524</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of two classes of heterocyclic dipeptidyl peptidase IV (DPP-4) inhibitors, pyrimidinones and pyrimidinediones, is described.  After a single oral dose, these potent, selective, and noncovalent inhibitors provide sustained redn. of plasma DPP-4 activity and lowering of blood glucose in animal models of diabetes.  Compds. I, II, and III were selected for development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxInStuMRjfbVg90H21EOLACvtfcHk0ljEgqfpZHMCSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1WgtL7M&md5=7e3b66916acf243ad7943add0eaf6b1f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm101016w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101016w%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWallace%26aufirst%3DM.%2BB.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DKassel%26aufirst%3DD.%2BB.%26aulast%3DKaldor%26aufirst%3DS.%2BW.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DWebb%26aufirst%3DD.%2BR.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520pyrimidinone%2520and%2520pyrimidinedione%2520inhibitors%2520of%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D510%26epage%3D524%26doi%3D10.1021%2Fjm101016w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazimierczuk, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shugar, D.</span></span> <span> </span><span class="NLM_article-title">Intermediates in the synthesis of purines and pteridines: selective hydrolysis of chloropyrimidines</span>. <i>Acta Biochim. Pol.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=4664351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADyaE3sXlvVeguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1972&pages=359-366&author=Z.+Kazimierczukauthor=M.+Lipskiauthor=D.+Shugar&title=Intermediates+in+the+synthesis+of+purines+and+pteridines%3A+selective+hydrolysis+of+chloropyrimidines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Intermediates in the synthesis of purines and pteridines.  Selective hydrolysis of chloropyrimidines</span></div><div class="casAuthors">Kazimierczuk, Z.; Lipski, M.; Shugar, D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica Polonica</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">359-66</span>CODEN:
                <span class="NLM_cas:coden">ABPLAF</span>;
        ISSN:<span class="NLM_cas:issn">0001-527X</span>.
    </div><div class="casAbstract">Alk. hydrolysis of 2,4,6-trichloropyrimidine gave 4,6-dichloro-2-hydroxypyrimidine (I), which gave 6-chlorouracil on acid hydrolysis.  Treatment of I with NH3 in anhyd. EtOH gave 4,6-diamino-2-hydroxypyrimidine, but Me2NH in anhyd. EtOH gave 4,6-bis(methylamino)-2-hydroxypyrimidine.  Alk. hydrolysis of 2,4-dichloropyrimidine gave 4-chloro-2-hydroxypyrimidine (II), which reacted with NH3 in anhyd. EtOH to give cytosine.  Treatment of II with Na and anhyd. EtOH gave 4-ethoxy-2-hydroxypyrimidine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL4eu2nqwz27Vg90H21EOLACvtfcHk0lifPYxmM7D_Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXlvVeguw%253D%253D&md5=45850a1d76daff71dee163db841f6727</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKazimierczuk%26aufirst%3DZ.%26aulast%3DLipski%26aufirst%3DM.%26aulast%3DShugar%26aufirst%3DD.%26atitle%3DIntermediates%2520in%2520the%2520synthesis%2520of%2520purines%2520and%2520pteridines%253A%2520selective%2520hydrolysis%2520of%2520chloropyrimidines%26jtitle%3DActa%2520Biochim.%2520Pol.%26date%3D1972%26volume%3D19%26spage%3D359%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Journet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, G.</span></span> <span> </span><span class="NLM_article-title">A highly regioselective amination of 6-aryl-2,4-dichloropyrimidine</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">398</span>, <span class="refDoi"> DOI: 10.1021/ol052578p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol052578p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvV2qug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=395-398&author=Z.-H.+Pengauthor=M.+Journetauthor=G.+Humphrey&title=A+highly+regioselective+amination+of+6-aryl-2%2C4-dichloropyrimidine&doi=10.1021%2Fol052578p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A Highly Regioselective Amination of 6-Aryl-2,4-dichloropyrimidine</span></div><div class="casAuthors">Peng, Zhi-Hui; Journet, Michel; Humphrey, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">395-398</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A highly regioselective amination of 6-aryl-2,4-dichloropyrimidines with aliph. secondary amines and arom. amines which strongly favors the formation of the C4-substituted product has been developed.  The reactions with aliph. amines are carried out using LiHMDS as the base and are catalyzed by Pd, while the arom. amines require no catalyst.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolnT2Begt9rLVg90H21EOLACvtfcHk0lifPYxmM7D_Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvV2qug%253D%253D&md5=64bfa91f732110ad28addb2041a5ea5f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fol052578p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol052578p%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DZ.-H.%26aulast%3DJournet%26aufirst%3DM.%26aulast%3DHumphrey%26aufirst%3DG.%26atitle%3DA%2520highly%2520regioselective%2520amination%2520of%25206-aryl-2%252C4-dichloropyrimidine%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D395%26epage%3D398%26doi%3D10.1021%2Fol052578p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cocuzza, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chidester, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarem, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilligan, P. J.</span></span> <span> </span><span class="NLM_article-title">4-aryl-2-anilinopyrimidines as corticotropin-releasing hormone (CRH) antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1057</span>– <span class="NLM_lpage">1062</span>, <span class="refDoi"> DOI: 10.1016/s0960-894x(99)00132-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2FS0960-894X%2899%2900132-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10230640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADyaK1MXivFGqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=1057-1062&author=A.+J.+Cocuzzaauthor=F.+W.+Hobbsauthor=C.+R.+Arnoldauthor=D.+R.+Chidesterauthor=J.+A.+Yaremauthor=S.+Culpauthor=L.+Fitzgeraldauthor=P.+J.+Gilligan&title=4-aryl-2-anilinopyrimidines+as+corticotropin-releasing+hormone+%28CRH%29+antagonists&doi=10.1016%2Fs0960-894x%2899%2900132-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">4-Aryl-2-anilinopyrimidines as corticotropin-releasing hormone (CRH) antagonists</span></div><div class="casAuthors">Cocuzza, Anthony J.; Hobbs, Frank W.; Arnold, Charles R.; Chidester, Dennis R.; Yarem, Jerry A.; Culp, Steven; Fitzgerald, Lawrence; Gilligan, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1057-1062</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of 4-aryl-2-(N-ethylanilino)pyrimidines has been synthesized as corticotropin-releasing hormone inhibitors.  The effect of substitution on each arom. ring on receptor binding was investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF2tVHScnbjLVg90H21EOLACvtfcHk0lifPYxmM7D_Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFGqt7o%253D&md5=d801177b5c7f7a8a6d1816c640685606</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900132-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900132-8%26sid%3Dliteratum%253Aachs%26aulast%3DCocuzza%26aufirst%3DA.%2BJ.%26aulast%3DHobbs%26aufirst%3DF.%2BW.%26aulast%3DArnold%26aufirst%3DC.%2BR.%26aulast%3DChidester%26aufirst%3DD.%2BR.%26aulast%3DYarem%26aufirst%3DJ.%2BA.%26aulast%3DCulp%26aufirst%3DS.%26aulast%3DFitzgerald%26aufirst%3DL.%26aulast%3DGilligan%26aufirst%3DP.%2BJ.%26atitle%3D4-aryl-2-anilinopyrimidines%2520as%2520corticotropin-releasing%2520hormone%2520%2528CRH%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D1057%26epage%3D1062%26doi%3D10.1016%2Fs0960-894x%2899%2900132-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauls, H. W.</span></span> <span> </span><span class="NLM_article-title">A convenient synthesis of heteroaryl benzoic acids via Suzuki reaction</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">831</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt12kurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=829-831&author=Y.+Gongauthor=H.+W.+Pauls&title=A+convenient+synthesis+of+heteroaryl+benzoic+acids+via+Suzuki+reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient synthesis of heteroarylbenzoic acids via Suzuki reaction</span></div><div class="casAuthors">Gong, Yong; Pauls, Henry W.</div><div class="citationInfo"><span class="NLM_cas:title">Synlett</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">829-831</span>CODEN:
                <span class="NLM_cas:coden">SYNLES</span>;
        ISSN:<span class="NLM_cas:issn">0936-5214</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">An 1-step approach to heteroarylbenzoic acids from readily accessible heteroaryl halides and carboxybenzeneboronic acids is described.  The Suzuki coupling is carried out in the presence of Pd(PPh3)4 and Na2CO3 in aq. MeCN.  Scope and limitations of the reaction are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq17FCpLbSbuLVg90H21EOLACvtfcHk0lgNT-DDyRtXgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt12kurs%253D&md5=dd9fd1a2aafff89ad576a24cb44938e9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DY.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DA%2520convenient%2520synthesis%2520of%2520heteroaryl%2520benzoic%2520acids%2520via%2520Suzuki%2520reaction%26jtitle%3DSynlett%26date%3D2000%26spage%3D829%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gronowitz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornfeldt, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristjansson, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, T.</span></span> <span> </span><span class="NLM_article-title">On the synthesis of various thienylpyrimidines and selenienylpyrimidines</span>. <i>Chem. Scr.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADyaL2sXksFyqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1986&pages=305-309&author=S.+Gronowitzauthor=A.+B.+Hornfeldtauthor=V.+Kristjanssonauthor=T.+Musil&title=On+the+synthesis+of+various+thienylpyrimidines+and+selenienylpyrimidines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">On the synthesis of various thienyl- and selenienylpyrimidines</span></div><div class="casAuthors">Gronowitz, S.; Hoernfeldt, A. B.; Kristjansson, V.; Musil, T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemica Scripta</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">305-9</span>CODEN:
                <span class="NLM_cas:coden">CSRPB9</span>;
        ISSN:<span class="NLM_cas:issn">0004-2056</span>.
    </div><div class="casAbstract">Various thienyl- and selenienylpyrimidines, including 5-substituted uracils, were prepd. by the Pd(0)-catalyzed coupling between halopyrimidines I (R = H, Cl, Br, Me3CO, PhCH2O; R1 = Br, H) and thiopheneboronic acids and selenopheneboronic acids II [R2 = B(OH)2; X = S, Se, resp.].  5-Bromouracil had to be protected as the tert-butoxy or benzyloxy deriv. in order to achieve successful coupling.  The compds. could also be obtained in a reversed manner, when pyrimidineboronic acids I [R = H, Me3CO; R1 = B(OH)2] were coupled with halothiophenes and haloselenophenes II (R2 = Br; X = S, Se).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7Ky04OIgzjbVg90H21EOLACvtfcHk0lgNT-DDyRtXgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXksFyqtLw%253D&md5=e8d534be2df9681cad062b92ed11522d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGronowitz%26aufirst%3DS.%26aulast%3DHornfeldt%26aufirst%3DA.%2BB.%26aulast%3DKristjansson%26aufirst%3DV.%26aulast%3DMusil%26aufirst%3DT.%26atitle%3DOn%2520the%2520synthesis%2520of%2520various%2520thienylpyrimidines%2520and%2520selenienylpyrimidines%26jtitle%3DChem.%2520Scr.%26date%3D1986%26volume%3D26%26spage%3D305%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-g.</span></span> <span> </span><span class="NLM_article-title">Synthesis of indolylpyrimidines via cross-coupling of indolylboronic acid with chloropyrimidines: facile synthesis of meridianin D</span>. <i>Heterocycles</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1489</span>– <span class="NLM_lpage">1498</span>, <span class="refDoi"> DOI: 10.3987/com-00-8890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.3987%2FCOM-00-8890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvF2lt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2000&pages=1489-1498&author=B.+Jiangauthor=C.-g.+Yang&title=Synthesis+of+indolylpyrimidines+via+cross-coupling+of+indolylboronic+acid+with+chloropyrimidines%3A+facile+synthesis+of+meridianin+D&doi=10.3987%2Fcom-00-8890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of indolylpyrimidines via cross-coupling of indolylboronic acid with chloropyrimidines: facile synthesis of meridianin D</span></div><div class="casAuthors">Jiang, Biao; Yang, Cai-Guang</div><div class="citationInfo"><span class="NLM_cas:title">Heterocycles</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1489-1498</span>CODEN:
                <span class="NLM_cas:coden">HTCYAM</span>;
        ISSN:<span class="NLM_cas:issn">0385-5414</span>.
    
            (<span class="NLM_cas:orgname">Japan Institute of Heterocyclic Chemistry</span>)
        </div><div class="casAbstract">Palladium catalyzed cross-coupling reaction of 3-indolylboronic acid with 2,4-dichloropyrimidines proceeded regioselectively to yield indolyl- or bis(indolyl)pyrimidines in high yield, depending on the projection of 3-indolylboronic acid.  The marine indole alkaloid meridianin D and an analog were synthesized via the palladium catalyzed cross-coupling reaction as a key step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP3SMLOMmgN7Vg90H21EOLACvtfcHk0lgNT-DDyRtXgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvF2lt78%253D&md5=ac7d54f31a6607b33f7064e83b1879fe</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3987%2FCOM-00-8890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-00-8890%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DC.-g.%26atitle%3DSynthesis%2520of%2520indolylpyrimidines%2520via%2520cross-coupling%2520of%2520indolylboronic%2520acid%2520with%2520chloropyrimidines%253A%2520facile%2520synthesis%2520of%2520meridianin%2520D%26jtitle%3DHeterocycles%26date%3D2000%26volume%3D53%26spage%3D1489%26epage%3D1498%26doi%3D10.3987%2Fcom-00-8890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schomaker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delia, T. J.</span></span> <span> </span><span class="NLM_article-title">Arylation of halogenated pyrimidines via a Suzuki coupling reaction</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">7125</span>– <span class="NLM_lpage">7128</span>, <span class="refDoi"> DOI: 10.1021/jo010573+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo010573%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmslOgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=7125-7128&author=J.+M.+Schomakerauthor=T.+J.+Delia&title=Arylation+of+halogenated+pyrimidines+via+a+Suzuki+coupling+reaction&doi=10.1021%2Fjo010573%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Arylation of Halogenated Pyrimidines via a Suzuki Coupling Reaction</span></div><div class="casAuthors">Schomaker, Jennifer M.; Delia, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7125-7128</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Suzuki coupling reaction was used extensively for the synthesis of a wide variety of unsym. biaryl compds.  The authors have extended this reaction to demonstrate the utility of prepg. monophenyl-, diphenyl-, or triphenylpyrimidine depending on the reaction conditions. Further, chloropyrimidine substrates are preferable over iodo-, bromo-, or fluoropyrimidines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVSwtp4e7HfrVg90H21EOLACvtfcHk0ljpF2C3WZ14Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmslOgsr8%253D&md5=e3bfe9e88b1757ebd0976ea166d61b58</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjo010573%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo010573%252B%26sid%3Dliteratum%253Aachs%26aulast%3DSchomaker%26aufirst%3DJ.%2BM.%26aulast%3DDelia%26aufirst%3DT.%2BJ.%26atitle%3DArylation%2520of%2520halogenated%2520pyrimidines%2520via%2520a%2520Suzuki%2520coupling%2520reaction%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D7125%26epage%3D7128%26doi%3D10.1021%2Fjo010573%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Basavaraja, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagamani, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padmashali, B.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial evaluation of novel substituted pyrimidinopyrazoles and pyrimidinotriazoles</span>. <i>J. Adv. Pharm. Technol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">236</span>– <span class="NLM_lpage">244</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=22247851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1arurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=236-244&author=H.+S.+Basavarajaauthor=J.+E.+Nagamaniauthor=M.+M.+Kumarauthor=B.+Padmashali&title=Antimicrobial+evaluation+of+novel+substituted+pyrimidinopyrazoles+and+pyrimidinotriazoles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial evaluation of novel substituted pyrimidinopyrazoles and pyrimidinotriazoles</span></div><div class="casAuthors">Basavaraja, H. S.; Nagamani, J. E.; Vijay kumar, M. M. J.; Padmashali, Basavaraj</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Advanced Pharmaceutical Technology & Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">236-244</span>CODEN:
                <span class="NLM_cas:coden">JAPTDW</span>;
        ISSN:<span class="NLM_cas:issn">0976-2094</span>.
    
            (<span class="NLM_cas:orgname">Journal of Advanced Pharmaceutical Technology & Research</span>)
        </div><div class="casAbstract">Some novel substituted pyramidinopyrazoles and pyrimidinotriazoles have been synthesized by using 6-anisyl-5-cyano-2-hydrazino-3-N-methyl-3, 4-dihydropyrimidine-4-one as the starting material.  Structures of these compds. have been established by IR, 1H NMR, Mass and elemental anal. data and have been evaluated for their antimicrobial activity.  Significant antimicrobial activity was obsd. for some members of these series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj6sw2UyZubrVg90H21EOLACvtfcHk0ljpF2C3WZ14Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1arurY%253D&md5=f76875ff813a242c3c222ddab77b0208</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBasavaraja%26aufirst%3DH.%2BS.%26aulast%3DNagamani%26aufirst%3DJ.%2BE.%26aulast%3DKumar%26aufirst%3DM.%2BM.%26aulast%3DPadmashali%26aufirst%3DB.%26atitle%3DAntimicrobial%2520evaluation%2520of%2520novel%2520substituted%2520pyrimidinopyrazoles%2520and%2520pyrimidinotriazoles%26jtitle%3DJ.%2520Adv.%2520Pharm.%2520Technol.%2520Res.%26date%3D2010%26volume%3D1%26spage%3D236%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasha, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kothari, R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of some novel heterocyclic compounds as protein tyrosine phosphatase (PTP-1B) Inhibitor</span>. <i>J. Chem. Pharmaceut. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">509</span>– <span class="NLM_lpage">517</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=509-517&author=A.+Patelauthor=T.+Y.+Pashaauthor=R.+Kothari&title=Synthesis+and+biological+evaluation+of+some+novel+heterocyclic+compounds+as+protein+tyrosine+phosphatase+%28PTP-1B%29+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DPasha%26aufirst%3DT.%2BY.%26aulast%3DKothari%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520some%2520novel%2520heterocyclic%2520compounds%2520as%2520protein%2520tyrosine%2520phosphatase%2520%2528PTP-1B%2529%2520Inhibitor%26jtitle%3DJ.%2520Chem.%2520Pharmaceut.%2520Res.%26date%3D2015%26volume%3D7%26spage%3D509%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yedage, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhanage, B. M.</span></span> <span> </span><span class="NLM_article-title">tert-Butyl nitrite-mediated synthesis of N-nitrosoamides, carboxylic acids, benzocoumarins, and isocoumarins from amides</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">5769</span>– <span class="NLM_lpage">5781</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.7b00570</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.7b00570" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFSksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2017&pages=5769-5781&author=S.+L.+Yedageauthor=B.+M.+Bhanage&title=tert-Butyl+nitrite-mediated+synthesis+of+N-nitrosoamides%2C+carboxylic+acids%2C+benzocoumarins%2C+and+isocoumarins+from+amides&doi=10.1021%2Facs.joc.7b00570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">tert-Butyl Nitrite-Mediated Synthesis of N-Nitrosoamides, Carboxylic Acids, Benzocoumarins, and Isocoumarins from Amides</span></div><div class="casAuthors">Yedage, Subhash L.; Bhanage, Bhalchandra M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5769-5781</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work reports tert-Bu nitrite (TBN) as a multitask reagent for (1) the controlled synthesis of N-nitrosoamide from N-alkyl amides, (2) hydrolysis of N-methoxyamides to carboxylic acids, (3) metal- and oxidant-free benzocoumarin synthesis from ortho-aryl-N-methoxyamides via N-H, C-N, and C-H bond activation, and (4) isocoumarin synthesis using Ru(II)/PEG as a recyclable catalytic system via ortho-C-H activation and TBN as an oxygen source.  The sequential functional group interconversion of amide to acid has also been examd. using IR spectroscopic anal.  Addnl., this methodol. is highly advantageous due to short reaction time, gram scale synthesis, and broad substrate scope.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpciv67mLNG6rVg90H21EOLACvtfcHk0ljpF2C3WZ14Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFSksbc%253D&md5=83e66f67054d281021e44def5492cef8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.7b00570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.7b00570%26sid%3Dliteratum%253Aachs%26aulast%3DYedage%26aufirst%3DS.%2BL.%26aulast%3DBhanage%26aufirst%3DB.%2BM.%26atitle%3Dtert-Butyl%2520nitrite-mediated%2520synthesis%2520of%2520N-nitrosoamides%252C%2520carboxylic%2520acids%252C%2520benzocoumarins%252C%2520and%2520isocoumarins%2520from%2520amides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2017%26volume%3D82%26spage%3D5769%26epage%3D5781%26doi%3D10.1021%2Facs.joc.7b00570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, R. L.</span></span> <span> </span><span class="NLM_article-title">One-pot synthesis of 5-(substituted-amino)pyrazoles</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4265</span>– <span class="NLM_lpage">4267</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2004.04.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2Fj.tetlet.2004.04.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVGjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=4265-4267&author=D.+S.+Doddauthor=R.+L.+Martinez&title=One-pot+synthesis+of+5-%28substituted-amino%29pyrazoles&doi=10.1016%2Fj.tetlet.2004.04.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">One-pot synthesis of 5-(substituted-amino)pyrazoles</span></div><div class="casAuthors">Dodd, Dharmpal S.; Martinez, Rogelio L.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4265-4267</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">An efficient and mild one-pot synthesis of substituted 5-alkylamino and/or 5-(arylamino)pyrazoles is described.  A suitably decorated β-keto amide, an aryl or alkyl hydrazine and Lawesson's reagent are suspended in THF/Py and gently heated to yield the requisite 5-aminopyrazoles.  For example, the reaction of N,N-diethyl-3-oxobutanamide with (phenyl)hydrazine in the presence of Lawesson's reagent gave N,N-diethyl-3-methyl-1-phenyl-1H-pyrazol-5-amine in 95% yield.  It is postulated that this method should also be easily adaptable for automated parallel synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXd6HDSARaV7Vg90H21EOLACvtfcHk0ljpF2C3WZ14Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVGjsLY%253D&md5=25f16fa7a331a7ae149b00c5c91cfb18</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2004.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2004.04.017%26sid%3Dliteratum%253Aachs%26aulast%3DDodd%26aufirst%3DD.%2BS.%26aulast%3DMartinez%26aufirst%3DR.%2BL.%26atitle%3DOne-pot%2520synthesis%2520of%25205-%2528substituted-amino%2529pyrazoles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2004%26volume%3D45%26spage%3D4265%26epage%3D4267%26doi%3D10.1016%2Fj.tetlet.2004.04.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peruncheralathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ila, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junjappa, H.</span></span> <span> </span><span class="NLM_article-title">Highly regioselective synthesis of 1-aryl-3 (or 5)-alkyl/aryl-5 (or 3)-(N-cycloamino)pyrazoles</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">9644</span>– <span class="NLM_lpage">9647</span>, <span class="refDoi"> DOI: 10.1021/jo051478u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo051478u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFahs7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=9644-9647&author=S.+Peruncheralathanauthor=A.+K.+Yadavauthor=H.+Ilaauthor=H.+Junjappa&title=Highly+regioselective+synthesis+of+1-aryl-3+%28or+5%29-alkyl%2Faryl-5+%28or+3%29-%28N-cycloamino%29pyrazoles&doi=10.1021%2Fjo051478u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Regioselective Synthesis of 1-Aryl-3 (or 5)-alkyl/aryl-5 (or 3)-(N-cycloamino)pyrazoles</span></div><div class="casAuthors">Peruncheralathan, S.; Yadav, A. K.; Ila, H.; Junjappa, H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9644-9647</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient highly regioselective protocol for the synthesis of isomeric 1,3-diaryl (or 1-aryl-3-alkyl) and 1,5-diaryl (or 1-aryl-5-alkyl)-5 (or 3)-(N-cycloamino)pyrazoles has been reported by cyclocondensation of common α-oxoketene N,S-acetal precursors with arylhydrazines by variation of reaction conditions.  E.g., reaction of PhCOCH:C(SMe)NMeCH2C6H4OMe-4 with PhNHNH2 in presence of NaH in DMF/C6H6 gave 65% 5-aminopyrazole I (R = CH2C6H4OMe-4).  On the other hand, reaction of PhCOCH:C(SMe)NMeCH2C6H4OMe-4 with PhNHNH2 in presence of DABCO gave 69% 3-aminopyrazole II (same R).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8oPPGC812ArVg90H21EOLACvtfcHk0lg6Q8_OsoaaUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFahs7zJ&md5=22bc2cf19d20f443540d69eb068ef96d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo051478u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo051478u%26sid%3Dliteratum%253Aachs%26aulast%3DPeruncheralathan%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DA.%2BK.%26aulast%3DIla%26aufirst%3DH.%26aulast%3DJunjappa%26aufirst%3DH.%26atitle%3DHighly%2520regioselective%2520synthesis%2520of%25201-aryl-3%2520%2528or%25205%2529-alkyl%252Faryl-5%2520%2528or%25203%2529-%2528N-cycloamino%2529pyrazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D9644%26epage%3D9647%26doi%3D10.1021%2Fjo051478u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ila, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junjappa, H.</span></span> <span> </span><span class="NLM_article-title">A novel and convenient synthesis of 2-amino-4-(N-alkyl-N-arylamino)-pyrimidines using polarized ketene S,S-acetals and S,N-acetals</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_fpage">748</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1055/s-1980-29200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1055%2Fs-1980-29200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADyaL3MXmsFKjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1980&pages=748-751&author=A.+Kumarauthor=V.+Aggarwalauthor=H.+Ilaauthor=H.+Junjappa&title=A+novel+and+convenient+synthesis+of+2-amino-4-%28N-alkyl-N-arylamino%29-pyrimidines+using+polarized+ketene+S%2CS-acetals+and+S%2CN-acetals&doi=10.1055%2Fs-1980-29200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A novel and convenient synthesis of 2-amino-4-(N-alkyl-N-arylamino)pyrimidines using polarized ketene S,S- and S,N-acetals.  Part 13</span></div><div class="casAuthors">Kumar, A.; Aggarwal, V.; Ila, H.; Junjappa, H.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">748-51</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">Ketene S,N-acetals EtO2CC(CN):C(SMe)NRR1 (R = Ph, 4-Me-, 4-MeO-, 4-Cl-, 4-FC6H4; R1 = H; NRR1 = morpholino), generated in situ by treating ketene S,S-acetals EtO2CC(CN):C(SMe)2 with amines RR1NH, were treated with guanidine nitrate to give 47-57% aminopyrimidones I.  R2COCH:C(SMe)NHR3 (R2 = H, Ph, 4-MeC6H4, 4-BrC6H4; R3 = Ph, 4-ClC6H4, Et), obtained in 75-85% yield by treating R2COMe with R3NCS, were treated with guanidine nitrate to give 28-50% II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_B6AH28EurbVg90H21EOLACvtfcHk0lg6Q8_OsoaaUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXmsFKjtA%253D%253D&md5=edd14a7ba503a9cb7eda73ec3c650747</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1055%2Fs-1980-29200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1980-29200%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DAggarwal%26aufirst%3DV.%26aulast%3DIla%26aufirst%3DH.%26aulast%3DJunjappa%26aufirst%3DH.%26atitle%3DA%2520novel%2520and%2520convenient%2520synthesis%2520of%25202-amino-4-%2528N-alkyl-N-arylamino%2529-pyrimidines%2520using%2520polarized%2520ketene%2520S%252CS-acetals%2520and%2520S%252CN-acetals%26jtitle%3DSynthesis%26date%3D1980%26spage%3D748%26epage%3D751%26doi%3D10.1055%2Fs-1980-29200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ila, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junjappa, H.</span></span> <span> </span><span class="NLM_article-title">Reaction of alpha-ketoketene S,N-acetals with hydroxylamine - a facile general-route to 5-aryl-3-(N-arylamino, N-alkylamino, or N-azacycloalkyl)-isoxazoles</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1055/s-1984-30793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1055%2Fs-1984-30793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADyaL2cXksFCqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1984&pages=247-249&author=A.+Rahmanauthor=J.+N.+Vishwakarmaauthor=R.+D.+Yadavauthor=H.+Ilaauthor=H.+Junjappa&title=Reaction+of+alpha-ketoketene+S%2CN-acetals+with+hydroxylamine+-+a+facile+general-route+to+5-aryl-3-%28N-arylamino%2C+N-alkylamino%2C+or+N-azacycloalkyl%29-isoxazoles&doi=10.1055%2Fs-1984-30793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction of α-ketoketene S,N-acetals with hydroxylamine: a facile general route to 5-aryl-3-(N-arylamino, N-alkylamino, or N-azacycloalkyl)isoxazoles. Part XXIX</span></div><div class="casAuthors">Rahman, A.; Vishwakarma, J. N.; Yadav, R. D.; Ila, H.; Junjappa, H.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-9</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">Cyclization of ketoketene acetals RCOCH:C(SMe)NR1R2 (R = Ph, p-tolyl, p-anisyl, p-Cl6H4; R1 = Ph, Et, PhCH2, R2 = H; R1R2 = (CH2)4, (CH2)5, (CH2)2O(CH2)2, (CH2)2NPh(CH2)2) with HONH2 gave 56-92% 14 isoxazoles I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7C7LmYl2Nt7Vg90H21EOLACvtfcHk0lg6Q8_OsoaaUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXksFCqtLo%253D&md5=eb418b535ebea9c5b4871a129a2ef0af</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1055%2Fs-1984-30793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1984-30793%26sid%3Dliteratum%253Aachs%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DVishwakarma%26aufirst%3DJ.%2BN.%26aulast%3DYadav%26aufirst%3DR.%2BD.%26aulast%3DIla%26aufirst%3DH.%26aulast%3DJunjappa%26aufirst%3DH.%26atitle%3DReaction%2520of%2520alpha-ketoketene%2520S%252CN-acetals%2520with%2520hydroxylamine%2520-%2520a%2520facile%2520general-route%2520to%25205-aryl-3-%2528N-arylamino%252C%2520N-alkylamino%252C%2520or%2520N-azacycloalkyl%2529-isoxazoles%26jtitle%3DSynthesis%26date%3D1984%26spage%3D247%26epage%3D249%26doi%3D10.1055%2Fs-1984-30793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junjappa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ila, H.</span></span> <span> </span><span class="NLM_article-title">Reaction of lithioamino anions with alpha-oxoketene dithioketals: an improved and a new general method for the synthesis of alpha-oxoketene S,N- and N,N-ketals</span>. <i>J. Chem. Soc., Perkin Trans. 1</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3561</span>– <span class="NLM_lpage">3566</span>, <span class="refDoi"> DOI: 10.1039/a701435j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1039%2Fa701435j" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3561-3566&author=O.+M.+Singhauthor=H.+Junjappaauthor=H.+Ila&title=Reaction+of+lithioamino+anions+with+alpha-oxoketene+dithioketals%3A+an+improved+and+a+new+general+method+for+the+synthesis+of+alpha-oxoketene+S%2CN-+and+N%2CN-ketals&doi=10.1039%2Fa701435j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2Fa701435j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa701435j%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DO.%2BM.%26aulast%3DJunjappa%26aufirst%3DH.%26aulast%3DIla%26aufirst%3DH.%26atitle%3DReaction%2520of%2520lithioamino%2520anions%2520with%2520alpha-oxoketene%2520dithioketals%253A%2520an%2520improved%2520and%2520a%2520new%2520general%2520method%2520for%2520the%2520synthesis%2520of%2520alpha-oxoketene%2520S%252CN-%2520and%2520N%252CN-ketals%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1997%26volume%3D23%26spage%3D3561%26epage%3D3566%26doi%3D10.1039%2Fa701435j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grange, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winstanley, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P. D. O.</span></span> <span> </span><span class="NLM_article-title">Clinically Significant Drug Interactions with Antituberculosis Agents</span>. <i>Drug Saf.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">242</span>– <span class="NLM_lpage">251</span>, <span class="refDoi"> DOI: 10.2165/00002018-199411040-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.2165%2F00002018-199411040-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=7848544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADyaK2cXmvFWrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1994&pages=242-251&author=J.+M.+Grangeauthor=P.+A.+Winstanleyauthor=P.+D.+O.+Davies&title=Clinically+Significant+Drug+Interactions+with+Antituberculosis+Agents&doi=10.2165%2F00002018-199411040-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Clinically significant drug interactions with antituberculosis agents</span></div><div class="casAuthors">Grange, John M.; Winstanley, Peter A.; Davies, Peter D. O.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Safety</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">242-51</span>CODEN:
                <span class="NLM_cas:coden">DRSAEA</span>;
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    </div><div class="casAbstract">A review with 39 refs.  There are very few clin. significant interactions among the first-line antituberculosis drugs themselves, although problems of bioavailability, notably of rifampicin (rifampin), have been encountered in the manuf. of combination tablets.  Of the first-line drugs used to treat tuberculosis, e.g., rifampicin, isoniazid and pyrazinamide, rifampicin is particularly likely to cause clin. significant drug interactions as it is a potent inducer of the cytochrome P 450 enzyme group, which is involved in the metab. of many drugs, in particular oral contraceptives, corticosteroids, oral anticoagulants and cyclosporin.  The use of quinolones to treat multiple drug-resistant tuberculosis and AIDS-related MAC disease raises further problems of drug interactions as, in contrast to rifampicin, these drugs inhibit some cytochrome isoenzymes, leading to reduced metab. of certain drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoit6DfoIzT67Vg90H21EOLACvtfcHk0ljHHPrRQ9Tyjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvFWrsbc%253D&md5=b2506b342150aed048e1e27a4bc3d433</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2165%2F00002018-199411040-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002018-199411040-00003%26sid%3Dliteratum%253Aachs%26aulast%3DGrange%26aufirst%3DJ.%2BM.%26aulast%3DWinstanley%26aufirst%3DP.%2BA.%26aulast%3DDavies%26aufirst%3DP.%2BD.%2BO.%26atitle%3DClinically%2520Significant%2520Drug%2520Interactions%2520with%2520Antituberculosis%2520Agents%26jtitle%3DDrug%2520Saf.%26date%3D1994%26volume%3D11%26spage%3D242%26epage%3D251%26doi%3D10.2165%2F00002018-199411040-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sriwijitalai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiwanitkit, V.</span></span> <span> </span><span class="NLM_article-title">Drug–drug interaction analysis: Antituberculosis drugs versus antiretroviral drugs</span>. <i>Biomed. Biotechnol. Res. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">101</span>, <span class="refDoi"> DOI: 10.4103/bbrj.bbrj_52_19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.4103%2Fbbrj.bbrj_52_19" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2019&pages=101&author=W.+Sriwijitalaiauthor=V.+Wiwanitkit&title=Drug%E2%80%93drug+interaction+analysis%3A+Antituberculosis+drugs+versus+antiretroviral+drugs&doi=10.4103%2Fbbrj.bbrj_52_19"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4103%2Fbbrj.bbrj_52_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252Fbbrj.bbrj_52_19%26sid%3Dliteratum%253Aachs%26aulast%3DSriwijitalai%26aufirst%3DW.%26aulast%3DWiwanitkit%26aufirst%3DV.%26atitle%3DDrug%25E2%2580%2593drug%2520interaction%2520analysis%253A%2520Antituberculosis%2520drugs%2520versus%2520antiretroviral%2520drugs%26jtitle%3DBiomed.%2520Biotechnol.%2520Res.%2520J.%26date%3D2019%26volume%3D3%26spage%3D101%26doi%3D10.4103%2Fbbrj.bbrj_52_19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, M. P.</span></span> <span> </span><span class="NLM_article-title">Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1021/jm060981b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060981b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlansbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=101-112&author=M.+P.+Gleeson&title=Plasma+protein+binding+affinity+and+its+relationship+to+molecular+structure%3A+an+in-silico+analysis&doi=10.1021%2Fjm060981b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma Protein Binding Affinity and Its Relationship to Molecular Structure: An In-silico Analysis</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-112</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In-silico plasma protein binding (PPB) models have been generated on human and rat inhouse datasets, and on a human dataset from the literature.  From the results reported herein, it is apparent that models built on datasets relevant to the chemotypes under investigation in lead optimization programs will perform considerably better in this role than those generated on diverse compds. from the literature.  The inhouse human and rat partial least-squares regression (PLS) models have cross-validated q2 values of 0.53 and 0.42 on the training sets, resp.  On the independent test and validation sets, they display similar predictive ability, with logK prediction errors of ∼0.5 log units.  This compares to ∼0.25 log units variability expected for expt.  Given the considerable interspecies PPB differences, the prediction of PPB in one species using measurements in the other is no better than a prediction from an in-silico model generated on that species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk60A2KkbYQLVg90H21EOLACvtfcHk0ljHHPrRQ9Tyjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlansbbN&md5=c17cec019dd0d088f8c403c745fcceec</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm060981b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060981b%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DPlasma%2520protein%2520binding%2520affinity%2520and%2520its%2520relationship%2520to%2520molecular%2520structure%253A%2520an%2520in-silico%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D101%26epage%3D112%26doi%3D10.1021%2Fjm060981b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, J. J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Vleet, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittelstadt, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blomme, E. A. G.</span></span> <span> </span><span class="NLM_article-title">Potential functional and pathological side effects related to off-target pharmacological activity</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/j.vascn.2017.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2Fj.vascn.2017.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=28216264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVGltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2017&pages=108-126&author=J.+J.+Lynchauthor=T.+R.+Van+Vleetauthor=S.+W.+Mittelstadtauthor=E.+A.+G.+Blomme&title=Potential+functional+and+pathological+side+effects+related+to+off-target+pharmacological+activity&doi=10.1016%2Fj.vascn.2017.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Potential functional and pathological side effects related to off-target pharmacological activity</span></div><div class="casAuthors">Lynch, James J., III; Van Vleet, Terry R.; Mittelstadt, Scott W.; Blomme, Eric A. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108-126</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Most pharmaceutical companies test their discovery-stage proprietary mols. in a battery of in vitro pharmacol. assays to try to det. off-target interactions.  During all phases of drug discovery and development, various questions arise regarding potential side effects assocd. with such off-target pharmacol. activity.  Here we present a scientific literature curation effort undertaken to det. and summarize the most likely functional and pathol. outcomes assocd. with interactions at 70 receptors, enzymes, ion channels and transporters with established links to adverse effects.  To that end, the scientific literature was reviewed using an online database, and the most commonly reported effects were summarized in tabular format.  The resultant table should serve as a practical guide for research scientists and clin. investigators for the prediction and interpretation of adverse side effects assocd. with mols. interacting with components of this screening battery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr73k3f-8KK17Vg90H21EOLACvtfcHk0lgr998JEq-XJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVGltrg%253D&md5=86b82acd8981a020f19e236d2d4ecb16</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2017.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2017.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DVan%2BVleet%26aufirst%3DT.%2BR.%26aulast%3DMittelstadt%26aufirst%3DS.%2BW.%26aulast%3DBlomme%26aufirst%3DE.%2BA.%2BG.%26atitle%3DPotential%2520functional%2520and%2520pathological%2520side%2520effects%2520related%2520to%2520off-target%2520pharmacological%2520activity%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2017%26volume%3D87%26spage%3D108%26epage%3D126%26doi%3D10.1016%2Fj.vascn.2017.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moosa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamprecht, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, A. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizrahi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D. F.</span></span> <span> </span><span class="NLM_article-title">Susceptibility of Mycobacterium tuberculosis cytochrome bd oxidase mutants to compounds targeting the terminal respiratory oxidase, cytochrome c</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>, <span class="NLM_elocation-id">e01338</span> <span class="refDoi"> DOI: 10.1128/aac.01338-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1128%2FAAC.01338-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=28760899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivVWjtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&author=A.+Moosaauthor=D.+A.+Lamprechtauthor=K.+Aroraauthor=C.+E.+Barryauthor=H.+I.+M.+Boshoffauthor=T.+R.+Ioergerauthor=A.+J.+C.+Steynauthor=V.+Mizrahiauthor=D.+F.+Warner&title=Susceptibility+of+Mycobacterium+tuberculosis+cytochrome+bd+oxidase+mutants+to+compounds+targeting+the+terminal+respiratory+oxidase%2C+cytochrome+c&doi=10.1128%2Faac.01338-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Susceptibility of Mycobacterium tuberculosis cytochrome bd oxidase mutants to compounds targeting the terminal respiratory oxidase, cytochrome c</span></div><div class="casAuthors">Moosa, Atica; Lamprecht, Dirk A.; Arora, Kriti; Barry, Clifton E., III; Boshoff, Helena I. M.; Ioerger, Thomas R.; Steyn, Adrie J. C.; Mizrahi, Valerie; Warner, Digby F.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e01338-17/1-e01338-17/5</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We deleted subunits I (cydA) and II (cydB) of the Mycobacterium tuberculosis cytochrome bd menaquinol oxidase.  The resulting ΔcydA and ΔcydAB mutants were hypersusceptible to compds. targeting the mycobacterial bc1 menaquinolcytochrome c oxidoreductase and exhibited bioenergetic profiles indistinguishable from strains deficient in the ABC-type transporter, CydDC, predicted to be essential for cytochrome bd assembly.  These results confirm CydAB and CydDC as potential targets for drugs aimed at inhibiting a terminal respiratory oxidase implicated in pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgW8kZXLGZ-7Vg90H21EOLACvtfcHk0lgr998JEq-XJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivVWjtb8%253D&md5=bcebcac60fdeec41edce1457923ab6eb</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1128%2FAAC.01338-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01338-17%26sid%3Dliteratum%253Aachs%26aulast%3DMoosa%26aufirst%3DA.%26aulast%3DLamprecht%26aufirst%3DD.%2BA.%26aulast%3DArora%26aufirst%3DK.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DSteyn%26aufirst%3DA.%2BJ.%2BC.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26atitle%3DSusceptibility%2520of%2520Mycobacterium%2520tuberculosis%2520cytochrome%2520bd%2520oxidase%2520mutants%2520to%2520compounds%2520targeting%2520the%2520terminal%2520respiratory%2520oxidase%252C%2520cytochrome%2520c%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26doi%3D10.1128%2Faac.01338-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moosa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizrahi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D. F.</span></span> <span> </span><span class="NLM_article-title">Bioluminescent Reporters for rapid mechanism of action assessment in tuberculosis drug discovery</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6748</span>– <span class="NLM_lpage">6757</span>, <span class="refDoi"> DOI: 10.1128/aac.01178-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1128%2FAAC.01178-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=27572410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitV2ntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=6748-6757&author=K.+Naranauthor=A.+Moosaauthor=C.+E.+Barryauthor=H.+I.+M.+Boshoffauthor=V.+Mizrahiauthor=D.+F.+Warner&title=Bioluminescent+Reporters+for+rapid+mechanism+of+action+assessment+in+tuberculosis+drug+discovery&doi=10.1128%2Faac.01178-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Bioluminescent reporters for rapid mechanism of action assessment in tuberculosis drug discovery</span></div><div class="casAuthors">Naran, Krupa; Moosa, Atica; Barry, Clifton E., III; Boshoff, Helena I. M.; Mizrahi, Valerie; Warner, Digby F.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6748-6757</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The tuberculosis (TB) drug discovery pipeline is fueled by compds.identified in whole-cell screens against the causative agent, Mycobacterium tuberculosis.  Phenotypic screening enables the selection of mols.that inhibit essential cellular functions in live, intact bacilli grown under a chosen in vitro condition.  However, deducing the mechanism of action (MOA), which is important to avoid promiscuous targets, often requires significant biol.resources in a lengthy process that risks decoupling medicinal chem.and biol.efforts.  Therefore, there is a need to develop methods enabling rapid MOA assessment of putative "actives" for triage decisions.  Here, we describe a modified version of a bioluminescence reporter assay that allows nondestructive detection of compds.targeting either of two macromol.processes in M.tuberculosis: cell wall biosynthesis or maintenance of DNA integrity.  Coupling the luxCDABE operon from Photorhabdus luminescens to mycobacterial promoters driving expression of the iniBAC operon (PiniB-LUX) or the DNA damage-inducible genes, recA (PrecA-LUX) or radA (PradA-LUX), provided quant.detection in real time of compds.triggering expression of any of these promoters over an extended 10- to 12-day incubation.  Testing against known anti-TB agents confirmed the specificity of each reporter in registering the MOA of the applied antibiotic in M.tuberculosis, independent of bactericidal or bacteriostatic activity.  Moreover, profiles obtained for exptl.compds.indicated the potential to infer complex MOAs in which multiple cellular processes are disrupted.  These results demonstrate the utility of the reporters for early triage of compds.based on the provisional MOA and suggest their application to investigate polypharmacol.in known and exptl.anti-TB agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1CWtsv8h-h7Vg90H21EOLACvtfcHk0lgr998JEq-XJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitV2ntbo%253D&md5=6f08794b0ae28a909e1282adfe642cb5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FAAC.01178-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01178-16%26sid%3Dliteratum%253Aachs%26aulast%3DNaran%26aufirst%3DK.%26aulast%3DMoosa%26aufirst%3DA.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26atitle%3DBioluminescent%2520Reporters%2520for%2520rapid%2520mechanism%2520of%2520action%2520assessment%2520in%2520tuberculosis%2520drug%2520discovery%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D6748%26epage%3D6757%26doi%3D10.1128%2Faac.01178-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guinn, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohaideen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizrahi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassetti, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span> <span> </span><span class="NLM_article-title">Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e75245</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0075245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1371%2Fjournal.pone.0075245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=24086479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFeku7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=T.+R.+Ioergerauthor=T.+O%E2%80%99Malleyauthor=R.+Liaoauthor=K.+M.+Guinnauthor=M.+J.+Hickeyauthor=N.+Mohaideenauthor=K.+C.+Murphyauthor=H.+I.+M.+Boshoffauthor=V.+Mizrahiauthor=E.+J.+Rubinauthor=C.+M.+Sassettiauthor=C.+E.+Barryauthor=D.+R.+Shermanauthor=T.+Parishauthor=J.+C.+Sacchettini&title=Identification+of+new+drug+targets+and+resistance+mechanisms+in+Mycobacterium+tuberculosis&doi=10.1371%2Fjournal.pone.0075245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis</span></div><div class="casAuthors">Ioerger, Thomas R.; O'Malley, Theresa; Liao, Reiling; Guinn, Kristine M.; Hickey, Mark J.; Mohaideen, Nilofar; Murphy, Kenan C.; Boshoff, Helena I. M.; Mizrahi, Valerie; Rubin, Eric J.; Sassetti, Christopher M.; Barry, Clifton E., III; Sherman, David R.; Parish, Tanya; Sacchettini, James C.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e75245</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Identification of new drug targets is vital for the advancement of drug discovery against Mycobacterium tuberculosis, esp. given the increase of resistance worldwide to first- and second-line drugs.  Because traditional target-based screening has largely proven unsuccessful for antibiotic discovery, we have developed a scalable platform for target identification in M. tuberculosis that is based on whole-cell screening, coupled with whole-genome sequencing of resistant mutants and recombineering to confirm.  The method yields targets paired with whole-cell active compds., which can serve as novel scaffolds for drug development, mol. tools for validation, and/or as ligands for co-crystn.  It may also reveal other information about mechanisms of action, such as activation or efflux.  Using this method, we identified resistance-linked genes for eight compds. with anti-tubercular activity.  Four of the genes have previously been shown to be essential: AspS, aspartyl-tRNA synthetase, Pks13, a polyketide synthase involved in mycolic acid biosynthesis, MmpL3, a membrane transporter, and EccB3, a component of the ESX-3 type VII secretion system.  AspS and Pks13 represent novel targets in protein translation and cell-wall biosynthesis.  Both MmpL3 and EccB3 are involved in membrane transport.  Pks13, AspS, and EccB3 represent novel candidates not targeted by existing TB drugs, and the availability of whole-cell active inhibitors greatly increases their potential for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoen2dg2HIM0LVg90H21EOLACvtfcHk0lgaXbOPjEJYHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFeku7rM&md5=2df0db796fc57f875aa12d4ac5f09984</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0075245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0075245%26sid%3Dliteratum%253Aachs%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DT.%26aulast%3DLiao%26aufirst%3DR.%26aulast%3DGuinn%26aufirst%3DK.%2BM.%26aulast%3DHickey%26aufirst%3DM.%2BJ.%26aulast%3DMohaideen%26aufirst%3DN.%26aulast%3DMurphy%26aufirst%3DK.%2BC.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DRubin%26aufirst%3DE.%2BJ.%26aulast%3DSassetti%26aufirst%3DC.%2BM.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DSherman%26aufirst%3DD.%2BR.%26aulast%3DParish%26aufirst%3DT.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26atitle%3DIdentification%2520of%2520new%2520drug%2520targets%2520and%2520resistance%2520mechanisms%2520in%2520Mycobacterium%2520tuberculosis%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0075245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddat, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, Z.</span></span> <span> </span><span class="NLM_article-title">Crystal Structures of membrane transporter MmpL3, an anti-TB drug target</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">636</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2019.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2Fj.cell.2019.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=30682372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFSrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=636-648&author=B.+Zhangauthor=J.+Liauthor=X.+Yangauthor=L.+Wuauthor=J.+Zhangauthor=Y.+Yangauthor=Y.+Zhaoauthor=L.+Zhangauthor=X.+Yangauthor=X.+Yangauthor=X.+Chengauthor=Z.+Liuauthor=B.+Jiangauthor=H.+Jiangauthor=L.+W.+Guddatauthor=H.+Yangauthor=Z.+Rao&title=Crystal+Structures+of+membrane+transporter+MmpL3%2C+an+anti-TB+drug+target&doi=10.1016%2Fj.cell.2019.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target</span></div><div class="casAuthors">Zhang, Bing; Li, Jun; Yang, Xiaolin; Wu, Lijie; Zhang, Jia; Yang, Yang; Zhao, Yao; Zhang, Lu; Yang, Xiuna; Yang, Xiaobao; Cheng, Xi; Liu, Zhijie; Jiang, Biao; Jiang, Hualiang; Guddat, Luke W.; Yang, Haitao; Rao, Zihe</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">636-648.e13</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Despite intensive efforts to discover highly effective treatments to eradicate tuberculosis (TB), it remains as a major threat to global human health.  For this reason, new TB drugs directed toward new targets are highly coveted.  MmpLs (Mycobacterial membrane proteins Large), which play crucial roles in transporting lipids, polymers and immunomodulators and which also extrude therapeutic drugs, are among the most important therapeutic drug targets to emerge in recent times.  Here, crystal structures of mycobacterial MmpL3 alone and in complex with four TB drug candidates, including SQ109 (in Phase 2b-3 clin. trials), are reported.  MmpL3 consists of a periplasmic pore domain and a twelve-helix transmembrane domain.  Two Asp-Tyr pairs centrally located in this domain appear to be key facilitators of proton-translocation.  SQ109, AU1235, ICA38, and rimonabant bind inside the transmembrane region and disrupt these Asp-Tyr pairs.  This structural data will greatly advance the development of MmpL3 inhibitors as new TB drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYvv_tRkozhbVg90H21EOLACvtfcHk0lgaXbOPjEJYHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFSrs7Y%253D&md5=1a64d246a9dee128d2faeb7e0709ca9f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2019.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2019.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DRao%26aufirst%3DZ.%26atitle%3DCrystal%2520Structures%2520of%2520membrane%2520transporter%2520MmpL3%252C%2520an%2520anti-TB%2520drug%2520target%26jtitle%3DCell%26date%3D2019%26volume%3D176%26spage%3D636%26epage%3D648%26doi%3D10.1016%2Fj.cell.2019.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Owens, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulding, C. W.</span></span> <span> </span><span class="NLM_article-title">Insights on how the Mycobacterium tuberculosis heme uptake pathway can be used as a drug target</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1391</span>– <span class="NLM_lpage">1403</span>, <span class="refDoi"> DOI: 10.4155/fmc.13.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.4155%2Ffmc.13.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=23919550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1391-1403&author=C.+P.+Owensauthor=N.+Chimauthor=C.+W.+Goulding&title=Insights+on+how+the+Mycobacterium+tuberculosis+heme+uptake+pathway+can+be+used+as+a+drug+target&doi=10.4155%2Ffmc.13.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Insights on how the Mycobacterium tuberculosis heme uptake pathway can be used as a drug target</span></div><div class="casAuthors">Owens, Cedric P.; Chim, Nicholas; Goulding, Celia W.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1391-1403</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Mycobacterium tuberculosis (Mtb) acquires non-heme iron through salicylate-derived siderophores termed mycobactins whereas heme iron is obtained through a cascade of heme uptake proteins.  Three proteins are proposed to mediate Mtb heme iron uptake, a secreted heme transporter (Rv0203), and MmpL3 and MmpL11, which are potential transmembrane heme transfer proteins.  Furthermore, MhuD, a cytoplasmic heme-degrading enzyme, was identified.  Rv0203, MmpL3, and MmpL11 are mycobacteria-specific proteins, making them excellent drug targets.  Importantly, MmpL3, a necessary protein, was also implicated in trehalose monomycolate export.  Recent drug-discovery efforts revealed that MmpL3 is the target of several compds. with antimycobacterial activity.  Inhibition of the Mtb heme uptake pathway has yet to be explored.  We propose that inhibitor design could focus on heme analogs, with the goal of blocking specific steps of this pathway.  In addn., heme uptake could be hijacked as a method of importing drugs into the mycobacterial cytosol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDQtDhE1-Qv7Vg90H21EOLACvtfcHk0lgaXbOPjEJYHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amurnF&md5=d2dce1500105bf13a4327399212930d7</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.109%26sid%3Dliteratum%253Aachs%26aulast%3DOwens%26aufirst%3DC.%2BP.%26aulast%3DChim%26aufirst%3DN.%26aulast%3DGoulding%26aufirst%3DC.%2BW.%26atitle%3DInsights%2520on%2520how%2520the%2520Mycobacterium%2520tuberculosis%2520heme%2520uptake%2520pathway%2520can%2520be%2520used%2520as%2520a%2520drug%2520target%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D1391%26epage%3D1403%26doi%3D10.4155%2Ffmc.13.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tullius, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmston, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morse, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMath, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iniguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawaya, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitelegge, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horwitz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulding, C. W.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of a unique mycobacterial heme acquisition system</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">5051</span>– <span class="NLM_lpage">5056</span>, <span class="refDoi"> DOI: 10.1073/pnas.1009516108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1073%2Fpnas.1009516108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=21383189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVChsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5051-5056&author=M.+V.+Tulliusauthor=C.+A.+Harmstonauthor=C.+P.+Owensauthor=N.+Chimauthor=R.+P.+Morseauthor=L.+M.+McMathauthor=A.+Iniguezauthor=J.+M.+Kimmeyauthor=M.+R.+Sawayaauthor=J.+P.+Whiteleggeauthor=M.+A.+Horwitzauthor=C.+W.+Goulding&title=Discovery+and+characterization+of+a+unique+mycobacterial+heme+acquisition+system&doi=10.1073%2Fpnas.1009516108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of a unique mycobacterial heme acquisition system</span></div><div class="casAuthors">Tullius, Michael V.; Harmston, Christine A.; Owens, Cedric P.; Chim, Nicholas; Morse, Robert P.; McMath, Lisa M.; Iniguez, Angelina; Kimmey, Jacqueline M.; Sawaya, Michael R.; Whitelegge, Julian P.; Horwitz, Marcus A.; Goulding, Celia W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5051-5056, S5051/1-S5051/18</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis must import iron from its host for survival, and its siderophore-dependent iron acquisition pathways are well established.  Here we demonstrate a newly characterized pathway, whereby M. tuberculosis can use free heme and heme from Hb as an iron source.  Significantly, we identified the genomic region, Rv0202c-Rv0207c, responsible for the passage of heme iron across the mycobacterial membrane.  Key players of this heme uptake system were characterized including a secreted protein and two transmembrane proteins, all three specific to mycobacteria.  Furthermore, the crystal structure of the key heme carrier protein Rv0203 was found to have a unique fold.  The discovery of a unique mycobacterial heme acquisition pathway opens new avenues of exploration into mycobacterial therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI_2E5hobkjbVg90H21EOLACvtfcHk0ljoEm9myBQVDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVChsbw%253D&md5=ed7cbd79a3ed917f9dab3a86f306962d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1009516108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1009516108%26sid%3Dliteratum%253Aachs%26aulast%3DTullius%26aufirst%3DM.%2BV.%26aulast%3DHarmston%26aufirst%3DC.%2BA.%26aulast%3DOwens%26aufirst%3DC.%2BP.%26aulast%3DChim%26aufirst%3DN.%26aulast%3DMorse%26aufirst%3DR.%2BP.%26aulast%3DMcMath%26aufirst%3DL.%2BM.%26aulast%3DIniguez%26aufirst%3DA.%26aulast%3DKimmey%26aufirst%3DJ.%2BM.%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DWhitelegge%26aufirst%3DJ.%2BP.%26aulast%3DHorwitz%26aufirst%3DM.%2BA.%26aulast%3DGoulding%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520unique%2520mycobacterial%2520heme%2520acquisition%2520system%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D5051%26epage%3D5056%26doi%3D10.1073%2Fpnas.1009516108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrero-Lérida, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, A. P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittingham, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Pérez, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Pacanowska, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of alpha-thymidine analogues as novel antimalarials</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10948</span>– <span class="NLM_lpage">10957</span>, <span class="refDoi"> DOI: 10.1021/jm301328h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301328h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCjurzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10948-10957&author=H.+Cuiauthor=J.+Carrero-L%C3%A9ridaauthor=A.+P.+G.+Silvaauthor=J.+L.+Whittinghamauthor=J.+A.+Branniganauthor=L.+M.+Ruiz-P%C3%A9rezauthor=K.+D.+Readauthor=K.+S.+Wilsonauthor=D.+Gonz%C3%A1lez-Pacanowskaauthor=I.+H.+Gilbert&title=Synthesis+and+evaluation+of+alpha-thymidine+analogues+as+novel+antimalarials&doi=10.1021%2Fjm301328h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of α-Thymidine Analogs as Novel Antimalarials</span></div><div class="casAuthors">Cui, Huaqing; Carrero-Lerida, Juana; Silva, Ana P. G.; Whittingham, Jean L.; Brannigan, James A.; Ruiz-Perez, Luis M.; Read, Kevin D.; Wilson, Keith S.; Gonzalez-Pacanowska, Dolores; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10948-10957</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Plasmodium falciparum thymidylate kinase (PfTMPK) is a key enzyme in pyrimidine nucleotide biosynthesis.  3-Trifluoromethyl-4-chloro-phenyl-urea-α-thymidine has been reported as an inhibitor of Mycobacterium tuberculosis TMPK (MtTMPK).  Starting from this point, we designed, synthesized and evaluated a no. of thymidine analogs, e.g. I, as antimalarials.  Both 5'-urea-α- and β-thymidine derivs. were moderate inhibitors of PfTMPK and furthermore showed moderate inhibition of parasite growth.  The structure of several enzyme-inhibitor complexes provides a basis for improved inhibitor design.  However, we found that certain 5'-urea-α-thymidine analogs had antimalarial activity where inhibition of PfTMPK is not the major mode of action.  Optimization of this series resulted in a compd. with potent antimalarial activity (EC50 = 28 nM; CC50 = 29 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_sLzWeWJq8rVg90H21EOLACvtfcHk0ljoEm9myBQVDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCjurzM&md5=ee4f6e2645af5199800173b108ac14df</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm301328h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301328h%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DH.%26aulast%3DCarrero-L%25C3%25A9rida%26aufirst%3DJ.%26aulast%3DSilva%26aufirst%3DA.%2BP.%2BG.%26aulast%3DWhittingham%26aufirst%3DJ.%2BL.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DRuiz-P%25C3%25A9rez%26aufirst%3DL.%2BM.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26aulast%3DGonz%25C3%25A1lez-Pacanowska%26aufirst%3DD.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520alpha-thymidine%2520analogues%2520as%2520novel%2520antimalarials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10948%26epage%3D10957%26doi%3D10.1021%2Fjm301328h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raichurkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandodkar, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varun, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalkhambkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogtherr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embrey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMiken, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarkar, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span> <span> </span><span class="NLM_article-title">Structure guided lead generation for M. tuberculosis thymidylate kinase (Mtb TMK): discovery of 3-cyanopyridone and 1,6-naphthyridin-2-one as potent inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">753</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1021/jm5012947</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012947" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCku7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=753-766&author=M.+Naikauthor=A.+Raichurkarauthor=B.+S.+Bandodkarauthor=B.+V.+Varunauthor=S.+Bhatauthor=R.+Kalkhambkarauthor=K.+Muruganauthor=R.+Menonauthor=J.+Bhatauthor=B.+Paulauthor=H.+Iyerauthor=S.+Husseinauthor=J.+A.+Tuckerauthor=M.+Vogtherrauthor=K.+J.+Embreyauthor=H.+McMikenauthor=S.+Prasadauthor=A.+Gillauthor=B.+G.+Ugarkarauthor=J.+Venkatramanauthor=J.+Readauthor=M.+Panda&title=Structure+guided+lead+generation+for+M.+tuberculosis+thymidylate+kinase+%28Mtb+TMK%29%3A+discovery+of+3-cyanopyridone+and+1%2C6-naphthyridin-2-one+as+potent+inhibitors&doi=10.1021%2Fjm5012947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Guided Lead Generation for M. tuberculosis Thymidylate Kinase (Mtb TMK): Discovery of 3-Cyanopyridone and 1,6-Naphthyridin-2-one as Potent Inhibitors</span></div><div class="casAuthors">Naik, Maruti; Raichurkar, Anandkumar; Bandodkar, Balachandra S.; Varun, Begur V.; Bhat, Shantika; Kalkhambkar, Rajesh; Murugan, Kannan; Menon, Rani; Bhat, Jyothi; Paul, Beena; Iyer, Harini; Hussein, Syeed; Tucker, Julie A.; Vogtherr, Martin; Embrey, Kevin J.; McMiken, Helen; Prasad, Swati; Gill, Adrian; Ugarkar, Bheemarao G.; Venkatraman, Janani; Read, Jon; Panda, Manoranjan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">753-766</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">M. tuberculosis thymidylate kinase (Mtb TMK) has been shown in vitro to be an essential enzyme in DNA synthesis.  In order to identify novel leads for Mtb TMK, the authors performed a high throughput biochem. screen and an NMR based fragment screen through which the authors discovered two novel classes of inhibitors, 3-cyanopyridones and 1,6-naphthyridin-2-ones, resp.  The authors describe three cyanopyridone subseries that arose during the hit to lead campaign, along with cocrystal structures of representatives with Mtb TMK.  Structure aided optimization of the cyanopyridones led to single digit nanomolar inhibitors of Mtb TMK.  Fragment based lead generation, augmented by crystal structures and the SAR from the cyanopyridones, enabled us to drive the potency of the 1,6-naphthyridin-2-one fragment hit from 500 μM to 200 nM while simultaneously improving the ligand efficiency.  Cyanopyridone derivs. contg. sulfoxides and sulfones, e.g. I, showed cellular activity against M. tuberculosis.  To the best of the knowledge, these compds. are the first reports of nonthymidine-like inhibitors of Mtb TMK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_Ua6j3LbGMLVg90H21EOLACvtfcHk0ljoEm9myBQVDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCku7jN&md5=3a9ec4e7eea4e656b12776f91091cebb</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm5012947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012947%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DM.%26aulast%3DRaichurkar%26aufirst%3DA.%26aulast%3DBandodkar%26aufirst%3DB.%2BS.%26aulast%3DVarun%26aufirst%3DB.%2BV.%26aulast%3DBhat%26aufirst%3DS.%26aulast%3DKalkhambkar%26aufirst%3DR.%26aulast%3DMurugan%26aufirst%3DK.%26aulast%3DMenon%26aufirst%3DR.%26aulast%3DBhat%26aufirst%3DJ.%26aulast%3DPaul%26aufirst%3DB.%26aulast%3DIyer%26aufirst%3DH.%26aulast%3DHussein%26aufirst%3DS.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DVogtherr%26aufirst%3DM.%26aulast%3DEmbrey%26aufirst%3DK.%2BJ.%26aulast%3DMcMiken%26aufirst%3DH.%26aulast%3DPrasad%26aufirst%3DS.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DUgarkar%26aufirst%3DB.%2BG.%26aulast%3DVenkatraman%26aufirst%3DJ.%26aulast%3DRead%26aufirst%3DJ.%26aulast%3DPanda%26aufirst%3DM.%26atitle%3DStructure%2520guided%2520lead%2520generation%2520for%2520M.%2520tuberculosis%2520thymidylate%2520kinase%2520%2528Mtb%2520TMK%2529%253A%2520discovery%2520of%25203-cyanopyridone%2520and%25201%252C6-naphthyridin-2-one%2520as%2520potent%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D753%26epage%3D766%26doi%3D10.1021%2Fjm5012947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkhill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiglmeier, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tekaia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badcock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chillingworth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devlin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feltwell, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentles, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamlin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holroyd, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornsby, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagels, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krogh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moule, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajandream, M.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skelton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squares, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squares, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulston, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitehead, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrell, B. G.</span></span> <span> </span><span class="NLM_article-title">Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>393</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1038/31159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1038%2F31159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=9634230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADyaK1cXjvV2ksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=1998&pages=537-544&author=S.+T.+Coleauthor=R.+Broschauthor=J.+Parkhillauthor=T.+Garnierauthor=C.+Churcherauthor=D.+Harrisauthor=S.+V.+Gordonauthor=K.+Eiglmeierauthor=S.+Gasauthor=C.+E.+Barryauthor=F.+Tekaiaauthor=K.+Badcockauthor=D.+Bashamauthor=D.+Brownauthor=T.+Chillingworthauthor=R.+Connorauthor=R.+Daviesauthor=K.+Devlinauthor=T.+Feltwellauthor=S.+Gentlesauthor=N.+Hamlinauthor=S.+Holroydauthor=T.+Hornsbyauthor=K.+Jagelsauthor=A.+Kroghauthor=J.+McLeanauthor=S.+Mouleauthor=L.+Murphyauthor=K.+Oliverauthor=J.+Osborneauthor=M.+A.+Quailauthor=M.-A.+Rajandreamauthor=J.+Rogersauthor=S.+Rutterauthor=K.+Seegerauthor=J.+Skeltonauthor=R.+Squaresauthor=S.+Squaresauthor=J.+E.+Sulstonauthor=K.+Taylorauthor=S.+Whiteheadauthor=B.+G.+Barrell&title=Deciphering+the+biology+of+Mycobacterium+tuberculosis+from+the+complete+genome+sequence&doi=10.1038%2F31159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence</span></div><div class="casAuthors">Cole, S. T.; Brosch, R.; Parkhill, J.; Garnier, T.; Churcher, C.; Harris, D.; Gordon, S. V.; Eiglmeier, K.; Gas, S.; Barry, C. E., III; Tekaia, F.; Badcock, K.; Basham, D.; Brown, D.; Chillingworth, T.; Connor, R.; Davies, R.; Devlin, K.; Feltwell, T.; Gentles, S.; Hamlin, N.; Holroyd, S.; Hornsby, T.; Jagels, K.; Krogh, A.; McLean, J.; Moule, S.; Murphy, L.; Oliver, K.; Osborne, J.; Quail, M. A.; Rajandream, M.-A.; Rogers, J.; Rutter, S.; Seeger, K.; Skelton, J.; Squares, R.; Squares, S.; Sulston, J. E.; Taylor, K.; Whitehead, S.; Barrell, B. G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue">6685</span>),
    <span class="NLM_cas:pages">537-544</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Countless millions of people have died from tuberculosis, a chronic infectious disease caused by the tubercle bacillus.  The complete genome sequence of the best-characterized strain of Mycobacterium tuberculosis, H37Rv, was detd. and analyzed in order to improve our understanding of the biol. of this slow-growing pathogen and to help the conception of new prophylactic and therapeutic interventions.  The genome comprises 4,411,529 base pairs, contains around 4000 genes, and has a very high G+C content that is reflected in the biased amino acid content of the proteins.  M. tuberculosis differs radically from other bacteria in that a very large portion of its coding capacity is devoted to the prodn. of enzymes involved in lipogenesis and lipolysis, and to 2 new families of glycine-rich proteins with a repetitive structure that may represent a source of antigenic variation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Q-iByIunurVg90H21EOLACvtfcHk0lj3ek_xh8uXrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvV2ksrY%253D&md5=44d23e7674bfeb1a3e30b55abf5268d2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2F31159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F31159%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DBrosch%26aufirst%3DR.%26aulast%3DParkhill%26aufirst%3DJ.%26aulast%3DGarnier%26aufirst%3DT.%26aulast%3DChurcher%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DD.%26aulast%3DGordon%26aufirst%3DS.%2BV.%26aulast%3DEiglmeier%26aufirst%3DK.%26aulast%3DGas%26aufirst%3DS.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DTekaia%26aufirst%3DF.%26aulast%3DBadcock%26aufirst%3DK.%26aulast%3DBasham%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DChillingworth%26aufirst%3DT.%26aulast%3DConnor%26aufirst%3DR.%26aulast%3DDavies%26aufirst%3DR.%26aulast%3DDevlin%26aufirst%3DK.%26aulast%3DFeltwell%26aufirst%3DT.%26aulast%3DGentles%26aufirst%3DS.%26aulast%3DHamlin%26aufirst%3DN.%26aulast%3DHolroyd%26aufirst%3DS.%26aulast%3DHornsby%26aufirst%3DT.%26aulast%3DJagels%26aufirst%3DK.%26aulast%3DKrogh%26aufirst%3DA.%26aulast%3DMcLean%26aufirst%3DJ.%26aulast%3DMoule%26aufirst%3DS.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DOliver%26aufirst%3DK.%26aulast%3DOsborne%26aufirst%3DJ.%26aulast%3DQuail%26aufirst%3DM.%2BA.%26aulast%3DRajandream%26aufirst%3DM.-A.%26aulast%3DRogers%26aufirst%3DJ.%26aulast%3DRutter%26aufirst%3DS.%26aulast%3DSeeger%26aufirst%3DK.%26aulast%3DSkelton%26aufirst%3DJ.%26aulast%3DSquares%26aufirst%3DR.%26aulast%3DSquares%26aufirst%3DS.%26aulast%3DSulston%26aufirst%3DJ.%2BE.%26aulast%3DTaylor%26aufirst%3DK.%26aulast%3DWhitehead%26aufirst%3DS.%26aulast%3DBarrell%26aufirst%3DB.%2BG.%26atitle%3DDeciphering%2520the%2520biology%2520of%2520Mycobacterium%2520tuberculosis%2520from%2520the%2520complete%2520genome%2520sequence%26jtitle%3DNature%26date%3D1998%26volume%3D393%26spage%3D537%26epage%3D544%26doi%3D10.1038%2F31159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeJesus, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerrick, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutte, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnappinger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortune, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassetti, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span> <span> </span><span class="NLM_article-title">Comprehensive essentiality analysis of the Mycobacterium tuberculosis genome via saturating transposon mutagenesis</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e02133</span> <span class="refDoi"> DOI: 10.1128/mbio.02133-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1128%2FmBio.02133-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=28096490" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=M.+A.+DeJesusauthor=E.+R.+Gerrickauthor=W.+Xuauthor=S.+W.+Parkauthor=J.+E.+Longauthor=C.+C.+Boutteauthor=E.+J.+Rubinauthor=D.+Schnappingerauthor=S.+Ehrtauthor=S.+M.+Fortuneauthor=C.+M.+Sassettiauthor=T.+R.+Ioerger&title=Comprehensive+essentiality+analysis+of+the+Mycobacterium+tuberculosis+genome+via+saturating+transposon+mutagenesis&doi=10.1128%2Fmbio.02133-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FmBio.02133-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.02133-16%26sid%3Dliteratum%253Aachs%26aulast%3DDeJesus%26aufirst%3DM.%2BA.%26aulast%3DGerrick%26aufirst%3DE.%2BR.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DPark%26aufirst%3DS.%2BW.%26aulast%3DLong%26aufirst%3DJ.%2BE.%26aulast%3DBoutte%26aufirst%3DC.%2BC.%26aulast%3DRubin%26aufirst%3DE.%2BJ.%26aulast%3DSchnappinger%26aufirst%3DD.%26aulast%3DEhrt%26aufirst%3DS.%26aulast%3DFortune%26aufirst%3DS.%2BM.%26aulast%3DSassetti%26aufirst%3DC.%2BM.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26atitle%3DComprehensive%2520essentiality%2520analysis%2520of%2520the%2520Mycobacterium%2520tuberculosis%2520genome%2520via%2520saturating%2520transposon%2520mutagenesis%26jtitle%3DmBio%26date%3D2017%26volume%3D8%26doi%3D10.1128%2Fmbio.02133-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gawronski, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dejesus, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akerley, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassetti, C. M.</span></span> <span> </span><span class="NLM_article-title">High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e1002251</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1002251</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1371%2Fjournal.ppat.1002251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=21980284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlCmsbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&author=J.+E.+Griffinauthor=J.+D.+Gawronskiauthor=M.+A.+Dejesusauthor=T.+R.+Ioergerauthor=B.+J.+Akerleyauthor=C.+M.+Sassetti&title=High-resolution+phenotypic+profiling+defines+genes+essential+for+mycobacterial+growth+and+cholesterol+catabolism&doi=10.1371%2Fjournal.ppat.1002251"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism</span></div><div class="casAuthors">Griffin, Jennifer E.; Gawronski, Jeffrey D.; DeJesus, Michael A.; Ioerger, Thomas R.; Akerley, Brian J.; Sassetti, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e1002251</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The pathways that comprise cellular metab. are highly interconnected, and alterations in individual enzymes can have far-reaching effects.  As a result, global profiling methods that measure gene expression are of limited value in predicting how the loss of an individual function will affect the cell.  In this work, we employed a new method of global phenotypic profiling to directly define the genes required for the growth of Mycobacterium tuberculosis.  A combination of high-d. mutagenesis and deep-sequencing was used to characterize the compn. of complex mutant libraries exposed to different conditions.  This allowed the unambiguous identification of the genes that are essential for Mtb to grow in vitro, and proved to be a significant improvement over previous approaches.  To further explore functions that are required for persistence in the host, we defined the pathways necessary for the utilization of cholesterol, a crit. carbon source during infection.  Few of the genes we identified had previously been implicated in this adaptation by transcriptional profiling, and only a fraction were encoded in the chromosomal region known to encode sterol catabolic functions.  These genes comprise an unexpectedly large percentage of those previously shown to be required for bacterial growth in mouse tissue.  Thus, this single nutritional change accounts for a significant fraction of the adaptation to the host.  This work provides the most comprehensive genetic characterization of a sterol catabolic pathway to date, suggests putative roles for uncharacterized virulence genes, and precisely maps genes encoding potential drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZFTpTTOIkA7Vg90H21EOLACvtfcHk0lj3ek_xh8uXrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlCmsbfN&md5=a97c2b9759b7a8bc9a304f5684701f13</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002251%26sid%3Dliteratum%253Aachs%26aulast%3DGriffin%26aufirst%3DJ.%2BE.%26aulast%3DGawronski%26aufirst%3DJ.%2BD.%26aulast%3DDejesus%26aufirst%3DM.%2BA.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DAkerley%26aufirst%3DB.%2BJ.%26aulast%3DSassetti%26aufirst%3DC.%2BM.%26atitle%3DHigh-resolution%2520phenotypic%2520profiling%2520defines%2520genes%2520essential%2520for%2520mycobacterial%2520growth%2520and%2520cholesterol%2520catabolism%26jtitle%3DPLoS%2520Pathog.%26date%3D2011%26volume%3D7%26doi%3D10.1371%2Fjournal.ppat.1002251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sassetti, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E. J.</span></span> <span> </span><span class="NLM_article-title">Genes required for mycobacterial growth defined by high density mutagenesis</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2958.2003.03425.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1046%2Fj.1365-2958.2003.03425.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=12657046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislOrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2003&pages=77-84&author=C.+M.+Sassettiauthor=D.+H.+Boydauthor=E.+J.+Rubin&title=Genes+required+for+mycobacterial+growth+defined+by+high+density+mutagenesis&doi=10.1046%2Fj.1365-2958.2003.03425.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Genes required for mycobacterial growth defined by high density mutagenesis</span></div><div class="casAuthors">Sassetti, Christopher M.; Boyd, Dana H.; Rubin, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Despite over a century of research, tuberculosis remains a leading cause of infectious death worldwide.  Faced with increasing rates of drug resistance, the identification of genes that are required for the growth of this organism should provide new targets for the design of antimycobacterial agents.  Here, we describe the use of transposon site hybridization (TraSH) to comprehensively identify the genes required by the causative agent, Mycobacterium tuberculosis, for optimal growth.  These genes include those that can be assigned to essential pathways as well as many of unknown function.  The genes important for the growth of M. tuberculosis are largely conserved in the degenerate genome of the leprosy bacillus, Mycobacterium leprae, indicating that non-essential functions have been selectively lost since this bacterium diverged from other mycobacteria.  In contrast, a surprisingly high proportion of these genes lack identifiable orthologues in other bacteria, suggesting that the minimal gene set required for survival varies greatly between organisms with different evolutionary histories.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRBfRLDyIMG7Vg90H21EOLACvtfcHk0ljOfaLBYwtHtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislOrsLY%253D&md5=fca1950336b0a179d83c94e701672523</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2003.03425.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2003.03425.x%26sid%3Dliteratum%253Aachs%26aulast%3DSassetti%26aufirst%3DC.%2BM.%26aulast%3DBoyd%26aufirst%3DD.%2BH.%26aulast%3DRubin%26aufirst%3DE.%2BJ.%26atitle%3DGenes%2520required%2520for%2520mycobacterial%2520growth%2520defined%2520by%2520high%2520density%2520mutagenesis%26jtitle%3DMol.%2520Microbiol.%26date%3D2003%26volume%3D48%26spage%3D77%26epage%3D84%26doi%3D10.1046%2Fj.1365-2958.2003.03425.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boldrin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palú, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganelli, R.</span></span> <span> </span><span class="NLM_article-title">Characterization of a Mycobacterium tuberculosis ESX-3 conditional mutant: essentiality and rescue by iron and zinc</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">6340</span>– <span class="NLM_lpage">6344</span>, <span class="refDoi"> DOI: 10.1128/jb.00756-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1128%2FJB.00756-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=19684129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSrsrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2009&pages=6340-6344&author=A.+Serafiniauthor=F.+Boldrinauthor=G.+Pal%C3%BAauthor=R.+Manganelli&title=Characterization+of+a+Mycobacterium+tuberculosis+ESX-3+conditional+mutant%3A+essentiality+and+rescue+by+iron+and+zinc&doi=10.1128%2Fjb.00756-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a Mycobacterium tuberculosis ESX-3 conditional mutant: Essentiality and rescue by iron and zinc</span></div><div class="casAuthors">Serafini, Agnese; Boldrin, Francesca; Palu, Giorgio; Manganelli, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6340-6344</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Recently, a novel type of secretory pathway, type VII secretion systems (T7SSs), has been characterized in mycobacteria.  The chromosomes of Mycobacterium tuberculosis and Mycobacterium bovis encode five T7SSs (ESX-1 to ESX-5).  The best characterized of them, ESX-1, is involved in host-pathogen interactions, and its deletion is one of the main causes of M. bovis BCG attenuation.  Another T7SS, ESX-3, has been previously shown to be transcriptionally controlled by the zinc uptake repressor (Zur) and by the iron-dependent transcriptional repressor (IdeR), suggesting that it might be involved in zinc and iron homeostasis.  In this study, the authors characterized an M. tuberculosis conditional mutant in which transcription of the ESX-3 gene cluster can be downregulated by anhydrotetracycline.  They showed that this T7SS is essential for growth and that this phenotype can be complemented by zinc, iron, or supernatant from a wild-type parental strain culture, demonstrating that the ESX-3 secretion system is responsible for the secretion of some sol. factor(s) required for growth that is probably involved in optimal iron and zinc uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-e8LI5CBVDrVg90H21EOLACvtfcHk0ljOfaLBYwtHtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSrsrvL&md5=f124b9feeb0728d080b9a516c7670f0d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1128%2FJB.00756-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.00756-09%26sid%3Dliteratum%253Aachs%26aulast%3DSerafini%26aufirst%3DA.%26aulast%3DBoldrin%26aufirst%3DF.%26aulast%3DPal%25C3%25BA%26aufirst%3DG.%26aulast%3DManganelli%26aufirst%3DR.%26atitle%3DCharacterization%2520of%2520a%2520Mycobacterium%2520tuberculosis%2520ESX-3%2520conditional%2520mutant%253A%2520essentiality%2520and%2520rescue%2520by%2520iron%2520and%2520zinc%26jtitle%3DJ.%2520Bacteriol.%26date%3D2009%26volume%3D191%26spage%3D6340%26epage%3D6344%26doi%3D10.1128%2Fjb.00756-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palù, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganelli, R.</span></span> <span> </span><span class="NLM_article-title">The ESX-3 secretion system is necessary for iron and zinc homeostasis in Mycobacterium tuberculosis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e78351</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0078351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1371%2Fjournal.pone.0078351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=24155985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yms73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=A.+Serafiniauthor=D.+Pisuauthor=G.+Pal%C3%B9author=G.+M.+Rodriguezauthor=R.+Manganelli&title=The+ESX-3+secretion+system+is+necessary+for+iron+and+zinc+homeostasis+in+Mycobacterium+tuberculosis&doi=10.1371%2Fjournal.pone.0078351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The ESX-3 secretion system is necessary for iron and zinc homeostasis in Mycobacterium tuberculosis</span></div><div class="casAuthors">Serafini, Agnese; Pisu, Davide; Palu, Giorgio; Rodriguez, G. Marcela; Manganelli, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e78351</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">ESX-3 is one of the five type VII secretion systems encoded by the Mycobacterium tuberculosis genome.  The authors recently showed the essentiality of ESX-3 for M. tuberculosis viability and proposed its involvement in iron and zinc metab.  The authors confirmed the role of ESX-3 in iron uptake and its involvement in the adaptation to low zinc environment in M. tuberculosis.  Moreover, the authors unveiled functional differences between the ESX-3 roles in M. tuberculosis and M. smegmatis showing that in the latter ESX-3 is only involved in the adaptation to iron and not to zinc restriction.  Finally, also in M. tuberculosis this secretion system is essential for iron and zinc homeostasis not only in conditions in which the concns. of these metals are limiting but also in metal sufficient conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2vxsdAbWiQrVg90H21EOLACvtfcHk0ljOfaLBYwtHtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yms73J&md5=e717f6213d69ad349d26bb94833bcb71</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0078351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0078351%26sid%3Dliteratum%253Aachs%26aulast%3DSerafini%26aufirst%3DA.%26aulast%3DPisu%26aufirst%3DD.%26aulast%3DPal%25C3%25B9%26aufirst%3DG.%26aulast%3DRodriguez%26aufirst%3DG.%2BM.%26aulast%3DManganelli%26aufirst%3DR.%26atitle%3DThe%2520ESX-3%2520secretion%2520system%2520is%2520necessary%2520for%2520iron%2520and%2520zinc%2520homeostasis%2520in%2520Mycobacterium%2520tuberculosis%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0078351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegrist, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steigedal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragset, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philips, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E. J.</span></span> <span> </span><span class="NLM_article-title">Mycobacterial Esx-3 requires multiple components for iron acquisition</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e01073</span> <span class="refDoi"> DOI: 10.1128/mbio.01073-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1128%2FmBio.01073-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=24803520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1OlsbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&author=M.+S.+Siegristauthor=M.+Steigedalauthor=R.+Ahmadauthor=A.+Mehraauthor=M.+S.+Dragsetauthor=B.+M.+Schusterauthor=J.+A.+Philipsauthor=S.+A.+Carrauthor=E.+J.+Rubin&title=Mycobacterial+Esx-3+requires+multiple+components+for+iron+acquisition&doi=10.1128%2Fmbio.01073-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Mycobacterial Esx-3 requires multiple components for iron acquisition</span></div><div class="casAuthors">Siegrist, M. Sloan; Steigedal, Magnus; Ahmad, Rushdy; Mehra, Alka; Dragset, Marte S.; Schuster, Brian M.; Philips, Jennifer A.; Carr, Steven A.; Rubin, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">mBio</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e01073/1-e01073/11, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">MBIOCL</span>;
        ISSN:<span class="NLM_cas:issn">2150-7511</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The type VII secretion systems are conserved across mycobacterial species and in many Gram-pos. bacteria.  While the well-characterized Esx-1 pathway is required for the virulence of pathogenic mycobacteria and conjugation in the model organism Mycobacterium smegmatis, Esx-3 contributes to mycobactin-mediated iron acquisition in these bacteria.  Here we show that several Esx-3 components are individually required for function under low-iron conditions but that at least one, the membrane-bound protease MycP3 of M. smegmatis, is partially expendable.  All of the esx-3 mutants tested, including the ΔmycP3ms mutant, failed to export the native Esx-3 substrates EsxHms and EsxGms to quantifiable levels, as detd. by targeted mass spectrometry.  Although we were able to restore low-iron growth to the esx-3 mutants by genetic complementation, we found a wide range of complementation levels for protein export.  Indeed, minute quantities of extracellular EsxHms and EsxGms were sufficient for iron acquisition under our exptl. conditions.  The apparent sepn. of Esx-3 function in iron acquisition from robust EsxGms and EsxHms secretion in the ΔmycP3ms mutant and in some of the complemented esx-3 mutants compels reexamn. of the structure-function relationships for type VII secretion systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQdC5LN3AvgbVg90H21EOLACvtfcHk0lgkBs_P837Pyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1OlsbfJ&md5=c6869042be60f9e332c84c1c4e3667a4</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1128%2FmBio.01073-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.01073-14%26sid%3Dliteratum%253Aachs%26aulast%3DSiegrist%26aufirst%3DM.%2BS.%26aulast%3DSteigedal%26aufirst%3DM.%26aulast%3DAhmad%26aufirst%3DR.%26aulast%3DMehra%26aufirst%3DA.%26aulast%3DDragset%26aufirst%3DM.%2BS.%26aulast%3DSchuster%26aufirst%3DB.%2BM.%26aulast%3DPhilips%26aufirst%3DJ.%2BA.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DRubin%26aufirst%3DE.%2BJ.%26atitle%3DMycobacterial%2520Esx-3%2520requires%2520multiple%2520components%2520for%2520iron%2520acquisition%26jtitle%3DmBio%26date%3D2014%26volume%3D5%26doi%3D10.1128%2Fmbio.01073-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegrist, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unnikrishnan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borowsky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortune, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E. J.</span></span> <span> </span><span class="NLM_article-title">Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">18792</span>– <span class="NLM_lpage">18797</span>, <span class="refDoi"> DOI: 10.1073/pnas.0900589106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1073%2Fpnas.0900589106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=19846780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A280%3ADC%252BD1MjjvVWmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=18792-18797&author=M.+S.+Siegristauthor=M.+Unnikrishnanauthor=M.+J.+McConnellauthor=M.+Borowskyauthor=T.-Y.+Chengauthor=N.+Siddiqiauthor=S.+M.+Fortuneauthor=D.+B.+Moodyauthor=E.+J.+Rubin&title=Mycobacterial+Esx-3+is+required+for+mycobactin-mediated+iron+acquisition&doi=10.1073%2Fpnas.0900589106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition</span></div><div class="casAuthors">Siegrist M Sloan; Unnikrishnan Meera; McConnell Matthew J; Borowsky Mark; Cheng Tan-Yun; Siddiqi Noman; Fortune Sarah M; Moody D Branch; Rubin Eric J</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">18792-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Esx secretion pathway is conserved across Gram-positive bacteria.  Esx-1, the best-characterized system, is required for virulence of Mycobacterium tuberculosis, although its precise function during infection remains unclear.  Esx-3, a paralogous system present in all mycobacterial species, is required for growth in vitro.  Here, we demonstrate that mycobacteria lacking Esx-3 are defective in acquiring iron.  To compete for the limited iron available in the host and the environment, these organisms use mycobactin, high-affinity iron-binding molecules.  In the absence of Esx-3, mycobacteria synthesize mycobactin but are unable to use the bound iron and are impaired severely for growth during macrophage infection.  Mycobacteria thus require a specialized secretion system for acquiring iron from siderophores.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQNYiDyKXAPLsAKB7Fa-xrUfW6udTcc2eaPUdWcgpHkA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjjvVWmsA%253D%253D&md5=5ee0124f43ce767310e831f260c0439e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0900589106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0900589106%26sid%3Dliteratum%253Aachs%26aulast%3DSiegrist%26aufirst%3DM.%2BS.%26aulast%3DUnnikrishnan%26aufirst%3DM.%26aulast%3DMcConnell%26aufirst%3DM.%2BJ.%26aulast%3DBorowsky%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DT.-Y.%26aulast%3DSiddiqi%26aufirst%3DN.%26aulast%3DFortune%26aufirst%3DS.%2BM.%26aulast%3DMoody%26aufirst%3DD.%2BB.%26aulast%3DRubin%26aufirst%3DE.%2BJ.%26atitle%3DMycobacterial%2520Esx-3%2520is%2520required%2520for%2520mycobactin-mediated%2520iron%2520acquisition%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D18792%26epage%3D18797%26doi%3D10.1073%2Fpnas.0900589106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voskuil, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoolnik, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, I.</span></span> <span> </span><span class="NLM_article-title">ideR, An essential gene in mycobacterium tuberculosis: role of IdeR in iron-dependent gene expression, iron metabolism, and oxidative stress response</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">3371</span>– <span class="NLM_lpage">3381</span>, <span class="refDoi"> DOI: 10.1128/iai.70.7.3371-3381.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1128%2FIAI.70.7.3371-3381.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=12065475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvV2ltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2002&pages=3371-3381&author=G.+M.+Rodriguezauthor=M.+I.+Voskuilauthor=B.+Goldauthor=G.+K.+Schoolnikauthor=I.+Smith&title=ideR%2C+An+essential+gene+in+mycobacterium+tuberculosis%3A+role+of+IdeR+in+iron-dependent+gene+expression%2C+iron+metabolism%2C+and+oxidative+stress+response&doi=10.1128%2Fiai.70.7.3371-3381.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">ideR, an essential gene in Mycobacterium tuberculosis: role of IdeR in iron-dependent gene expression, iron metabolism, and oxidative stress response</span></div><div class="casAuthors">Rodriguez, G. Marcela; Voskuil, Martin I.; Gold, Benjamin; Schoolnik, Gary K.; Smith, Issar</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3371-3381</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The mycobacterial IdeR protein is a metal-dependent regulator of the DtxR (diphtheria toxin repressor) family.  In the presence of iron, it binds to a specific DNA sequence in the promoter regions of the genes that it regulates, thus controlling their transcription.  In this study, we provide evidence that ideR is an essential gene in Mycobacterium tuberculosis.  IdeR cannot normally be disrupted in this mycobacterium in the absence of a second functional copy of the gene.  However, a rare ideR mutant was obtained in which the lethal effects of ideR inactivation were alleviated by a second-site suppressor mutation and which exhibited restricted iron assimilation capacity.  Studies of this strain and a deriv. in which IdeR expression was restored allowed us to identify phenotypic effects resulting from ideR inactivation.  Using DNA microarrays, the iron-dependent transcriptional profiles of the wild-type, ideR mutant, and ideR-complemented mutant strains were analyzed, and the genes regulated by iron and IdeR were identified.  These genes encode a variety of proteins, including putative transporters, proteins involved in siderophore synthesis and iron storage, members of the PE/PPE family, a membrane protein involved in virulence, transcriptional regulators, and enzymes involved in lipid metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBAyvgQc0sFrVg90H21EOLACvtfcHk0lgkBs_P837Pyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvV2ltbg%253D&md5=408f6bc94fad7c1a273f12db4f74aeb9</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1128%2FIAI.70.7.3371-3381.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.70.7.3371-3381.2002%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DG.%2BM.%26aulast%3DVoskuil%26aufirst%3DM.%2BI.%26aulast%3DGold%26aufirst%3DB.%26aulast%3DSchoolnik%26aufirst%3DG.%2BK.%26aulast%3DSmith%26aufirst%3DI.%26atitle%3DideR%252C%2520An%2520essential%2520gene%2520in%2520mycobacterium%2520tuberculosis%253A%2520role%2520of%2520IdeR%2520in%2520iron-dependent%2520gene%2520expression%252C%2520iron%2520metabolism%252C%2520and%2520oxidative%2520stress%2520response%26jtitle%3DInfect.%2520Immun.%26date%3D2002%26volume%3D70%26spage%3D3371%26epage%3D3381%26doi%3D10.1128%2Fiai.70.7.3371-3381.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurthkoti, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marakalala, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghanny, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subbian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakatos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortune, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, G. M.</span></span> <span> </span><span class="NLM_article-title">The capacity of Mycobacterium tuberculosis To survive iron starvation might enable it to persist in iron-deprived microenvironments of human granulomas</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e01092</span> <span class="refDoi"> DOI: 10.1128/mbio.01092-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1128%2FmBio.01092-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=28811344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVCmsbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=K.+Kurthkotiauthor=H.+Aminauthor=M.+J.+Marakalalaauthor=S.+Ghannyauthor=S.+Subbianauthor=A.+Sakatosauthor=J.+Livnyauthor=S.+M.+Fortuneauthor=M.+Berneyauthor=G.+M.+Rodriguez&title=The+capacity+of+Mycobacterium+tuberculosis+To+survive+iron+starvation+might+enable+it+to+persist+in+iron-deprived+microenvironments+of+human+granulomas&doi=10.1128%2Fmbio.01092-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The capacity of Mycobacterium tuberculosis to survive iron starvation might enable it to persist in iron-deprived microenvironments of human granulomas</span></div><div class="casAuthors">Kurthkoti, Krishna; Amin, Hamel; Marakalala, Mohlopheni J.; Ghanny, Saleena; Subbian, Selvakumar; Sakatos, Alexandra; Livny, Jonathan; Fortune, Sarah M.; Berney, Michael; Rodriguez, G. Marcela</div><div class="citationInfo"><span class="NLM_cas:title">mBio</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e01092/1-e01092/17</span>CODEN:
                <span class="NLM_cas:coden">MBIOCL</span>;
        ISSN:<span class="NLM_cas:issn">2150-7511</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">This study was conducted to investigate the role of iron deprivation in the persistence of Mycobacterium tuberculosis.  We present evidence of iron restriction in human necrotic granulomas and demonstrate that under iron starvation M. tuberculosispersists, refractive to antibiotics and capable of restarting replication when iron is made available.  Transcriptomics and metabolomic analyses indicated that the persistence of M.tuberculosis under iron starvation is dependent on strict control of endogenous Fe utilization and is assocd. with upregulation of pathogenicity and intrinsic antibiotic resistance determinants.  M. tuberculosis mutants compromised in their ability to survive Fe starvation were identified.  The findings of this study advance the understanding of the physiol. settings that may underpin the chronicity of human tuberculosis (TB) and are relevant to the design of effective antitubercular therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8_XOUur4HKrVg90H21EOLACvtfcHk0lj1AsLFWNkY5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVCmsbjF&md5=6fbf9593b85030a76068fbbfd35dc7c7</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1128%2FmBio.01092-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.01092-17%26sid%3Dliteratum%253Aachs%26aulast%3DKurthkoti%26aufirst%3DK.%26aulast%3DAmin%26aufirst%3DH.%26aulast%3DMarakalala%26aufirst%3DM.%2BJ.%26aulast%3DGhanny%26aufirst%3DS.%26aulast%3DSubbian%26aufirst%3DS.%26aulast%3DSakatos%26aufirst%3DA.%26aulast%3DLivny%26aufirst%3DJ.%26aulast%3DFortune%26aufirst%3DS.%2BM.%26aulast%3DBerney%26aufirst%3DM.%26aulast%3DRodriguez%26aufirst%3DG.%2BM.%26atitle%3DThe%2520capacity%2520of%2520Mycobacterium%2520tuberculosis%2520To%2520survive%2520iron%2520starvation%2520might%2520enable%2520it%2520to%2520persist%2520in%2520iron-deprived%2520microenvironments%2520of%2520human%2520granulomas%26jtitle%3DmBio%26date%3D2017%26volume%3D8%26doi%3D10.1128%2Fmbio.01092-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brecik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svetlíková, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaško, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackburn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikušová, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizrahi, V.</span></span> <span> </span><span class="NLM_article-title">The complex mechanism of antimycobacterial action of 5-fluorouracil</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2014.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2Fj.chembiol.2014.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=25544046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvFWksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=63-75&author=V.+Singhauthor=M.+Brecikauthor=R.+Mukherjeeauthor=J.+C.+Evansauthor=Z.+Svetl%C3%ADkov%C3%A1author=J.+Bla%C5%A1koauthor=S.+Suradeauthor=J.+Blackburnauthor=D.+F.+Warnerauthor=K.+Miku%C5%A1ov%C3%A1author=V.+Mizrahi&title=The+complex+mechanism+of+antimycobacterial+action+of+5-fluorouracil&doi=10.1016%2Fj.chembiol.2014.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The Complex Mechanism of Antimycobacterial Action of 5-Fluorouracil</span></div><div class="casAuthors">Singh, Vinayak; Brecik, Miroslav; Mukherjee, Raju; Evans, Joanna C.; Svetlikova, Zuzana; Blasko, Jaroslav; Surade, Sachin; Blackburn, Jonathan; Warner, Digby F.; Mikusova, Katarina; Mizrahi, Valerie</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-75</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A combination of chem. genetic and biochem. assays was applied to investigate the mechanism of action of the anticancer drug 5-fluorouracil (5-FU), against Mycobacterium tuberculosis (Mtb). 5-FU resistance was assocd. with mutations in upp or pyrR.  Upp-catalyzed conversion of 5-FU to FUMP was shown to constitute the first step in the mechanism of action, and resistance conferred by nonsynonymous SNPs in pyrR shown to be due to derepression of the pyr operon and rescue from the toxic effects of FUMP and downstream antimetabolites through de novo prodn. of UMP.  5-FU-derived metabolites identified in Mtb were consistent with the obsd. incorporation of 5-FU into RNA and DNA and the reduced amt. of mycolyl arabinogalactan peptidoglycan in 5-FU-treated cells.  Conditional depletion of the essential thymidylate synthase ThyX resulted in modest hypersensitivity to 5-FU, implicating inhibition of ThyX by fluorodeoxyuridylate as a further component of the mechanism of antimycobacterial action of this drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonZa6FzoC5DbVg90H21EOLACvtfcHk0lj1AsLFWNkY5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvFWksA%253D%253D&md5=854a8fb9a8755b071b2ff0e5188146f7</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DV.%26aulast%3DBrecik%26aufirst%3DM.%26aulast%3DMukherjee%26aufirst%3DR.%26aulast%3DEvans%26aufirst%3DJ.%2BC.%26aulast%3DSvetl%25C3%25ADkov%25C3%25A1%26aufirst%3DZ.%26aulast%3DBla%25C5%25A1ko%26aufirst%3DJ.%26aulast%3DSurade%26aufirst%3DS.%26aulast%3DBlackburn%26aufirst%3DJ.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26aulast%3DMiku%25C5%25A1ov%25C3%25A1%26aufirst%3DK.%26aulast%3DMizrahi%26aufirst%3DV.%26atitle%3DThe%2520complex%2520mechanism%2520of%2520antimycobacterial%2520action%2520of%25205-fluorouracil%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D63%26epage%3D75%26doi%3D10.1016%2Fj.chembiol.2014.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacitto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartkoorn, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ascher, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondésert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vocat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupien, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sommer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagrange, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buechler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pato, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizrahi, V.</span></span> <span> </span><span class="NLM_article-title">The inosine monophosphate dehydrogenase, GuaB2, is a vulnerable new bactericidal drug target for tuberculosis</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.6b00102</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.6b00102" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVeht7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=5-17&author=V.+Singhauthor=S.+Doniniauthor=A.+Pacittoauthor=C.+Salaauthor=R.+C.+Hartkoornauthor=N.+Dharauthor=G.+Keriauthor=D.+B.+Ascherauthor=G.+Mond%C3%A9sertauthor=A.+Vocatauthor=A.+Lupienauthor=R.+Sommerauthor=H.+Vermetauthor=S.+Lagrangeauthor=J.+Buechlerauthor=D.+F.+Warnerauthor=J.+D.+McKinneyauthor=J.+Patoauthor=S.+T.+Coleauthor=T.+L.+Blundellauthor=M.+Rizziauthor=V.+Mizrahi&title=The+inosine+monophosphate+dehydrogenase%2C+GuaB2%2C+is+a+vulnerable+new+bactericidal+drug+target+for+tuberculosis&doi=10.1021%2Facsinfecdis.6b00102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis</span></div><div class="casAuthors">Singh, Vinayak; Donini, Stefano; Pacitto, Angela; Sala, Claudia; Hartkoorn, Ruben C.; Dhar, Neeraj; Keri, Gyorgy; Ascher, David B.; Mondesert, Guillaume; Vocat, Anthony; Lupien, Andreanne; Sommer, Raphael; Vermet, Helene; Lagrange, Sophie; Buechler, Joe; Warner, Digby F.; McKinney, John D.; Pato, Janos; Cole, Stewart T.; Blundell, Tom L.; Rizzi, Menico; Mizrahi, Valerie</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-17</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">VCC234718, a mol. with growth inhibitory activity against Mycobacterium tuberculosis (Mtb), was identified by phenotypic screening of a 15,344-compd. library.  Sequencing of a VCC234718-resistant mutant identified a Y487C substitution in the inosine monophosphate dehydrogenase, GuaB2, which was subsequently validated to be the primary mol. target of VCC234718 in Mtb.  VCC234718 inhibits Mtb GuaB2 with a Ki 100 nM and is uncompetitive with respect to IMP and NAD+.  This compd. binds at the NAD+ site, after IMP has bound, and makes direct interactions with IMP; therefore, the inhibitor is by definition uncompetitive.  VCC234718 forms strong pi interactions with the Y487 residue side chain from the adjacent protomer in the tetramer, explaining the resistance-conferring mutation.  In addn. to sensitizing Mtb to VCC2344718, depletion of GuaB2 was bactericidal in Mtb in vitro and in macrophages.  When supplied at a high concn. (≥125 μM), guanine alleviated the toxicity of VCC234718 treatment or GuaB2 depletion via purine salvage.  However, transcriptional silencing of guaB2 prevented Mtb from establishing an infection in mice, confirming that Mtb has limited access to guanine in this animal model.  Together, these data provide compelling validation of GuaB2 as a new TB drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokN3rgePLpSLVg90H21EOLACvtfcHk0lj1AsLFWNkY5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVeht7bM&md5=84f5cc19bdbfe4f1bdd6497e66f7bf3d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.6b00102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.6b00102%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DV.%26aulast%3DDonini%26aufirst%3DS.%26aulast%3DPacitto%26aufirst%3DA.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DKeri%26aufirst%3DG.%26aulast%3DAscher%26aufirst%3DD.%2BB.%26aulast%3DMond%25C3%25A9sert%26aufirst%3DG.%26aulast%3DVocat%26aufirst%3DA.%26aulast%3DLupien%26aufirst%3DA.%26aulast%3DSommer%26aufirst%3DR.%26aulast%3DVermet%26aufirst%3DH.%26aulast%3DLagrange%26aufirst%3DS.%26aulast%3DBuechler%26aufirst%3DJ.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DPato%26aufirst%3DJ.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DRizzi%26aufirst%3DM.%26aulast%3DMizrahi%26aufirst%3DV.%26atitle%3DThe%2520inosine%2520monophosphate%2520dehydrogenase%252C%2520GuaB2%252C%2520is%2520a%2520vulnerable%2520new%2520bactericidal%2520drug%2520target%2520for%2520tuberculosis%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2017%26volume%3D3%26spage%3D5%26epage%3D17%26doi%3D10.1021%2Facsinfecdis.6b00102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ollinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraski, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alling, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, T.</span></span> <span> </span><span class="NLM_article-title">A dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e60531</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0060531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1371%2Fjournal.pone.0060531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=23593234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Gls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=J.+Ollingerauthor=M.+A.+Baileyauthor=G.+C.+Moraskiauthor=A.+Caseyauthor=S.+Florioauthor=T.+Allingauthor=M.+J.+Millerauthor=T.+Parish&title=A+dual+read-out+assay+to+evaluate+the+potency+of+compounds+active+against+Mycobacterium+tuberculosis&doi=10.1371%2Fjournal.pone.0060531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosis</span></div><div class="casAuthors">Ollinger, Juliane; Bailey, Mai Ann; Moraski, Garrett C.; Casey, Allen; Florio, Stephanie; Alling, Torey; Miller, Marvin J.; Parish, Tanya</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e60531</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Tuberculosis is a serious global health problem caused by the bacterium Mycobacterium tuberculosis.  There is an urgent need for discovery and development of new treatments, but this can only be accomplished through rapid and reproducible M. tuberculosis assays designed to identify potent inhibitors.  We developed an automated 96-well assay utilizing a recombinant strain of M. tuberculosis expressing a far-red fluorescent reporter to det. the activity of novel compds.; this allowed us to measure growth by monitoring both optical d. and fluorescence.  We detd. that optical d. and fluorescence were correlated with cell no. during logarithmic phase growth.  Fluorescence was stably maintained without antibiotic selection over 5 days, during which time cells remained actively growing.  We optimized parameters for the assay, with the final format being 5 days' growth in 96-well plates in the presence of 2% w/v DMSO.  We confirmed reproducibility using rifampicin and other antibiotics.  The dual detection method allows for a reproducible calcn. of the min. inhibitory concn. (MIC), at the same time detecting artifacts such as fluorescence quenching or compd. pptn.  We used our assay to confirm anti-tubercular activity and establish the structure activity relationship (SAR) around the imidazo[1,2-a]pyridine-3-carboxamides, a promising series of M. tuberculosis inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzifhn6ZGfK7Vg90H21EOLACvtfcHk0liCQYDrs1RzAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Gls74%253D&md5=f8e7dcf8aa8dfe4b71c7a8885ad44bf1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0060531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0060531%26sid%3Dliteratum%253Aachs%26aulast%3DOllinger%26aufirst%3DJ.%26aulast%3DBailey%26aufirst%3DM.%2BA.%26aulast%3DMoraski%26aufirst%3DG.%2BC.%26aulast%3DCasey%26aufirst%3DA.%26aulast%3DFlorio%26aufirst%3DS.%26aulast%3DAlling%26aufirst%3DT.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26aulast%3DParish%26aufirst%3DT.%26atitle%3DA%2520dual%2520read-out%2520assay%2520to%2520evaluate%2520the%2520potency%2520of%2520compounds%2520active%2520against%2520Mycobacterium%2520tuberculosis%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0060531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copp, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeil, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span> <span> </span><span class="NLM_article-title">The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism novel insights into drug mechanisms of action</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">40174</span>– <span class="NLM_lpage">40184</span>, <span class="refDoi"> DOI: 10.1074/jbc.m406796200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1074%2Fjbc.M406796200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=15247240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVKrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=40174-40184&author=H.+I.+M.+Boshoffauthor=T.+G.+Myersauthor=B.+R.+Coppauthor=M.+R.+McNeilauthor=M.+A.+Wilsonauthor=C.+E.+Barry&title=The+transcriptional+responses+of+Mycobacterium+tuberculosis+to+inhibitors+of+metabolism+novel+insights+into+drug+mechanisms+of+action&doi=10.1074%2Fjbc.m406796200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The Transcriptional Responses of Mycobacterium tuberculosis to Inhibitors of Metabolism: Novel insights into drug mechanisms of action</span></div><div class="casAuthors">Boshoff, Helena I. M.; Myers, Timothy G.; Copp, Brent R.; McNeil, Michael R.; Wilson, Michael A.; Barry, Clifton E., III</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">40174-40184</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The differential transcriptional response of Mycobacterium tuberculosis to drugs and growth-inhibitory conditions was monitored to generate a data set of 430 microarray profiles.  Unbiased grouping of these profiles independently clustered agents of known mechanism of action accurately and was successful at predicting the mechanism of action of several unknown agents.  These predictions were validated biochem. for two agents of previously uncategorized mechanism, pyridoacridones and phenothiazines.  Anal. of this data set further revealed 150 underlying clusters of coordinately regulated genes offering the first glimpse at the full metabolic potential of this organism.  A signature subset of these gene clusters was sufficient to classify all known agents as to mechanism of action.  Transcriptional profiling of both crude and purified natural products can provide crit. information on both mechanism and detoxification prior to purifn. that can be used to guide the drug discovery process.  Thus, the transcriptional profile generated by a crude marine natural product recapitulated the mechanistic prediction from the pure active component.  The underlying gene clusters further provide fundamental insights into the metabolic response of bacteria to drug-induced stress and provide a rational basis for the selection of crit. metabolic targets for screening for new agents with improved activity against this important human pathogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5g6sYE8fWOLVg90H21EOLACvtfcHk0liCQYDrs1RzAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVKrsLs%253D&md5=677489fe3a9981eba62d990ec037f71a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M406796200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M406796200%26sid%3Dliteratum%253Aachs%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DCopp%26aufirst%3DB.%2BR.%26aulast%3DMcNeil%26aufirst%3DM.%2BR.%26aulast%3DWilson%26aufirst%3DM.%2BA.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26atitle%3DThe%2520transcriptional%2520responses%2520of%2520Mycobacterium%2520tuberculosis%2520to%2520inhibitors%2520of%2520metabolism%2520novel%2520insights%2520into%2520drug%2520mechanisms%2520of%2520action%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D40174%26epage%3D40184%26doi%3D10.1074%2Fjbc.m406796200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Vinayak Singh, <span class="NLM_string-name hlFld-ContribAuthor">Kelly Chibale</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies to Combat Multi-Drug Resistance in Tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2021,</strong> <em>54 </em>
                                    (10)
                                     , 2361-2376. <a href="https://doi.org/10.1021/acs.accounts.0c00878" title="DOI URL">https://doi.org/10.1021/acs.accounts.0c00878</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.0c00878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.0c00878%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DStrategies%252Bto%252BCombat%252BMulti-Drug%252BResistance%252Bin%252BTuberculosis%26aulast%3DSingh%26aufirst%3DVinayak%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D24122020%26date%3D22042021%26volume%3D54%26issue%3D10%26spage%3D2361%26epage%3D2376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Generic structure of pyrazolylpyrimidones.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Structure of PZP; and (b) depiction of metal chelation by pyrazolylpyrimidinone <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to Explore R1 and R2 on the Pyrimidinone and Polar Modifications at R5 on the Pyrazole<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (a) thiourea, KOH, EtOH, reflux (b) iodomethane, NaOH, H<sub>2</sub>O/EtOH; (ii) NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O, EtOH, reflux; (iii) Br<sub>2</sub>, AcOH, 60 °C; (iv) phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, 1,4-dioxane, K<sub>2</sub>CO<sub>3</sub>; (v) acetylacetone, EtOH, AcOH, reflux; (vi) 3-aminocrotonitrile, EtOH, reflux; (vii) acetyl chloride, pyridine, CH<sub>2</sub>Cl<sub>2</sub>; and (viii) ethyl acetoacetate, EtOH, AcOH, reflux.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes to Access Core Modifications<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) MeOH, PPh<sub>3</sub>, DIAD, THF, 25 °C; (ii) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C; (iii) NaOCH<sub>3</sub>, MeOH, 80 °C; (iv) phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, reflux; (v) 3,5-dimethylpyrazole, xanphos, Pd(OAc)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 130 °C; (vi) BBr<sub>3</sub>, MeOH; (vii) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (viii) urea, 1,4-dioxane, 140 °C, microwave; (ix) POCl<sub>3,</sub> DMF; (x) 3,5-dimethylpyrazole, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 80 °C, microwave; and (xi) 20% aq NaOH, 80 °C.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route for Pyrazole Replacements<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) urea, 1,4-dioxane, 140 °C, microwave; (ii) POCl<sub>3</sub>, DMF; (iii) 20% aq NaOH, 80 °C (iv) 5-membered heterocycle, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 80 °C, microwave; and (v) EtOH, reflux, 1 h.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route to Polar Substitutions on R1 of the Pyrimidinone<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) aqueous NaOH, dioxane; (ii) boronic acid, Cs<sub>2</sub>CO<sub>3</sub>, Pd(OAc)<sub>2</sub>, dppf, 1,4-dioxane, 70 °C or K<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub>(dppf)<sub>2</sub>, 1,4-dioxane, 70 °C; and (iii) 3,5-dimethylpyrazole, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 130 °C, microwave.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route to Amide <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) CH<sub>3</sub>ONa, THF, 0 °C; (ii) 3,5-dimethylpyrazole, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 110 °C, microwave; (iii) 4-fluoroaniline, HATU, Et<sub>3</sub>N, DMF; and (iv) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Route to Polar Substitutions on R2 of the Pyrimidinone<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) ethyl 2-cyanoacetate, KOH, ethanol, reflux; (ii) (a) MeI, NaOH, H<sub>2</sub>O (b) NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O, EtOH, reflux; (iii) acetylacetone, AcOH, EtOH, 85 °C; (iv) H<sub>2</sub>SO<sub>4</sub>, 80 °C; and (v) <i>tert</i>-butyl nitrite, AcOH, 75 °C.</p></p></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthetic Routes Used to Explore the Pyrazole R5 Position<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) diketone, EtOH, AcOH, reflux; (ii) 3-aminocrotonitrile, EtOH, reflux; (iii) acetaldehyde, DMF, AcOH, NaCNBH<sub>4</sub>, MeOH, 25 °C; (iv) <i>N</i>-(2-methoxyethyl)-3-oxobutanamide, Lawesson’s reagent, THF, 25 °C; and (v) Cs<sub>2</sub>CO<sub>3</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, XantPhos, 1,4-dioxane, aryl halide, 120 °C</p></p></figure><figure data-id="sch8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthetic Route to Compounds <b>36–39</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) NH<sub>2</sub>-R, EtOH, reflux; (ii) <b>33</b>, AcOH, EtOH, 100 °C.</p></p></figure><figure data-id="sch9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Compound <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) (a) thiourea, KOH, EtOH and (b) MeI, NaOH, H<sub>2</sub>O; (ii) <i>m</i>CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C; (iii) N<sub>2</sub>H<sub>2</sub>. H<sub>2</sub>O, EtOH; (iv) EtI, K<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C; and (v) Cs<sub>2</sub>CO<sub>3</sub>, 1,4-Dioxane, 130 °C.</p></p></figure><figure data-id="sch10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Compounds with Pyrazole C4 Substitutions<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Br<sub>2</sub>, AcOH, 100 °C, 2h; (ii) pyridine-3-boronic acid, K<sub>2</sub>CO<sub>3</sub>, Pd(dppf)Cl<sub>2</sub>, THF/water (10:1), 70 °C, 16h; (iii) <i>N</i>-bromosuccinamide, <i>p</i>-toluene sulphonic acid, CH<sub>2</sub>Cl<sub>2</sub>; 0 °C; (iv) morpholine, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; and (v) EtOH/AcOH reflux, 16 h.</p></p></figure><figure data-id="sch11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Synthesis of Compounds with Pyrazole C3 Modifications<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions. (i) DMF, 130 °C, 2 h; (ii) Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 130 °C, microwave; (iii) <i>N</i>,<i>N</i>-dimethylamine, HATU, Et<sub>3</sub>N, DMF; (iv) (a) DIBALH, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C; (b) <i>N</i>,<i>N</i>-dimethylamine, NaCNBH<sub>3</sub>, THF, RT, 24 h; and (v) Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 130 °C, microwave.</p></p></figure><figure data-id="fig3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Essential pharmacophoric features and scope for further SAR studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/medium/jm0c01727_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Fe<sup>2+</sup> plays a critical role in the MoA of <b>45</b>. (A) Fe<sup>2+</sup> rescue of <i>Mtb</i> from growth inhibition mediated by <b>45</b>. (B) Spectroscopic titration of <b>45</b> with Fe<sup>2+</sup>. The data are representative of two biological replicates performed in duplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01727/20210107/images/large/jm0c01727_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01727&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i101">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58677" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58677" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 54 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">World Health Organization</span>.  <i>Global Tuberculosis Report</i>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=World+Health+Organization&title=Global+Tuberculosis+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DGlobal%2520Tuberculosis%2520Report%26pub%3DWorld%2520Health%2520Organization%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mabhula, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span> <span> </span><span class="NLM_article-title">Drug-resistance in Mycobacterium tuberculosis: where we stand</span>. <i>Medchemcomm</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1342</span>– <span class="NLM_lpage">1360</span>, <span class="refDoi"> DOI: 10.1039/c9md00057g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1039%2FC9MD00057G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=31534654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFeqsbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1342-1360&author=A.+Mabhulaauthor=V.+Singh&title=Drug-resistance+in+Mycobacterium+tuberculosis%3A+where+we+stand&doi=10.1039%2Fc9md00057g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-resistance in Mycobacterium tuberculosis: where we stand</span></div><div class="casAuthors">Mabhula, Amanda; Singh, Vinayak</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1342-1360</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Tuberculosis (TB), an infectious disease caused by the bacterium Mycobacterium tuberculosis (Mtb), has burdened vulnerable populations in modern day societies for decades.  Recently, this global health threat has been heightened by the emergence and propagation of multi drug-resistant (MDR) and extensively drug-resistant (XDR) strains of Mtb that are resistant to current treatment regimens.  The End-TB strategy, launched by the World Health Organization (WHO), aims to reduce TB-related deaths by 90%.  This program encourages universal access to drug susceptibility testing, which is not widely available owing to the lack of lab. capacity or resources in certain under-resourced areas.  Clin. assays are further complicated by the slow growth of Mtb, resulting in the long turn-around time of tests which severely limits their application in guiding a patient's treatment regimen.  This review provides a comprehensive overview of current TB treatments, mechanisms of resistance to anti-tubercular drugs and their diagnosis and the current pipeline of drugs targeting drug-resistant TB (DR-TB) with particular attention paid to ways in which drug-resistance is combated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTopGTHhPSh7Vg90H21EOLACvtfcHk0lhloWoNx12KVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFeqsbzN&md5=0894281ecd5a9d9353f97a8ea79c3d33</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1039%2FC9MD00057G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9MD00057G%26sid%3Dliteratum%253Aachs%26aulast%3DMabhula%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DV.%26atitle%3DDrug-resistance%2520in%2520Mycobacterium%2520tuberculosis%253A%2520where%2520we%2520stand%26jtitle%3DMedchemcomm%26date%3D2019%26volume%3D10%26spage%3D1342%26epage%3D1360%26doi%3D10.1039%2Fc9md00057g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><a href="https://www.newtbdrugs.org/pipeline" class="extLink">https://www.newtbdrugs.org/pipeline</a> (accessed March 18, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.newtbdrugs.org%2Fpipeline+%28accessed+March+18%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soares
de Melo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, T.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Westhuyzen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessner, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgans, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moosa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span> <span> </span><span class="NLM_article-title">Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: structure activity relationships and ADME characterization</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">7240</span>– <span class="NLM_lpage">7250</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2Fj.bmc.2015.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=26522089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslent7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=7240-7250&author=C.+Soares%0Ade+Meloauthor=T.-S.+Fengauthor=R.+van+der+Westhuyzenauthor=R.+K.+Gessnerauthor=L.+J.+Streetauthor=G.+L.+Morgansauthor=D.+F.+Warnerauthor=A.+Moosaauthor=K.+Naranauthor=N.+Lawrenceauthor=H.+I.+M.+Boshoffauthor=C.+E.+Barryauthor=C.+J.+Harrisauthor=R.+Gordonauthor=K.+Chibale&title=Aminopyrazolo%5B1%2C5-a%5Dpyrimidines+as+potential+inhibitors+of+Mycobacterium+tuberculosis%3A+structure+activity+relationships+and+ADME+characterization&doi=10.1016%2Fj.bmc.2015.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization</span></div><div class="casAuthors">Soares de Melo, Candice; Feng, Tzu-Shean; van der Westhuyzen, Renier; Gessner, Richard K.; Street, Leslie J.; Morgans, Garreth L.; Warner, Digby F.; Moosa, Atica; Naran, Krupa; Lawrence, Nina; Boshoff, Helena I. M.; Barry, Clifton E., III; Harris, C. John; Gordon, Richard; Chibale, Kelly</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7240-7250</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Whole-cell high-throughput screening of a diverse SoftFocus library against Mycobacterium tuberculosis (Mtb) generated a novel aminopyrazolo[1,5-a]pyrimidine hit series.  The synthesis and structure activity relationship studies identified compds. with potent antimycobacterial activity.  The SAR of over 140 compds. shows that the 2-pyridylmethylamine moiety at the C-7 position of the pyrazolopyrimidine scaffold was important for Mtb activity, whereas the C-3 position offered a higher degree of flexibility.  The series was also profiled for in vitro cytotoxicity and microsomal metabolic stability as well as physicochem. properties.  Consequently liabilities to be addressed in a future lead optimization campaign have been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTbOBTZI7RdrVg90H21EOLACvtfcHk0lgeUJODC-elZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslent7zL&md5=29c1f665f7c8e2039e9ae1c9d9aa2d1e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DSoares%2Bde%2BMelo%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DT.-S.%26aulast%3Dvan%2Bder%2BWesthuyzen%26aufirst%3DR.%26aulast%3DGessner%26aufirst%3DR.%2BK.%26aulast%3DStreet%26aufirst%3DL.%2BJ.%26aulast%3DMorgans%26aufirst%3DG.%2BL.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26aulast%3DMoosa%26aufirst%3DA.%26aulast%3DNaran%26aufirst%3DK.%26aulast%3DLawrence%26aufirst%3DN.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DAminopyrazolo%255B1%252C5-a%255Dpyrimidines%2520as%2520potential%2520inhibitors%2520of%2520Mycobacterium%2520tuberculosis%253A%2520structure%2520activity%2520relationships%2520and%2520ADME%2520characterization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D7240%26epage%3D7250%26doi%3D10.1016%2Fj.bmc.2015.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessner, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moosa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seldon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizrahi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares de
Melo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simelane, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nchinda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abay, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunschwig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirgel, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Helden, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli-Disse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pflaumer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boesche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebollo-Lopez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urones, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selenski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafuente-Monasterio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axtman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelièvre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghorpade, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span> <span> </span><span class="NLM_article-title">Novel antitubercular 6-dialkylaminopyrimidine carboxamides from phenotypic whole-cell high throughput screening of a softfocus library: structure-activity relationship and target identification studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">10118</span>– <span class="NLM_lpage">10134</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01347</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01347" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVWqtbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=10118-10134&author=C.+R.+Wilsonauthor=R.+K.+Gessnerauthor=A.+Moosaauthor=R.+Seldonauthor=D.+F.+Warnerauthor=V.+Mizrahiauthor=C.+Soares+de%0AMeloauthor=S.+B.+Simelaneauthor=A.+Nchindaauthor=E.+Abayauthor=D.+Taylorauthor=M.+Njorogeauthor=C.+Brunschwigauthor=N.+Lawrenceauthor=H.+I.+M.+Boshoffauthor=C.+E.+Barryauthor=F.+A.+Sirgelauthor=P.+van+Heldenauthor=C.+J.+Harrisauthor=R.+Gordonauthor=S.+Ghidelli-Disseauthor=H.+Pflaumerauthor=M.+Boescheauthor=G.+Drewesauthor=O.+Sanzauthor=G.+Santosauthor=M.+J.+Rebollo-Lopezauthor=B.+Uronesauthor=C.+Selenskiauthor=M.+J.+Lafuente-Monasterioauthor=M.+Axtmanauthor=J.+Leli%C3%A8vreauthor=L.+Ballellauthor=R.+Muellerauthor=L.+J.+Streetauthor=S.+R.+Ghorpadeauthor=K.+Chibale&title=Novel+antitubercular+6-dialkylaminopyrimidine+carboxamides+from+phenotypic+whole-cell+high+throughput+screening+of+a+softfocus+library%3A+structure-activity+relationship+and+target+identification+studies&doi=10.1021%2Facs.jmedchem.7b01347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification Studies</span></div><div class="casAuthors">Wilson, Colin R.; Gessner, Richard K.; Moosa, Atica; Seldon, Ronnett; Warner, Digby F.; Mizrahi, Valerie; Soares de Melo, Candice; Simelane, Sandile B.; Nchinda, Aloysius; Abay, Efrem; Taylor, Dale; Njoroge, Mathew; Brunschwig, Christel; Lawrence, Nina; Boshoff, Helena I. M.; Barry, Clifton E.; Sirgel, Frederick A.; van Helden, Paul; Harris, C. John; Gordon, Richard; Ghidelli-Disse, Sonja; Pflaumer, Hannah; Boesche, Markus; Drewes, Gerard; Sanz, Olalla; Santos, Gracia; Rebollo-Lopez, Maria Jose; Urones, Beatriz; Selenski, Carolyn; Lafuente-Monasterio, Maria Jose; Axtman, Matthew; Lelievre, Joel; Ballell, Lluis; Mueller, Rudolf; Street, Leslie J.; Ghorpade, Sandeep R.; Chibale, Kelly</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10118-10134</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A BioFocus DPI SoftFocus library of ∼35,000 compds. was screened against Mycobacterium tuberculosis (Mtb) to identify novel hits with antitubercular activity.  The hits were evaluated in biol. triage assays to exclude compds. suggested to function via frequently encountered promiscuous mechanisms of action including inhibition of the QcrB subunit of the cytochrome bc1 complex, disruption of cell-wall homeostasis, and DNA damage.  Among the hits that passed this screening cascade, a 6-dialkylaminopyrimidine carboxamide series was prioritized for hit to lead optimization.  Compds. from this series were active against clin. Mtb strains, while no cross-resistance to conventional antituberculosis drugs was obsd.  This suggested a novel mechanism of action, which was confirmed by chemoproteomic anal. leading to the identification of BCG_3193 and BCG_3827 as putative targets of the series with unknown function.  Initial structure-activity relationship studies have resulted in compds. with moderate to potent antitubercular activity and improved physicochem. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdBt_xcb2SIbVg90H21EOLACvtfcHk0lgeUJODC-elZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWqtbjL&md5=364c9cd37481ad64be7ea86ea0c042e3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01347%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DC.%2BR.%26aulast%3DGessner%26aufirst%3DR.%2BK.%26aulast%3DMoosa%26aufirst%3DA.%26aulast%3DSeldon%26aufirst%3DR.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DSoares%2Bde%2BMelo%26aufirst%3DC.%26aulast%3DSimelane%26aufirst%3DS.%2BB.%26aulast%3DNchinda%26aufirst%3DA.%26aulast%3DAbay%26aufirst%3DE.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DNjoroge%26aufirst%3DM.%26aulast%3DBrunschwig%26aufirst%3DC.%26aulast%3DLawrence%26aufirst%3DN.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DSirgel%26aufirst%3DF.%2BA.%26aulast%3Dvan%2BHelden%26aufirst%3DP.%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DGhidelli-Disse%26aufirst%3DS.%26aulast%3DPflaumer%26aufirst%3DH.%26aulast%3DBoesche%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DSanz%26aufirst%3DO.%26aulast%3DSantos%26aufirst%3DG.%26aulast%3DRebollo-Lopez%26aufirst%3DM.%2BJ.%26aulast%3DUrones%26aufirst%3DB.%26aulast%3DSelenski%26aufirst%3DC.%26aulast%3DLafuente-Monasterio%26aufirst%3DM.%2BJ.%26aulast%3DAxtman%26aufirst%3DM.%26aulast%3DLeli%25C3%25A8vre%26aufirst%3DJ.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DMueller%26aufirst%3DR.%26aulast%3DStreet%26aufirst%3DL.%2BJ.%26aulast%3DGhorpade%26aufirst%3DS.%2BR.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DNovel%2520antitubercular%25206-dialkylaminopyrimidine%2520carboxamides%2520from%2520phenotypic%2520whole-cell%2520high%2520throughput%2520screening%2520of%2520a%2520softfocus%2520library%253A%2520structure-activity%2520relationship%2520and%2520target%2520identification%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D10118%26epage%3D10134%26doi%3D10.1021%2Facs.jmedchem.7b01347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labadie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinogradova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehling, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmange, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Porten, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liederer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Classon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragovich, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L.</span></span> <span> </span><span class="NLM_article-title">From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2974</span>– <span class="NLM_lpage">2981</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2Fj.bmcl.2017.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=28512031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvFCqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2974-2981&author=J.+Liangauthor=S.+Labadieauthor=B.+Zhangauthor=D.+F.+Ortwineauthor=S.+Patelauthor=M.+Vinogradovaauthor=J.+R.+Kieferauthor=T.+Mauerauthor=V.+S.+Gehlingauthor=J.-C.+Harmangeauthor=R.+Cummingsauthor=T.+Laiauthor=J.+Liaoauthor=X.+Zhengauthor=Y.+Liuauthor=A.+Gustafsonauthor=E.+Van+der+Portenauthor=W.+Maoauthor=B.+M.+Liedererauthor=G.+Deshmukhauthor=L.+Anauthor=Y.+Ranauthor=M.+Classonauthor=P.+Trojerauthor=P.+S.+Dragovichauthor=L.+Murray&title=From+a+novel+HTS+hit+to+potent%2C+selective%2C+and+orally+bioavailable+KDM5+inhibitors&doi=10.1016%2Fj.bmcl.2017.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors</span></div><div class="casAuthors">Liang, Jun; Labadie, Sharada; Zhang, Birong; Ortwine, Daniel F.; Patel, Snahel; Vinogradova, Maia; Kiefer, James R.; Mauer, Till; Gehling, Victor S.; Harmange, Jean-Christophe; Cummings, Richard; Lai, Tommy; Liao, Jiangpeng; Zheng, Xiaoping; Liu, Yichin; Gustafson, Amy; Van der Porten, Erica; Mao, Weifeng; Liederer, Bianca M.; Deshmukh, Gauri; An, Le; Ran, Yingqing; Classon, Marie; Trojer, Patrick; Dragovich, Peter S.; Murray, Lesley</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2974-2981</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A high-throughput screening (HTS) of the Genentech/Roche library identified a novel, uncharged scaffold as a KDM5A inhibitor.  Lacking insight into the binding mode, initial attempts to improve inhibitor potency failed to improve potency, and synthesis of analogs was further hampered by the presence of a C-C bond between the pyrrolidine and pyridine.  Replacing this with a C-N bond significantly simplified synthesis, yielding pyrazole analog, [3-(4-bromo-1H-pyrazol-1-yl)-1-pyrrolidinyl][5-(1-methylethyl)-1H-pyrazol-3-yl]methanone (35), of which the authors obtained a co-crystal structure with KDM5A.  Using structure-based design approach, the authors identified, N-[(3R)-1-[[5-(1-methylethyl)-1H-pyrazol-3-yl]carbonyl]-3-pyrrolidinyl]cyclopropanecarboxamide (50), with improved biochem., cell potency and reduced MW and lower lipophilicity (Log D) compared with the original hit.  Furthermore, 50 showed lower clearance than [5-(1-methylethyl)-1H-pyrazol-3-yl][(3S)-3-[6-methyl-4-(1-methyl-1H-pyrazol-4-yl)-2-pyridinyl]-1-pyrrolidinyl]methanone (9) in mice.  In combination with its remarkably low plasma protein binding (PPB) in mice (40%), oral dosing of 50 at 5 mg/kg resulted in unbound Cmax ∼2-fold of its cell potency (PC9 H3K4Me3 0.96 μM), meeting the authors' criteria for an in vivo tool compd. from a new scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpksjXQBrVYsrVg90H21EOLACvtfcHk0lh-shurmYAUOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvFCqtr4%253D&md5=04bee4e29775202fb1882adeccb8e722</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DLabadie%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DVinogradova%26aufirst%3DM.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DMauer%26aufirst%3DT.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DLai%26aufirst%3DT.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DVan%2Bder%2BPorten%26aufirst%3DE.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DAn%26aufirst%3DL.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DClasson%26aufirst%3DM.%26aulast%3DTrojer%26aufirst%3DP.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DMurray%26aufirst%3DL.%26atitle%3DFrom%2520a%2520novel%2520HTS%2520hit%2520to%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520KDM5%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2974%26epage%3D2981%26doi%3D10.1016%2Fj.bmcl.2017.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dragset, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poce, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alfonso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padilla-Benavides, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biava, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argüello, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steigedal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E. J.</span></span> <span> </span><span class="NLM_article-title">A novel antimycobacterial compound acts as an intracellular iron chelator</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2256</span>– <span class="NLM_lpage">2264</span>, <span class="refDoi"> DOI: 10.1128/aac.05114-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1128%2FAAC.05114-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=25645825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvFSgt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=2256-2264&author=M.+S.+Dragsetauthor=G.+Poceauthor=S.+Alfonsoauthor=T.+Padilla-Benavidesauthor=T.+R.+Ioergerauthor=T.+Kanekoauthor=J.+C.+Sacchettiniauthor=M.+Biavaauthor=T.+Parishauthor=J.+M.+Arg%C3%BCelloauthor=M.+Steigedalauthor=E.+J.+Rubin&title=A+novel+antimycobacterial+compound+acts+as+an+intracellular+iron+chelator&doi=10.1128%2Faac.05114-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A novel antimycobacterial compound acts as an intracellular iron chelator</span></div><div class="casAuthors">Dragset, Marte S.; Poce, Giovanna; Alfonso, Salvatore; Padilla-Benavides, Teresita; Ioerger, Thomas R.; Kaneko, Takushi; Sacchettini, James C.; Biava, Mariangela; Parish, Tanya; Arguello, Jose M.; Steigedal, Magnus; Rubin, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2256-2264</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Efficient iron acquisition is crucial for the pathogenesis of Mycobacterium tuberculosis.  Mycobacterial iron uptake and metab. are therefore attractive targets for antitubercular drug development.  Resistance mutations against a novel pyrazolopyrimidinone compd. (PZP) that is active against M. tuberculosis have been identified within the gene cluster encoding the ESX-3 type VII secretion system.  ESX-3 is required for mycobacterial iron acquisition through the mycobactin siderophore pathway, which could indicate that PZP restricts mycobacterial growth by targeting ESX-3 and thus iron uptake.  Surprisingly, we show that ESX-3 is not the cellular target of the compd.  We demonstrate that PZP indeed targets iron metab.; however, we found that instead of inhibiting uptake of iron, PZP acts as an iron chelator, and we present evidence that the compd. restricts mycobacterial growth by chelating intrabacterial iron.  Thus, we have unraveled the unexpected mechanism of a novel antimycobacterial compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUHSJO1B-DKrVg90H21EOLACvtfcHk0lgj5WWTtGeFjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvFSgt7c%253D&md5=e4e9b83c344f8f2be78ee613c7f26ae0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FAAC.05114-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.05114-14%26sid%3Dliteratum%253Aachs%26aulast%3DDragset%26aufirst%3DM.%2BS.%26aulast%3DPoce%26aufirst%3DG.%26aulast%3DAlfonso%26aufirst%3DS.%26aulast%3DPadilla-Benavides%26aufirst%3DT.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DBiava%26aufirst%3DM.%26aulast%3DParish%26aufirst%3DT.%26aulast%3DArg%25C3%25BCello%26aufirst%3DJ.%2BM.%26aulast%3DSteigedal%26aufirst%3DM.%26aulast%3DRubin%26aufirst%3DE.%2BJ.%26atitle%3DA%2520novel%2520antimycobacterial%2520compound%2520acts%2520as%2520an%2520intracellular%2520iron%2520chelator%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D2256%26epage%3D2264%26doi%3D10.1128%2Faac.05114-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Bis{tris-[3-(2-pyrid-yl)-1H-pyrazole]nickel(II)} dodeca-molybdo(V,VI)phosphate hexa-hydrate</span>. <i>Acta Crystallogr., Sect. E: Struct. Rep. Online</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">m319</span>– <span class="NLM_lpage">m320</span>, <span class="refDoi"> DOI: 10.1107/s1600536810005945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1107%2FS1600536810005945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=21580258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3cXislWrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=m319-m320&author=L.+Haoauthor=T.+Liuauthor=J.+Chenauthor=X.+Zhang&title=Bis%7Btris-%5B3-%282-pyrid-yl%29-1H-pyrazole%5Dnickel%28II%29%7D+dodeca-molybdo%28V%2CVI%29phosphate+hexa-hydrate&doi=10.1107%2Fs1600536810005945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Bis{tris[3-(2-pyridyl)-1H-pyrazole]nickel(II)} dodecamolybdo(V,VI)phosphate hexahydrate</span></div><div class="casAuthors">Hao, Lujiang; Liu, Tongjun; Chen, Jiangkui; Zhang, Xiaofei</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section E: Structure Reports Online</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">m319-m320</span>CODEN:
                <span class="NLM_cas:coden">ACSEBH</span>;
        ISSN:<span class="NLM_cas:issn">1600-5368</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The hydrothermally prepd. title compd., [Ni(C8H7N3)3]2[PMo12O40]·6H2O, is a member of the isotypic series [M(C8H7N3)3]2[PMo12O40]·6H2O where M is Mn, Cd, and Fe.  Crystallog. data and at. coordinates are given.  The Ni2+ cation is in a distorted octahedral environment, coordinated by six N atoms from three chelating 3-(2-pyridyl)-1H-pyrazole ligands.  In the 1-electron reduced heteropolyanion, two O atoms of the central PO4 group (‾1 symmetry) are equally disordered about an inversion center.  N-H...O and O-H...O H bonds contribute to the crystal packing.  Compared with the isotypic structures, the main difference is related with the M-N bond lengths, whereas all other bond lengths, angles and the H-bonding motifs are very similar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoQvxRrfRPvbVg90H21EOLACvtfcHk0lgj5WWTtGeFjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXislWrsL8%253D&md5=53d4087fd37992c1c546e96614d894aa</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1107%2FS1600536810005945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1600536810005945%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DBis%257Btris-%255B3-%25282-pyrid-yl%2529-1H-pyrazole%255Dnickel%2528II%2529%257D%2520dodeca-molybdo%2528V%252CVI%2529phosphate%2520hexa-hydrate%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520E%253A%2520Struct.%2520Rep.%2520Online%26date%3D2010%26volume%3D66%26spage%3Dm319%26epage%3Dm320%26doi%3D10.1107%2Fs1600536810005945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rajnák, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šalitroš, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuhr, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruben, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boča, R.</span></span> <span> </span><span class="NLM_article-title">Influence of the charge of the complex unit on the SCO properties in pyrazolyl-pyridinyl-benzimidazole based Fe(II) complexes</span>. <i>Polyhedron</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.1016/j.poly.2017.06.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2Fj.poly.2017.06.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFChtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2017&pages=189-194&author=C.+Rajn%C3%A1kauthor=B.+Sch%C3%A4ferauthor=I.+%C5%A0alitro%C5%A1author=O.+Fuhrauthor=M.+Rubenauthor=R.+Bo%C4%8Da&title=Influence+of+the+charge+of+the+complex+unit+on+the+SCO+properties+in+pyrazolyl-pyridinyl-benzimidazole+based+Fe%28II%29+complexes&doi=10.1016%2Fj.poly.2017.06.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of the charge of the complex unit on the SCO properties in pyrazolyl-pyridinyl-benzimidazole based Fe(II) complexes</span></div><div class="casAuthors">Rajnak, C.; Schafer, B.; Salitros, I.; Fuhr, O.; Ruben, M.; Boca, R.</div><div class="citationInfo"><span class="NLM_cas:title">Polyhedron</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">189-194</span>CODEN:
                <span class="NLM_cas:coden">PLYHDE</span>;
        ISSN:<span class="NLM_cas:issn">0277-5387</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A tridentate ligand 2-(6-pyrazol-1-yl-pyridin-2-yl)-1H-benzimidazole (L1H) was synthesized and characterized by NMR, UV-visible, IR and MS spectroscopy.  Starting from L1H, two complexes were prepd., one contg. a complex dication counterbalanced by anions, [Fe(L1H)2](BF4)2 (1), and the other one is a charge neutral complex [Fe(L1)2] (2).  The distorted octahedral coordination of 1 was confirmed by x-ray diffraction anal.  Both complexes show a thermally induced spin crossover with the crit. temp. lying above room temp.  The photomagnetic study confirmed the LIESST effect for both compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpImxAQDM0xJrVg90H21EOLACvtfcHk0lgj5WWTtGeFjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFChtL7M&md5=2a3ffa08fa121aabfacc9613fced44a0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.poly.2017.06.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.poly.2017.06.035%26sid%3Dliteratum%253Aachs%26aulast%3DRajn%25C3%25A1k%26aufirst%3DC.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DB.%26aulast%3D%25C5%25A0alitro%25C5%25A1%26aufirst%3DI.%26aulast%3DFuhr%26aufirst%3DO.%26aulast%3DRuben%26aufirst%3DM.%26aulast%3DBo%25C4%258Da%26aufirst%3DR.%26atitle%3DInfluence%2520of%2520the%2520charge%2520of%2520the%2520complex%2520unit%2520on%2520the%2520SCO%2520properties%2520in%2520pyrazolyl-pyridinyl-benzimidazole%2520based%2520Fe%2528II%2529%2520complexes%26jtitle%3DPolyhedron%26date%3D2017%26volume%3D135%26spage%3D189%26epage%3D194%26doi%3D10.1016%2Fj.poly.2017.06.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Attaby, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldin, S. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of pyrimidine, thiazolopyrimidine, pyrimidotriazine and triazolopyrimidine derivatives and their biological evaluation</span>. <i>Z. Naturforsch., B: J. Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">788</span>– <span class="NLM_lpage">798</span>, <span class="refDoi"> DOI: 10.1515/znb-1999-0614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1515%2Fznb-1999-0614" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1999&pages=788-798&author=F.+A.+Attabyauthor=S.+M.+Eldin&title=Synthesis+of+pyrimidine%2C+thiazolopyrimidine%2C+pyrimidotriazine+and+triazolopyrimidine+derivatives+and+their+biological+evaluation&doi=10.1515%2Fznb-1999-0614"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1515%2Fznb-1999-0614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fznb-1999-0614%26sid%3Dliteratum%253Aachs%26aulast%3DAttaby%26aufirst%3DF.%2BA.%26aulast%3DEldin%26aufirst%3DS.%2BM.%26atitle%3DSynthesis%2520of%2520pyrimidine%252C%2520thiazolopyrimidine%252C%2520pyrimidotriazine%2520and%2520triazolopyrimidine%2520derivatives%2520and%2520their%2520biological%2520evaluation%26jtitle%3DZ.%2520Naturforsch.%252C%2520B%253A%2520J.%2520Chem.%2520Sci.%26date%3D1999%26volume%3D54%26spage%3D788%26epage%3D798%26doi%3D10.1515%2Fznb-1999-0614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tait, B. P.</span>; <span class="NLM_string-name">Noel, A.</span>; <span class="NLM_string-name">Cullen, M.</span></span> <span> </span><span class="NLM_article-title">Proteostasis Regulators for Treating Cystic Fibrosis and other Protein Misfolding Diseases</span>. <span class="NLM_patent">WO2012154880 A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=B.+P.+Tait&author=A.+Noel&author=M.+Cullen&title=Proteostasis+Regulators+for+Treating+Cystic+Fibrosis+and+other+Protein+Misfolding+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTait%26aufirst%3DB.%2BP.%26atitle%3DProteostasis%2520Regulators%2520for%2520Treating%2520Cystic%2520Fibrosis%2520and%2520other%2520Protein%2520Misfolding%2520Diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burgula, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radhakrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundu, L. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of modified uracil and cytosine nucleobases using a microwave-assisted method</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2639</span>– <span class="NLM_lpage">2642</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2012.03.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2Fj.tetlet.2012.03.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFWhtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=2639-2642&author=L.+N.+Burgulaauthor=K.+Radhakrishnanauthor=L.+M.+Kundu&title=Synthesis+of+modified+uracil+and+cytosine+nucleobases+using+a+microwave-assisted+method&doi=10.1016%2Fj.tetlet.2012.03.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of modified uracil and cytosine nucleobases using a microwave-assisted method</span></div><div class="casAuthors">Burgula, Laxmi Narayana; Radhakrishnan, K.; Kundu, Lal Mohan</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2639-2642</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Here we report a microwave-directed synthesis of a variety of modified uracil and cytosine nucleobases with high yields under solvent-free conditions.  The reaction yields were further improved by addn. of Lewis acid.  The crystal structures of 5-isopropyl-6-methyluracil and 6-phenyluracil were also detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYrvNqHPAexrVg90H21EOLACvtfcHk0lhxaH531AOb7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFWhtbs%253D&md5=c6f5fa2f912c067c66db1c980f0ffb98</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2012.03.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2012.03.056%26sid%3Dliteratum%253Aachs%26aulast%3DBurgula%26aufirst%3DL.%2BN.%26aulast%3DRadhakrishnan%26aufirst%3DK.%26aulast%3DKundu%26aufirst%3DL.%2BM.%26atitle%3DSynthesis%2520of%2520modified%2520uracil%2520and%2520cytosine%2520nucleobases%2520using%2520a%2520microwave-assisted%2520method%26jtitle%3DTetrahedron%2520Lett.%26date%3D2012%26volume%3D53%26spage%3D2639%26epage%3D2642%26doi%3D10.1016%2Fj.tetlet.2012.03.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aertgeerts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassel, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaldor, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwaltney, S. L.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1021/jm101016w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101016w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1WgtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=510-524&author=Z.+Zhangauthor=M.+B.+Wallaceauthor=J.+Fengauthor=J.+A.+Staffordauthor=R.+J.+Skeneauthor=L.+Shiauthor=B.+Leeauthor=K.+Aertgeertsauthor=A.+Jenningsauthor=R.+Xuauthor=D.+B.+Kasselauthor=S.+W.+Kaldorauthor=M.+Navreauthor=D.+R.+Webbauthor=S.+L.+Gwaltney&title=Design+and+synthesis+of+pyrimidinone+and+pyrimidinedione+inhibitors+of+dipeptidyl+peptidase+IV&doi=10.1021%2Fjm101016w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV</span></div><div class="casAuthors">Zhang, Zhi-Yuan; Wallace, Michael B.; Feng, Jun; Stafford, Jeffrey A.; Skene, Robert J.; Shi, Li-Hong; Lee, Bum-Sup; Aertgeerts, Kathleen; Jennings, Andy; Xu, Rong-Da; Kassel, Daniel B.; Kaldor, Stephen W.; Navre, Marc; Webb, David R.; Gwaltney, Stephen L., II</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">510-524</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of two classes of heterocyclic dipeptidyl peptidase IV (DPP-4) inhibitors, pyrimidinones and pyrimidinediones, is described.  After a single oral dose, these potent, selective, and noncovalent inhibitors provide sustained redn. of plasma DPP-4 activity and lowering of blood glucose in animal models of diabetes.  Compds. I, II, and III were selected for development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxInStuMRjfbVg90H21EOLACvtfcHk0lhxaH531AOb7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1WgtL7M&md5=7e3b66916acf243ad7943add0eaf6b1f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm101016w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101016w%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWallace%26aufirst%3DM.%2BB.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DStafford%26aufirst%3DJ.%2BA.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DKassel%26aufirst%3DD.%2BB.%26aulast%3DKaldor%26aufirst%3DS.%2BW.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DWebb%26aufirst%3DD.%2BR.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520pyrimidinone%2520and%2520pyrimidinedione%2520inhibitors%2520of%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D510%26epage%3D524%26doi%3D10.1021%2Fjm101016w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazimierczuk, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shugar, D.</span></span> <span> </span><span class="NLM_article-title">Intermediates in the synthesis of purines and pteridines: selective hydrolysis of chloropyrimidines</span>. <i>Acta Biochim. Pol.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=4664351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADyaE3sXlvVeguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1972&pages=359-366&author=Z.+Kazimierczukauthor=M.+Lipskiauthor=D.+Shugar&title=Intermediates+in+the+synthesis+of+purines+and+pteridines%3A+selective+hydrolysis+of+chloropyrimidines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Intermediates in the synthesis of purines and pteridines.  Selective hydrolysis of chloropyrimidines</span></div><div class="casAuthors">Kazimierczuk, Z.; Lipski, M.; Shugar, D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica Polonica</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">359-66</span>CODEN:
                <span class="NLM_cas:coden">ABPLAF</span>;
        ISSN:<span class="NLM_cas:issn">0001-527X</span>.
    </div><div class="casAbstract">Alk. hydrolysis of 2,4,6-trichloropyrimidine gave 4,6-dichloro-2-hydroxypyrimidine (I), which gave 6-chlorouracil on acid hydrolysis.  Treatment of I with NH3 in anhyd. EtOH gave 4,6-diamino-2-hydroxypyrimidine, but Me2NH in anhyd. EtOH gave 4,6-bis(methylamino)-2-hydroxypyrimidine.  Alk. hydrolysis of 2,4-dichloropyrimidine gave 4-chloro-2-hydroxypyrimidine (II), which reacted with NH3 in anhyd. EtOH to give cytosine.  Treatment of II with Na and anhyd. EtOH gave 4-ethoxy-2-hydroxypyrimidine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL4eu2nqwz27Vg90H21EOLACvtfcHk0lhxaH531AOb7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXlvVeguw%253D%253D&md5=45850a1d76daff71dee163db841f6727</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKazimierczuk%26aufirst%3DZ.%26aulast%3DLipski%26aufirst%3DM.%26aulast%3DShugar%26aufirst%3DD.%26atitle%3DIntermediates%2520in%2520the%2520synthesis%2520of%2520purines%2520and%2520pteridines%253A%2520selective%2520hydrolysis%2520of%2520chloropyrimidines%26jtitle%3DActa%2520Biochim.%2520Pol.%26date%3D1972%26volume%3D19%26spage%3D359%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Journet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, G.</span></span> <span> </span><span class="NLM_article-title">A highly regioselective amination of 6-aryl-2,4-dichloropyrimidine</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">398</span>, <span class="refDoi"> DOI: 10.1021/ol052578p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol052578p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvV2qug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=395-398&author=Z.-H.+Pengauthor=M.+Journetauthor=G.+Humphrey&title=A+highly+regioselective+amination+of+6-aryl-2%2C4-dichloropyrimidine&doi=10.1021%2Fol052578p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A Highly Regioselective Amination of 6-Aryl-2,4-dichloropyrimidine</span></div><div class="casAuthors">Peng, Zhi-Hui; Journet, Michel; Humphrey, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">395-398</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A highly regioselective amination of 6-aryl-2,4-dichloropyrimidines with aliph. secondary amines and arom. amines which strongly favors the formation of the C4-substituted product has been developed.  The reactions with aliph. amines are carried out using LiHMDS as the base and are catalyzed by Pd, while the arom. amines require no catalyst.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolnT2Begt9rLVg90H21EOLACvtfcHk0lh-iuTk2QiLag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvV2qug%253D%253D&md5=64bfa91f732110ad28addb2041a5ea5f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fol052578p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol052578p%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DZ.-H.%26aulast%3DJournet%26aufirst%3DM.%26aulast%3DHumphrey%26aufirst%3DG.%26atitle%3DA%2520highly%2520regioselective%2520amination%2520of%25206-aryl-2%252C4-dichloropyrimidine%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D395%26epage%3D398%26doi%3D10.1021%2Fol052578p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cocuzza, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chidester, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarem, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilligan, P. J.</span></span> <span> </span><span class="NLM_article-title">4-aryl-2-anilinopyrimidines as corticotropin-releasing hormone (CRH) antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1057</span>– <span class="NLM_lpage">1062</span>, <span class="refDoi"> DOI: 10.1016/s0960-894x(99)00132-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2FS0960-894X%2899%2900132-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10230640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADyaK1MXivFGqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=1057-1062&author=A.+J.+Cocuzzaauthor=F.+W.+Hobbsauthor=C.+R.+Arnoldauthor=D.+R.+Chidesterauthor=J.+A.+Yaremauthor=S.+Culpauthor=L.+Fitzgeraldauthor=P.+J.+Gilligan&title=4-aryl-2-anilinopyrimidines+as+corticotropin-releasing+hormone+%28CRH%29+antagonists&doi=10.1016%2Fs0960-894x%2899%2900132-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">4-Aryl-2-anilinopyrimidines as corticotropin-releasing hormone (CRH) antagonists</span></div><div class="casAuthors">Cocuzza, Anthony J.; Hobbs, Frank W.; Arnold, Charles R.; Chidester, Dennis R.; Yarem, Jerry A.; Culp, Steven; Fitzgerald, Lawrence; Gilligan, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1057-1062</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of 4-aryl-2-(N-ethylanilino)pyrimidines has been synthesized as corticotropin-releasing hormone inhibitors.  The effect of substitution on each arom. ring on receptor binding was investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF2tVHScnbjLVg90H21EOLACvtfcHk0lh-iuTk2QiLag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFGqt7o%253D&md5=d801177b5c7f7a8a6d1816c640685606</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900132-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900132-8%26sid%3Dliteratum%253Aachs%26aulast%3DCocuzza%26aufirst%3DA.%2BJ.%26aulast%3DHobbs%26aufirst%3DF.%2BW.%26aulast%3DArnold%26aufirst%3DC.%2BR.%26aulast%3DChidester%26aufirst%3DD.%2BR.%26aulast%3DYarem%26aufirst%3DJ.%2BA.%26aulast%3DCulp%26aufirst%3DS.%26aulast%3DFitzgerald%26aufirst%3DL.%26aulast%3DGilligan%26aufirst%3DP.%2BJ.%26atitle%3D4-aryl-2-anilinopyrimidines%2520as%2520corticotropin-releasing%2520hormone%2520%2528CRH%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D1057%26epage%3D1062%26doi%3D10.1016%2Fs0960-894x%2899%2900132-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauls, H. W.</span></span> <span> </span><span class="NLM_article-title">A convenient synthesis of heteroaryl benzoic acids via Suzuki reaction</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">831</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt12kurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=829-831&author=Y.+Gongauthor=H.+W.+Pauls&title=A+convenient+synthesis+of+heteroaryl+benzoic+acids+via+Suzuki+reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A convenient synthesis of heteroarylbenzoic acids via Suzuki reaction</span></div><div class="casAuthors">Gong, Yong; Pauls, Henry W.</div><div class="citationInfo"><span class="NLM_cas:title">Synlett</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">829-831</span>CODEN:
                <span class="NLM_cas:coden">SYNLES</span>;
        ISSN:<span class="NLM_cas:issn">0936-5214</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">An 1-step approach to heteroarylbenzoic acids from readily accessible heteroaryl halides and carboxybenzeneboronic acids is described.  The Suzuki coupling is carried out in the presence of Pd(PPh3)4 and Na2CO3 in aq. MeCN.  Scope and limitations of the reaction are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq17FCpLbSbuLVg90H21EOLACvtfcHk0lh-iuTk2QiLag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt12kurs%253D&md5=dd9fd1a2aafff89ad576a24cb44938e9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DY.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DA%2520convenient%2520synthesis%2520of%2520heteroaryl%2520benzoic%2520acids%2520via%2520Suzuki%2520reaction%26jtitle%3DSynlett%26date%3D2000%26spage%3D829%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gronowitz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornfeldt, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristjansson, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, T.</span></span> <span> </span><span class="NLM_article-title">On the synthesis of various thienylpyrimidines and selenienylpyrimidines</span>. <i>Chem. Scr.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADyaL2sXksFyqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1986&pages=305-309&author=S.+Gronowitzauthor=A.+B.+Hornfeldtauthor=V.+Kristjanssonauthor=T.+Musil&title=On+the+synthesis+of+various+thienylpyrimidines+and+selenienylpyrimidines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">On the synthesis of various thienyl- and selenienylpyrimidines</span></div><div class="casAuthors">Gronowitz, S.; Hoernfeldt, A. B.; Kristjansson, V.; Musil, T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemica Scripta</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">305-9</span>CODEN:
                <span class="NLM_cas:coden">CSRPB9</span>;
        ISSN:<span class="NLM_cas:issn">0004-2056</span>.
    </div><div class="casAbstract">Various thienyl- and selenienylpyrimidines, including 5-substituted uracils, were prepd. by the Pd(0)-catalyzed coupling between halopyrimidines I (R = H, Cl, Br, Me3CO, PhCH2O; R1 = Br, H) and thiopheneboronic acids and selenopheneboronic acids II [R2 = B(OH)2; X = S, Se, resp.].  5-Bromouracil had to be protected as the tert-butoxy or benzyloxy deriv. in order to achieve successful coupling.  The compds. could also be obtained in a reversed manner, when pyrimidineboronic acids I [R = H, Me3CO; R1 = B(OH)2] were coupled with halothiophenes and haloselenophenes II (R2 = Br; X = S, Se).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7Ky04OIgzjbVg90H21EOLACvtfcHk0ljw1c-Y7IrEpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXksFyqtLw%253D&md5=e8d534be2df9681cad062b92ed11522d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGronowitz%26aufirst%3DS.%26aulast%3DHornfeldt%26aufirst%3DA.%2BB.%26aulast%3DKristjansson%26aufirst%3DV.%26aulast%3DMusil%26aufirst%3DT.%26atitle%3DOn%2520the%2520synthesis%2520of%2520various%2520thienylpyrimidines%2520and%2520selenienylpyrimidines%26jtitle%3DChem.%2520Scr.%26date%3D1986%26volume%3D26%26spage%3D305%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-g.</span></span> <span> </span><span class="NLM_article-title">Synthesis of indolylpyrimidines via cross-coupling of indolylboronic acid with chloropyrimidines: facile synthesis of meridianin D</span>. <i>Heterocycles</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1489</span>– <span class="NLM_lpage">1498</span>, <span class="refDoi"> DOI: 10.3987/com-00-8890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.3987%2FCOM-00-8890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvF2lt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2000&pages=1489-1498&author=B.+Jiangauthor=C.-g.+Yang&title=Synthesis+of+indolylpyrimidines+via+cross-coupling+of+indolylboronic+acid+with+chloropyrimidines%3A+facile+synthesis+of+meridianin+D&doi=10.3987%2Fcom-00-8890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of indolylpyrimidines via cross-coupling of indolylboronic acid with chloropyrimidines: facile synthesis of meridianin D</span></div><div class="casAuthors">Jiang, Biao; Yang, Cai-Guang</div><div class="citationInfo"><span class="NLM_cas:title">Heterocycles</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1489-1498</span>CODEN:
                <span class="NLM_cas:coden">HTCYAM</span>;
        ISSN:<span class="NLM_cas:issn">0385-5414</span>.
    
            (<span class="NLM_cas:orgname">Japan Institute of Heterocyclic Chemistry</span>)
        </div><div class="casAbstract">Palladium catalyzed cross-coupling reaction of 3-indolylboronic acid with 2,4-dichloropyrimidines proceeded regioselectively to yield indolyl- or bis(indolyl)pyrimidines in high yield, depending on the projection of 3-indolylboronic acid.  The marine indole alkaloid meridianin D and an analog were synthesized via the palladium catalyzed cross-coupling reaction as a key step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP3SMLOMmgN7Vg90H21EOLACvtfcHk0ljw1c-Y7IrEpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvF2lt78%253D&md5=ac7d54f31a6607b33f7064e83b1879fe</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3987%2FCOM-00-8890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-00-8890%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DC.-g.%26atitle%3DSynthesis%2520of%2520indolylpyrimidines%2520via%2520cross-coupling%2520of%2520indolylboronic%2520acid%2520with%2520chloropyrimidines%253A%2520facile%2520synthesis%2520of%2520meridianin%2520D%26jtitle%3DHeterocycles%26date%3D2000%26volume%3D53%26spage%3D1489%26epage%3D1498%26doi%3D10.3987%2Fcom-00-8890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schomaker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delia, T. J.</span></span> <span> </span><span class="NLM_article-title">Arylation of halogenated pyrimidines via a Suzuki coupling reaction</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">7125</span>– <span class="NLM_lpage">7128</span>, <span class="refDoi"> DOI: 10.1021/jo010573+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo010573%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmslOgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=7125-7128&author=J.+M.+Schomakerauthor=T.+J.+Delia&title=Arylation+of+halogenated+pyrimidines+via+a+Suzuki+coupling+reaction&doi=10.1021%2Fjo010573%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Arylation of Halogenated Pyrimidines via a Suzuki Coupling Reaction</span></div><div class="casAuthors">Schomaker, Jennifer M.; Delia, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7125-7128</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Suzuki coupling reaction was used extensively for the synthesis of a wide variety of unsym. biaryl compds.  The authors have extended this reaction to demonstrate the utility of prepg. monophenyl-, diphenyl-, or triphenylpyrimidine depending on the reaction conditions. Further, chloropyrimidine substrates are preferable over iodo-, bromo-, or fluoropyrimidines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVSwtp4e7HfrVg90H21EOLACvtfcHk0ljw1c-Y7IrEpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmslOgsr8%253D&md5=e3bfe9e88b1757ebd0976ea166d61b58</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjo010573%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo010573%252B%26sid%3Dliteratum%253Aachs%26aulast%3DSchomaker%26aufirst%3DJ.%2BM.%26aulast%3DDelia%26aufirst%3DT.%2BJ.%26atitle%3DArylation%2520of%2520halogenated%2520pyrimidines%2520via%2520a%2520Suzuki%2520coupling%2520reaction%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D7125%26epage%3D7128%26doi%3D10.1021%2Fjo010573%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Basavaraja, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagamani, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padmashali, B.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial evaluation of novel substituted pyrimidinopyrazoles and pyrimidinotriazoles</span>. <i>J. Adv. Pharm. Technol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">236</span>– <span class="NLM_lpage">244</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=22247851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1arurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=236-244&author=H.+S.+Basavarajaauthor=J.+E.+Nagamaniauthor=M.+M.+Kumarauthor=B.+Padmashali&title=Antimicrobial+evaluation+of+novel+substituted+pyrimidinopyrazoles+and+pyrimidinotriazoles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial evaluation of novel substituted pyrimidinopyrazoles and pyrimidinotriazoles</span></div><div class="casAuthors">Basavaraja, H. S.; Nagamani, J. E.; Vijay kumar, M. M. J.; Padmashali, Basavaraj</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Advanced Pharmaceutical Technology & Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">236-244</span>CODEN:
                <span class="NLM_cas:coden">JAPTDW</span>;
        ISSN:<span class="NLM_cas:issn">0976-2094</span>.
    
            (<span class="NLM_cas:orgname">Journal of Advanced Pharmaceutical Technology & Research</span>)
        </div><div class="casAbstract">Some novel substituted pyramidinopyrazoles and pyrimidinotriazoles have been synthesized by using 6-anisyl-5-cyano-2-hydrazino-3-N-methyl-3, 4-dihydropyrimidine-4-one as the starting material.  Structures of these compds. have been established by IR, 1H NMR, Mass and elemental anal. data and have been evaluated for their antimicrobial activity.  Significant antimicrobial activity was obsd. for some members of these series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj6sw2UyZubrVg90H21EOLACvtfcHk0ljw1c-Y7IrEpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1arurY%253D&md5=f76875ff813a242c3c222ddab77b0208</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBasavaraja%26aufirst%3DH.%2BS.%26aulast%3DNagamani%26aufirst%3DJ.%2BE.%26aulast%3DKumar%26aufirst%3DM.%2BM.%26aulast%3DPadmashali%26aufirst%3DB.%26atitle%3DAntimicrobial%2520evaluation%2520of%2520novel%2520substituted%2520pyrimidinopyrazoles%2520and%2520pyrimidinotriazoles%26jtitle%3DJ.%2520Adv.%2520Pharm.%2520Technol.%2520Res.%26date%3D2010%26volume%3D1%26spage%3D236%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasha, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kothari, R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of some novel heterocyclic compounds as protein tyrosine phosphatase (PTP-1B) Inhibitor</span>. <i>J. Chem. Pharmaceut. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">509</span>– <span class="NLM_lpage">517</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=509-517&author=A.+Patelauthor=T.+Y.+Pashaauthor=R.+Kothari&title=Synthesis+and+biological+evaluation+of+some+novel+heterocyclic+compounds+as+protein+tyrosine+phosphatase+%28PTP-1B%29+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DPasha%26aufirst%3DT.%2BY.%26aulast%3DKothari%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520some%2520novel%2520heterocyclic%2520compounds%2520as%2520protein%2520tyrosine%2520phosphatase%2520%2528PTP-1B%2529%2520Inhibitor%26jtitle%3DJ.%2520Chem.%2520Pharmaceut.%2520Res.%26date%3D2015%26volume%3D7%26spage%3D509%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yedage, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhanage, B. M.</span></span> <span> </span><span class="NLM_article-title">tert-Butyl nitrite-mediated synthesis of N-nitrosoamides, carboxylic acids, benzocoumarins, and isocoumarins from amides</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">5769</span>– <span class="NLM_lpage">5781</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.7b00570</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.7b00570" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFSksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2017&pages=5769-5781&author=S.+L.+Yedageauthor=B.+M.+Bhanage&title=tert-Butyl+nitrite-mediated+synthesis+of+N-nitrosoamides%2C+carboxylic+acids%2C+benzocoumarins%2C+and+isocoumarins+from+amides&doi=10.1021%2Facs.joc.7b00570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">tert-Butyl Nitrite-Mediated Synthesis of N-Nitrosoamides, Carboxylic Acids, Benzocoumarins, and Isocoumarins from Amides</span></div><div class="casAuthors">Yedage, Subhash L.; Bhanage, Bhalchandra M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5769-5781</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work reports tert-Bu nitrite (TBN) as a multitask reagent for (1) the controlled synthesis of N-nitrosoamide from N-alkyl amides, (2) hydrolysis of N-methoxyamides to carboxylic acids, (3) metal- and oxidant-free benzocoumarin synthesis from ortho-aryl-N-methoxyamides via N-H, C-N, and C-H bond activation, and (4) isocoumarin synthesis using Ru(II)/PEG as a recyclable catalytic system via ortho-C-H activation and TBN as an oxygen source.  The sequential functional group interconversion of amide to acid has also been examd. using IR spectroscopic anal.  Addnl., this methodol. is highly advantageous due to short reaction time, gram scale synthesis, and broad substrate scope.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpciv67mLNG6rVg90H21EOLACvtfcHk0lihaBueeLg_Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFSksbc%253D&md5=83e66f67054d281021e44def5492cef8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.7b00570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.7b00570%26sid%3Dliteratum%253Aachs%26aulast%3DYedage%26aufirst%3DS.%2BL.%26aulast%3DBhanage%26aufirst%3DB.%2BM.%26atitle%3Dtert-Butyl%2520nitrite-mediated%2520synthesis%2520of%2520N-nitrosoamides%252C%2520carboxylic%2520acids%252C%2520benzocoumarins%252C%2520and%2520isocoumarins%2520from%2520amides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2017%26volume%3D82%26spage%3D5769%26epage%3D5781%26doi%3D10.1021%2Facs.joc.7b00570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, R. L.</span></span> <span> </span><span class="NLM_article-title">One-pot synthesis of 5-(substituted-amino)pyrazoles</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4265</span>– <span class="NLM_lpage">4267</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2004.04.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2Fj.tetlet.2004.04.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVGjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=4265-4267&author=D.+S.+Doddauthor=R.+L.+Martinez&title=One-pot+synthesis+of+5-%28substituted-amino%29pyrazoles&doi=10.1016%2Fj.tetlet.2004.04.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">One-pot synthesis of 5-(substituted-amino)pyrazoles</span></div><div class="casAuthors">Dodd, Dharmpal S.; Martinez, Rogelio L.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4265-4267</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">An efficient and mild one-pot synthesis of substituted 5-alkylamino and/or 5-(arylamino)pyrazoles is described.  A suitably decorated β-keto amide, an aryl or alkyl hydrazine and Lawesson's reagent are suspended in THF/Py and gently heated to yield the requisite 5-aminopyrazoles.  For example, the reaction of N,N-diethyl-3-oxobutanamide with (phenyl)hydrazine in the presence of Lawesson's reagent gave N,N-diethyl-3-methyl-1-phenyl-1H-pyrazol-5-amine in 95% yield.  It is postulated that this method should also be easily adaptable for automated parallel synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXd6HDSARaV7Vg90H21EOLACvtfcHk0lihaBueeLg_Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVGjsLY%253D&md5=25f16fa7a331a7ae149b00c5c91cfb18</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2004.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2004.04.017%26sid%3Dliteratum%253Aachs%26aulast%3DDodd%26aufirst%3DD.%2BS.%26aulast%3DMartinez%26aufirst%3DR.%2BL.%26atitle%3DOne-pot%2520synthesis%2520of%25205-%2528substituted-amino%2529pyrazoles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2004%26volume%3D45%26spage%3D4265%26epage%3D4267%26doi%3D10.1016%2Fj.tetlet.2004.04.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peruncheralathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ila, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junjappa, H.</span></span> <span> </span><span class="NLM_article-title">Highly regioselective synthesis of 1-aryl-3 (or 5)-alkyl/aryl-5 (or 3)-(N-cycloamino)pyrazoles</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">9644</span>– <span class="NLM_lpage">9647</span>, <span class="refDoi"> DOI: 10.1021/jo051478u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo051478u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFahs7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=9644-9647&author=S.+Peruncheralathanauthor=A.+K.+Yadavauthor=H.+Ilaauthor=H.+Junjappa&title=Highly+regioselective+synthesis+of+1-aryl-3+%28or+5%29-alkyl%2Faryl-5+%28or+3%29-%28N-cycloamino%29pyrazoles&doi=10.1021%2Fjo051478u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Regioselective Synthesis of 1-Aryl-3 (or 5)-alkyl/aryl-5 (or 3)-(N-cycloamino)pyrazoles</span></div><div class="casAuthors">Peruncheralathan, S.; Yadav, A. K.; Ila, H.; Junjappa, H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9644-9647</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient highly regioselective protocol for the synthesis of isomeric 1,3-diaryl (or 1-aryl-3-alkyl) and 1,5-diaryl (or 1-aryl-5-alkyl)-5 (or 3)-(N-cycloamino)pyrazoles has been reported by cyclocondensation of common α-oxoketene N,S-acetal precursors with arylhydrazines by variation of reaction conditions.  E.g., reaction of PhCOCH:C(SMe)NMeCH2C6H4OMe-4 with PhNHNH2 in presence of NaH in DMF/C6H6 gave 65% 5-aminopyrazole I (R = CH2C6H4OMe-4).  On the other hand, reaction of PhCOCH:C(SMe)NMeCH2C6H4OMe-4 with PhNHNH2 in presence of DABCO gave 69% 3-aminopyrazole II (same R).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8oPPGC812ArVg90H21EOLACvtfcHk0lihaBueeLg_Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFahs7zJ&md5=22bc2cf19d20f443540d69eb068ef96d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo051478u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo051478u%26sid%3Dliteratum%253Aachs%26aulast%3DPeruncheralathan%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DA.%2BK.%26aulast%3DIla%26aufirst%3DH.%26aulast%3DJunjappa%26aufirst%3DH.%26atitle%3DHighly%2520regioselective%2520synthesis%2520of%25201-aryl-3%2520%2528or%25205%2529-alkyl%252Faryl-5%2520%2528or%25203%2529-%2528N-cycloamino%2529pyrazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D9644%26epage%3D9647%26doi%3D10.1021%2Fjo051478u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ila, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junjappa, H.</span></span> <span> </span><span class="NLM_article-title">A novel and convenient synthesis of 2-amino-4-(N-alkyl-N-arylamino)-pyrimidines using polarized ketene S,S-acetals and S,N-acetals</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_fpage">748</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1055/s-1980-29200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1055%2Fs-1980-29200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADyaL3MXmsFKjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1980&pages=748-751&author=A.+Kumarauthor=V.+Aggarwalauthor=H.+Ilaauthor=H.+Junjappa&title=A+novel+and+convenient+synthesis+of+2-amino-4-%28N-alkyl-N-arylamino%29-pyrimidines+using+polarized+ketene+S%2CS-acetals+and+S%2CN-acetals&doi=10.1055%2Fs-1980-29200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A novel and convenient synthesis of 2-amino-4-(N-alkyl-N-arylamino)pyrimidines using polarized ketene S,S- and S,N-acetals.  Part 13</span></div><div class="casAuthors">Kumar, A.; Aggarwal, V.; Ila, H.; Junjappa, H.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">748-51</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">Ketene S,N-acetals EtO2CC(CN):C(SMe)NRR1 (R = Ph, 4-Me-, 4-MeO-, 4-Cl-, 4-FC6H4; R1 = H; NRR1 = morpholino), generated in situ by treating ketene S,S-acetals EtO2CC(CN):C(SMe)2 with amines RR1NH, were treated with guanidine nitrate to give 47-57% aminopyrimidones I.  R2COCH:C(SMe)NHR3 (R2 = H, Ph, 4-MeC6H4, 4-BrC6H4; R3 = Ph, 4-ClC6H4, Et), obtained in 75-85% yield by treating R2COMe with R3NCS, were treated with guanidine nitrate to give 28-50% II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_B6AH28EurbVg90H21EOLACvtfcHk0lgUmK8elApssg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXmsFKjtA%253D%253D&md5=edd14a7ba503a9cb7eda73ec3c650747</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1055%2Fs-1980-29200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1980-29200%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DAggarwal%26aufirst%3DV.%26aulast%3DIla%26aufirst%3DH.%26aulast%3DJunjappa%26aufirst%3DH.%26atitle%3DA%2520novel%2520and%2520convenient%2520synthesis%2520of%25202-amino-4-%2528N-alkyl-N-arylamino%2529-pyrimidines%2520using%2520polarized%2520ketene%2520S%252CS-acetals%2520and%2520S%252CN-acetals%26jtitle%3DSynthesis%26date%3D1980%26spage%3D748%26epage%3D751%26doi%3D10.1055%2Fs-1980-29200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ila, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junjappa, H.</span></span> <span> </span><span class="NLM_article-title">Reaction of alpha-ketoketene S,N-acetals with hydroxylamine - a facile general-route to 5-aryl-3-(N-arylamino, N-alkylamino, or N-azacycloalkyl)-isoxazoles</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1055/s-1984-30793</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1055%2Fs-1984-30793" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADyaL2cXksFCqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1984&pages=247-249&author=A.+Rahmanauthor=J.+N.+Vishwakarmaauthor=R.+D.+Yadavauthor=H.+Ilaauthor=H.+Junjappa&title=Reaction+of+alpha-ketoketene+S%2CN-acetals+with+hydroxylamine+-+a+facile+general-route+to+5-aryl-3-%28N-arylamino%2C+N-alkylamino%2C+or+N-azacycloalkyl%29-isoxazoles&doi=10.1055%2Fs-1984-30793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction of α-ketoketene S,N-acetals with hydroxylamine: a facile general route to 5-aryl-3-(N-arylamino, N-alkylamino, or N-azacycloalkyl)isoxazoles. Part XXIX</span></div><div class="casAuthors">Rahman, A.; Vishwakarma, J. N.; Yadav, R. D.; Ila, H.; Junjappa, H.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-9</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">Cyclization of ketoketene acetals RCOCH:C(SMe)NR1R2 (R = Ph, p-tolyl, p-anisyl, p-Cl6H4; R1 = Ph, Et, PhCH2, R2 = H; R1R2 = (CH2)4, (CH2)5, (CH2)2O(CH2)2, (CH2)2NPh(CH2)2) with HONH2 gave 56-92% 14 isoxazoles I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7C7LmYl2Nt7Vg90H21EOLACvtfcHk0lgUmK8elApssg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXksFCqtLo%253D&md5=eb418b535ebea9c5b4871a129a2ef0af</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1055%2Fs-1984-30793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1984-30793%26sid%3Dliteratum%253Aachs%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DVishwakarma%26aufirst%3DJ.%2BN.%26aulast%3DYadav%26aufirst%3DR.%2BD.%26aulast%3DIla%26aufirst%3DH.%26aulast%3DJunjappa%26aufirst%3DH.%26atitle%3DReaction%2520of%2520alpha-ketoketene%2520S%252CN-acetals%2520with%2520hydroxylamine%2520-%2520a%2520facile%2520general-route%2520to%25205-aryl-3-%2528N-arylamino%252C%2520N-alkylamino%252C%2520or%2520N-azacycloalkyl%2529-isoxazoles%26jtitle%3DSynthesis%26date%3D1984%26spage%3D247%26epage%3D249%26doi%3D10.1055%2Fs-1984-30793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junjappa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ila, H.</span></span> <span> </span><span class="NLM_article-title">Reaction of lithioamino anions with alpha-oxoketene dithioketals: an improved and a new general method for the synthesis of alpha-oxoketene S,N- and N,N-ketals</span>. <i>J. Chem. Soc., Perkin Trans. 1</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3561</span>– <span class="NLM_lpage">3566</span>, <span class="refDoi"> DOI: 10.1039/a701435j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1039%2Fa701435j" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3561-3566&author=O.+M.+Singhauthor=H.+Junjappaauthor=H.+Ila&title=Reaction+of+lithioamino+anions+with+alpha-oxoketene+dithioketals%3A+an+improved+and+a+new+general+method+for+the+synthesis+of+alpha-oxoketene+S%2CN-+and+N%2CN-ketals&doi=10.1039%2Fa701435j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2Fa701435j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa701435j%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DO.%2BM.%26aulast%3DJunjappa%26aufirst%3DH.%26aulast%3DIla%26aufirst%3DH.%26atitle%3DReaction%2520of%2520lithioamino%2520anions%2520with%2520alpha-oxoketene%2520dithioketals%253A%2520an%2520improved%2520and%2520a%2520new%2520general%2520method%2520for%2520the%2520synthesis%2520of%2520alpha-oxoketene%2520S%252CN-%2520and%2520N%252CN-ketals%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1997%26volume%3D23%26spage%3D3561%26epage%3D3566%26doi%3D10.1039%2Fa701435j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grange, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winstanley, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P. D. O.</span></span> <span> </span><span class="NLM_article-title">Clinically Significant Drug Interactions with Antituberculosis Agents</span>. <i>Drug Saf.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">242</span>– <span class="NLM_lpage">251</span>, <span class="refDoi"> DOI: 10.2165/00002018-199411040-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.2165%2F00002018-199411040-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=7848544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADyaK2cXmvFWrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1994&pages=242-251&author=J.+M.+Grangeauthor=P.+A.+Winstanleyauthor=P.+D.+O.+Davies&title=Clinically+Significant+Drug+Interactions+with+Antituberculosis+Agents&doi=10.2165%2F00002018-199411040-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Clinically significant drug interactions with antituberculosis agents</span></div><div class="casAuthors">Grange, John M.; Winstanley, Peter A.; Davies, Peter D. O.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Safety</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">242-51</span>CODEN:
                <span class="NLM_cas:coden">DRSAEA</span>;
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    </div><div class="casAbstract">A review with 39 refs.  There are very few clin. significant interactions among the first-line antituberculosis drugs themselves, although problems of bioavailability, notably of rifampicin (rifampin), have been encountered in the manuf. of combination tablets.  Of the first-line drugs used to treat tuberculosis, e.g., rifampicin, isoniazid and pyrazinamide, rifampicin is particularly likely to cause clin. significant drug interactions as it is a potent inducer of the cytochrome P 450 enzyme group, which is involved in the metab. of many drugs, in particular oral contraceptives, corticosteroids, oral anticoagulants and cyclosporin.  The use of quinolones to treat multiple drug-resistant tuberculosis and AIDS-related MAC disease raises further problems of drug interactions as, in contrast to rifampicin, these drugs inhibit some cytochrome isoenzymes, leading to reduced metab. of certain drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoit6DfoIzT67Vg90H21EOLACvtfcHk0lgUmK8elApssg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvFWrsbc%253D&md5=b2506b342150aed048e1e27a4bc3d433</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2165%2F00002018-199411040-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002018-199411040-00003%26sid%3Dliteratum%253Aachs%26aulast%3DGrange%26aufirst%3DJ.%2BM.%26aulast%3DWinstanley%26aufirst%3DP.%2BA.%26aulast%3DDavies%26aufirst%3DP.%2BD.%2BO.%26atitle%3DClinically%2520Significant%2520Drug%2520Interactions%2520with%2520Antituberculosis%2520Agents%26jtitle%3DDrug%2520Saf.%26date%3D1994%26volume%3D11%26spage%3D242%26epage%3D251%26doi%3D10.2165%2F00002018-199411040-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sriwijitalai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiwanitkit, V.</span></span> <span> </span><span class="NLM_article-title">Drug–drug interaction analysis: Antituberculosis drugs versus antiretroviral drugs</span>. <i>Biomed. Biotechnol. Res. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">101</span>, <span class="refDoi"> DOI: 10.4103/bbrj.bbrj_52_19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.4103%2Fbbrj.bbrj_52_19" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2019&pages=101&author=W.+Sriwijitalaiauthor=V.+Wiwanitkit&title=Drug%E2%80%93drug+interaction+analysis%3A+Antituberculosis+drugs+versus+antiretroviral+drugs&doi=10.4103%2Fbbrj.bbrj_52_19"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4103%2Fbbrj.bbrj_52_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252Fbbrj.bbrj_52_19%26sid%3Dliteratum%253Aachs%26aulast%3DSriwijitalai%26aufirst%3DW.%26aulast%3DWiwanitkit%26aufirst%3DV.%26atitle%3DDrug%25E2%2580%2593drug%2520interaction%2520analysis%253A%2520Antituberculosis%2520drugs%2520versus%2520antiretroviral%2520drugs%26jtitle%3DBiomed.%2520Biotechnol.%2520Res.%2520J.%26date%3D2019%26volume%3D3%26spage%3D101%26doi%3D10.4103%2Fbbrj.bbrj_52_19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, M. P.</span></span> <span> </span><span class="NLM_article-title">Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1021/jm060981b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060981b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlansbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=101-112&author=M.+P.+Gleeson&title=Plasma+protein+binding+affinity+and+its+relationship+to+molecular+structure%3A+an+in-silico+analysis&doi=10.1021%2Fjm060981b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma Protein Binding Affinity and Its Relationship to Molecular Structure: An In-silico Analysis</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-112</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In-silico plasma protein binding (PPB) models have been generated on human and rat inhouse datasets, and on a human dataset from the literature.  From the results reported herein, it is apparent that models built on datasets relevant to the chemotypes under investigation in lead optimization programs will perform considerably better in this role than those generated on diverse compds. from the literature.  The inhouse human and rat partial least-squares regression (PLS) models have cross-validated q2 values of 0.53 and 0.42 on the training sets, resp.  On the independent test and validation sets, they display similar predictive ability, with logK prediction errors of ∼0.5 log units.  This compares to ∼0.25 log units variability expected for expt.  Given the considerable interspecies PPB differences, the prediction of PPB in one species using measurements in the other is no better than a prediction from an in-silico model generated on that species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk60A2KkbYQLVg90H21EOLACvtfcHk0lgaGVPs943DBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlansbbN&md5=c17cec019dd0d088f8c403c745fcceec</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm060981b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060981b%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DPlasma%2520protein%2520binding%2520affinity%2520and%2520its%2520relationship%2520to%2520molecular%2520structure%253A%2520an%2520in-silico%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D101%26epage%3D112%26doi%3D10.1021%2Fjm060981b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, J. J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Vleet, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittelstadt, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blomme, E. A. G.</span></span> <span> </span><span class="NLM_article-title">Potential functional and pathological side effects related to off-target pharmacological activity</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/j.vascn.2017.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2Fj.vascn.2017.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=28216264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVGltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2017&pages=108-126&author=J.+J.+Lynchauthor=T.+R.+Van+Vleetauthor=S.+W.+Mittelstadtauthor=E.+A.+G.+Blomme&title=Potential+functional+and+pathological+side+effects+related+to+off-target+pharmacological+activity&doi=10.1016%2Fj.vascn.2017.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Potential functional and pathological side effects related to off-target pharmacological activity</span></div><div class="casAuthors">Lynch, James J., III; Van Vleet, Terry R.; Mittelstadt, Scott W.; Blomme, Eric A. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108-126</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Most pharmaceutical companies test their discovery-stage proprietary mols. in a battery of in vitro pharmacol. assays to try to det. off-target interactions.  During all phases of drug discovery and development, various questions arise regarding potential side effects assocd. with such off-target pharmacol. activity.  Here we present a scientific literature curation effort undertaken to det. and summarize the most likely functional and pathol. outcomes assocd. with interactions at 70 receptors, enzymes, ion channels and transporters with established links to adverse effects.  To that end, the scientific literature was reviewed using an online database, and the most commonly reported effects were summarized in tabular format.  The resultant table should serve as a practical guide for research scientists and clin. investigators for the prediction and interpretation of adverse side effects assocd. with mols. interacting with components of this screening battery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr73k3f-8KK17Vg90H21EOLACvtfcHk0lgaGVPs943DBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVGltrg%253D&md5=86b82acd8981a020f19e236d2d4ecb16</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2017.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2017.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DVan%2BVleet%26aufirst%3DT.%2BR.%26aulast%3DMittelstadt%26aufirst%3DS.%2BW.%26aulast%3DBlomme%26aufirst%3DE.%2BA.%2BG.%26atitle%3DPotential%2520functional%2520and%2520pathological%2520side%2520effects%2520related%2520to%2520off-target%2520pharmacological%2520activity%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2017%26volume%3D87%26spage%3D108%26epage%3D126%26doi%3D10.1016%2Fj.vascn.2017.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moosa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamprecht, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, A. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizrahi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D. F.</span></span> <span> </span><span class="NLM_article-title">Susceptibility of Mycobacterium tuberculosis cytochrome bd oxidase mutants to compounds targeting the terminal respiratory oxidase, cytochrome c</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>, <span class="NLM_elocation-id">e01338</span> <span class="refDoi"> DOI: 10.1128/aac.01338-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1128%2FAAC.01338-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=28760899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivVWjtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&author=A.+Moosaauthor=D.+A.+Lamprechtauthor=K.+Aroraauthor=C.+E.+Barryauthor=H.+I.+M.+Boshoffauthor=T.+R.+Ioergerauthor=A.+J.+C.+Steynauthor=V.+Mizrahiauthor=D.+F.+Warner&title=Susceptibility+of+Mycobacterium+tuberculosis+cytochrome+bd+oxidase+mutants+to+compounds+targeting+the+terminal+respiratory+oxidase%2C+cytochrome+c&doi=10.1128%2Faac.01338-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Susceptibility of Mycobacterium tuberculosis cytochrome bd oxidase mutants to compounds targeting the terminal respiratory oxidase, cytochrome c</span></div><div class="casAuthors">Moosa, Atica; Lamprecht, Dirk A.; Arora, Kriti; Barry, Clifton E., III; Boshoff, Helena I. M.; Ioerger, Thomas R.; Steyn, Adrie J. C.; Mizrahi, Valerie; Warner, Digby F.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e01338-17/1-e01338-17/5</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We deleted subunits I (cydA) and II (cydB) of the Mycobacterium tuberculosis cytochrome bd menaquinol oxidase.  The resulting ΔcydA and ΔcydAB mutants were hypersusceptible to compds. targeting the mycobacterial bc1 menaquinolcytochrome c oxidoreductase and exhibited bioenergetic profiles indistinguishable from strains deficient in the ABC-type transporter, CydDC, predicted to be essential for cytochrome bd assembly.  These results confirm CydAB and CydDC as potential targets for drugs aimed at inhibiting a terminal respiratory oxidase implicated in pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgW8kZXLGZ-7Vg90H21EOLACvtfcHk0lgaGVPs943DBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivVWjtb8%253D&md5=bcebcac60fdeec41edce1457923ab6eb</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1128%2FAAC.01338-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01338-17%26sid%3Dliteratum%253Aachs%26aulast%3DMoosa%26aufirst%3DA.%26aulast%3DLamprecht%26aufirst%3DD.%2BA.%26aulast%3DArora%26aufirst%3DK.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DSteyn%26aufirst%3DA.%2BJ.%2BC.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26atitle%3DSusceptibility%2520of%2520Mycobacterium%2520tuberculosis%2520cytochrome%2520bd%2520oxidase%2520mutants%2520to%2520compounds%2520targeting%2520the%2520terminal%2520respiratory%2520oxidase%252C%2520cytochrome%2520c%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26doi%3D10.1128%2Faac.01338-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moosa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizrahi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D. F.</span></span> <span> </span><span class="NLM_article-title">Bioluminescent Reporters for rapid mechanism of action assessment in tuberculosis drug discovery</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6748</span>– <span class="NLM_lpage">6757</span>, <span class="refDoi"> DOI: 10.1128/aac.01178-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1128%2FAAC.01178-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=27572410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitV2ntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=6748-6757&author=K.+Naranauthor=A.+Moosaauthor=C.+E.+Barryauthor=H.+I.+M.+Boshoffauthor=V.+Mizrahiauthor=D.+F.+Warner&title=Bioluminescent+Reporters+for+rapid+mechanism+of+action+assessment+in+tuberculosis+drug+discovery&doi=10.1128%2Faac.01178-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Bioluminescent reporters for rapid mechanism of action assessment in tuberculosis drug discovery</span></div><div class="casAuthors">Naran, Krupa; Moosa, Atica; Barry, Clifton E., III; Boshoff, Helena I. M.; Mizrahi, Valerie; Warner, Digby F.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6748-6757</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The tuberculosis (TB) drug discovery pipeline is fueled by compds.identified in whole-cell screens against the causative agent, Mycobacterium tuberculosis.  Phenotypic screening enables the selection of mols.that inhibit essential cellular functions in live, intact bacilli grown under a chosen in vitro condition.  However, deducing the mechanism of action (MOA), which is important to avoid promiscuous targets, often requires significant biol.resources in a lengthy process that risks decoupling medicinal chem.and biol.efforts.  Therefore, there is a need to develop methods enabling rapid MOA assessment of putative "actives" for triage decisions.  Here, we describe a modified version of a bioluminescence reporter assay that allows nondestructive detection of compds.targeting either of two macromol.processes in M.tuberculosis: cell wall biosynthesis or maintenance of DNA integrity.  Coupling the luxCDABE operon from Photorhabdus luminescens to mycobacterial promoters driving expression of the iniBAC operon (PiniB-LUX) or the DNA damage-inducible genes, recA (PrecA-LUX) or radA (PradA-LUX), provided quant.detection in real time of compds.triggering expression of any of these promoters over an extended 10- to 12-day incubation.  Testing against known anti-TB agents confirmed the specificity of each reporter in registering the MOA of the applied antibiotic in M.tuberculosis, independent of bactericidal or bacteriostatic activity.  Moreover, profiles obtained for exptl.compds.indicated the potential to infer complex MOAs in which multiple cellular processes are disrupted.  These results demonstrate the utility of the reporters for early triage of compds.based on the provisional MOA and suggest their application to investigate polypharmacol.in known and exptl.anti-TB agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1CWtsv8h-h7Vg90H21EOLACvtfcHk0liXKnfbWwTakg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitV2ntbo%253D&md5=6f08794b0ae28a909e1282adfe642cb5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FAAC.01178-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01178-16%26sid%3Dliteratum%253Aachs%26aulast%3DNaran%26aufirst%3DK.%26aulast%3DMoosa%26aufirst%3DA.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26atitle%3DBioluminescent%2520Reporters%2520for%2520rapid%2520mechanism%2520of%2520action%2520assessment%2520in%2520tuberculosis%2520drug%2520discovery%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D6748%26epage%3D6757%26doi%3D10.1128%2Faac.01178-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guinn, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohaideen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizrahi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassetti, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span> <span> </span><span class="NLM_article-title">Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e75245</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0075245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1371%2Fjournal.pone.0075245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=24086479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFeku7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=T.+R.+Ioergerauthor=T.+O%E2%80%99Malleyauthor=R.+Liaoauthor=K.+M.+Guinnauthor=M.+J.+Hickeyauthor=N.+Mohaideenauthor=K.+C.+Murphyauthor=H.+I.+M.+Boshoffauthor=V.+Mizrahiauthor=E.+J.+Rubinauthor=C.+M.+Sassettiauthor=C.+E.+Barryauthor=D.+R.+Shermanauthor=T.+Parishauthor=J.+C.+Sacchettini&title=Identification+of+new+drug+targets+and+resistance+mechanisms+in+Mycobacterium+tuberculosis&doi=10.1371%2Fjournal.pone.0075245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis</span></div><div class="casAuthors">Ioerger, Thomas R.; O'Malley, Theresa; Liao, Reiling; Guinn, Kristine M.; Hickey, Mark J.; Mohaideen, Nilofar; Murphy, Kenan C.; Boshoff, Helena I. M.; Mizrahi, Valerie; Rubin, Eric J.; Sassetti, Christopher M.; Barry, Clifton E., III; Sherman, David R.; Parish, Tanya; Sacchettini, James C.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e75245</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Identification of new drug targets is vital for the advancement of drug discovery against Mycobacterium tuberculosis, esp. given the increase of resistance worldwide to first- and second-line drugs.  Because traditional target-based screening has largely proven unsuccessful for antibiotic discovery, we have developed a scalable platform for target identification in M. tuberculosis that is based on whole-cell screening, coupled with whole-genome sequencing of resistant mutants and recombineering to confirm.  The method yields targets paired with whole-cell active compds., which can serve as novel scaffolds for drug development, mol. tools for validation, and/or as ligands for co-crystn.  It may also reveal other information about mechanisms of action, such as activation or efflux.  Using this method, we identified resistance-linked genes for eight compds. with anti-tubercular activity.  Four of the genes have previously been shown to be essential: AspS, aspartyl-tRNA synthetase, Pks13, a polyketide synthase involved in mycolic acid biosynthesis, MmpL3, a membrane transporter, and EccB3, a component of the ESX-3 type VII secretion system.  AspS and Pks13 represent novel targets in protein translation and cell-wall biosynthesis.  Both MmpL3 and EccB3 are involved in membrane transport.  Pks13, AspS, and EccB3 represent novel candidates not targeted by existing TB drugs, and the availability of whole-cell active inhibitors greatly increases their potential for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoen2dg2HIM0LVg90H21EOLACvtfcHk0liXKnfbWwTakg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFeku7rM&md5=2df0db796fc57f875aa12d4ac5f09984</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0075245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0075245%26sid%3Dliteratum%253Aachs%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DT.%26aulast%3DLiao%26aufirst%3DR.%26aulast%3DGuinn%26aufirst%3DK.%2BM.%26aulast%3DHickey%26aufirst%3DM.%2BJ.%26aulast%3DMohaideen%26aufirst%3DN.%26aulast%3DMurphy%26aufirst%3DK.%2BC.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DRubin%26aufirst%3DE.%2BJ.%26aulast%3DSassetti%26aufirst%3DC.%2BM.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DSherman%26aufirst%3DD.%2BR.%26aulast%3DParish%26aufirst%3DT.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26atitle%3DIdentification%2520of%2520new%2520drug%2520targets%2520and%2520resistance%2520mechanisms%2520in%2520Mycobacterium%2520tuberculosis%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0075245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddat, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, Z.</span></span> <span> </span><span class="NLM_article-title">Crystal Structures of membrane transporter MmpL3, an anti-TB drug target</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">636</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2019.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2Fj.cell.2019.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=30682372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFSrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=636-648&author=B.+Zhangauthor=J.+Liauthor=X.+Yangauthor=L.+Wuauthor=J.+Zhangauthor=Y.+Yangauthor=Y.+Zhaoauthor=L.+Zhangauthor=X.+Yangauthor=X.+Yangauthor=X.+Chengauthor=Z.+Liuauthor=B.+Jiangauthor=H.+Jiangauthor=L.+W.+Guddatauthor=H.+Yangauthor=Z.+Rao&title=Crystal+Structures+of+membrane+transporter+MmpL3%2C+an+anti-TB+drug+target&doi=10.1016%2Fj.cell.2019.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target</span></div><div class="casAuthors">Zhang, Bing; Li, Jun; Yang, Xiaolin; Wu, Lijie; Zhang, Jia; Yang, Yang; Zhao, Yao; Zhang, Lu; Yang, Xiuna; Yang, Xiaobao; Cheng, Xi; Liu, Zhijie; Jiang, Biao; Jiang, Hualiang; Guddat, Luke W.; Yang, Haitao; Rao, Zihe</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">636-648.e13</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Despite intensive efforts to discover highly effective treatments to eradicate tuberculosis (TB), it remains as a major threat to global human health.  For this reason, new TB drugs directed toward new targets are highly coveted.  MmpLs (Mycobacterial membrane proteins Large), which play crucial roles in transporting lipids, polymers and immunomodulators and which also extrude therapeutic drugs, are among the most important therapeutic drug targets to emerge in recent times.  Here, crystal structures of mycobacterial MmpL3 alone and in complex with four TB drug candidates, including SQ109 (in Phase 2b-3 clin. trials), are reported.  MmpL3 consists of a periplasmic pore domain and a twelve-helix transmembrane domain.  Two Asp-Tyr pairs centrally located in this domain appear to be key facilitators of proton-translocation.  SQ109, AU1235, ICA38, and rimonabant bind inside the transmembrane region and disrupt these Asp-Tyr pairs.  This structural data will greatly advance the development of MmpL3 inhibitors as new TB drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYvv_tRkozhbVg90H21EOLACvtfcHk0liXKnfbWwTakg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFSrs7Y%253D&md5=1a64d246a9dee128d2faeb7e0709ca9f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2019.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2019.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DRao%26aufirst%3DZ.%26atitle%3DCrystal%2520Structures%2520of%2520membrane%2520transporter%2520MmpL3%252C%2520an%2520anti-TB%2520drug%2520target%26jtitle%3DCell%26date%3D2019%26volume%3D176%26spage%3D636%26epage%3D648%26doi%3D10.1016%2Fj.cell.2019.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Owens, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulding, C. W.</span></span> <span> </span><span class="NLM_article-title">Insights on how the Mycobacterium tuberculosis heme uptake pathway can be used as a drug target</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1391</span>– <span class="NLM_lpage">1403</span>, <span class="refDoi"> DOI: 10.4155/fmc.13.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.4155%2Ffmc.13.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=23919550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1391-1403&author=C.+P.+Owensauthor=N.+Chimauthor=C.+W.+Goulding&title=Insights+on+how+the+Mycobacterium+tuberculosis+heme+uptake+pathway+can+be+used+as+a+drug+target&doi=10.4155%2Ffmc.13.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Insights on how the Mycobacterium tuberculosis heme uptake pathway can be used as a drug target</span></div><div class="casAuthors">Owens, Cedric P.; Chim, Nicholas; Goulding, Celia W.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1391-1403</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Mycobacterium tuberculosis (Mtb) acquires non-heme iron through salicylate-derived siderophores termed mycobactins whereas heme iron is obtained through a cascade of heme uptake proteins.  Three proteins are proposed to mediate Mtb heme iron uptake, a secreted heme transporter (Rv0203), and MmpL3 and MmpL11, which are potential transmembrane heme transfer proteins.  Furthermore, MhuD, a cytoplasmic heme-degrading enzyme, was identified.  Rv0203, MmpL3, and MmpL11 are mycobacteria-specific proteins, making them excellent drug targets.  Importantly, MmpL3, a necessary protein, was also implicated in trehalose monomycolate export.  Recent drug-discovery efforts revealed that MmpL3 is the target of several compds. with antimycobacterial activity.  Inhibition of the Mtb heme uptake pathway has yet to be explored.  We propose that inhibitor design could focus on heme analogs, with the goal of blocking specific steps of this pathway.  In addn., heme uptake could be hijacked as a method of importing drugs into the mycobacterial cytosol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDQtDhE1-Qv7Vg90H21EOLACvtfcHk0ljb30EScZjSZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amurnF&md5=d2dce1500105bf13a4327399212930d7</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.109%26sid%3Dliteratum%253Aachs%26aulast%3DOwens%26aufirst%3DC.%2BP.%26aulast%3DChim%26aufirst%3DN.%26aulast%3DGoulding%26aufirst%3DC.%2BW.%26atitle%3DInsights%2520on%2520how%2520the%2520Mycobacterium%2520tuberculosis%2520heme%2520uptake%2520pathway%2520can%2520be%2520used%2520as%2520a%2520drug%2520target%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D1391%26epage%3D1403%26doi%3D10.4155%2Ffmc.13.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tullius, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmston, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morse, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMath, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iniguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawaya, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitelegge, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horwitz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulding, C. W.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of a unique mycobacterial heme acquisition system</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">5051</span>– <span class="NLM_lpage">5056</span>, <span class="refDoi"> DOI: 10.1073/pnas.1009516108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1073%2Fpnas.1009516108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=21383189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVChsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5051-5056&author=M.+V.+Tulliusauthor=C.+A.+Harmstonauthor=C.+P.+Owensauthor=N.+Chimauthor=R.+P.+Morseauthor=L.+M.+McMathauthor=A.+Iniguezauthor=J.+M.+Kimmeyauthor=M.+R.+Sawayaauthor=J.+P.+Whiteleggeauthor=M.+A.+Horwitzauthor=C.+W.+Goulding&title=Discovery+and+characterization+of+a+unique+mycobacterial+heme+acquisition+system&doi=10.1073%2Fpnas.1009516108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of a unique mycobacterial heme acquisition system</span></div><div class="casAuthors">Tullius, Michael V.; Harmston, Christine A.; Owens, Cedric P.; Chim, Nicholas; Morse, Robert P.; McMath, Lisa M.; Iniguez, Angelina; Kimmey, Jacqueline M.; Sawaya, Michael R.; Whitelegge, Julian P.; Horwitz, Marcus A.; Goulding, Celia W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5051-5056, S5051/1-S5051/18</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis must import iron from its host for survival, and its siderophore-dependent iron acquisition pathways are well established.  Here we demonstrate a newly characterized pathway, whereby M. tuberculosis can use free heme and heme from Hb as an iron source.  Significantly, we identified the genomic region, Rv0202c-Rv0207c, responsible for the passage of heme iron across the mycobacterial membrane.  Key players of this heme uptake system were characterized including a secreted protein and two transmembrane proteins, all three specific to mycobacteria.  Furthermore, the crystal structure of the key heme carrier protein Rv0203 was found to have a unique fold.  The discovery of a unique mycobacterial heme acquisition pathway opens new avenues of exploration into mycobacterial therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI_2E5hobkjbVg90H21EOLACvtfcHk0ljb30EScZjSZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVChsbw%253D&md5=ed7cbd79a3ed917f9dab3a86f306962d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1009516108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1009516108%26sid%3Dliteratum%253Aachs%26aulast%3DTullius%26aufirst%3DM.%2BV.%26aulast%3DHarmston%26aufirst%3DC.%2BA.%26aulast%3DOwens%26aufirst%3DC.%2BP.%26aulast%3DChim%26aufirst%3DN.%26aulast%3DMorse%26aufirst%3DR.%2BP.%26aulast%3DMcMath%26aufirst%3DL.%2BM.%26aulast%3DIniguez%26aufirst%3DA.%26aulast%3DKimmey%26aufirst%3DJ.%2BM.%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DWhitelegge%26aufirst%3DJ.%2BP.%26aulast%3DHorwitz%26aufirst%3DM.%2BA.%26aulast%3DGoulding%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520unique%2520mycobacterial%2520heme%2520acquisition%2520system%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D5051%26epage%3D5056%26doi%3D10.1073%2Fpnas.1009516108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrero-Lérida, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, A. P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittingham, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannigan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Pérez, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Pacanowska, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of alpha-thymidine analogues as novel antimalarials</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10948</span>– <span class="NLM_lpage">10957</span>, <span class="refDoi"> DOI: 10.1021/jm301328h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301328h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCjurzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10948-10957&author=H.+Cuiauthor=J.+Carrero-L%C3%A9ridaauthor=A.+P.+G.+Silvaauthor=J.+L.+Whittinghamauthor=J.+A.+Branniganauthor=L.+M.+Ruiz-P%C3%A9rezauthor=K.+D.+Readauthor=K.+S.+Wilsonauthor=D.+Gonz%C3%A1lez-Pacanowskaauthor=I.+H.+Gilbert&title=Synthesis+and+evaluation+of+alpha-thymidine+analogues+as+novel+antimalarials&doi=10.1021%2Fjm301328h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of α-Thymidine Analogs as Novel Antimalarials</span></div><div class="casAuthors">Cui, Huaqing; Carrero-Lerida, Juana; Silva, Ana P. G.; Whittingham, Jean L.; Brannigan, James A.; Ruiz-Perez, Luis M.; Read, Kevin D.; Wilson, Keith S.; Gonzalez-Pacanowska, Dolores; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10948-10957</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Plasmodium falciparum thymidylate kinase (PfTMPK) is a key enzyme in pyrimidine nucleotide biosynthesis.  3-Trifluoromethyl-4-chloro-phenyl-urea-α-thymidine has been reported as an inhibitor of Mycobacterium tuberculosis TMPK (MtTMPK).  Starting from this point, we designed, synthesized and evaluated a no. of thymidine analogs, e.g. I, as antimalarials.  Both 5'-urea-α- and β-thymidine derivs. were moderate inhibitors of PfTMPK and furthermore showed moderate inhibition of parasite growth.  The structure of several enzyme-inhibitor complexes provides a basis for improved inhibitor design.  However, we found that certain 5'-urea-α-thymidine analogs had antimalarial activity where inhibition of PfTMPK is not the major mode of action.  Optimization of this series resulted in a compd. with potent antimalarial activity (EC50 = 28 nM; CC50 = 29 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_sLzWeWJq8rVg90H21EOLACvtfcHk0ljb30EScZjSZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCjurzM&md5=ee4f6e2645af5199800173b108ac14df</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm301328h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301328h%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DH.%26aulast%3DCarrero-L%25C3%25A9rida%26aufirst%3DJ.%26aulast%3DSilva%26aufirst%3DA.%2BP.%2BG.%26aulast%3DWhittingham%26aufirst%3DJ.%2BL.%26aulast%3DBrannigan%26aufirst%3DJ.%2BA.%26aulast%3DRuiz-P%25C3%25A9rez%26aufirst%3DL.%2BM.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26aulast%3DGonz%25C3%25A1lez-Pacanowska%26aufirst%3DD.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520alpha-thymidine%2520analogues%2520as%2520novel%2520antimalarials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10948%26epage%3D10957%26doi%3D10.1021%2Fjm301328h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raichurkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandodkar, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varun, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalkhambkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogtherr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embrey, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMiken, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarkar, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, M.</span></span> <span> </span><span class="NLM_article-title">Structure guided lead generation for M. tuberculosis thymidylate kinase (Mtb TMK): discovery of 3-cyanopyridone and 1,6-naphthyridin-2-one as potent inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">753</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1021/jm5012947</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012947" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCku7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=753-766&author=M.+Naikauthor=A.+Raichurkarauthor=B.+S.+Bandodkarauthor=B.+V.+Varunauthor=S.+Bhatauthor=R.+Kalkhambkarauthor=K.+Muruganauthor=R.+Menonauthor=J.+Bhatauthor=B.+Paulauthor=H.+Iyerauthor=S.+Husseinauthor=J.+A.+Tuckerauthor=M.+Vogtherrauthor=K.+J.+Embreyauthor=H.+McMikenauthor=S.+Prasadauthor=A.+Gillauthor=B.+G.+Ugarkarauthor=J.+Venkatramanauthor=J.+Readauthor=M.+Panda&title=Structure+guided+lead+generation+for+M.+tuberculosis+thymidylate+kinase+%28Mtb+TMK%29%3A+discovery+of+3-cyanopyridone+and+1%2C6-naphthyridin-2-one+as+potent+inhibitors&doi=10.1021%2Fjm5012947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Guided Lead Generation for M. tuberculosis Thymidylate Kinase (Mtb TMK): Discovery of 3-Cyanopyridone and 1,6-Naphthyridin-2-one as Potent Inhibitors</span></div><div class="casAuthors">Naik, Maruti; Raichurkar, Anandkumar; Bandodkar, Balachandra S.; Varun, Begur V.; Bhat, Shantika; Kalkhambkar, Rajesh; Murugan, Kannan; Menon, Rani; Bhat, Jyothi; Paul, Beena; Iyer, Harini; Hussein, Syeed; Tucker, Julie A.; Vogtherr, Martin; Embrey, Kevin J.; McMiken, Helen; Prasad, Swati; Gill, Adrian; Ugarkar, Bheemarao G.; Venkatraman, Janani; Read, Jon; Panda, Manoranjan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">753-766</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">M. tuberculosis thymidylate kinase (Mtb TMK) has been shown in vitro to be an essential enzyme in DNA synthesis.  In order to identify novel leads for Mtb TMK, the authors performed a high throughput biochem. screen and an NMR based fragment screen through which the authors discovered two novel classes of inhibitors, 3-cyanopyridones and 1,6-naphthyridin-2-ones, resp.  The authors describe three cyanopyridone subseries that arose during the hit to lead campaign, along with cocrystal structures of representatives with Mtb TMK.  Structure aided optimization of the cyanopyridones led to single digit nanomolar inhibitors of Mtb TMK.  Fragment based lead generation, augmented by crystal structures and the SAR from the cyanopyridones, enabled us to drive the potency of the 1,6-naphthyridin-2-one fragment hit from 500 μM to 200 nM while simultaneously improving the ligand efficiency.  Cyanopyridone derivs. contg. sulfoxides and sulfones, e.g. I, showed cellular activity against M. tuberculosis.  To the best of the knowledge, these compds. are the first reports of nonthymidine-like inhibitors of Mtb TMK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_Ua6j3LbGMLVg90H21EOLACvtfcHk0ljKtKvO41bdHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCku7jN&md5=3a9ec4e7eea4e656b12776f91091cebb</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm5012947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012947%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DM.%26aulast%3DRaichurkar%26aufirst%3DA.%26aulast%3DBandodkar%26aufirst%3DB.%2BS.%26aulast%3DVarun%26aufirst%3DB.%2BV.%26aulast%3DBhat%26aufirst%3DS.%26aulast%3DKalkhambkar%26aufirst%3DR.%26aulast%3DMurugan%26aufirst%3DK.%26aulast%3DMenon%26aufirst%3DR.%26aulast%3DBhat%26aufirst%3DJ.%26aulast%3DPaul%26aufirst%3DB.%26aulast%3DIyer%26aufirst%3DH.%26aulast%3DHussein%26aufirst%3DS.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DVogtherr%26aufirst%3DM.%26aulast%3DEmbrey%26aufirst%3DK.%2BJ.%26aulast%3DMcMiken%26aufirst%3DH.%26aulast%3DPrasad%26aufirst%3DS.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DUgarkar%26aufirst%3DB.%2BG.%26aulast%3DVenkatraman%26aufirst%3DJ.%26aulast%3DRead%26aufirst%3DJ.%26aulast%3DPanda%26aufirst%3DM.%26atitle%3DStructure%2520guided%2520lead%2520generation%2520for%2520M.%2520tuberculosis%2520thymidylate%2520kinase%2520%2528Mtb%2520TMK%2529%253A%2520discovery%2520of%25203-cyanopyridone%2520and%25201%252C6-naphthyridin-2-one%2520as%2520potent%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D753%26epage%3D766%26doi%3D10.1021%2Fjm5012947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkhill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnier, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiglmeier, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tekaia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badcock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chillingworth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devlin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feltwell, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentles, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamlin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holroyd, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornsby, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagels, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krogh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moule, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajandream, M.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skelton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squares, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Squares, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulston, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitehead, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrell, B. G.</span></span> <span> </span><span class="NLM_article-title">Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>393</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1038/31159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1038%2F31159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=9634230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADyaK1cXjvV2ksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=1998&pages=537-544&author=S.+T.+Coleauthor=R.+Broschauthor=J.+Parkhillauthor=T.+Garnierauthor=C.+Churcherauthor=D.+Harrisauthor=S.+V.+Gordonauthor=K.+Eiglmeierauthor=S.+Gasauthor=C.+E.+Barryauthor=F.+Tekaiaauthor=K.+Badcockauthor=D.+Bashamauthor=D.+Brownauthor=T.+Chillingworthauthor=R.+Connorauthor=R.+Daviesauthor=K.+Devlinauthor=T.+Feltwellauthor=S.+Gentlesauthor=N.+Hamlinauthor=S.+Holroydauthor=T.+Hornsbyauthor=K.+Jagelsauthor=A.+Kroghauthor=J.+McLeanauthor=S.+Mouleauthor=L.+Murphyauthor=K.+Oliverauthor=J.+Osborneauthor=M.+A.+Quailauthor=M.-A.+Rajandreamauthor=J.+Rogersauthor=S.+Rutterauthor=K.+Seegerauthor=J.+Skeltonauthor=R.+Squaresauthor=S.+Squaresauthor=J.+E.+Sulstonauthor=K.+Taylorauthor=S.+Whiteheadauthor=B.+G.+Barrell&title=Deciphering+the+biology+of+Mycobacterium+tuberculosis+from+the+complete+genome+sequence&doi=10.1038%2F31159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence</span></div><div class="casAuthors">Cole, S. T.; Brosch, R.; Parkhill, J.; Garnier, T.; Churcher, C.; Harris, D.; Gordon, S. V.; Eiglmeier, K.; Gas, S.; Barry, C. E., III; Tekaia, F.; Badcock, K.; Basham, D.; Brown, D.; Chillingworth, T.; Connor, R.; Davies, R.; Devlin, K.; Feltwell, T.; Gentles, S.; Hamlin, N.; Holroyd, S.; Hornsby, T.; Jagels, K.; Krogh, A.; McLean, J.; Moule, S.; Murphy, L.; Oliver, K.; Osborne, J.; Quail, M. A.; Rajandream, M.-A.; Rogers, J.; Rutter, S.; Seeger, K.; Skelton, J.; Squares, R.; Squares, S.; Sulston, J. E.; Taylor, K.; Whitehead, S.; Barrell, B. G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue">6685</span>),
    <span class="NLM_cas:pages">537-544</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Countless millions of people have died from tuberculosis, a chronic infectious disease caused by the tubercle bacillus.  The complete genome sequence of the best-characterized strain of Mycobacterium tuberculosis, H37Rv, was detd. and analyzed in order to improve our understanding of the biol. of this slow-growing pathogen and to help the conception of new prophylactic and therapeutic interventions.  The genome comprises 4,411,529 base pairs, contains around 4000 genes, and has a very high G+C content that is reflected in the biased amino acid content of the proteins.  M. tuberculosis differs radically from other bacteria in that a very large portion of its coding capacity is devoted to the prodn. of enzymes involved in lipogenesis and lipolysis, and to 2 new families of glycine-rich proteins with a repetitive structure that may represent a source of antigenic variation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Q-iByIunurVg90H21EOLACvtfcHk0ljKtKvO41bdHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvV2ksrY%253D&md5=44d23e7674bfeb1a3e30b55abf5268d2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2F31159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F31159%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DBrosch%26aufirst%3DR.%26aulast%3DParkhill%26aufirst%3DJ.%26aulast%3DGarnier%26aufirst%3DT.%26aulast%3DChurcher%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DD.%26aulast%3DGordon%26aufirst%3DS.%2BV.%26aulast%3DEiglmeier%26aufirst%3DK.%26aulast%3DGas%26aufirst%3DS.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DTekaia%26aufirst%3DF.%26aulast%3DBadcock%26aufirst%3DK.%26aulast%3DBasham%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DChillingworth%26aufirst%3DT.%26aulast%3DConnor%26aufirst%3DR.%26aulast%3DDavies%26aufirst%3DR.%26aulast%3DDevlin%26aufirst%3DK.%26aulast%3DFeltwell%26aufirst%3DT.%26aulast%3DGentles%26aufirst%3DS.%26aulast%3DHamlin%26aufirst%3DN.%26aulast%3DHolroyd%26aufirst%3DS.%26aulast%3DHornsby%26aufirst%3DT.%26aulast%3DJagels%26aufirst%3DK.%26aulast%3DKrogh%26aufirst%3DA.%26aulast%3DMcLean%26aufirst%3DJ.%26aulast%3DMoule%26aufirst%3DS.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DOliver%26aufirst%3DK.%26aulast%3DOsborne%26aufirst%3DJ.%26aulast%3DQuail%26aufirst%3DM.%2BA.%26aulast%3DRajandream%26aufirst%3DM.-A.%26aulast%3DRogers%26aufirst%3DJ.%26aulast%3DRutter%26aufirst%3DS.%26aulast%3DSeeger%26aufirst%3DK.%26aulast%3DSkelton%26aufirst%3DJ.%26aulast%3DSquares%26aufirst%3DR.%26aulast%3DSquares%26aufirst%3DS.%26aulast%3DSulston%26aufirst%3DJ.%2BE.%26aulast%3DTaylor%26aufirst%3DK.%26aulast%3DWhitehead%26aufirst%3DS.%26aulast%3DBarrell%26aufirst%3DB.%2BG.%26atitle%3DDeciphering%2520the%2520biology%2520of%2520Mycobacterium%2520tuberculosis%2520from%2520the%2520complete%2520genome%2520sequence%26jtitle%3DNature%26date%3D1998%26volume%3D393%26spage%3D537%26epage%3D544%26doi%3D10.1038%2F31159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeJesus, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerrick, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutte, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnappinger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortune, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassetti, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span> <span> </span><span class="NLM_article-title">Comprehensive essentiality analysis of the Mycobacterium tuberculosis genome via saturating transposon mutagenesis</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e02133</span> <span class="refDoi"> DOI: 10.1128/mbio.02133-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1128%2FmBio.02133-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=28096490" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=M.+A.+DeJesusauthor=E.+R.+Gerrickauthor=W.+Xuauthor=S.+W.+Parkauthor=J.+E.+Longauthor=C.+C.+Boutteauthor=E.+J.+Rubinauthor=D.+Schnappingerauthor=S.+Ehrtauthor=S.+M.+Fortuneauthor=C.+M.+Sassettiauthor=T.+R.+Ioerger&title=Comprehensive+essentiality+analysis+of+the+Mycobacterium+tuberculosis+genome+via+saturating+transposon+mutagenesis&doi=10.1128%2Fmbio.02133-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FmBio.02133-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.02133-16%26sid%3Dliteratum%253Aachs%26aulast%3DDeJesus%26aufirst%3DM.%2BA.%26aulast%3DGerrick%26aufirst%3DE.%2BR.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DPark%26aufirst%3DS.%2BW.%26aulast%3DLong%26aufirst%3DJ.%2BE.%26aulast%3DBoutte%26aufirst%3DC.%2BC.%26aulast%3DRubin%26aufirst%3DE.%2BJ.%26aulast%3DSchnappinger%26aufirst%3DD.%26aulast%3DEhrt%26aufirst%3DS.%26aulast%3DFortune%26aufirst%3DS.%2BM.%26aulast%3DSassetti%26aufirst%3DC.%2BM.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26atitle%3DComprehensive%2520essentiality%2520analysis%2520of%2520the%2520Mycobacterium%2520tuberculosis%2520genome%2520via%2520saturating%2520transposon%2520mutagenesis%26jtitle%3DmBio%26date%3D2017%26volume%3D8%26doi%3D10.1128%2Fmbio.02133-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gawronski, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dejesus, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akerley, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassetti, C. M.</span></span> <span> </span><span class="NLM_article-title">High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e1002251</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1002251</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1371%2Fjournal.ppat.1002251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=21980284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlCmsbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&author=J.+E.+Griffinauthor=J.+D.+Gawronskiauthor=M.+A.+Dejesusauthor=T.+R.+Ioergerauthor=B.+J.+Akerleyauthor=C.+M.+Sassetti&title=High-resolution+phenotypic+profiling+defines+genes+essential+for+mycobacterial+growth+and+cholesterol+catabolism&doi=10.1371%2Fjournal.ppat.1002251"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism</span></div><div class="casAuthors">Griffin, Jennifer E.; Gawronski, Jeffrey D.; DeJesus, Michael A.; Ioerger, Thomas R.; Akerley, Brian J.; Sassetti, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e1002251</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The pathways that comprise cellular metab. are highly interconnected, and alterations in individual enzymes can have far-reaching effects.  As a result, global profiling methods that measure gene expression are of limited value in predicting how the loss of an individual function will affect the cell.  In this work, we employed a new method of global phenotypic profiling to directly define the genes required for the growth of Mycobacterium tuberculosis.  A combination of high-d. mutagenesis and deep-sequencing was used to characterize the compn. of complex mutant libraries exposed to different conditions.  This allowed the unambiguous identification of the genes that are essential for Mtb to grow in vitro, and proved to be a significant improvement over previous approaches.  To further explore functions that are required for persistence in the host, we defined the pathways necessary for the utilization of cholesterol, a crit. carbon source during infection.  Few of the genes we identified had previously been implicated in this adaptation by transcriptional profiling, and only a fraction were encoded in the chromosomal region known to encode sterol catabolic functions.  These genes comprise an unexpectedly large percentage of those previously shown to be required for bacterial growth in mouse tissue.  Thus, this single nutritional change accounts for a significant fraction of the adaptation to the host.  This work provides the most comprehensive genetic characterization of a sterol catabolic pathway to date, suggests putative roles for uncharacterized virulence genes, and precisely maps genes encoding potential drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZFTpTTOIkA7Vg90H21EOLACvtfcHk0lj04KVDK0IVCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlCmsbfN&md5=a97c2b9759b7a8bc9a304f5684701f13</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002251%26sid%3Dliteratum%253Aachs%26aulast%3DGriffin%26aufirst%3DJ.%2BE.%26aulast%3DGawronski%26aufirst%3DJ.%2BD.%26aulast%3DDejesus%26aufirst%3DM.%2BA.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DAkerley%26aufirst%3DB.%2BJ.%26aulast%3DSassetti%26aufirst%3DC.%2BM.%26atitle%3DHigh-resolution%2520phenotypic%2520profiling%2520defines%2520genes%2520essential%2520for%2520mycobacterial%2520growth%2520and%2520cholesterol%2520catabolism%26jtitle%3DPLoS%2520Pathog.%26date%3D2011%26volume%3D7%26doi%3D10.1371%2Fjournal.ppat.1002251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sassetti, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E. J.</span></span> <span> </span><span class="NLM_article-title">Genes required for mycobacterial growth defined by high density mutagenesis</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2958.2003.03425.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1046%2Fj.1365-2958.2003.03425.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=12657046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislOrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2003&pages=77-84&author=C.+M.+Sassettiauthor=D.+H.+Boydauthor=E.+J.+Rubin&title=Genes+required+for+mycobacterial+growth+defined+by+high+density+mutagenesis&doi=10.1046%2Fj.1365-2958.2003.03425.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Genes required for mycobacterial growth defined by high density mutagenesis</span></div><div class="casAuthors">Sassetti, Christopher M.; Boyd, Dana H.; Rubin, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Despite over a century of research, tuberculosis remains a leading cause of infectious death worldwide.  Faced with increasing rates of drug resistance, the identification of genes that are required for the growth of this organism should provide new targets for the design of antimycobacterial agents.  Here, we describe the use of transposon site hybridization (TraSH) to comprehensively identify the genes required by the causative agent, Mycobacterium tuberculosis, for optimal growth.  These genes include those that can be assigned to essential pathways as well as many of unknown function.  The genes important for the growth of M. tuberculosis are largely conserved in the degenerate genome of the leprosy bacillus, Mycobacterium leprae, indicating that non-essential functions have been selectively lost since this bacterium diverged from other mycobacteria.  In contrast, a surprisingly high proportion of these genes lack identifiable orthologues in other bacteria, suggesting that the minimal gene set required for survival varies greatly between organisms with different evolutionary histories.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRBfRLDyIMG7Vg90H21EOLACvtfcHk0lj04KVDK0IVCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislOrsLY%253D&md5=fca1950336b0a179d83c94e701672523</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2003.03425.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2003.03425.x%26sid%3Dliteratum%253Aachs%26aulast%3DSassetti%26aufirst%3DC.%2BM.%26aulast%3DBoyd%26aufirst%3DD.%2BH.%26aulast%3DRubin%26aufirst%3DE.%2BJ.%26atitle%3DGenes%2520required%2520for%2520mycobacterial%2520growth%2520defined%2520by%2520high%2520density%2520mutagenesis%26jtitle%3DMol.%2520Microbiol.%26date%3D2003%26volume%3D48%26spage%3D77%26epage%3D84%26doi%3D10.1046%2Fj.1365-2958.2003.03425.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boldrin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palú, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganelli, R.</span></span> <span> </span><span class="NLM_article-title">Characterization of a Mycobacterium tuberculosis ESX-3 conditional mutant: essentiality and rescue by iron and zinc</span>. <i>J. Bacteriol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">6340</span>– <span class="NLM_lpage">6344</span>, <span class="refDoi"> DOI: 10.1128/jb.00756-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1128%2FJB.00756-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=19684129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSrsrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2009&pages=6340-6344&author=A.+Serafiniauthor=F.+Boldrinauthor=G.+Pal%C3%BAauthor=R.+Manganelli&title=Characterization+of+a+Mycobacterium+tuberculosis+ESX-3+conditional+mutant%3A+essentiality+and+rescue+by+iron+and+zinc&doi=10.1128%2Fjb.00756-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a Mycobacterium tuberculosis ESX-3 conditional mutant: Essentiality and rescue by iron and zinc</span></div><div class="casAuthors">Serafini, Agnese; Boldrin, Francesca; Palu, Giorgio; Manganelli, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bacteriology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6340-6344</span>CODEN:
                <span class="NLM_cas:coden">JOBAAY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9193</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Recently, a novel type of secretory pathway, type VII secretion systems (T7SSs), has been characterized in mycobacteria.  The chromosomes of Mycobacterium tuberculosis and Mycobacterium bovis encode five T7SSs (ESX-1 to ESX-5).  The best characterized of them, ESX-1, is involved in host-pathogen interactions, and its deletion is one of the main causes of M. bovis BCG attenuation.  Another T7SS, ESX-3, has been previously shown to be transcriptionally controlled by the zinc uptake repressor (Zur) and by the iron-dependent transcriptional repressor (IdeR), suggesting that it might be involved in zinc and iron homeostasis.  In this study, the authors characterized an M. tuberculosis conditional mutant in which transcription of the ESX-3 gene cluster can be downregulated by anhydrotetracycline.  They showed that this T7SS is essential for growth and that this phenotype can be complemented by zinc, iron, or supernatant from a wild-type parental strain culture, demonstrating that the ESX-3 secretion system is responsible for the secretion of some sol. factor(s) required for growth that is probably involved in optimal iron and zinc uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-e8LI5CBVDrVg90H21EOLACvtfcHk0lhg2ZKm1nCTJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSrsrvL&md5=f124b9feeb0728d080b9a516c7670f0d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1128%2FJB.00756-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJB.00756-09%26sid%3Dliteratum%253Aachs%26aulast%3DSerafini%26aufirst%3DA.%26aulast%3DBoldrin%26aufirst%3DF.%26aulast%3DPal%25C3%25BA%26aufirst%3DG.%26aulast%3DManganelli%26aufirst%3DR.%26atitle%3DCharacterization%2520of%2520a%2520Mycobacterium%2520tuberculosis%2520ESX-3%2520conditional%2520mutant%253A%2520essentiality%2520and%2520rescue%2520by%2520iron%2520and%2520zinc%26jtitle%3DJ.%2520Bacteriol.%26date%3D2009%26volume%3D191%26spage%3D6340%26epage%3D6344%26doi%3D10.1128%2Fjb.00756-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serafini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palù, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganelli, R.</span></span> <span> </span><span class="NLM_article-title">The ESX-3 secretion system is necessary for iron and zinc homeostasis in Mycobacterium tuberculosis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e78351</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0078351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1371%2Fjournal.pone.0078351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=24155985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yms73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=A.+Serafiniauthor=D.+Pisuauthor=G.+Pal%C3%B9author=G.+M.+Rodriguezauthor=R.+Manganelli&title=The+ESX-3+secretion+system+is+necessary+for+iron+and+zinc+homeostasis+in+Mycobacterium+tuberculosis&doi=10.1371%2Fjournal.pone.0078351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The ESX-3 secretion system is necessary for iron and zinc homeostasis in Mycobacterium tuberculosis</span></div><div class="casAuthors">Serafini, Agnese; Pisu, Davide; Palu, Giorgio; Rodriguez, G. Marcela; Manganelli, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e78351</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">ESX-3 is one of the five type VII secretion systems encoded by the Mycobacterium tuberculosis genome.  The authors recently showed the essentiality of ESX-3 for M. tuberculosis viability and proposed its involvement in iron and zinc metab.  The authors confirmed the role of ESX-3 in iron uptake and its involvement in the adaptation to low zinc environment in M. tuberculosis.  Moreover, the authors unveiled functional differences between the ESX-3 roles in M. tuberculosis and M. smegmatis showing that in the latter ESX-3 is only involved in the adaptation to iron and not to zinc restriction.  Finally, also in M. tuberculosis this secretion system is essential for iron and zinc homeostasis not only in conditions in which the concns. of these metals are limiting but also in metal sufficient conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2vxsdAbWiQrVg90H21EOLACvtfcHk0lhg2ZKm1nCTJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yms73J&md5=e717f6213d69ad349d26bb94833bcb71</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0078351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0078351%26sid%3Dliteratum%253Aachs%26aulast%3DSerafini%26aufirst%3DA.%26aulast%3DPisu%26aufirst%3DD.%26aulast%3DPal%25C3%25B9%26aufirst%3DG.%26aulast%3DRodriguez%26aufirst%3DG.%2BM.%26aulast%3DManganelli%26aufirst%3DR.%26atitle%3DThe%2520ESX-3%2520secretion%2520system%2520is%2520necessary%2520for%2520iron%2520and%2520zinc%2520homeostasis%2520in%2520Mycobacterium%2520tuberculosis%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0078351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegrist, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steigedal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragset, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philips, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E. J.</span></span> <span> </span><span class="NLM_article-title">Mycobacterial Esx-3 requires multiple components for iron acquisition</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e01073</span> <span class="refDoi"> DOI: 10.1128/mbio.01073-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1128%2FmBio.01073-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=24803520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1OlsbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&author=M.+S.+Siegristauthor=M.+Steigedalauthor=R.+Ahmadauthor=A.+Mehraauthor=M.+S.+Dragsetauthor=B.+M.+Schusterauthor=J.+A.+Philipsauthor=S.+A.+Carrauthor=E.+J.+Rubin&title=Mycobacterial+Esx-3+requires+multiple+components+for+iron+acquisition&doi=10.1128%2Fmbio.01073-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Mycobacterial Esx-3 requires multiple components for iron acquisition</span></div><div class="casAuthors">Siegrist, M. Sloan; Steigedal, Magnus; Ahmad, Rushdy; Mehra, Alka; Dragset, Marte S.; Schuster, Brian M.; Philips, Jennifer A.; Carr, Steven A.; Rubin, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">mBio</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e01073/1-e01073/11, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">MBIOCL</span>;
        ISSN:<span class="NLM_cas:issn">2150-7511</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The type VII secretion systems are conserved across mycobacterial species and in many Gram-pos. bacteria.  While the well-characterized Esx-1 pathway is required for the virulence of pathogenic mycobacteria and conjugation in the model organism Mycobacterium smegmatis, Esx-3 contributes to mycobactin-mediated iron acquisition in these bacteria.  Here we show that several Esx-3 components are individually required for function under low-iron conditions but that at least one, the membrane-bound protease MycP3 of M. smegmatis, is partially expendable.  All of the esx-3 mutants tested, including the ΔmycP3ms mutant, failed to export the native Esx-3 substrates EsxHms and EsxGms to quantifiable levels, as detd. by targeted mass spectrometry.  Although we were able to restore low-iron growth to the esx-3 mutants by genetic complementation, we found a wide range of complementation levels for protein export.  Indeed, minute quantities of extracellular EsxHms and EsxGms were sufficient for iron acquisition under our exptl. conditions.  The apparent sepn. of Esx-3 function in iron acquisition from robust EsxGms and EsxHms secretion in the ΔmycP3ms mutant and in some of the complemented esx-3 mutants compels reexamn. of the structure-function relationships for type VII secretion systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQdC5LN3AvgbVg90H21EOLACvtfcHk0lhg2ZKm1nCTJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1OlsbfJ&md5=c6869042be60f9e332c84c1c4e3667a4</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1128%2FmBio.01073-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.01073-14%26sid%3Dliteratum%253Aachs%26aulast%3DSiegrist%26aufirst%3DM.%2BS.%26aulast%3DSteigedal%26aufirst%3DM.%26aulast%3DAhmad%26aufirst%3DR.%26aulast%3DMehra%26aufirst%3DA.%26aulast%3DDragset%26aufirst%3DM.%2BS.%26aulast%3DSchuster%26aufirst%3DB.%2BM.%26aulast%3DPhilips%26aufirst%3DJ.%2BA.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DRubin%26aufirst%3DE.%2BJ.%26atitle%3DMycobacterial%2520Esx-3%2520requires%2520multiple%2520components%2520for%2520iron%2520acquisition%26jtitle%3DmBio%26date%3D2014%26volume%3D5%26doi%3D10.1128%2Fmbio.01073-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegrist, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unnikrishnan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borowsky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortune, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E. J.</span></span> <span> </span><span class="NLM_article-title">Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">18792</span>– <span class="NLM_lpage">18797</span>, <span class="refDoi"> DOI: 10.1073/pnas.0900589106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1073%2Fpnas.0900589106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=19846780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A280%3ADC%252BD1MjjvVWmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=18792-18797&author=M.+S.+Siegristauthor=M.+Unnikrishnanauthor=M.+J.+McConnellauthor=M.+Borowskyauthor=T.-Y.+Chengauthor=N.+Siddiqiauthor=S.+M.+Fortuneauthor=D.+B.+Moodyauthor=E.+J.+Rubin&title=Mycobacterial+Esx-3+is+required+for+mycobactin-mediated+iron+acquisition&doi=10.1073%2Fpnas.0900589106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition</span></div><div class="casAuthors">Siegrist M Sloan; Unnikrishnan Meera; McConnell Matthew J; Borowsky Mark; Cheng Tan-Yun; Siddiqi Noman; Fortune Sarah M; Moody D Branch; Rubin Eric J</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">18792-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Esx secretion pathway is conserved across Gram-positive bacteria.  Esx-1, the best-characterized system, is required for virulence of Mycobacterium tuberculosis, although its precise function during infection remains unclear.  Esx-3, a paralogous system present in all mycobacterial species, is required for growth in vitro.  Here, we demonstrate that mycobacteria lacking Esx-3 are defective in acquiring iron.  To compete for the limited iron available in the host and the environment, these organisms use mycobactin, high-affinity iron-binding molecules.  In the absence of Esx-3, mycobacteria synthesize mycobactin but are unable to use the bound iron and are impaired severely for growth during macrophage infection.  Mycobacteria thus require a specialized secretion system for acquiring iron from siderophores.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQNYiDyKXAPLsAKB7Fa-xrUfW6udTcc2ebnV6IWTuwrCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjjvVWmsA%253D%253D&md5=5ee0124f43ce767310e831f260c0439e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0900589106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0900589106%26sid%3Dliteratum%253Aachs%26aulast%3DSiegrist%26aufirst%3DM.%2BS.%26aulast%3DUnnikrishnan%26aufirst%3DM.%26aulast%3DMcConnell%26aufirst%3DM.%2BJ.%26aulast%3DBorowsky%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DT.-Y.%26aulast%3DSiddiqi%26aufirst%3DN.%26aulast%3DFortune%26aufirst%3DS.%2BM.%26aulast%3DMoody%26aufirst%3DD.%2BB.%26aulast%3DRubin%26aufirst%3DE.%2BJ.%26atitle%3DMycobacterial%2520Esx-3%2520is%2520required%2520for%2520mycobactin-mediated%2520iron%2520acquisition%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D18792%26epage%3D18797%26doi%3D10.1073%2Fpnas.0900589106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voskuil, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoolnik, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, I.</span></span> <span> </span><span class="NLM_article-title">ideR, An essential gene in mycobacterium tuberculosis: role of IdeR in iron-dependent gene expression, iron metabolism, and oxidative stress response</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">3371</span>– <span class="NLM_lpage">3381</span>, <span class="refDoi"> DOI: 10.1128/iai.70.7.3371-3381.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1128%2FIAI.70.7.3371-3381.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=12065475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvV2ltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2002&pages=3371-3381&author=G.+M.+Rodriguezauthor=M.+I.+Voskuilauthor=B.+Goldauthor=G.+K.+Schoolnikauthor=I.+Smith&title=ideR%2C+An+essential+gene+in+mycobacterium+tuberculosis%3A+role+of+IdeR+in+iron-dependent+gene+expression%2C+iron+metabolism%2C+and+oxidative+stress+response&doi=10.1128%2Fiai.70.7.3371-3381.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">ideR, an essential gene in Mycobacterium tuberculosis: role of IdeR in iron-dependent gene expression, iron metabolism, and oxidative stress response</span></div><div class="casAuthors">Rodriguez, G. Marcela; Voskuil, Martin I.; Gold, Benjamin; Schoolnik, Gary K.; Smith, Issar</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3371-3381</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The mycobacterial IdeR protein is a metal-dependent regulator of the DtxR (diphtheria toxin repressor) family.  In the presence of iron, it binds to a specific DNA sequence in the promoter regions of the genes that it regulates, thus controlling their transcription.  In this study, we provide evidence that ideR is an essential gene in Mycobacterium tuberculosis.  IdeR cannot normally be disrupted in this mycobacterium in the absence of a second functional copy of the gene.  However, a rare ideR mutant was obtained in which the lethal effects of ideR inactivation were alleviated by a second-site suppressor mutation and which exhibited restricted iron assimilation capacity.  Studies of this strain and a deriv. in which IdeR expression was restored allowed us to identify phenotypic effects resulting from ideR inactivation.  Using DNA microarrays, the iron-dependent transcriptional profiles of the wild-type, ideR mutant, and ideR-complemented mutant strains were analyzed, and the genes regulated by iron and IdeR were identified.  These genes encode a variety of proteins, including putative transporters, proteins involved in siderophore synthesis and iron storage, members of the PE/PPE family, a membrane protein involved in virulence, transcriptional regulators, and enzymes involved in lipid metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBAyvgQc0sFrVg90H21EOLACvtfcHk0lhSXbQtiW5tDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvV2ltbg%253D&md5=408f6bc94fad7c1a273f12db4f74aeb9</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1128%2FIAI.70.7.3371-3381.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.70.7.3371-3381.2002%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DG.%2BM.%26aulast%3DVoskuil%26aufirst%3DM.%2BI.%26aulast%3DGold%26aufirst%3DB.%26aulast%3DSchoolnik%26aufirst%3DG.%2BK.%26aulast%3DSmith%26aufirst%3DI.%26atitle%3DideR%252C%2520An%2520essential%2520gene%2520in%2520mycobacterium%2520tuberculosis%253A%2520role%2520of%2520IdeR%2520in%2520iron-dependent%2520gene%2520expression%252C%2520iron%2520metabolism%252C%2520and%2520oxidative%2520stress%2520response%26jtitle%3DInfect.%2520Immun.%26date%3D2002%26volume%3D70%26spage%3D3371%26epage%3D3381%26doi%3D10.1128%2Fiai.70.7.3371-3381.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurthkoti, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marakalala, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghanny, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subbian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakatos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortune, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, G. M.</span></span> <span> </span><span class="NLM_article-title">The capacity of Mycobacterium tuberculosis To survive iron starvation might enable it to persist in iron-deprived microenvironments of human granulomas</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e01092</span> <span class="refDoi"> DOI: 10.1128/mbio.01092-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1128%2FmBio.01092-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=28811344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVCmsbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=K.+Kurthkotiauthor=H.+Aminauthor=M.+J.+Marakalalaauthor=S.+Ghannyauthor=S.+Subbianauthor=A.+Sakatosauthor=J.+Livnyauthor=S.+M.+Fortuneauthor=M.+Berneyauthor=G.+M.+Rodriguez&title=The+capacity+of+Mycobacterium+tuberculosis+To+survive+iron+starvation+might+enable+it+to+persist+in+iron-deprived+microenvironments+of+human+granulomas&doi=10.1128%2Fmbio.01092-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The capacity of Mycobacterium tuberculosis to survive iron starvation might enable it to persist in iron-deprived microenvironments of human granulomas</span></div><div class="casAuthors">Kurthkoti, Krishna; Amin, Hamel; Marakalala, Mohlopheni J.; Ghanny, Saleena; Subbian, Selvakumar; Sakatos, Alexandra; Livny, Jonathan; Fortune, Sarah M.; Berney, Michael; Rodriguez, G. Marcela</div><div class="citationInfo"><span class="NLM_cas:title">mBio</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e01092/1-e01092/17</span>CODEN:
                <span class="NLM_cas:coden">MBIOCL</span>;
        ISSN:<span class="NLM_cas:issn">2150-7511</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">This study was conducted to investigate the role of iron deprivation in the persistence of Mycobacterium tuberculosis.  We present evidence of iron restriction in human necrotic granulomas and demonstrate that under iron starvation M. tuberculosispersists, refractive to antibiotics and capable of restarting replication when iron is made available.  Transcriptomics and metabolomic analyses indicated that the persistence of M.tuberculosis under iron starvation is dependent on strict control of endogenous Fe utilization and is assocd. with upregulation of pathogenicity and intrinsic antibiotic resistance determinants.  M. tuberculosis mutants compromised in their ability to survive Fe starvation were identified.  The findings of this study advance the understanding of the physiol. settings that may underpin the chronicity of human tuberculosis (TB) and are relevant to the design of effective antitubercular therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8_XOUur4HKrVg90H21EOLACvtfcHk0lhSXbQtiW5tDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVCmsbjF&md5=6fbf9593b85030a76068fbbfd35dc7c7</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1128%2FmBio.01092-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.01092-17%26sid%3Dliteratum%253Aachs%26aulast%3DKurthkoti%26aufirst%3DK.%26aulast%3DAmin%26aufirst%3DH.%26aulast%3DMarakalala%26aufirst%3DM.%2BJ.%26aulast%3DGhanny%26aufirst%3DS.%26aulast%3DSubbian%26aufirst%3DS.%26aulast%3DSakatos%26aufirst%3DA.%26aulast%3DLivny%26aufirst%3DJ.%26aulast%3DFortune%26aufirst%3DS.%2BM.%26aulast%3DBerney%26aufirst%3DM.%26aulast%3DRodriguez%26aufirst%3DG.%2BM.%26atitle%3DThe%2520capacity%2520of%2520Mycobacterium%2520tuberculosis%2520To%2520survive%2520iron%2520starvation%2520might%2520enable%2520it%2520to%2520persist%2520in%2520iron-deprived%2520microenvironments%2520of%2520human%2520granulomas%26jtitle%3DmBio%26date%3D2017%26volume%3D8%26doi%3D10.1128%2Fmbio.01092-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brecik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svetlíková, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaško, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackburn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikušová, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizrahi, V.</span></span> <span> </span><span class="NLM_article-title">The complex mechanism of antimycobacterial action of 5-fluorouracil</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2014.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1016%2Fj.chembiol.2014.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=25544046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvFWksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=63-75&author=V.+Singhauthor=M.+Brecikauthor=R.+Mukherjeeauthor=J.+C.+Evansauthor=Z.+Svetl%C3%ADkov%C3%A1author=J.+Bla%C5%A1koauthor=S.+Suradeauthor=J.+Blackburnauthor=D.+F.+Warnerauthor=K.+Miku%C5%A1ov%C3%A1author=V.+Mizrahi&title=The+complex+mechanism+of+antimycobacterial+action+of+5-fluorouracil&doi=10.1016%2Fj.chembiol.2014.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The Complex Mechanism of Antimycobacterial Action of 5-Fluorouracil</span></div><div class="casAuthors">Singh, Vinayak; Brecik, Miroslav; Mukherjee, Raju; Evans, Joanna C.; Svetlikova, Zuzana; Blasko, Jaroslav; Surade, Sachin; Blackburn, Jonathan; Warner, Digby F.; Mikusova, Katarina; Mizrahi, Valerie</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-75</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A combination of chem. genetic and biochem. assays was applied to investigate the mechanism of action of the anticancer drug 5-fluorouracil (5-FU), against Mycobacterium tuberculosis (Mtb). 5-FU resistance was assocd. with mutations in upp or pyrR.  Upp-catalyzed conversion of 5-FU to FUMP was shown to constitute the first step in the mechanism of action, and resistance conferred by nonsynonymous SNPs in pyrR shown to be due to derepression of the pyr operon and rescue from the toxic effects of FUMP and downstream antimetabolites through de novo prodn. of UMP.  5-FU-derived metabolites identified in Mtb were consistent with the obsd. incorporation of 5-FU into RNA and DNA and the reduced amt. of mycolyl arabinogalactan peptidoglycan in 5-FU-treated cells.  Conditional depletion of the essential thymidylate synthase ThyX resulted in modest hypersensitivity to 5-FU, implicating inhibition of ThyX by fluorodeoxyuridylate as a further component of the mechanism of antimycobacterial action of this drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonZa6FzoC5DbVg90H21EOLACvtfcHk0lgHPqzrzdshpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvFWksA%253D%253D&md5=854a8fb9a8755b071b2ff0e5188146f7</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2014.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2014.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DV.%26aulast%3DBrecik%26aufirst%3DM.%26aulast%3DMukherjee%26aufirst%3DR.%26aulast%3DEvans%26aufirst%3DJ.%2BC.%26aulast%3DSvetl%25C3%25ADkov%25C3%25A1%26aufirst%3DZ.%26aulast%3DBla%25C5%25A1ko%26aufirst%3DJ.%26aulast%3DSurade%26aufirst%3DS.%26aulast%3DBlackburn%26aufirst%3DJ.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26aulast%3DMiku%25C5%25A1ov%25C3%25A1%26aufirst%3DK.%26aulast%3DMizrahi%26aufirst%3DV.%26atitle%3DThe%2520complex%2520mechanism%2520of%2520antimycobacterial%2520action%2520of%25205-fluorouracil%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D63%26epage%3D75%26doi%3D10.1016%2Fj.chembiol.2014.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacitto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartkoorn, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ascher, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondésert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vocat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupien, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sommer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagrange, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buechler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pato, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizrahi, V.</span></span> <span> </span><span class="NLM_article-title">The inosine monophosphate dehydrogenase, GuaB2, is a vulnerable new bactericidal drug target for tuberculosis</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.6b00102</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.6b00102" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVeht7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=5-17&author=V.+Singhauthor=S.+Doniniauthor=A.+Pacittoauthor=C.+Salaauthor=R.+C.+Hartkoornauthor=N.+Dharauthor=G.+Keriauthor=D.+B.+Ascherauthor=G.+Mond%C3%A9sertauthor=A.+Vocatauthor=A.+Lupienauthor=R.+Sommerauthor=H.+Vermetauthor=S.+Lagrangeauthor=J.+Buechlerauthor=D.+F.+Warnerauthor=J.+D.+McKinneyauthor=J.+Patoauthor=S.+T.+Coleauthor=T.+L.+Blundellauthor=M.+Rizziauthor=V.+Mizrahi&title=The+inosine+monophosphate+dehydrogenase%2C+GuaB2%2C+is+a+vulnerable+new+bactericidal+drug+target+for+tuberculosis&doi=10.1021%2Facsinfecdis.6b00102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis</span></div><div class="casAuthors">Singh, Vinayak; Donini, Stefano; Pacitto, Angela; Sala, Claudia; Hartkoorn, Ruben C.; Dhar, Neeraj; Keri, Gyorgy; Ascher, David B.; Mondesert, Guillaume; Vocat, Anthony; Lupien, Andreanne; Sommer, Raphael; Vermet, Helene; Lagrange, Sophie; Buechler, Joe; Warner, Digby F.; McKinney, John D.; Pato, Janos; Cole, Stewart T.; Blundell, Tom L.; Rizzi, Menico; Mizrahi, Valerie</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-17</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">VCC234718, a mol. with growth inhibitory activity against Mycobacterium tuberculosis (Mtb), was identified by phenotypic screening of a 15,344-compd. library.  Sequencing of a VCC234718-resistant mutant identified a Y487C substitution in the inosine monophosphate dehydrogenase, GuaB2, which was subsequently validated to be the primary mol. target of VCC234718 in Mtb.  VCC234718 inhibits Mtb GuaB2 with a Ki 100 nM and is uncompetitive with respect to IMP and NAD+.  This compd. binds at the NAD+ site, after IMP has bound, and makes direct interactions with IMP; therefore, the inhibitor is by definition uncompetitive.  VCC234718 forms strong pi interactions with the Y487 residue side chain from the adjacent protomer in the tetramer, explaining the resistance-conferring mutation.  In addn. to sensitizing Mtb to VCC2344718, depletion of GuaB2 was bactericidal in Mtb in vitro and in macrophages.  When supplied at a high concn. (≥125 μM), guanine alleviated the toxicity of VCC234718 treatment or GuaB2 depletion via purine salvage.  However, transcriptional silencing of guaB2 prevented Mtb from establishing an infection in mice, confirming that Mtb has limited access to guanine in this animal model.  Together, these data provide compelling validation of GuaB2 as a new TB drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokN3rgePLpSLVg90H21EOLACvtfcHk0lgHPqzrzdshpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVeht7bM&md5=84f5cc19bdbfe4f1bdd6497e66f7bf3d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.6b00102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.6b00102%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DV.%26aulast%3DDonini%26aufirst%3DS.%26aulast%3DPacitto%26aufirst%3DA.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DDhar%26aufirst%3DN.%26aulast%3DKeri%26aufirst%3DG.%26aulast%3DAscher%26aufirst%3DD.%2BB.%26aulast%3DMond%25C3%25A9sert%26aufirst%3DG.%26aulast%3DVocat%26aufirst%3DA.%26aulast%3DLupien%26aufirst%3DA.%26aulast%3DSommer%26aufirst%3DR.%26aulast%3DVermet%26aufirst%3DH.%26aulast%3DLagrange%26aufirst%3DS.%26aulast%3DBuechler%26aufirst%3DJ.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26aulast%3DMcKinney%26aufirst%3DJ.%2BD.%26aulast%3DPato%26aufirst%3DJ.%26aulast%3DCole%26aufirst%3DS.%2BT.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DRizzi%26aufirst%3DM.%26aulast%3DMizrahi%26aufirst%3DV.%26atitle%3DThe%2520inosine%2520monophosphate%2520dehydrogenase%252C%2520GuaB2%252C%2520is%2520a%2520vulnerable%2520new%2520bactericidal%2520drug%2520target%2520for%2520tuberculosis%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2017%26volume%3D3%26spage%3D5%26epage%3D17%26doi%3D10.1021%2Facsinfecdis.6b00102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ollinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraski, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alling, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, T.</span></span> <span> </span><span class="NLM_article-title">A dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e60531</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0060531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1371%2Fjournal.pone.0060531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=23593234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Gls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=J.+Ollingerauthor=M.+A.+Baileyauthor=G.+C.+Moraskiauthor=A.+Caseyauthor=S.+Florioauthor=T.+Allingauthor=M.+J.+Millerauthor=T.+Parish&title=A+dual+read-out+assay+to+evaluate+the+potency+of+compounds+active+against+Mycobacterium+tuberculosis&doi=10.1371%2Fjournal.pone.0060531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosis</span></div><div class="casAuthors">Ollinger, Juliane; Bailey, Mai Ann; Moraski, Garrett C.; Casey, Allen; Florio, Stephanie; Alling, Torey; Miller, Marvin J.; Parish, Tanya</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e60531</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Tuberculosis is a serious global health problem caused by the bacterium Mycobacterium tuberculosis.  There is an urgent need for discovery and development of new treatments, but this can only be accomplished through rapid and reproducible M. tuberculosis assays designed to identify potent inhibitors.  We developed an automated 96-well assay utilizing a recombinant strain of M. tuberculosis expressing a far-red fluorescent reporter to det. the activity of novel compds.; this allowed us to measure growth by monitoring both optical d. and fluorescence.  We detd. that optical d. and fluorescence were correlated with cell no. during logarithmic phase growth.  Fluorescence was stably maintained without antibiotic selection over 5 days, during which time cells remained actively growing.  We optimized parameters for the assay, with the final format being 5 days' growth in 96-well plates in the presence of 2% w/v DMSO.  We confirmed reproducibility using rifampicin and other antibiotics.  The dual detection method allows for a reproducible calcn. of the min. inhibitory concn. (MIC), at the same time detecting artifacts such as fluorescence quenching or compd. pptn.  We used our assay to confirm anti-tubercular activity and establish the structure activity relationship (SAR) around the imidazo[1,2-a]pyridine-3-carboxamides, a promising series of M. tuberculosis inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzifhn6ZGfK7Vg90H21EOLACvtfcHk0lgHPqzrzdshpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Gls74%253D&md5=f8e7dcf8aa8dfe4b71c7a8885ad44bf1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0060531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0060531%26sid%3Dliteratum%253Aachs%26aulast%3DOllinger%26aufirst%3DJ.%26aulast%3DBailey%26aufirst%3DM.%2BA.%26aulast%3DMoraski%26aufirst%3DG.%2BC.%26aulast%3DCasey%26aufirst%3DA.%26aulast%3DFlorio%26aufirst%3DS.%26aulast%3DAlling%26aufirst%3DT.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26aulast%3DParish%26aufirst%3DT.%26atitle%3DA%2520dual%2520read-out%2520assay%2520to%2520evaluate%2520the%2520potency%2520of%2520compounds%2520active%2520against%2520Mycobacterium%2520tuberculosis%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0060531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copp, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeil, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span> <span> </span><span class="NLM_article-title">The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism novel insights into drug mechanisms of action</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">40174</span>– <span class="NLM_lpage">40184</span>, <span class="refDoi"> DOI: 10.1074/jbc.m406796200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=10.1074%2Fjbc.M406796200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=15247240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVKrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=40174-40184&author=H.+I.+M.+Boshoffauthor=T.+G.+Myersauthor=B.+R.+Coppauthor=M.+R.+McNeilauthor=M.+A.+Wilsonauthor=C.+E.+Barry&title=The+transcriptional+responses+of+Mycobacterium+tuberculosis+to+inhibitors+of+metabolism+novel+insights+into+drug+mechanisms+of+action&doi=10.1074%2Fjbc.m406796200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The Transcriptional Responses of Mycobacterium tuberculosis to Inhibitors of Metabolism: Novel insights into drug mechanisms of action</span></div><div class="casAuthors">Boshoff, Helena I. M.; Myers, Timothy G.; Copp, Brent R.; McNeil, Michael R.; Wilson, Michael A.; Barry, Clifton E., III</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">40174-40184</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The differential transcriptional response of Mycobacterium tuberculosis to drugs and growth-inhibitory conditions was monitored to generate a data set of 430 microarray profiles.  Unbiased grouping of these profiles independently clustered agents of known mechanism of action accurately and was successful at predicting the mechanism of action of several unknown agents.  These predictions were validated biochem. for two agents of previously uncategorized mechanism, pyridoacridones and phenothiazines.  Anal. of this data set further revealed 150 underlying clusters of coordinately regulated genes offering the first glimpse at the full metabolic potential of this organism.  A signature subset of these gene clusters was sufficient to classify all known agents as to mechanism of action.  Transcriptional profiling of both crude and purified natural products can provide crit. information on both mechanism and detoxification prior to purifn. that can be used to guide the drug discovery process.  Thus, the transcriptional profile generated by a crude marine natural product recapitulated the mechanistic prediction from the pure active component.  The underlying gene clusters further provide fundamental insights into the metabolic response of bacteria to drug-induced stress and provide a rational basis for the selection of crit. metabolic targets for screening for new agents with improved activity against this important human pathogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5g6sYE8fWOLVg90H21EOLACvtfcHk0lj3wdXPfgwCTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVKrsLs%253D&md5=677489fe3a9981eba62d990ec037f71a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M406796200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M406796200%26sid%3Dliteratum%253Aachs%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DCopp%26aufirst%3DB.%2BR.%26aulast%3DMcNeil%26aufirst%3DM.%2BR.%26aulast%3DWilson%26aufirst%3DM.%2BA.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26atitle%3DThe%2520transcriptional%2520responses%2520of%2520Mycobacterium%2520tuberculosis%2520to%2520inhibitors%2520of%2520metabolism%2520novel%2520insights%2520into%2520drug%2520mechanisms%2520of%2520action%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D40174%26epage%3D40184%26doi%3D10.1074%2Fjbc.m406796200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i95"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01727">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_53151"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01727?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01727</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthesis and analytical data of intermediates, microbiology assays, MIC data against clinical isolates, screening data against MmpL3 under-expressing strain of <i>Mtb</i>, <i>in vitro</i> DMPK assays, and mouse pharmacokinetic studies (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_001.pdf">PDF</a>)</p></li><li><p class="inline">LCMS HPLC and NMRs of lead compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Data from RNA microarray experiment (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_003.xlsx">XLSX</a>)</p></li><li><p class="inline">Data from RNA microarray experiment (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_004.xlsx">XLSX</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_005.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_001.pdf">jm0c01727_si_001.pdf (440.97 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_002.pdf">jm0c01727_si_002.pdf (1.22 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_003.xlsx">jm0c01727_si_003.xlsx (385.88 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_004.xlsx">jm0c01727_si_004.xlsx (12.7 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01727/suppl_file/jm0c01727_si_005.csv">jm0c01727_si_005.csv (3.58 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01727&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01727%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-1%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01727" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799dbf218b73c28","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
